ÌåäÓíèâåð - MedUniver.com Âñå ðàçäåëû ñàéòà Âèäåî ïî ìåäèöèíå Êíèãè ïî ìåäèöèíå Ôîðóì êîíñóëüòàöèé âðà÷åé  
Ðåêîìåíäóåì:
Ïåäèàòðèÿ:
Ïåäèàòðèÿ
Ãåíåòèêà â ïåäèàòðèè
Äåòñêàÿ àëëåðãîëîãèÿ è èììóíîëîãèÿ
Äåòñêàÿ ãàñòðîýíòåðîëîãèÿ
Äåòñêàÿ è ïîäðîñòêîâàÿ ñòîìàòîëîãèÿ
Äåòñêàÿ ïóëüìîíîëîãèÿ
Äåòñêàÿ ðåâìàòîëîãèÿ
Äåòñêàÿ ôàðìàêîëîãèÿ
Èíôåêöèîííûå áîëåçíè ó äåòåé
Íåîíàòîëîãèÿ
Íåîòëîæíûå ñîñòîÿíèÿ äåòåé
Ïîäðîñòêîâàÿ ìåäèöèíà
Ðîñò è ðàçâèòèå ðåáåíêà
Îðãàíèçàöèÿ ïåäèàòðè÷åñêîé ïîìîùè
Ôîðóì
 

Àâòîðû òðóäîâ (ñòàòåé) èñïîëüçîâàííûå ïðè ïîäãîòîâêå ìàòåðèàëîâ ïî ïåäèàòðèè

 ñòàòüÿõ íà ñàéòå èñïîëüçîâàíû ñëåäóþùèå ñîêðàùåíèÿ:

  • °F — òåìïåðàòóðà ïî Ôàðåíãåéòó
  • °C — òåìïåðàòóðà ïî Öåëüñèþ
  • 5-ÍÒ — 5-ãèäðîêñèèíäîëóêñóñíàÿ êèñëîòà ìî÷è
  • ÀÁ — àíòèáèîòèê(è)
  • ÀÁËÀ — àëëåðãè÷åñêèé áðîíõîëåãî÷íûé àñïåðãèëëåç
  • ÀÁÒ — àíòèáàêòåðèàëüíàÿ òåðàïèÿ
  • ÀÂ — àòðèîâåíòðèêóëÿðíûé
  • ÀÃ — àðòåðèàëüíàÿ ãèïåðòåíçèÿ
  • ÀÃí — àíòèãåí
  • ÀÄ — àðòåðèàëüíîå äàâëåíèå
  • ÀÄà — àíòèäèóðåòè÷åñêèé ãîðìîí
  • ÀÄÑ — àíàòîêñèí äèôòåðèéíî-ñòîëáíÿ÷íûé
  • ÀÄÑ-Ì — àíàòîêñèí äèôòåðèéíî-ñòîëáíÿ÷íûé (ìàëûå äîçû)
  • ÀÄÔ — àäåíîçèíäèôîñôîðíàÿ êèñëîòà, àäåíîçèíäèôîñôàò
  • ÀÊÄÑ — àíàòîêñèí êîêëþøíî-äèôòåðèéíî-ñòîëáíÿ÷íûé
  • ÀÊÒÃ — àäðåíîêîðòèêîòðîïíûé ãîðìîí
  • ÀÊØ — àîðòîêîðîíàðíîå øóíòèðîâàíèå
  • ÀËÒ — àëàíèíàìèíîòðàíñôåðàçà
  • àìåð. — àìåðèêàíñêèé
  • ÀÌÊ — àçîò ìî÷åâèíû êðîâè
  • ÀÌÔ — àäåíîçèíìîíîôîñôîðíàÿ êèñëîòà, àäåíîçèíìîíîôîñôàò
  • ÀÍÀ — àíòèíóêëåàðíûå àíòèòåëà
  • àíàò. — àíàòîìè÷åñêèé
  • àíãë. — àíãëèéñêèé
  • ÀÏÔ — àíãèîòåíçèí-ïðåâðàùàþùèé ôåðìåíò
  • ÀÐÂÒ — àíòèðåòðîâèðóñíàÿ òåðàïèÿ
  • ÀÐÏ — àêòèâíîñòü ðåíèíà â ïëàçìå êðîâè
  • ACT — àñïàðòàòàìèíîòðàíñôåðàçà
  • ÀÒë — àíòèòåëî
  • ÀÒÔ — àäåíîçèíòðèôîñôîðíàÿ êèñëîòà, àäåíîçèíòðèôîñôàò
  • ÀóÄ — àóòîñîìíî-äîìèíàíòíûé
  • ÀóÐ — àóòîñîìíî-ðåöåññèâíûé
  • ÀÔÏ — α-ôåòîïðîòåèí
  • ÀÔÑ — àíòèôîñôîëèïèäíûé ñèíäðîì
  • ÀÕÝ — àöåòèëõîëèíýñòåðàçà
  • ÀÖÕ — àöåòèëõîëèí
  • À×Ò — àêòèâèðîâàííîå ÷àñòè÷íîå òðîìáîïëàñòèíîâîå âðåìÿ
  • ÁÀ — áðîíõèàëüíàÿ àñòìà
  • ÁÀÄ — áèîëîãè÷åñêè àêòèâíàÿ äîáàâêà
  • ÁÀË — áðîíõîàëüâåîëÿðíûé ëàâàæ
  • ÁÀÐ — áèïîëÿðíîå àôôåêòèâíîå ðàññòðîéñòâî (I èëè II òèïà)
  • ÁÊÊ — áîëüøîé êðóã êðîâîîáðàùåíèÿ
  • ÁËÍÏà — áëîêàäà ëåâîé íîæêè ïó÷êà Ãèñà
  • ÁÌÑÝ — áþðî ìåäèêî-ñîöèàëüíîé ýêñïåðòèçû
  • ÁÏ — áðþøíàÿ ïîëîñòü
  • ÁÏÍÏà — áëîêàäà ïðàâîé íîæêè ïó÷êà Ãèñà
  • ÁÐÌ — áàçîâûå ðåàíèìàöèîííûå ìåðîïðèÿòèÿ
  • ÁÐÍÑ — áûñòðî ðàçðåøèâøååñÿ íåîáúÿñíèìîå ñîáûòèå
  • ÁÖÆ — áàöèëëà Êàëüìåòòà-Ãåðåíà â ò.÷. — â òîì ÷èñëå
  • â. — âåê
  • â/ — âíóòðè... â ñëîæíîñîñòàâíûõ ñëîâàõ (íàïð. â/ñîñóäèñòûé, â/÷åðåïíîé è ò.ï.)
  • â/à — âíóòðèàðòåðèàëüíî
  • â/â — âíóòðèâåííî
  • â/ê — âíóòðèêîæíî
  • â/ì — âíóòðèìûøå÷íî
  • ââ. — âåêà
  • â-âî — âåùåñòâî
  • ÂÂÝ — âîåííî-âðà÷åáíàÿ ýêñïåðòèçà
  • ÂÃÄ — âíóòðèãëàçíîå äàâëåíèå
  • ÂÃ× — âèðóñ ãåðïåñà ÷åëîâåêà
  • ÂÄÏ — âåðõíèå äûõàòåëüíûå ïóòè
  • ÂÆÊ — âíóòðèæåëóäî÷êîâîå êðîâîèçëèÿíèå
  • ÂÇÊ — âîñïàëèòåëüíûå çàáîëåâàíèÿ êèøå÷íèêà
  • ÂÇÎÌÒ—âîñïàëèòåëüíûå çàáîëåâàíèÿ îðãàíîâ ìàëîãî òàçà
  • ÂÈÏ — âàçîàêòèâíûé èíòåñòèíàëüíûé ïåïòèä
  • ÂÈ× — âèðóñ èììóíîäåôèöèòà ÷åëîâåêà
  • ÂÌÏ — âûñîêîòåõíîëîãè÷íàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÂÌÑ — âíóòðèìàòî÷íîå ñðåäñòâî (ñïèðàëü)
  • ÂÍ — âèðóñíàÿ íàãðóçêà
  • ÂÍÑ — âåãåòàòèâíàÿ íåðâíàÿ ñèñòåìà
  • ÂΠ— Âåëèêàÿ Îòå÷åñòâåííàÿ âîéíà
  • ÂÎÃÌ — âûñîêîãîðíûé îòåê ãîëîâíîãî ìîçãà
  • ÂÎÇ — Âñåìèðíàÿ îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ
  • ÂÎË — âûñîêîãîðíûé îòåê ëåãêèõ
  • ÂÎÌÊ — âðà÷, îñóùåñòâëÿþùèé ìåäèöèíñêèé êîíòðîëü
  • ÂÎÏ — âðà÷ îáùåé ïðàêòèêè
  • ÂÏÂ — âåðõíÿÿ ïîëàÿ âåíà
  • ÂÏÃ — âèðóñ ïðîñòîãî ãåðïåñà
  • ÂÏÐ — âðîæäåííûå ïîðîêè ðàçâèòèÿ
  • ÂÏÑ — âðîæäåííûé ïîðîê ñåðäöà
  • ÂÏ× — âèðóñ ïàïèëëîìû ÷åëîâåêà
  • ÂÐÒ — âñïîìîãàòåëüíûå ðåïðîäóêòèâíûå òåõíîëîãèè
  • ÂÑÎ — âîäíî-ñîëåâîé îáìåí
  • Â×Ä — âíóòðè÷åðåïíîå äàâëåíèå
  • Â×ÈÂË — âûñîêî÷àñòîòíàÿ èñêóññòâåííàÿ âåíòèëÿöèÿ ëåãêèõ (HFV)
  • ÂÝÁ — âèðóñ Ýïøòåéíà-Áàðð
  • ã — ãðàìì
  • ã. — ãîä
  • Ã-6-ÔÄ — ãëþêîçî-6-ôîñôàòäåãèäðîãåíàçà
  • ÃÀÌÊ — ãàììà-àìèíîìàñëÿíàÿ êèñëîòà
  • ÃÁ — ãèïåðòîíè÷åñêàÿ áîëåçíü
  • ÃÁÍ — ãåìîëèòè÷åñêàÿ áîëåçíü íîâîðîæäåííîãî
  • ÃÁÎ — ãèïåðáàðè÷åñêàÿ îêñèãåíàöèÿ
  • ÃÇÒ — ãèïåð÷óâñòâèòåëüíîñòü çàìåäëåííîãî òèïà
  • ãèñò. — ãèñòîëîãè÷åñêèé
  • ÃÊ — ãðóäíàÿ êëåòêà
  • ÃÊÌÏ — ãèïåðòðîôè÷åñêàÿ êàðäèîìèîïàòèÿ
  • ÃÊÑ — ãëþêîêîðòèêîñòåðîèä(û)
  • ÃËÃ — ãåìîôàãîöèòàðíûé ëèìôîãèñòèîöèòîç
  • ÃËÏÑ — ãåìîððàãè÷åñêàÿ ëèõîðàäêà ñ ïî÷å÷íûì ñèíäðîìîì
  • ÃÌ — ãîëîâíîé ìîçã
  • ÃÌ-ÊÑÔ — ãðàíóëîöèòàðíî-ìàêðîôàãàëüíûé êîëîíèåñòèìóëèðóþùèé ôàêòîð
  • ÃÌÔ — ãóàíîçèíìîíîôîñôàò
  • ÃíÐà — ãîíàäîòðîïèí-ðèëèçèíã-ãîðìîí
  • ÃÍÒ — ãèïåð÷óâñòâèòåëüíîñòü íåìåäëåííîãî òèïà
  • ÃÏÎÄ — ãðûæà ïèùåâîäíîãî îòâåðñòèÿ äèàôðàãìû
  • ÃÐÄÑ — ãèïîêñè÷åñêàÿ ðåàêöèÿ äûõàòåëüíîé ñèñòåìû ãðå÷. — ãðå÷åñêèé
  • ÃÒÔ — ãóàíîçèíòðèôîñôàò
  • ÃÓÑ — ãåìîëèòèêî-óðåìè÷åñêèé ñèíäðîì
  • Ãö — ãåðö
  • ÃÝÁ — ãåìàòîýíöåôàëè÷åñêèé áàðüåð
  • ÃÝÐ — ãàñòðîýçîôàãåàëüíûé ðåôëþêñ
  • ÃÝÐÁ — ãàñòðîýçîôàãåàëüíàÿ ðåôëþêñíàÿ áîëåçíü
  • äÁ — äåöèáåë
  • ÄÂÑ — äèññåìèíèðîâàííîå âíóòðèñîñóäèñòîå ñâåðòûâàíèå
  • ÄÃÒ — äèãèäðîòåñòîñòåðîí
  • ÄÄ — äèôôåðåíöèàëüíàÿ äèàãíîñòèêà, äèôôåðåíöèàëüíî-äèàãíîñòè÷åñêèé
  • ÄÄÁÀ — äëèòåëüíîäåéñòâóþùèå β2-àãîíèñòû
  • ÄÄÊ — äèôôåðåíöèàëüíî-äèàãíîñòè÷åñêèé êðèòåðèé (êðèòåðèè)
  • ÄÄÐÌ - äîïóñòèìûé äèàïàçîí ðàñïðåäåëåíèÿ ìàêðîíóòðèåíòîâ
  • ÄÈ — äîâåðèòåëüíûé èíòåðâàë
  • ÄÊ — äèàãíîñòè÷åñêèé êðèòåðèé
  • ÄÊÀ — äèàáåòè÷åñêèé êåòîàöèäîç
  • ÄÊÌÏ — äèëàòàöèîííàÿ êàðäèîìèîïàòèÿ
  • ÄÌÆÏ — äåôåêò ìåææåëóäî÷êîâîé ïåðåãîðîäêè
  • ÄÌÏÏ — äåôåêò ìåæïðåäñåðäíîé ïåðåãîðîäêè
  • ÄÌÑ — äîáðîâîëüíîå ìåäèöèíñêîå ñòðàõîâàíèå
  • ÄÍ — äûõàòåëüíàÿ íåäîñòàòî÷íîñòü
  • ÄÍÊ — äåçîêñèðèáîíóêëåèíîâàÿ êèñëîòà
  • ÄÍÒ — äåôåêòû íåðâíîé òðóáêè
  • ÄÎ - äûõàòåëüíûé îáúåì
  • ÄÎÔÀ — äèãèäðîêñèôåíèëàëàíèí
  • ÄÏ — äûõàòåëüíûå ïóòè
  • ÄÏÊ — äâåíàäöàòèïåðñòíàÿ êèøêà
  • ÄÏÌ — äàòà ïîñëåäíåé ìåíñòðóàöèè
  • ÄÏÏ - äîïóñòèìûé ïðåäåë ïîòðåáëåíèÿ
  • äð. — äðóãèå
  • ÄÒÏ — äîðîæíî-òðàíñïîðòíîå ïðîèñøåñòâèå
  • ÄÖÏ — äåòñêèé öåðåáðàëüíûé ïàðàëè÷
  • ÅÄ — åäèíèöà äåéñòâèÿ, åäèíèöà
  • ÆÂÏ — æåë÷åâûâîäÿùèå ïóòè
  • ÆÄÀ — æåëåçîäåôèöèòíàÿ àíåìèÿ
  • ÆÅË — æèçíåííàÿ åìêîñòü ëåãêèõ
  • ÆÊÁ — æåë÷åêàìåííàÿ áîëåçíü
  • ÆÊÊ — æåëóäî÷íî-êèøå÷íîå êðîâîòå÷åíèå
  • ÆÊÒ — æåëóäî÷íî-êèøå÷íûé òðàêò
  • ÆÍÂËÏ — æèçíåííî íåîáõîäèìûå è âàæíûå ëåêàðñòâåííûå ïðåïàðàòû (ñïèñîê, ïåðå÷åíü)
  • ÇÂÓÐ — çàäåðæêà âíóòðèóòðîáíîãî ðàçâèòèÿ
  • ÇË — çäîðîâûå ëþäè (ëèöà)
  • ÇÍÎ — çëîêà÷åñòâåííîå íîâîîáðàçîâàíèå
  • ÇÎ — çäðàâîîõðàíåíèå
  • ÇÎÆ — çäîðîâûé îáðàç æèçíè
  • ÇÑÍ — çàñòîéíàÿ ñåðäå÷íàÿ íåäîñòàòî÷íîñòü
  • èÀÏÔ — èíãèáèòîðû àíãèîòåíçèí-ïðåâðàùàþùåãî ôåðìåíòà
  • ÈÁÑ — èøåìè÷åñêàÿ áîëåçíü ñåðäöà
  • ÈÂË — èñêóññòâåííàÿ âåíòèëÿöèÿ ëåãêèõ
  • ÈÃÊÑ — èíãàëÿöèîííûå ãëþêîêîðòèêîñòåðîèäû
  • ÈÇË — èíòåðñòèöèàëüíûå çàáîëåâàíèÿ ëåãêèõ
  • ÈÊÏ — èììóíîêîìïðîìåòèðîâàííûå ïàöèåíòû
  • ÈË — èíòåðëåéêèí
  • ÈËÄÁ — èíòåãðèðîâàííîå ëå÷åíèå äåòñêèõ áîëåçíåé
  • ÈÌ — èíôàðêò ìèîêàðäà
  • ÈÌÀÎ — èíãèáèòîð(û) ìîíîàìèíîêñèäàçû
  • ÈÌáïÁÒ — èíôàðêò ìèîêàðäà áåç ïîäúåìà ñåãìåíòà ST
  • ÈÌÏ — èíôåêöèÿ ìî÷åâûõ (ìî÷åâûâîäÿùèõ) ïóòåé
  • ÈÌïÇÒ — èíôàðêò ìèîêàðäà ñ ïîäúåìîì ñåãìåíòà
  • ST ÈÌÒ — èíäåêñ ìàññû òåëà
  • ÈÎË — èíòðàîêóëÿðíàÿ ëèíçà
  • ÈÏÏ — èíãèáèòîðû ïðîòîííîé ïîìïû (ïðîòîííîãî íàñîñà)
  • ÈÏÏÏ — èíôåêöèè, ïåðåäàâàåìûå ïîëîâûì ïóòåì
  • ÈÑÑ — èíäèâèäóàëüíûå ñïàñàòåëüíûå ñðåäñòâà èñòîð. — èñòîðè÷åñêîå èòàë. — èòàëüÿíñêèé
  • ÈÒÏ — èäèîïàòè÷åñêàÿ òðîìáîöèòîïåíè÷åñêàÿ ïóðïóðà
  • ÈÒØ — èíôåêöèîííî-òîêñè÷åñêèé øîê ÈÔÀ — èììóíîôåðìåíòíûé àíàëèç
  • ÊÀ — êîðîíàðíàÿ(ûå) àðòåðèÿ(è)
  • ê — êèëîâîëüò
  • êã — êèëîãðàìì
  • ÊÄÁÀ — êîðîòêîäåéñòâóþùèå β2-àãîíèñòû
  • ÊÄÄ — êîíå÷íî-äèàñòîëè÷åñêîå äàâëåíèå
  • ÊÄÎ — êîíå÷íî-äèàñòîëè÷åñêèé îáúåì
  • ÊÄÐ — êîíå÷íî-äèàñòîëè÷åñêèé ðàçìåð
  • êèò. — êèòàéñêèé
  • êêàë — êèëîêàëîðèÿ
  • êë. — êëåòêè, êëåòîê
  • ÊÌÏ — êà÷åñòâî ìåäèöèíñêîé ïîìîùè
  • ÊîÀ — êîýíçèì À, êîôåðìåíò À
  • ÊÎÅ — êîëîíèåîáðàçóþùàÿ åäèíèöà
  • ÊÎÊ — êîìáèíèðîâàííûå îðàëüíûå êîíòðàöåïòèâû
  • ÊÏÒ — êîãíèòèâíî-ïîâåäåí÷åñêàÿ òåðàïèÿ
  • ÊÐ — êëèíè÷åñêèå ðåêîìåíäàöèè
  • ÊÑÄ — êîíå÷íî-ñèñòîëè÷åñêîå äàâëåíèå
  • ÊÑÎ — êîíå÷íî-ñèñòîëè÷åñêèé îáúåì
  • ÊÑÐ — êîíå÷íî-ñèñòîëè÷åñêèé ðàçìåð
  • ÊÒ — êîìïüþòåðíàÿ òîìîãðàôèÿ
  • ÊÒÂÐ — êîìïüþòåðíàÿ òîìîãðàôèÿ âûñîêîãî ðàçðåøåíèÿ
  • ÊÒÃ — êàðäèîòîêîãðàôèÿ
  • ÊÔÊ — êðåàòèíôîñôîêèíàçà
  • ÊÙÑ — êèñëîòíî-ùåëî÷íîå ñîñòîÿíèå
  • ë — ëèòð
  • ë/î — ëîæíîîòðèöàòåëüíûé
  • ë/ï — ëîæíîïîëîæèòåëüíûé
  • ËÀ — ëåãî÷íàÿ àðòåðèÿ
  • ëàò. — ëàòèíñêèé
  • ËÃ — ëþòåèíèçèðóþùèé ãîðìîí
  • ËÄÃ — ëàêòàòäåãèäðîãåíàçà
  • ËÆ — ëåâûé æåëóäî÷åê
  • ËÎÐ — èìåþùèé îòíîøåíèå ê îòîðèíîëàðèíãîëîãèè (ËÎÐ-âðà÷, ËÎÐ-îðãàíû)
  • ËÏ — ëåêàðñòâåííûé ïðåïàðàò
  • ËÏÂÏ — ëèïîïðîòåèíû âûñîêîé ïëîòíîñòè
  • ËÏÍÏ — ëèïîïðîòåèíû íèçêîé ïëîòíîñòè
  • ËÏÎÍÏ — ëèïîïðîòåèíû î÷åíü íèçêîé ïëîòíîñòè
  • ËÏÓ — ëå÷åáíî-ïðîôèëàêòè÷åñêîå ó÷ðåæäåíèå
  • ËÑ — ëåêàðñòâåííîå ñðåäñòâî
  • ËÓ — ëèìôàòè÷åñêèé óçåë, ëèìôîóçëû
  • ËÔÊ — ëå÷åáíàÿ ôèçêóëüòóðà
  • ì.á. — ìîæåò (ìîã, ìîãóò, ìîãëè) áûòü
  • Ì/Æ — ñîîòíîøåíèå ìóæ÷èí è æåíùèí
  • ìàêñÄ — ìàêñèìàëüíàÿ äîçà
  • ìàêñÍÄ — ìàêñèìàëüíàÿ íà÷àëüíàÿ äîçà
  • ìàêñÐÄ — ìàêñèìàëüíàÿ ðàçîâàÿ äîçà
  • ìàêñÑÄ — ìàêñèìàëüíàÿ ñóòî÷íàÿ äîçà
  • ÌÀÍÊ — ìåòîä àìïëèôèêàöèè íóêëåèíîâûõ êèñëîò
  • ÌÀÎ — ìîíîàìèíîêñèäàçà
  • ÌÂÏ — ìî÷åâûâîäÿùèå ïóòè ìã — ìèëëèãðàìì
  • ÌÄÁ — ìûøå÷íàÿ äèñòðîôèÿ Áåêêåðà
  • ÌÄÄ — ìûøå÷íàÿ äèñòðîôèÿ Äþøåííà
  • ÌÄÌÀ — ìåòèëåíäèîêñèìåòàìôåòàìèí
  • ME — ìåæäóíàðîäíàÿ åäèíèöà
  • ìåä. — ìåäèöèíñêèé
  • ìåñ — ìåñÿö
  • ÌÆ — ìîëî÷íàÿ æåëåçà
  • ÌÆÏ — ìåææåëóäî÷êîâàÿ ïåðåãîðîäêà
  • ÌÇ — ìèíèñòåðñòâî çäðàâîîõðàíåíèÿ
  • ìèí — ìèíóò(à)
  • ìèíÄ — ìèíèìàëüíàÿ äîçà
  • ìèíÑÄ — ìèíèìàëüíàÿ ñóòî÷íàÿ äîçà
  • ÌÊÁ — ìî÷åêàìåííàÿ áîëåçíü
  • ÌÊÁ-10 — Ìåæäóíàðîäíàÿ êëàññèôèêàöèÿ áîëåçíåé 10-ãî ïåðåñìîòðà
  • ÌÊÁ-11 — Ìåæäóíàðîäíàÿ êëàññèôèêàöèÿ áîëåçíåé 11-ãî ïåðåñìîòðà
  • ìê — ìèêðîâîëüò
  • ìêã — ìèêðîãðàìì
  • ÌÊÊ — ìàëûé êðóã êðîâîîáðàùåíèÿ
  • ìêë — ìèêðîëèòð
  • ìë — ìèëëèëèòð
  • ìëí — ìèëëèîí
  • ìëðä — ìèëëèàðä
  • ìì — ìèëëèìåòð
  • ìì ðò.ñò. — ìèëëèìåòð ðòóòíîãî ñòîëáà ììîëü — ìèëëèìîëü
  • ÌÍÍ — ìåæäóíàðîäíîå íåïàòåíòîâàííîå íàèìåíîâàíèå
  • ÌÍÎ — ìåæäóíàðîäíîå íîðìàëèçîâàííîå îòíîøåíèå
  • ÌÎ — ìåäèöèíñêàÿ îðãàíèçàöèÿ
  • ÌÏ — ìåäèöèíñêàÿ ïîìîùü
  • ÌÏÑ — ìî÷åïîëîâàÿ ñèñòåìà
  • ÌÐ — ìàãíèòíî-ðåçîíàíñíûé
  • ÌÐ-âåíîãðàôèÿ — ÌÐÒ âåí è ñèíóñîâ ãîëîâíîãî ìîçãà
  • ÌÐÒ — ìàãíèòíî-ðåçîíàíñíàÿ òîìîãðàôèÿ
  • ìñ — ìèëëèñåêóíäà
  • ÌÑÊÒ — ìóëüòèñïèðàëüíàÿ êîìïüþòåðíàÿ òîìîãðàôèÿ
  • ÌÑÝ — ìåäèêî-ñîöèàëüíàÿ ýêñïåðòèçà
  • ÌÒ — ìàññà òåëà
  • ìòÄÍÊ — ìèòîõîíäðèàëüíàÿ äåçîêñèðèáîíóêëåèíîâàÿ êèñëîòà
  • ÌÒÐ — ìàññà òåëà ïðè ðîæäåíèè
  • í.ý. — íàøåé ýðû
  • ÍÀ — íåðâíàÿ àíîðåêñèÿ
  • ÍÀÄ — íèêîòèíàìèäàäåíèíäèíóêëåîòèä
  • ÍÀÄÍ — íèêîòèíàìèäàäåíèíäèíóêëåîòèä (âîññòàíîâëåííûé)
  • ÍÀÄÔ — íèêîòèíàìèäàäåíèíäèíóêëåîòèäôîñôàò
  • ÍÀÆÁÏ — íåàëêîãîëüíàÿ æèðîâàÿ áîëåçíü ïå÷åíè íàïð. — íàïðèìåð
  • ÍÁ — íåðâíàÿ áóëèìèÿ
  • ÍÄÎ — íåãàòèâíûé äåòñêèé îïûò
  • íåä — íåäåëè
  • íåì. — íåìåöêèé
  • íì — íàíîìåòð
  • ÍÌÈÖ — íàöèîíàëüíûé ìåäèöèíñêèé èññëåäîâàòåëüñêèé öåíòð
  • ÍÌÏ — íåîòëîæíàÿ (ìåäèöèíñêàÿ) ïîìîùü
  • ÍÌÒ — íèçêàÿ ìàññà òåëà
  • ÍÏÀ — íîðìàòèâíî-ïðàâîâîé àêò
  • ÍÏÂ — íèæíÿÿ ïîëàÿ âåíà
  • ÍÏÂÑ — íåñòåðîèäíûå ïðîòèâîâîñïàëèòåëüíûå ñðåäñòâà
  • ÍÑ — íåðâíàÿ ñèñòåìà
  • ÍÐÏ — íîðìû ðàöèîíà ïèòàíèÿ
  • ÍÑÃ — íåéðîñîíîãðàôèÿ
  • ÍÝÊ — íåêðîòè÷åñêèé ýíòåðîêîëèò
  • ÍßÊ — íåñïåöèôè÷åñêèé ÿçâåííûé êîëèò
  • ÎÀÊ — îáùèé àíàëèç êðîâè
  • ÎÀÌ — îáùèé àíàëèç ìî÷è
  • ÎÀÏ — îòêðûòûé àðòåðèàëüíûé ïðîòîê
  • ÎÁÏ — îðãàíû áðþøíîé ïîëîñòè
  • ÎÃÁ — îñòðàÿ ãîðíàÿ áîëåçíü
  • ÎÃÌ — îòåê ãîëîâíîãî ìîçãà
  • ÎÄÍ — îñòðàÿ äûõàòåëüíàÿ íåäîñòàòî÷íîñòü
  • ÎÆÑÑ — îáùàÿ æåëåçîñâÿçûâàþùàÿ ñïîñîáíîñòü ñûâîðîòêè
  • ÎÇ — îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ
  • îê. — îêîëî
  • ÎÊÐ — îáñåññèâíî-êîìïóëüñèâíîå ðàññòðîéñòâî
  • ÎÊÑ — îñòðûé êîðîíàðíûé ñèíäðîì
  • ÎËË — îñòðûé ëèìôîáëàñòíûé ëåéêîç
  • ÎÌÑ — îáÿçàòåëüíîå ìåäèöèíñêîå ñòðàõîâàíèå
  • ÎÌÒ — îðãàíû ìàëîãî òàçà
  • ÎÍÌÊ — îñòðîå íàðóøåíèå ìîçãîâîãî êðîâîîáðàùåíèÿ
  • ÎÍÌÏ — îòäåëåíèå íåîòëîæíîé (ìåäèöèíñêîé) ïîìîùè
  • ÎÍÌÒ — î÷åíü íèçêàÿ ìàññà òåëà
  • ÎÎÇ — îðãàíû (îðãàíèçàöèè/óïðàâëåíèÿ) çäðàâîîõðàíåíèÿ
  • ÎÎÍ — Îðãàíèçàöèÿ Îáúåäèíåííûõ Íàöèé
  • ÎÏÆ — îæèäàåìàÿ ïðîäîëæèòåëüíîñòü æèçíè
  • ÎÏÍ — îñòðàÿ ïî÷å÷íàÿ íåäîñòàòî÷íîñòü
  • ÎÏÑÑ - îáùåå ïåðèôåðè÷åñêîå ñîñóäèñòîå ñîïðîòèâëåíèå
  • ÎÐÂÈ — îñòðàÿ ðåñïèðàòîðíàÿ âèðóñíàÿ èíôåêöèÿ
  • ÎÐÄÑ — îñòðûé ðåñïèðàòîðíûé äèñòðåññ-ñèíäðîì
  • ÎÐÇ — îñòðîå ðåñïèðàòîðíîå çàáîëåâàíèå
  • ÎÐÈÒ — îòäåëåíèå ðåàíèìàöèè è èíòåíñèâíîé òåðàïèè (ICU)
  • ÎÑÂÎ — îáùåå ñîäåðæàíèå âîäû â îðãàíèçìå
  • ÎÔÂ — îáúåì ôîðñèðîâàííîãî âûäîõà
  • ÎÔÂ1 — îáúåì ôîðñèðîâàííîãî âûäîõà çà 1-þ ñåêóíäó
  • ÎÖÊ — îáúåì öèðêóëèðóþùåé êðîâè
  • ï.ç. — ïîëå çðåíèÿ (ìèêðîñêîïà)
  • ï/ê — ïîäêîæíî
  • ÏÀÂ — ïñèõîàêòèâíûå âåùåñòâà
  • ÏÂ — ïðîòðîìáèíîâîå âðåìÿ
  • ÏÂÊ — ïåðèôåðè÷åñêèé âåíîçíûé êàòåòåð
  • ÏÂË — ïåðèâåíòðèêóëÿðíàÿ ëåéêîìàëÿöèÿ
  • Ïã — ïðîñòàãëàíäèí
  • ÏÃÃ — ïðîãðàììà ãîñóäàðñòâåííûõ ãàðàíòèé îêàçàíèÿ ãðàæäàíàì ÐÔ áåñïëàòíîé ìåäèöèíñêîé ïîìîùè
  • ÏÄÊÂ — ïîëîæèòåëüíîå äàâëåíèå êîíöà âûäîõà (PEEP)
  • ÏÆ — ïðàâûé æåëóäî÷åê
  • ÏÆÆ — ïîäæåëóäî÷íàÿ æåëåçà
  • ÏÆÊ — ïîäêîæíî-æèðîâàÿ êëåò÷àòêà (ãèïîäåðìà)
  • ÏÊÀ — ïî÷å÷íûé êàíàëüöåâûé àöèäîç
  • ÏÊÌÄ — ïîÿñíî-êîíå÷íîñòíàÿ ìûøå÷íàÿ äèñòðîôèÿ
  • ÏËÑÃ — ïÿòíèñòàÿ ëèõîðàäêà Ñêàëèñòûõ ãîð
  • ÏÌÄÐ — ïðåäìåíñòðóàëüíîå äèñôîðè÷åñêîå ðàññòðîéñòâî
  • ÏÌÊ — ïðîëàïñ ìèòðàëüíîãî êëàïàíà
  • ÏÌÑ — ïðåäìåíñòðóàëüíûé ñèíäðîì
  • ÏÌÑÏ — ïåðâè÷íàÿ ìåäèêî-ñàíèòàðíàÿ ïîìîùü
  • ÏÍÆÊ — ïîëèíåíàñûùåííûå æèðíûå êèñëîòû
  • ÏÎÐÈÒ— ïåäèàòðè÷åñêîå îòäåëåíèå ðåàíèìàöèè è èíòåíñèâíîé òåðàïèè
  • ÏÎÒ — ïîñòóðàëüíàÿ îðòîñòàòè÷åñêàÿ òàõèêàðäèÿ
  • ÏÏÂ — ïíåâìîêîêêîâàÿ ïîëèñàõàðèäíàÿ âàêöèíà
  • ÏÏÎÀÊ — ïðÿìûå ïåðîðàëüíûå àíòèêîàãóëÿíòû
  • ÏÏÒ — ïëîùàäü ïîâåðõíîñòè òåëà
  • ÏÑÀ — ïðîñòàòîñïåöèôè÷åñêèé àíòèãåí
  • ÏÑÂ — ïèêîâàÿ ñêîðîñòü âûäîõà
  • ÏÑÂÕ — ïðîãðåññèðóþùèé ñåìåéíûé âíóòðèïå÷åíî÷-íûé õîëåñòàç
  • ÏÒ — ïñèõîòåðàïèÿ
  • ÏÒÂ — ïðîòðîìáèíîâîå âðåìÿ
  • ÏÒÃ — ïàðàòèðåîèäíûé ãîðìîí
  • ÏÒÈ — ïðîòðîìáèíîâûé èíäåêñ
  • ÏÒÑÐ — ïîñòòðàâìàòè÷åñêîå ñòðåññîâîå ðàññòðîéñòâî
  • ÏÔÝ — ïèùåâîé ôîëàòíûé ýêâèâàëåíò
  • ÏÖÐ — ïîëèìåðàçíàÿ öåïíàÿ ðåàêöèÿ
  • ÏØÃ — ïóðïóðà Øåíëåéíà-Ãåíîõà
  • ÏÙÆ — ïàðàùèòîâèäíûå æåëåçû
  • ÏÝÒ — ïîçèòðîííî-ýìèññèîííàÿ òîìîãðàôèÿ ð/ — ðàç â ... (ñ, ìèí, ÷, ñóò è ò.ï.)
  • ÐÀ — ðåâìàòîèäíûé àðòðèò
  • ÐÀÀÑ — ðåíèí-àíãèîòåíçèí-àëüäîñòåðîíîâàÿ ñèñòåìà ðàçã. — ðàçãîâîðíîå ðàçë. — ðàçëè÷íîå
  • ÐÀÑ — ðàññòðîéñòâî àóòèñòè÷åñêîãî ñïåêòðà
  • ÐÄÑ — ðåñïèðàòîðíûé äèñòðåññ-ñèíäðîì ðèì. — ðèìñêèé
  • ÐÈÔ — ðåàêöèÿ èììóíîôëþîðåñöåíöèè
  • ÐÊÈ — ðàíäîìèçèðîâàííûå êëèíè÷åñêèå èññëåäîâàíèÿ
  • ÐÊÌÏ — ðåñòðèêòèâíàÿ êàðäèîìèîïàòèÿ
  • ÐÈÃÀ — ðåàêöèÿ íåïðÿìîé ãåìàããëþòèíàöèè
  • ÐÍÊ — ðèáîíóêëåèíîâàÿ êèñëîòà
  • ÐÍÏ - ðåêîìåíäóåìóþ íîðìó ïîòðåáëåíèÿ
  • ÐÎÃÊ — ðåíòãåíîãðàôèÿ (ðåíòãåíîãðàììà) îðãàíîâ ãðóäíîé êëåòêè
  • ÐÎËÑÍÑ — ðåêîìåíäàöèè ïî îöåíêå è ëå÷åíèþ ïðè ñîðòèðîâêå â íåîòëîæíûõ ñèòóàöèÿõ
  • ÐÏÃÀ — ðåàêöèÿ ïðÿìîé ãåìàããëþòèíàöèè
  • ð-ð — ðàñòâîð
  • ð-ðèòåëü — ðàñòâîðèòåëü
  • ÐÐÊ — ðåöåïòîðû ðåòèíîåâîé êèñëîòû
  • PPM — ðàñøèðåííûå ðåàíèìàöèîííûå ìåðîïðèÿòèÿ
  • ÐÑÂ — ðåñïèðàòîðíî-ñèíöèòèàëüíûé âèðóñ
  • ÐÑÄ — ðàññòðîéñòâî ñòåðåîòèïíûõ äâèæåíèé
  • ÐÑÊ — ðåàêöèÿ ñâÿçûâàíèÿ êîìïëåìåíòà
  • ÐÑÏ - ðàñ÷åòíàÿ ñðåäíÿÿ ïîòðåáíîñòü
  • ÐÒÃÀ — ðåàêöèÿ òîðìîæåíèÿ ãåìàããëþòèíàöèè
  • ÐÒÍÃÀ — ðåàêöèÿ òîðìîæåíèÿ íåïðÿìîé ãåìàããëþòèíàöèè
  • ÐÔ — Ðîññèéñêàÿ Ôåäåðàöèÿ
  • ÐÕÐ — ðåòèíîåâûå Õ-ðåöåïòîðû
  • Ð×À — ðàäèî÷àñòîòíàÿ àáëÿöèÿ
  • ÐÝÑ — ðåòèêóëîýíäîòåëèàëüíàÿ ñèñòåìà
  • ñ — ñåêóíäà
  • ñâ-âî — ñâîéñòâî
  • ÑÂÄÑ — ñèíäðîì âíåçàïíîé äåòñêîé ñìåðòè
  • ÑÃß — ñèíäðîì ãèïåðñòèìóëÿöèè ÿè÷íèêîâ
  • ÑÄ — ñàõàðíûé äèàáåò
  • ÑÄ-1 — ñàõàðíûé äèàáåò 1-ãî òèïà
  • ÑÄ-2 — ñàõàðíûé äèàáåò 2-ãî òèïà
  • ÑÄÂÃ — ñèíäðîì äåôèöèòà âíèìàíèÿ è ãèïåðàêòèâíîñòè
  • ÑÅ — ñóáúåäèíèöà
  • ÑÆÊ — ñâîáîäíûå æèðíûå êèñëîòû
  • ÑÇÄ - ñëóæáà çàùèòû äåòåé
  • ÑÇÑÒ — ñèñòåìíîå(ûå) çàáîëåâàíèå(ÿ) ñîåäèíèòåëüíîé òêàíè
  • ÑÈÇ — ñðåäñòâà èíäèâèäóàëüíîé çàùèòû
  • ÑÈÎÇÑ— ñåëåêòèâíûé èíãèáèòîð îáðàòíîãî çàõâàòà ñåðîòîíèíà
  • ÑÈÎÇÑÍ — ñåëåêòèâíûå èíãèáèòîðû îáðàòíîãî çàõâàòà ñåðîòîíèíà è íîðýïèíåôðèíà
  • ÑÊÀ — ñåðïîâèäíî-êëåòî÷íàÿ àíåìèÿ
  • ÑÊ — ñåðïîâèäíî-êëåòî÷íàÿ áîëåçíü
  • ÑÊ — ñèñòåìíàÿ êðàñíàÿ âîë÷àíêà
  • ÑÊÔ — ñêîðîñòü êëóáî÷êîâîé ôèëüòðàöèè
  • ÑËÐ — ñåðäå÷íî-ëåãî÷íàÿ ðåàíèìàöèÿ
  • ñì — ñàíòèìåòð
  • ñì âîä.ñò. — ñàíòèìåòð âîäÿíîãî ñòîëáà
  • ÑÌÆ — ñïèííîìîçãîâàÿ æèäêîñòü
  • ÑÌÈ — ñðåäñòâà ìàññîâîé èíôîðìàöèè
  • ÑÌÎ — ñòðàõîâàÿ ìåäèöèíñêàÿ îðãàíèçàöèÿ
  • ÑÌÏ — ñêîðàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÑÌÝ — ñóäåáíî-ìåäèöèíñêàÿ ýêñïåðòèçà
  • ÑÍ — ñåðäå÷íàÿ íåäîñòàòî÷íîñòü
  • ÑÍÑÀÄÃ — ñèíäðîì íåàäåêâàòíîé ñåêðåöèè ÀÄÃ
  • ÑÎÀÑ — ñèíäðîì îáñòðóêòèâíîãî àïíîý ñíà (âî ñíå) ñîâð. — ñîâðåìåííûé
  • ÑÎÝ — ñêîðîñòü îñåäàíèÿ ýðèòðîöèòîâ
  • ÑÏÈÄ — ñèíäðîì ïðèîáðåòåííîãî èììóíîäåôèöèòà
  • ÑÏÊß — ñèíäðîì ïîëèêèñòîçíûõ ÿè÷íèêîâ
  • ÑÏÎÍ — ñèíäðîì ïîëèîðãàííîé íåäîñòàòî÷íîñòè
  • ÑÐÂ — Ñ-ðåàêòèâíûé áåëîê
  • ÑÐÊ — ñèíäðîì ðàçäðàæåííîãî êèøå÷íèêà
  • ÑðÑÄ — ñðåäíÿÿ ñóòî÷íàÿ äîçà
  • ÑÑÂ — ñèíäðîì Ñòåðäæà-Âåáåðà
  • ÑÑÂÐ — ñèíäðîì ñèñòåìíîé âîñïàëèòåëüíîé ðåàêöèè
  • ÑÑÇ — ñåðäå÷íî-ñîñóäèñòûå çàáîëåâàíèÿ
  • ÑÑÑ — ñåðäå÷íî-ñîñóäèñòàÿ ñèñòåìà
  • ÑÑÑÓ — ñèíäðîì ñëàáîñòè ñèíóñîâîãî óçëà
  • ÑÒ — Ñèíäðîì Òóðåòòà
  • ÑÒÃ — ñîìàòîòðîïíûé ãîðìîí
  • ÑÒÐ — ñòîéêîå (õðîíè÷åñêîå) ìîòîðíîå èëè âîêàëüíîå òèêîçíîå ðàññòðîéñòâî
  • ñóò — ñóòêè
  • ÑÕÓ — ñèíäðîì õðîíè÷åñêîé óñòàëîñòè
  • ò.ä. — òàê äàëåå
  • ò.å. — òî åñòü
  • ò.ê. — òàê êàê
  • ò.î. — òàêèì îáðàçîì
  • ò.ï. — òîìó ïîäîáíîå
  • Ò3 — òðèéîäòèðîíèí
  • Ò4 — òèðîêñèí
  • ÒÀÍÊ — òåñò àìïëèôèêàöèè íóêëåèíîâûõ êèñëîò
  • ÒÁÑ — òàçîáåäðåííûé ñóñòàâ
  • ÒÃÂ — òðîìáîç ãëóáîêèõ âåí
  • ÒÃÑÊ — òðàíñïëàíòàöèÿ ãåìîïîýòè÷åñêèõ ñòâîëîâûõ êëåòîê
  • ÒÈÀ — òðàíçèòîðíàÿ èøåìè÷åñêàÿ àòàêà
  • ÒÈÀÁ — òîíêîèãîëüíàÿ àñïèðàöèîííàÿ áèîïñèÿ
  • ÒÌÎ — òâåðäàÿ ìîçãîâàÿ îáîëî÷êà
  • TH — òîðãîâîå íàèìåíîâàíèå ëåêàðñòâåííûõ ñðåäñòâ
  • ÒÏÃÃ — òåððèòîðèàëüíàÿ ïðîãðàììà ãîñóäàðñòâåííûõ ãàðàíòèé îêàçàíèÿ ãðàæäàíàì ÐÔ áåñïëàòíîé ìåäèöèíñêîé ïîìîùè
  • ÒÏÌ — òðàâìàòè÷åñêîå ïîâðåæäåíèå ìîçãà
  • ÒÒ — òåìïåðàòóðà òåëà
  • ÒÒÃ — òèðåîòðîïíûé ãîðìîí
  • ÒÔÐ — òðàíñôîðìèðóþùèé ôàêòîð ðîñòà
  • ÒÖÀ — òðèöèêëè÷åñêèå àíòèäåïðåññàíòû
  • òûñ. — òûñÿ÷à
  • ÒÝÄ —òðàíçèòîðíàÿ ýðèòðîáëàñòîïåíèÿ äåòñêîãî âîçðàñòà
  • ÒÝËÀ — òðîìáîýìáîëèÿ ëåãî÷íîé àðòåðèè
  • ÒÝÎ — òðîìáîýìáîëè÷åñêèå îñëîæíåíèÿ
  • ÓÇÄÑ — óëüòðàçâóêîâîå äóïëåêñíîå ñêàíèðîâàíèå
  • ÓÇÈ — óëüòðàçâóêîâîå èññëåäîâàíèå
  • óñòàð. — óñòàðåâøåå
  • ÓÔ — óëüòðàôèîëåòîâûé
  • ÓÔÎ — óëüòðàôèîëåòîâîå îáëó÷åíèå
  • ÔÀÏ — ôåëüäøåðñêî-àêóøåðñêèé ïóíêò
  • ÔÂ — ôðàêöèÿ âûáðîñà
  • ÔÂÄ — ôóíêöèè âíåøíåãî äûõàíèÿ
  • ÔÆÅË — ôîðñèðîâàííàÿ æèçíåííàÿ åìêîñòü ëåãêèõ
  • ÔÇ — Ôåäåðàëüíûé çàêîí
  • ôèçèîë. — ôèçèîëîãè÷åñêèé
  • ÔÊ — ôóíêöèîíàëüíûé êëàññ
  • ÔÊÑ — ôèáðîêîëîíîñêîïèÿ
  • ÔÊÓ — ôåíèëêåòîíóðèÿ
  • ÔÍ — ôèçè÷åñêàÿ íàãðóçêà
  • ÔÈÎ — ôàêòîð íåêðîçà îïóõîëè
  • ÔÎÌÑ — ôåäåðàëüíûé ôîíä îáÿçàòåëüíîãî ìåäèöèíñêîãî ñòðàõîâàíèÿ
  • ÔÎÑ — ôîñôîðîðãàíè÷åñêèå ñîåäèíåíèÿ
  • ÔÏ — ôèáðèëëÿöèÿ ïðåäñåðäèé
  • ôð. — ôðàíöóçñêèé
  • ÔÑÃ — ôîëëèêóëîñòèìóëèðóþùèé ãîðìîí
  • ÔÝÃÄÑ — ôèáðîýçîôàãîãàñòðîäóîäåíîñêîïèÿ
  • ÕÁÏ — õðîíè÷åñêàÿ áîëåçíü ïî÷åê
  • ÕÃ× — õîðèîíè÷åñêèé ãîíàäîòðîïèí ÷åëîâåêà
  • ÕÄÍ — õðîíè÷åñêàÿ äûõàòåëüíàÿ íåäîñòàòî÷íîñòü
  • õèì. — õèìè÷åñêàÿ
  • ÕÍÇË —õðîíè÷åñêèå íåñïåöèôè÷åñêèå çàáîëåâàíèÿ ëåãêèõ
  • ÕÎÁË — õðîíè÷åñêàÿ îáñòðóêòèâíàÿ áîëåçíü ëåãêèõ
  • ÕÏÍ — õðîíè÷åñêàÿ ïî÷å÷íàÿ íåäîñòàòî÷íîñòü
  • ÕÑ — õîëåñòåðèí
  • ÕÑÍ — õðîíè÷åñêàÿ ñåðäå÷íàÿ íåäîñòàòî÷íîñòü
  • XT — õèìèîòåðàïèÿ
  • ÖÂÄ — öåíòðàëüíîå âåíîçíîå äàâëåíèå
  • ÖÂÊ — öåíòðàëüíûé âåíîçíûé êàòåòåð
  • ÖÈÊ — öèðêóëèðóþùèå èììóííûå êîìïëåêñû
  • ÖÌÂ — öèòîìåãàëîâèðóñ
  • ÖÍÑ — öåíòðàëüíàÿ íåðâíàÿ ñèñòåìà
  • ÖÎÃ — öèêëîîêñèãåíàçà
  • ÖÏÄ — öåðåáðàëüíîå ïåðôóçèîííîå äàâëåíèå
  • ÖÑÒÑ — öåðåáðàëüíûé ñîëüòåðÿþùèé ñèíäðîì ÷ — ÷àñ
  • ×Ä — ÷àñòîòà äûõàíèÿ
  • ×ÄÄ — ÷àñòîòà äûõàòåëüíûõ äâèæåíèé
  • ×Ê — ÷ðåñêîæíîå êîðîíàðíîå âìåøàòåëüñòâî
  • ×ÌÍ — ÷åðåïíî-ìîçãîâûå íåðâû
  • ×ÌÒ — ÷åðåïíî-ìîçãîâàÿ òðàâìà
  • ×Í — ÷åðåïíûå íåðâû
  • ×Ñ — ÷óâñòâèòåëüíîñòü/ñïåöèôè÷íîñòü (×Ñ 97%/87%)
  • ×ÑÑ — ÷àñòîòà ñåðäå÷íûõ ñîêðàùåíèé
  • ×Ò — ÷àñòè÷íîå òðîìáîïëàñòèíîâîå âðåìÿ
  • ØÊÃ — øêàëà êîìû Ãëàçãî
  • ØÎÏ — øåéíûé îòäåë ïîçâîíî÷íèêà
  • ÙÆ — ùèòîâèäíàÿ æåëåçà
  • ÃÖÔ — ùåëî÷íàÿ ôîñôàòàçà
  • ÝÀÐ — ýêâèâàëåíò àêòèâíîñòè ðåòèíîëà
  • ÝÄÒÀ — ýòèëåíäèàìèíòåòðàóêñóñíàÿ êèñëîòà (ýòèëåíäèàìèíòåòðààöåòàò)
  • ÝÊÃ — ýëåêòðîêàðäèîãðàôèÿ
  • ÝÊÌÎ — ýêñòðàêîðïîðàëüíàÿ ìåìáðàííàÿ îêñèãåíàöèÿ
  • ÝÊÎ — ýêñòðàêîðïîðàëüíîå îïëîäîòâîðåíèå
  • ÝÊÑ — ýëåêòðîêàðäèîñòèìóëÿòîð, ýëåêãðîêàðäèîñòèìóëÿöèÿ
  • ÝÌÃ — ýëåêòðîìèîãðàôèÿ
  • ÝÌÊ — ýëåêòðîííàÿ ìåäèöèíñêàÿ êàðòà
  • ÝÌÏ — ýêñòðåííàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÝÍÌÏ — ýêñòðåííàÿ è íåîòëîæíàÿ ìåäèöèíñêàÿ ïîìîùü
  • ÝÍÌÒ — ýêñòðåìàëüíî íèçêàÿ ìàññà òåëà
  • ÝÒÒ — ýíäîòðàõåàëüíàÿ òðóáêà
  • ÝõîÊà — ýõîêàðäèîãðàôèÿ
  • ÝÝÃ — ýëåêòðîýíöåôàëîãðàôèÿ
  • ÞÄÌ — þâåíèëüíûé äåðìàòîìèîçèò
  • ÞÈÀ — þâåíèëüíûé èäèîïàòè÷åñêèé àðòðèò
  • ßÁ — ÿçâåííàÿ áîëåçíü
  • ÀÀ — àìèëîèä A (amyloid À)
  • ÀÀÐ — Àìåðèêàíñêàÿ àêàäåìèÿ ïåäèàòðèè (American Academy of Pediatrics)
  • ABC — àëãîðèòì íåîòëîæíîé ïîìîùè «äûõàòåëüíûå ïóòè-äûõàíèå-êðîâîîáðàùåíèå» (Airways-Breathing-Circulation)
  • ÀÂÑÀ3 — áåëêîâûé ÷ëåí ÀÒÔ-ñâÿçûâàþùåé êàññåòû À3
  • ÀÂÑÂ11— ãåí ÀÒÔ-ñâÿçûâàþùåé êàññåòû, 11-é ÷ëåí ïîäñåìåéñòâà  (ATP-binding cassette, sub-family  member 11)
  • ÀÂÑÂ4 — ãåí ÀÒÔ-ñâÿçûâàþùåé êàññåòû, 4-é ÷ëåí ïîäñåìåéñòâà  (ATP-binding cassette 4 gene)
  • ÀÂÑÑ2 — ãåí, êîäèðóþùèé 2-é ÷ëåí ïîäñåìåéñòâà Ñ ÀÒÔ-ñâÿçûâàþùèõ êàññåò (ATP-binding cassette sub-family Ñ member 2)
  • ABCDE — àëãîðèòì íåîòëîæíîé ïîìîùè «äûõàòåëüíûå ïóòè-äûõàíèå-êðîâîîáðàùåíèå-íåâðîëîãè÷åñêèé ñòàòóñ-âíåøíèé âèä» (Airways-Breathing-Circulation-Disability- Exposure)
  • ABCG5/G8 — ãåòåðîäèìåð ïåðåíîñ÷èêà ÀÒÔ-ñâÿçûâàþùåé êàññåòû ABCG5 è ABCG8 (The heterodimer of ATP-binding cassette transporter ABCG5 and ABCG8)
  • AC — äî åäû (ïðè íàçíà÷åíèÿõ) — ante cibum
  • ÀÑÅÐ — Àìåðèêàíñêàÿ êîëëåãèÿ âðà÷åé íåîòëîæíîé ïîìîùè (American College of Emergency Physicians)
  • ACOG — Àìåðèêàíñêàÿ êîëëåãèÿ àêóøåðîâ è ãèíåêîëîãîâ (American College of Obstetricians and Gynecologists)
  • AHA — Àìåðèêàíñêàÿ êàðäèîëîãè÷åñêàÿ àññîöèàöèÿ (American Heart Association)
  • ALTE — î÷åâèäíîå îïàñíîå äëÿ æèçíè ñîáûòèå (apparent life-threatening event)
  • APLS — êóðñû ðàñøèðåííûõ ðåàíèìàöèîííûõ ìåðîïðèÿòèé â ïåäèàòðèè, ñïîíñèðóåìûå Àìåðèêàíñêîé àêàäåìèåé ïåäèàòðèè è Àìåðèêàíñêîé êîëëåãèåé âðà÷åé íåîòëîæíîé ïîìîùè (Advanced Pediatric Life Support)
  • ARPKD — àóòîñîìíî-ðåöåññèâíûé ïîëèêèñòîç ïî÷åê
  • ASCVD-ðèñê — ðèñê ðàçâèòèÿ àòåðîñêëåðîòè÷åñêîãî ñåðäå÷íî-ñîñóäèñòîãî çàáîëåâàíèÿ (ArterioSclerotic Cardiovascular Disease, ASCVD)
  • AVPU — øêàëà äëÿ îöåíêè óðîâíÿ ñîçíàíèÿ («â ÿñíîì ñîçíàíèè»; «ðåàêöèÿ íà âåðáàëüíûå ðàçäðàæèòåëè»; «ðåàêöèÿ íà áîëü»; «áåç ñîçíàíèÿ») (alert, verbal, pain, unresponsive)
  • BCS — ìèòîõîíäðèàëüíûé øàïåðîí BCS1 (mitochondrial chaperone BCS1)
  • BIN — áèíîìèíàëüíàÿ íîìåíêëàòóðà «æèâîé» ïðèðîäû
  • BiPAP — ðåæèì èñêóññòâåííîé âåíòèëÿöèè ëåãêèõ ñ äâóìÿ óðîâíÿìè ïîëîæèòåëüíîãî äàâëåíèÿ (bilevel positive airway pressure) = ÂÐÀÐ
  • BNP — íàòðèéóðåòè÷åñêèé ïåïòèä Â-òèïà — ìîçãîâîé ( (brain)-type natriuretic peptide)
  • BRUE — áûñòðî ðàçðåøèâøèåñÿ íåîáúÿñíèìûå ñîáûòèÿ (Brief resolved unexplained events)
  • BSEP — íàñîñ âûâåäåíèÿ ñîëåé æåë÷íûõ êèñëîò
  • CADASIL — öåðåáðàëüíàÿ àóòîñîìíî-äîìèíàíòíàÿ àðòåðèîïàòèÿ ñ ïîäêîðêîâûìè èíôàðêòàìè è ëåéêîýíöåôàëîïàòèåé (cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)
  • CAPS — êðèîïèðèí-àññîöèèðîâàííûé ïåðèîäè÷åñêèé ñèíäðîì (cryopyrin-associated periodic syndrome)
  • CBIT — êîìïëåêñíîå ïîâåäåí÷åñêîå âîçäåéñòâèå ïðè òèêàõ (Comprehensive behavioral intervention for tics)
  • CD — êëàñòåðû äèôôåðåíöèðîâêè (clusters of differentiation)
  • CDC — Öåíòð ïî êîíòðîëþ è ïðîôèëàêòèêå çàáîëåâàíèé, ÑØÀ (Center for Disease Control and Prevention)
  • CDG — âðîæäåííûå íàðóøåíèÿ ãëèêîçèëèðîâàíèÿ (Congenital Disorder of Glycosylation)
  • CFTR — òðàíñìåìáðàííûé ðåãóëÿòîð ìóêîâèñöèäîçà (cystic fibrosis transmembrane regulator)
  • CH — ãåìîëèòè÷åñêèé êîìïëåìåíò (hemolytic complement)
  • CLLS — øêàëà îöåíêè îñòðîé ãîðíîé áîëåçíè îçåðà Ëóèç ó äåòåé (Childrens Lake Louise Score)
  • CMT — Øàðêî-Ìàðè-Òóòà áîëåçíü (Charcot-Marie-Tooth disease)
  • ÑÐÀÐ — ïîñòîÿííîå ïîëîæèòåëüíîå äàâëåíèå â äûõàòåëüíûõ ïóòÿõ (Constant Positive Airway Pressure)
  • CYP — öèòîõðîì îáùèé
  • DAF — ôàêòîð óñêîðåíèÿ ðàñïàäà (decay-accelerating factor)
  • DGAT1 —äèàöèëãëèöåðèí-1-àöèëòðàíñôåðàçà (diacylglycerol acyltransferase 1)
  • DHR — äèãèäðîðîäàìèí (dihydrorhodamine)
  • DSM — Äèàãíîñòè÷åñêîå è ñòàòèñòè÷åñêîå ðóêîâîäñòâî ïî ïñèõè÷åñêèì ðàññòðîéñòâàì (Diagnostic and Statistical Manual of Mental Disorders)
  • EAST syndrome — ýïèëåïñèÿ, àòàêñèÿ, ñåíñîíåâðàëüíàÿ òóãîóõîñòü è òóáóëîïàòèÿ (epilepsy, ataxia, sensorineural hearing loss, and tubulopath)
  • EBM — äîêàçàòåëüíàÿ ìåäèöèíà (Evidence based medicine)
  • EPCAM— ìîëåêóëà àäãåçèè ýïèòåëèàëüíûõ êëåòîê (epithelial cell adhesion molecule)
  • ESC — Åâðîïåéñêîå îáùåñòâî êàðäèîëîãèè (European Society of Cardiology)
  • EXIT — ëå÷åíèå âíå ìàòêè âî âðåìÿ ðîäîâ (Ex utero intrapartum treatment)
  • FAST — ñôîêóñèðîâàííàÿ ñîíîãðàôèÿ áðþøíîé ïîëîñòè ïðè òðàâìå (focused assessment with sonography in trauma)
  • FDA — Êîìèòåò ïî êîíòðîëþ çà ëåêàðñòâåííûìè âåùåñòâàìè è ïèùåâûìè äîáàâêàìè, ÑØÀ (Food and Drug Administration)
  • FFR — ôðàêöèîííûé ðåçåðâ êðîâîòîêà (Fractional Flow Reserve)
  • FGF-23 — ôàêòîð ðîñòà ôèáðîáëàñòîâ-23 (Fibroblast growth factor-23)
  • FIC 1 —ñåìåéíûé âíóòðèïå÷åíî÷íûé õîëåñòàç 1-ãî òèïà, áîëåçíü Áàéëåðà (familial intrahepatic cholestasis)
  • FiO2 — ôðàêöèÿ êèñëîðîäà (âî âäûõàåìîì âîçäóõå, ãàçîâîé ñìåñè)
  • FISH — ôëóîðåñöåíòíàÿ in situ ãèáðèäèçàöèÿ (fluorescence in situ hybridization)
  • FLAIR — âîññòàíîâëåíèå èíâåðñèè ñ îñëàáëåíèåì æèäêîñòè (fluid-attenuated inversion recovery)
  • FMF — ñåìåéíàÿ ñðåäèçåìíîìîðñêàÿ ëèõîðàäêà (Familial Mediterranean fever)
  • GATA — gata-ñâÿçûâàþùèé áåëîê
  • HADH — ãèäðîêñèëàöèë-ÊîÀ-äåãèäðîãåíàçà (Hydro-xyacyl-Coenzyme A dehydrogenase)
  • HAV — âèðóñ ãåïàòèòà Â (hepatitis A virus)
  • Hb — ãåìîãëîáèí
  • HBcAg — ñåðäöåâèííûé àíòèãåí âèðóñà ãåïàòèòà Â
  • HBeAg — àíòèãåí âèðóñà ãåïàòèòà Â
  • HBsAg — ïîâåðõíîñòíûé àíòèãåí âèðóñà ãåïàòèòà Â
  • HBV — âèðóñ ãåïàòèòà  (hepatitis  virus)
  • HCV — âèðóñ ãåïàòèòà Ñ (hepatitis Ñ virus)
  • HDV — âèðóñ ãåïàòèòà D (hepatitis D virus)
  • HFNC — íàçàëüíûå êàíþëè âûñîêîãî ïîòîêà (heated, high-flow nasal cannula)
  • Hib — ãåìîôèëüíàÿ ïàëî÷êà òèïà  (Haemophilus influenzae  type)
  • HLA — ëåéêîöèòàðíûå àíòèãåíû (ãëàâíîãî êîìïëåêñà ãèñòîñîâìåñòèìîñòè) ÷åëîâåêà (human leukocyte antigens)
  • HR — îòíîøåíèå ðèñêîâ (hazard ratio)
  • HRT — òåðàïèÿ îòìåíû ïðèâû÷êè (Habit reversal therapy)
  • Ht — ãåìàòîêðèò
  • HTLV — Ò-ëèìôîòðîïíûé âèðóñ ÷åëîâåêà (human T-lymphotropic virus)
  • Ig — èììóíîãëîáóëèí
  • IgA — èììóíîãëîáóëèí A
  • IgE — èììóíîãëîáóëèí E
  • IgG — èììóíîãëîáóëèí G
  • IgM — èììóíîãëîáóëèí M
  • IL — èíòåðëåéêèí
  • IPEX — Õ-ñöåïëåííûé ñèíäðîì èììóííîé äèñðå-ãóëÿöèè, ïîëèýíäîêðèíîïàòèè è ýíòåðîïàòèè (Immunedysregulation polyendocrinopathy enteropathy, X-linked)
  • IQ — êîýôôèöèåíò óìñòâåííîãî ðàçâèòèÿ (intelligence quotient)
  • JAK — ÿíóñ-êèíàçà (Janus kinase)
  • LFA — àíòèãåí, àêòèâèðóþùèé ôóíêöèþ ëåéêîöèòîâ (Lymphocyte function-associated antigen)
  • LT — ëåéêîòðèåí
  • MALT — ëèìôîèäíàÿ òêàíü ñëèçèñòîé îáîëî÷êè (mucosa-associated lymphoid tissue)
  • MASP — ÌÑË-àññîöèèðîâàííàÿ ñåðèíîâàÿ ïðîòåàçà (MBL-associated serine protease)
  • MBL — ìàííîçî-ñâÿçûâàþùèé ëåêòèí (mannose-
  • binding lectin)
  • MCP — ìåìáðàííûé áåëîê-êîôàêòîð (membrane cofactor protein)
  • MDR3 — áåëîê ìíîæåñòâåííîé ëåêàðñòâåííîé óñòîé÷èâîñòè 3 (multidrug resistance protein 3)
  • MELAS — ìèòîõîíäðèàëüíàÿ ýíöåôàëîïàòèÿ, ëàêòîàöèäîç è èíñóëüòîïîäîáíûå ýïèçîäû (mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes)
  • MERRF — ìèîêëîíè÷åñêàÿ ýïèëåïñèÿ ñ ðâàíûìè êðàñíûìè âîëîêíàìè (Myoclonic epilepsy with ragged red fibers)
  • Mr — êàæóùàÿñÿ ìîëåêóëÿðíàÿ ìàññà
  • MRP — áåëîê ñ ìíîæåñòâåííîé ëåêàðñòâåííîé óñòîé÷èâîñòüþ (multidrug-resistant protein)
  • MRSA — ìåòèöèëëèíðåçèñòåíòíûé çîëîòèñòûé ñòàôèëîêîêê
  • MSSA — ìåòèöèëëèí÷óâñòâèòåëüíûé çîëîòèñòûé ñòàôèëîêîêê
  • NB! — âàæíî, îáðàòèòü âíèìàíèå (Nota bene)
  • NICE — Íàöèîíàëüíûé èíñòèòóò çäîðîâüÿ è êëèíè÷åñêîãî ñîâåðøåíñòâîâàíèÿ (êà÷åñòâà ìåäèöèíñêîé ïîìîùè) Âåëèêîáðèòàíèè (National Institute for Health and Clinical Excellence)
  • NK — åñòåñòâåííûå êëåòêè-êèëëåðû (natural killer)
  • NMDA — N-ìåòèë-D-àñïàðòàò (N-methyl-D-aspartate)
  • NMDA — N-ìåòèë-D-àñïàðòàòíûå ðåöåïòîðû
  • NNT — ÷èñëî áîëüíûõ, êîòîðûõ íåîáõîäèìî ïðîëå÷èòü, ÷òîáû äîñòè÷ü êàêîãî-òî óêàçàííîãî ýôôåêòà (Number Need to Treatment)
  • OR — îòíîøåíèå øàíñîâ (odds ratio)
  • paCO2 — ïàðöèàëüíîå äàâëåíèå óãëåêèñëîãî ãàçà â àðòåðèàëüíîé êðîâè
  • PALS — êóðñû ðàñøèðåííûõ ðåàíèìàöèîííûõ ìåðîïðèÿòèé â ïåäèàòðèè (Pediatric Advanced Life Support)
  • PANDAS — àóòîèììóííîå íåéðîïñèõèàòðè÷åñêîå ðàññòðîéñòâî â äåòñêîì âîçðàñòå, àññîöèèðîâàííîå ñî ñòðåïòîêîêêîâîé èíôåêöèåé (Pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection)
  • PANS — îñòðûé íåéðîïñèõèàòðè÷åñêèé ñèíäðîì â äåòñêîì âîçðàñòå (Pediatric acute-onset neuropsychiatric syndrome)
  • paO2 — ïàðöèàëüíîå äàâëåíèå êèñëîðîäà â àðòåðèàëüíîé êðîâè
  • PAS — ôóêñèíñåðíèñòàÿ êèñëîòà, ðåàêòèâ Øèôôà (periodic acid-Shiff)
  • PC — ïîñëå åäû (ïðè íàçíà÷åíèÿõ) — post cibum ðÑO2 — ïàðöèàëüíîå äàâëåíèå óãëåêèñëîãî ãàçà
  • PCSK-9 — ïðîïðîòåèíîâàÿ êîíâåðòàçà ñóáòèëèçèí-êåêñè-íîâîãî òèïà 9 (proprotein convertase subtilisin/ kexin type 9)
  • PFAPA — ïåðèîäè÷åñêàÿ ëèõîðàäêà ñ àôòîçíûì ñòîìàòèòîì, ôàðèíãèòîì è ëèìôàäåíèòîì (Periodic Fevers with Aphthous stomatitis, Pharyngitis and Adenitis)
  • PFIC — ñåìåéíûé âíóòðèïå÷åíî÷íûé õîëåñòàç (familial intrahepatic cholestasis)
  • Pg — ïðîñòàãëàíäèí
  • pH — âîäîðîäíûé ïîêàçàòåëü
  • PIM — ïîêàçàòåëü ëåòàëüíîãî èñõîäà ó äåòåé (Pediatric Index of Mortality)
  • piO2 — ïàðöèàëüíîå äàâëåíèå êèñëîðîäà âî âäûõàåìîì
  • âîçäóõå
  • ðO2 — ïàðöèàëüíîå äàâëåíèå êèñëîðîäà
  • POLG — ñóáúåäèíèöà ÄÍÊ-ïîëèìåðàçû ó
  • PRISA II — îöåíêà ðèñêà ãîñïèòàëèçàöèè ó äåòåé II (Pediatric Risk of Admission)
  • PRISM — ðèñê ëåòàëüíîãî èñõîäà ó äåòåé (Pediatric Risk of Mortality)
  • PRN — ïðè (ïî) íåîáõîäèìîñòè (Pro re nata — ïðè âîçíèêíîâåíèè îáñòîÿòåëüñòâ)
  • PRSS — ãåí ñåðèíîâîé ïðîòåàçû
  • PS. — ïðèìå÷àíèå (Post scriptum)
  • PUVA-òåðàïèÿ — ïñîðàëåí-óëüòðàôèîëåò À-òåðàïèÿ (psoralen and ultraviolet À)
  • Q#H — êàæäûå # ÷àñîâ (ïðè íàçíà÷åíèÿõ) — quaque ... hora
  • QAM — êàæäîå óòðî (ïðè íàçíà÷åíèÿõ) — quaque ante meridiem
  • QPM — êàæäûé âå÷åð (ïðè íàçíà÷åíèÿõ) — quaque post meridiem
  • RAG — ãåí, àêòèâèðóþùèé ðåêîìáèíàçó
  • RePEAT— ïåðåñìîòðåííûé èíñòðóìåíò äëÿ îöåíêè ïåäèàòðè÷åñêîé íåîòëîæíîé ìåäèöèíñêîé ïîìîùè (Revised Pediatric Emergency Assessment Tool)
  • RF — ðåâìàòîèäíûé ôàêòîð
  • Rh — ðåçóñ(-ôàêòîð)
  • Rh«-» — ðåçóñ-îòðèöàòåëüí(ûé)
  • Rh«+» — ðåçóñ-ïîëîæèòåëüí(ûé)
  • ROHHAD — áûñòðî ðàçâèâàþùååñÿ îæèðåíèå ñ äèñôóíêöèåé ãèïîòàëàìóñà, ãèïîâåíòèëÿöèåé è ñïîíòàííîé äèñðåãóëÿöèåé (rapid-onset obesity with hypothalamic dysfunction, hypoventilation and autonomic dysregulation)
  • RR — îòíîñèòåëüíûé ðèñê (relative risk èëè risk ratio) RW — ðåàêöèÿ Âàññåðìàíà (reaction of Wassermann)
  • SaO2 — ñàòóðàöèÿ àðòåðèàëüíîé êðîâè êèñëîðîäîì SatO2 — íàñûùåíèå êðîâè êèñëîðîäîì
  • ScvO2 — íàñûùåíèå êèñëîðîäîì öåíòðàëüíîé âåíîçíîé êðîâè (Central venous oxygen saturation)
  • SD — ñòàíäàðòíîå îòêëîíåíèå (standart deviation) SFTPA — ãåí ñóðôàêòàíòíîãî áåëêà A
  • SFTPB — ãåí ñóðôàêòàíòíîãî áåëêà Â
  • SFTPC — ãåí ñóðôàêòàíòíîãî áåëêà Ñ
  • SPINK — èíãèáèòîð ñåðèíîâîé ïðîòåàçû
  • SpO2 — íàñûùåíèå (ñàòóðàöèÿ) ãåìîãëîáèíà êèñëîðîäîì spp. — âèäû (ïðè ðîäîâîì èìåíè ìèêðîîðãàíèçìîâ)
  • Src. — èñòî÷íèê èíôîðìàöèè, áèáëèîãðàôè÷åñêàÿ ññûëêà (source)
  • STAT1 — ñèãíàëüíûé ïðåîáðàçîâàòåëü è àêòèâàòîð òðàíñêðèïöèè 1 (signal transducer and activator of transcription)
  • TA — ìåæäóíàðîäíàÿ àíàòîìè÷åñêàÿ òåðìèíîëîãèÿ TCR — T-êëåòî÷íûé ðåöåïòîð (T-cell receptor)
  • TLRs — Òîëë-ïîäîáíûå ðåöåïòîðû (Toll-like receptors) TNF — ôàêòîð íåêðîçà îïóõîëè (tumor necrosis factor)
  • TORCH — òîêñîïëàçìîç, êðàñíóõà, öèòîìåãàëîâèðóñíàÿ èíôåêöèÿ, ãåðïåñ è äðóãèå èíôåêöèè (Toxoplasmosis, Other infections, Rubella, Cytomegalovirus Herpes simplex)
  • TPM — ìóòàöèÿ òðîïîìèîçèíà (mutation of the tropomyosin)
  • TRAP — ñèíäðîì îáðàòíîé àðòåðèàëüíîé ïåðôóçèè áëèçíåöîâ (twin reversed arterial perfusion)
  • TRAPS — ïåðèîäè÷åñêèé ñèíäðîì, àññîöèèðîâàííûé ñ ðåöåïòîðîì ôàêòîðà íåêðîçà îïóõîëè (Tumor Necrosis Factor Receptor-Associated Periodic Syndrome)
  • ™ — òîðãîâàÿ ìàðêà
  • URL — èíòåðíåò-ññûëêà, àäðåñ èíòåðíåò-ðåñóðñà (Uniform Resource Locator)
  • VEGF — ôàêòîð ðîñòà ýíäîòåëèÿ ñîñóäîâ (Vascular Endothelial Growth Factor)
  • WPW — ñèíäðîì Âîëüôà-Ïàðêèíñîíà-Óàéòà (Wolff-Parkinson-White)
  • XLA — Õ-ñöåïëåííàÿ àãàììàãëîáóëèíåìèÿ (X-linked agammaglobulinemia)
  • aDG-RD — äèñòðîôèè, ñâÿçàííûå ñ a-äèñòðîãëèêàíàìè (alpha dystroglycan-related dystrophies)
  • β-ÕÃ× — β-ñóáúåäèíèöà õîðèîíè÷åñêîãî ãîíàäîòðîïèíà ÷åëîâåêà

 õîäå ïîäãîòîâêè ñòàòåé ïî ïåäèàòðèè äëÿ ïîëüçîâàòåëåé ñàéòà ÌåäÓíèâåð èñïîëüçîâàíû òðóäû ñëåäóþùèõ àâòîðîâ:

  1. Adams JA, Kellogg ND, Farst KJ, et al: Updated guidelines for medical assessment and care of children who may have been sexually abused, J Pediatr Adolesc Gynecol 29:81–87, 2016.
  2. American Academy of Pediatrics, Committee on Child Abuse and Neglect: The evaluation of sexual abuse in children, Pediatrics 116:506–512, 2005.
  3. American Academy of Pediatrics, Committee on Child Abuse and Neglect: The evaluation of children in the primary care setting when sexual abuse is suspected, Pediatrics 132:e558–e567, 2013.
  4. Bandea CI, Joseph K, Secor EW, et al: Development of PCR testing for detection of Trichomonas vaginalis in urine specimens, J Clin Microbiol 51:1298–1300, 2013.
  5. Black CM, Driebe EM, Howard LA, et al: Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse, Pediatr Infect Dis J 28:608–612, 2009.
  6. DeLago C, Deblinger E, Schroeder C, et al: Girls who disclose sexual abuse: urogenital symptoms and signs after genital contact, Pediatrics 122:e281–e286, 2008.
  7. Garland SM, Subasinghe AK: HPV vaccination for victims of childhood sexual abuse, Lancet 386:1919–1920, 2015.
  8. Giradet RG, Lahoti S, Howard LA, et al: Epidemiology of sexually transmitted infections in suspected child victims of sexual assault, Pediatrics 124:79–86, 2009.
  9. Hammerschlag MR: Sexual assault and abuse of children, Clin Infect Dis 53(Suppl 3):S103–S109, 2011.
  10. Hobbs MM, Se?a AC: Modern diagnosis of Trichomonas vaginalis infection, Sex Transm Infect 89:434–438, 2013.
  11. Paras ML, Murad MH, Chen LP, et al: Sexual abuse and lifetime diagnosis of somatic disorders, JAMA 302:550–561, 2009.
  12. Sena AC, Hsu KK, Kellogg N, et al: Sexual assault and sexually transmitted infections in adults, adolescents, and children, Clin Infect Dis 61:SB56–SB64, 2015.
  13. Workowski KA, Bolan GA, Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, 2015, MMWR Recomm Rep 64(RR–3):1–137, 2015.
  14. Petska HW, Gordon JB, Jablonski D, Sheets LK: The intersection of medical child abuse and medical complexity, Pediatr Clin North Am 64(1):253–264, 2017.
  15. Rabbone I, Galderisi A, Tinti D, et al: Case report: when an induced illness looks like a rare disease, Pediatrics 136(5):e1361, 2015.
  16. Roesler TA, Jenny C: Medical child abuse: beyond munchausen syndrome by proxy, Elk Grove Village, IL, 2009, American Academy of Pediatrics.
  17. Stirling J Jr, Committee on Child Abuse and Neglect: Beyond munchausen syndrome by proxy: identification and treatment of child abuse in a medical setting, Pediatrics 119(5):1026–1030, 2007.
  18. Barnes AJ, Gold MA: Promoting healthy behaviors in pediatrics: motivational interviewing, Pediatr Rev 33(9):e57–e68, 2012.
  19. Brown D.J., Jaffe J.E., Henson J.K. Advanced laceration management // Emerg. Med. Clin. North Am. 2007. Vol. 25. P. 83–99.
  20. Chatterjee J.S. A critical review of irrigation techniques in acute wounds // Int. Wound. J. 2005. Vol. 2. P. 258–265.
  21. Cummings P., Del Beccaro M.A. Antibiotics to prevent infection of simple wounds: a meta-analysis of randomized studies // Am. J. Emerg. Med. 1995. Vol. 13. P. 396–400.
  22. Fernandez R., Griffiths R. Water for wound cleansing // Cochrane Database Syst. Rev. 2012. CD003861.
  23. Field F.K., Kerstein M.D. Overview of wound healing in a moist environment // Am. J. Surg. 1994. Vol. 167. Suppl. 1A. P 2S–6S.
  24. Frank S.G., Lalonde D.H. How acidic is the lidocaine we are injecting, and how much bicarbonate should we add? // Can. J. Plast. Surg. 2012. Vol. 20. P. 71–74.
  25. Hines E.Q., Cohen J.S., Klein B.L. Glue adhesives for repairing minor skin lacerations // Contemp. Pediatr. 2013. Vol. 30. P. 25–34.
  26. Hollander J.E., Singer A.J., Valentine S.M. et al. Risk factors for infection in patients with traumatic lacerations // Acad. Emerg. Med. 2001. Vol. 8. P. 716–720.
  27. Lammers R.L., Hudson D.L., Seaman M.E. Prediction of traumatic wound infection with a neural network-derived decision model // Am. J. Emerg. Med. 2003. Vol. 21. P. 1–7.
  28. Luck R.P., Flood R., Eyal D. et al. Cosmetic outcomes of absorbable versus nonabsorbable sutures in pediatric facial lacerations // Pediatr. Emerg. Care. 2008. Vol. 24. P. 137–142.
  29. Nakamura Y., Daya M. Use of appropriate antimicrobials in wound management // Emerg. Med. Clin. North Am. 2007. Vol. 25. P. 159–176.
  30. Singer A.J., Dagum A.B. Current management of acute cutaneous wounds // N. Engl. J. Med. 2008. Vol. 359. P. 1037–1046.
  31. Singer A.J., Hollander J.E., Quinn J.V. Evaluation and management of traumatic lacerations // N. Engl. J. Med. 1997. Vol. 337. P. 1142–1148.
  32. Singer A.J., Kinariwala M., Lirov R. et al. Patterns of use of topical skin adhesives in the emergency department // Acad. Emerg. Med. 2010. Vol. 17. P. 670–672.
  33. Singer A.J., Thode H.C. Jr., Hollander J.E. National trends in ED lacerations between 1992 and 2002 // Am. J. Emerg. Med. 2006. Vol. 24. P. 183–188.
  34. Sinha M., Christopher N.C., Fenn R. et al. Evaluation of nonpharmacologic methods of pain and anxiety management for laceration repair in the pediatric emergency department // Pediatrics. 2006. Vol. 117. P. 1162–1168.
  35. Spiro D.M., Zonfrillo M.R., Meckler G.D. Wounds // Pediatr. Rev. 2010. Vol. 31. P. 326–334.
  36. Xu B., Xu B., Wang L. et al. Absorbable versus nonabsorbable sutures for skin closure: a meta-analysis of randomized controlled trials // Ann. Plast. Surg. 2016. Vol. 76. P. 598–606.
  37. Adelson P.D., Wisniewski S.R., Beca J. et al. Comparison of hypothermia and normothermia after severe traumatic brain injury in children (cool kids): a phase 3, randomized controlled trial // Lancet Neurol. 2013. Vol. 12. P. 546–553.
  38. Andrews P.J.D., Sinclair L., Rodriguez A. et al. Hypothermia for intracranial hypertension after traumatic brain injury // N. Engl. J. Med. 2015. Vol. 373. N. 25. P. 2403–2412.
  39. Babl F.E., Borland M.L., Phillips N. et al. Accuracy of PECARN, CATCH, and CHALICE head injury decision rules in children: prospective cohort study // Lancet. 2017. Vol. 389. P. 2393–2402.
  40. Bell M.J., Adelson P.D., Hutchison J.S. et al. Differences in medical therapy goals for children with severe traumatic brain injury—an international study // Pediatr. Crit. Care Med. 2013. Vol. 14. P. 811–818.
  41. Chesnut R.M., Temkin N., Carney N. et al. A trial of intracranial-pressure monitoring in traumatic brain injury // N. Engl. J. Med. 2012. Vol. 367. P. 2471–2481.
  42. Chin K.H., Bell M.J., Wisniewski S.R. et al. Effect of administration of neuromuscular blocking agents in children with severe traumatic brain injury (TBI) on acute complication rates and outcomes: a secondary analysis from a randomized, controlled trial of therapeutic hypothermia // Pediatr. Crit. Care Med. 2015. Vol. 16. P. 352–358.
  43. Crompton E.M., Lubomiriva I., Cotlarcius I. et al. Meta-analysis of therapeutic hypothermia for traumatic brain injury in adult and pediatric patients // Crit. Care Med. 2017. Vol. 45. N. 4. P. 575–583,
  44. Edlow J.A., Rabinstein A., Traub S.J. et al. Diagnosis of reversible causes of coma // Lancet. 2014. Vol. 384. P. 2064–2076.
  45. Heather N., Cutfield W. Traumatic brain injury: is the pituitary out of harm’s way? // J. Pediatr. 2011. Vol. 159. P. 686–690.
  46. Hutchinson P.J., Kolias A.G., Czosnyka M. et al. Intracranial pressure monitoring in severe traumatic brain injury // BMJ. 2013. Vol. 346. P. f1000.
  47. Hutchinson P.J., Kolias A.G., Timofeev E.A. et al. Trial of decompressive craniectomy for traumatic intracranial hypertension // N. Engl. J. Med. 2016. Vol. 375. N. 12. P. 1119–1130.
  48. Jamal A., Sankhyan N., Jayashree M. et al. Full outline of unresponsiveness score and the Glasgow coma scale in prediction of pediatric coma // World J. Emerg. Med. 2017. Vol. 8. P. 55–60.
  49. Kochanek P.M., Carney N., Adelson P.D. et al. Guidelines for the acute medical management of severe traumatic brain injury in infants, children, and adolescents—second edition // Pediatr. Crit. Care Med. 2012. Vol. 13. Suppl. 1. P. S1–S82.
  50. Meinert E., Bell M.J., Buttram S. et al. Initiating nutritional support before 72 hours is associated with favorable outcome after severe traumatic brain injury in children: a secondary analysis of a randomized, controlled trial of therapeutic hypothermia // Pediatr. Crit. Care Med. 2018. Vol. 19. P. 345–352.
  51. Mellion S.A., Bennett K.S., Ellsworth G.L. et al. High-dose barbiturates for refractory intracranial hypertension in children with severe traumatic brain injury // Pediatr. Crit. Care Med. 2013. Vol. 14. P. 239–247.
  52. Miller Ferguson N., Shein S.L., Kochanek P.M. et al. Intracranial hypertension and cerebral hypoperfusion in children with severe traumatic brain injury: thresholds and burden in accidental and abusive insults // Pediatr. Crit. Care Med. 2016. Vol. 17. P. 444–450.
  53. Mtaweh H., Smith R., Kochanek P.M. et al. Energy expenditure in children after severe traumatic brain injury // Pediatr. Crit. Care Med. 2014. Vol. 15. P. 242–249.
  54. National Center for Health Statistics: Percentage of traumatic brain injury (TBI)-related deaths by underlying cause and age group—United States // MMWR Morb. Mortal. Wkly Rep. 2013. Vol. 64. N. 19. P. 539–2015.
  55. Rhee C.J., Kobler K.K., Brady K.M. et al. Detection of neurologic injury using vascular reactivity monitoring and glial fibrillary acidic protein // Pediatrics. 2013. Vol. 131. P. e950–e954.
  56. Shein S.L., Ferguson N.M., Kochanek P.M. et al. Effectiveness of pharmacological therapies for intracranial hypertension in children with severe traumatic brain injury—results from an automated data collection system time-synched to drug administration // Pediatr. Crit. Care Med. 2016. Vol. 17. P. 236–245.
  57. Smith R.L., Lin J.C., Adelson P.D. et al. Relationship between hyperglycemia and outcome in children with severe traumatic brain injury // Pediatr. Crit. Care Med. 2012. Vol. 13. P. 85–91.
  58. Tasker R.C., Vonberg F.W., Ulano E.D., Akhondi-Asl A. Updating evidence for using hypothermia in pediatric severe traumatic brain injury: conventional and bayesian meta-analytic perspectives // Pediatr. Crit. Care Med. 2017. Vol. 18. N. 4. P. 355–362.
  59. The Lancet. The burden of traumatic brain injury in children // Lancet. 2018. Vol. 391. P. 813.
  60. Vavilala M., Lee L.A., Lam A.M. The lower limit of cerebral autoregulation in children during sevoflurane anesthesia // J. Neurosurg. Anesthesiol. 2003. Vol. 15. P. 307–312.
  61. Watson H.I., Shepherd A.A., Rhodes J.K.J., Andrews P.J.D. Revisited: a systematic review of therapeutic hypothermia for adult patients following traumatic brain injury // Crit. Care Med. 2018. Vol. 46. N. 6. P. 972–979.
  62. Welch T.P., Wallendorf M.J., Kharasch E.D. et al. Fentanyl and midazolam are ineffective in reducing episodic intracranial hypertension in severe pediatric traumatic brain injury // Crit. Care Med. 2016. Vol. 44. P. 809–818.
  63. American Academy of Pediatrics Task Force on Brain Death in Children. Guidelines for the determination of brain death in children // Pediatrics. 1987. Vol. 80. P. 298–300.
  64. Nakagawa T.A., Ashwal S., Mathur M. et al. Guidelines for the determination of brain death in infants and children: an update of the 1987 task force recommendations // Pediatrics. 2011. Vol. 128. P. e720–e740.
  65. Al Dhahri K.N., Potts J.E., Chiu C.C. et al. Are implantable loop recorders useful in detecting arrhythmias in children with unexplained syncope? // Pacing Clin. Electrophysiol. 2009. Vol. 32. P. 1422–1427.
  66. Anderson J.B., Czosek R.J., Cnota J. et al. Pediatric syncope: national hospital ambulatory medical care survey results // J. Emerg. Med. 2012. Vol. 43. P. 575–583.
  67. Dovgalyuk J., Holstege C., Mattu A. et al. The electrocardiogram in the patient with syncope // Am. J. Emerg. Med. 2007. Vol. 25. P. 688–701.
  68. Evans W.N., Acherman R., Kip K. et al. Hair-grooming syncope in children // Clin. Pediatr. (Phila.). 2009. Vol. 48. P. 834–836.
  69. Frangini P.A., Cecchin F., Jordao L. et al. How revealing are insertable loop recorders in pediatrics? // Pacing Clin. Electrophysiol. 2008. Vol. 31. P. 338–343.
  70. Friedman K.G., Alexander M.E. Chest pain and syncope in children: a practical approach to the diagnosis of cardiac disease // J. Pediatr. 2013. Vol. 163. P. 896–901.
  71. MacCormick J.M., Crawford J.R., Chung S.K. et al. Symptoms and signs associated with syncope in young people with primary cardiac arrhythmias // Heart Lung. Circ. 2011. Vol. 20. P. 593–598.
  72. Moodley M. Clinical approach to syncope in children // Semin. Pediatr. Neurol. 2013. Vol. 20. P. 12–17.
  73. Shen W.K., Sheldon R.S., Benditt D.G. et al. 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope // J. Am. Coll. Cardiol. 2017. Vol. 14. N. 8. P. e155–e217.
  74. Singer W., Sletten D.M., Opfer-Gehrking T.L. et al. Postural tachycardia in children and adolescents: what is abnormal? // J. Pediatr. 2012. Vol. 160. P. 222–226.
  75. Strieper M.J. Distinguishing benign syncope from life-threatening cardiac causes of syncope // Semin. Pediatr. Neurol. 2005. Vol. 12. P. 32–38.
  76. Tan C., Sim T.B., Thng S.Y. Validation of the San Francisco syncope rule in two hospital emergency departments in an Asian population // Acad. Emerg. Med. 2013. Vol. 20. P. 487–497.
  77. Tretter J.T., Kavey R.E.W. Distinguishing cardiac syncope from vasovagal syncope in a referral population // J. Pediatr. 2013. Vol. 163. P. 1618–1623.
  78. Varosy P.D., Chen L.Y., Miller A.M. et al. Pacing as a treatment for reflex-mediated (vasovagal, situational, or carotis sinus hypersensitivity) syncope: a systematic review for the 2017 ACC/AHA/HRS guideline for the evaluation and management of patients with syncope // J. Am. Coll. Cardiol. 2017. Vol. 70. N. 5. P. 664–679.
  79. Anderson J.B., Willis M.W. Differentiating between postural tachycardia syndrome and vasovagal syncope // Pediatrics. 2017. Vol. 139. N. 4. P. e20164161.
  80. Benarroch E.E. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder // Mayo Clin. Proc. 2012. Vol. 87. N. 12. P. 1214–1225.
  81. Chelimsky G., Kovacic K., Nugent M. et al. Comorbid conditions do not differ in children and young adults with functional disorders with or without postural tachycardia syndrome // J. Pediatr. 2015. Vol. 167. N. 1. P. 120–124.
  82. Chelimsky G., Kovacic K., Simpson P. et al. Benign joint hypermobility minimally impacts autonomic abnormalities in pediatric subjects with chronic functional pain disorders // J. Pediatr. 2016. Vol. 177. P. 49–52.
  83. Chen L., Wang L., Sun J. et al. Midodrine hydrochloride is effective in the treatment of children with postural orthostatic tachycardia syndrome // Circulation. 2011. Vol. 75. N. 4. P. 927–931.
  84. El-Sayed H., Hainsworth R. Salt supplement increases plasma volume and orthostatic tolerance in patients with unexplained syncope // Heart. 1996. Vol. 75. N. 2. P. 134–140.
  85. Fortunato J.E., Shaltout H.A., Larkin M.M. et al. Fludrocortisone improves nausea in children with orthostatic intolerance (OI) // Clin. Auton. Res. 2011. Vol. 21. N. 6. P. 419–423.
  86. Fortunato J.E., Wagoner A.L., Harbinson R.L. et al. Effect of fludrocortisone acetate on chronic unexplained nausea and abdominal pain in children with orthostatic intolerance // J. Pediatr. Gastroenterol. Nutr. 2014. Vol. 59. N. 1. P. 39–43.
  87. Freeman R., Wieling W., Axelrod F.B. et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome // Clin. Auton. Res. 2011. Vol. 21. N. 2. P. 69–72.
  88. Freitas J., Santos R., Azevedo E. et al. Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone // Clin. Auton. Res. 2000. Vol. 10. N. 5. P. 293–299.
  89. Fu Q., Levine B.D. Exercise in the postural orthostatic tachycardia syndrome // Auton. Neurosci. 2015. Vol. 188. P. 86–89.
  90. Gazit Y., Nahir A.M., Grahame R., Jacob G. Dysautonomia in the joint hypermobility syndrome // Am. J. Med. 2003. Vol. 115. P. 33–40.
  91. Hoeldtke R.D., Horvath G.G., Bryner K.D., Hobbs G.R. Treatment of orthostatic hypotension with midodrine and octreotide // J. Clin. Endocrinol. Metab. 1998. Vol. 83. N. 2. P. 339–343.
  92. Jones P.K., Shaw B.H., Raj S.R. Clinical challenges in the diagnosis and management of postural tachycardia syndrome // Pract. Neurol. 2016. Vol. 16. N. 6. P. 431–438.
  93. Kanjwal K., Karabin B., Sheikh M. et al. Pyridostigmine in the treatment of postural orthostatic tachycardia: a single-center experience // Pacing Clin. Electrophysiol. 2011. Vol. 34. N. 6. P. 750–755.
  94. Kanjwal K., Saeed B., Karabin B. et al. Comparative clinical profile of postural orthostatic tachycardia patients with and without joint hypermobility syndrome // Indian Pacing Electrophysiol. J. 2010. Vol. 10. N. 4. P. 173–178.
  95. Lai C.C., Fischer P.R., Brands C.K. et al. Outcomes in adolescents with postural orthostatic tachycardia syndrome treated with midodrine and beta-blockers // Pacing Clin. Electrophysiol. 2009. Vol. 32. N. 2. P. 234–238.
  96. Lawal A., Barboi A., Krasnow A. et al. Rapid gastric emptying is more common than gastroparesis in patients with autonomic dysfunction // Am. J. Gastroenterol. 2007. Vol. 102. N. 3. P. 618–623.
  97. Li H., Yu X., Liles C. et al. Autoimmune basis for postural tachycardia syndrome // J. Am. Heart Assoc. 2014. Vol. 3. P. e000755.
  98. Li J., White J., Guo L. et al. Salt inactivates endothelial nitric oxide synthase in endothelial cells // J. Nutr. 2009. Vol. 139. N. 3. P. 447–451.
  99. Macarthur H., Wilken G.H., Westfall T.C., Kolo L.L. Neuronal and non-neuronal modulation of sympathetic neurovascular transmission // Acta Physiol. (Oxf.). 2011. Vol. 203. N. 1. P. 37–45.
  100. May M., Jordan J. The osmopressor response to water drinking // Am. J. Physiol. 2011. Vol. 300. N. 1. P. R40–R46.
  101. Medow M.S., Merchant S., Suggs M. et al. Postural heart rate changes in young patients with vasovagal syncope // Pediatrics. 2017. Vol. 139. N. 4. P. e20163189.
  102. Ojha A., Chelimsky T.C., Chelimsky G. Comorbidities in pediatric patients with postural tachycardia syndrome // J. Pediatr. 2011. Vol. 158. N. 1. P. 20–23.
  103. Park K.J., Singer W., Sletten D.M. et al. Gastric emptying in postural tachycardia syndrome: a preliminary report // Clin. Auton. Res. 2013. Vol. 23. N. 4. P. 163–167.
  104. Plash W.B., Diedrich A., Biaggioni I. et al. Diagnosing postural tachycardia syndrome: comparison of tilt testing compared with standing haemodynamics // Clin. Sci. (Lond.). 2013. Vol. 124. N. 2. P. 109–114.
  105. Raj S.R., Black B.K., Biaggioni I. et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more // Circulation. 2009. Vol. 120. N. 9. P. 725–734.
  106. Raj S.R., Biaggioni I., Yamhure P.C. et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome // Circulation. 2005. Vol. 111. N. 13. P. 1574–1582.
  107. Robertson D., Biaggioni I., Burnstock G., Low P.A. Primer on the autonomic nervous system. Ed. 2. New York, 2004.
  108. Robertson D., Flattem N., Tellioglu T. et al. Familial orthostatic tachycardia due to norepinephrine transporter deficiency // Ann. N. Y. Acad. Sci. 2001. Vol. 940. P. 527–543.
  109. Ross A.J., Ocon A.J., Medow M.S., Stewart J.M. A double-blind placebo-controlled crossover study of the vascular effects of midodrine in neuropathic compared with hyperadrenergic postural tachycardia syndrome // Clin. Sci. (Lond.). 2014. Vol. 126. N. 4. P. 289–296.
  110. Safder S., Chelimsky T.C., O’Riordan M.A., Chelimsky G. Gastric electrical activity becomes abnormal in the upright position in patients with postural tachycardia syndrome // J. Pediatr. Gastroenterol. Nutr. 2010. Vol. 51. N. 3. P. 314–318.
  111. Sandroni P., Opfer-Gehrking T.L., McPhee B.R., Low P.A. Postural tachycardia syndrome: clinical features and follow-up study // Mayo Clin. Proc. 1999. Vol. 74. N. 11. P. 1106–1110.
  112. Sheriff D.D., Nadland I.H., Toska K. Role of sympathetic responses on the hemodynamic consequences of rapid changes in posture in humans // J. Appl. Physiol. (1985). 2010. Vol. 108. N. 3. P. 523–532.
  113. Singer W., Sletten D.M., Opfer-Gehrking T.L. et al. Postural tachycardia in children and adolescents: what is abnormal? // J. Pediatr. 2012. Vol. 160. N. 2. P. 222–226.
  114. Skinner J.E., Driscoll S.W., Porter C.B. et al. Orthostatic heart rate and blood pressure in adolescents: reference ranges // J. Child Neurol. 2010. Vol. 25. N. 10. P. 1210–1215.
  115. Stewart J.M. Common syndromes of orthostatic intolerance // Pediatrics. 2013. Vol. 131. N. 5. P. 968–980.
  116. Sullivan S., Hanauer J., Rowe P. et al. Gastrointestinal symptoms associated with orthostatic intolerance // J. Pediatr. Gastroenterol. Nutr. 2005. Vol. 40. P. 425–428.
  117. Vernino S. Neurologic autoantibodies: cautious enthusiasm // Neurology. 2005. Vol. 65. N. 11. P. 1688–1689.
  118. Vernino S., Sandroni P., Singer W., Low P.A. Invited article: autonomic ganglia: target and novel therapeutic tool // Neurology. 2008. Vol. 70. N. 20. P. 1926–1932.
  119. Wieling W., Krediet C.T., van Dijk N. et al. Initial orthostatic hypotension: review of a forgotten condition // Clin. Sci. (Lond.). 2007. Vol. 112. N. 3. P. 157–165.
  120. Zhang Q., Chen X., Li J., Du J. Orthostatic plasma norepinephrine level as a predictor for therapeutic response to metoprolol in children with postural tachycardia syndrome // J. Transl. Med. 2014. Vol. 12. P. 249.
  121. Zhang Q., Liao Y., Tang C. et al. Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome // J. Pediatr. 2012. Vol. 161. N. 2. P. 281–284.
  122. Angus C.D., van der Poll T. Severe sepsis and septic shock // N. Engl. J. Med. 2013. Vol. 369. P. 840–850.
  123. Annane D., Renault A., Brun-Buisson C. et al. Hydrocortisone plus fludrocortisone for adults with septic shock // N. Engl. J. Med. 2018. Vol. 378. N. 9. P. 809–818.
  124. Annane D., Siami S., Jaber S. et al. Effects of fluid resuscitation with colloids vs crystalloids on mortality in critically ill patients presenting with hypovolemic shock // JAMA. 2013. Vol. 310. P. 1809–1817.
  125. Boonen E., Vervenne H., Meersseman P. et al. Reduced cortisol metabolism during critical illness // N. Engl. J. Med. 2013. Vol. 368. P. 1477–1488.
  126. Cannon J.W. Hemorrhagic shock // N. Engl. J. Med. 2018. Vol. 378. N. 4. P. 370–379.
  127. Casserly B., Gerlach H., Phillips G.S. et al. Low-dose steroids in adult septic shock: results of the Surviving Sepsis campaign // Intensive Care Med. 2012. Vol. 38. P. 1946–1954.
  128. Davis A.L., Carcillo J.A., Aneja R.K. et al. American College of Critical Care Medicine clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock // Crit. Care Med. 2017. Vol. 45. P. 1061–1093.
  129. De Backer D., Dorman T. Surviving sepsis guidelines: a continuous move toward better care of patients with sepsis // JAMA. 2017. Vol. 317. N. 8. P. 807–808.
  130. Delaney A.P., Dan A., McCaffrey J. et al. The role of albumin as a resuscitation fluid for patients with sepsis: a systematic review and meta-analysis // Crit. Care Med. 2011. Vol. 39. P. 386–391.
  131. Dellinger P.R., Levy M.M., Rhodes A. et al. Surviving Sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012 // Crit. Care Med. 2013. Vol. 41. N. 2. P. 580–637.
  132. Duke T. What the African fluid-bolus trial means // Lancet. 2011. Vol. 378. P. 1685–1687.
  133. Haase N., Perner A., Hennings L.I. et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis // BMJ. 2013. Vol. 346. P. f839.
  134. Havel C., Arrich J., Losert H. et al. Vasopressors for hypotensive shock (review) // Cochrane Database Syst. Rev. 2011. CD003709.
  135. Henning D.J., Puskarich M.A., Self W.S. et al. An emergency department validation of the SEP-3 sepsis and septic shock definitions and comparison with 1992 consensus definitions // Ann. Emerg. Med. 2017. Vol. 70. N. 4. P. 544–552.
  136. Howell M.D., Davis A.M. Management of sepsis and septic shock // JAMA. 2017. Vol. 317. N. 8. P. 847–848.
  137. Khanna A., English S.W., Wang X.S. et al. Angiotensin II for the treatment of vasodilatory shock // N. Engl. J. Med. 2017. Vol. 377. N. 5. P. 419–430.
  138. Kim Y.A., Ha E.J., Jhang W.K. et al. Early blood lactate area as a prognostic marker in pediatric septic shock // Intensive Care Med. 2013. Vol. 39. P. 1818–1823.
  139. Larsen G.Y., Mecham N., Grenberg R. An emergency department septic shock protocol and care guideline for children initiated at triage // Pediatrics. 2011. Vol. 127. P. e1585–e1592.
  140. Levy B., Perez P., Perny J. et al. Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock: a prospective, randomized pilot study // Crit. Care Med. 2011. Vol. 39. P. 450–455.
  141. Maitland K., Kiguli S., Opoka R.O. et al. Mortality after fluid bolus in African children with severe infection // N. Engl. J. Med. 2011. Vol. 364. P. 2483–2495.
  142. Mearelli F., Fiotto N., Giansante C. et al. Derivation and validation of a biomarker-based clinical algorithm to rule out sepsis from noninfectious systematic inflammatory response syndrome at emergency department admission: a multicenter prospective study // Crit. Care Med. 2018. Vol. 46. N. 9. P. 1421–1429.
  143. The Medical Letter. Vasopressors and inotropes // Med. Lett. Drugs Ther. 2011. Vol. 53. P. 90–92.
  144. Menon K., McNally D., Choong K. et al. A systematic review and meta-analysis on the effect of steroids in pediatric shock // Pediatr. Crit. Care Med. 2013. Vol. 14. N. 5. P. 474–480.
  145. Mickiewicz B., Vogel H.J., Wong H.R. et al. Metabolomics as a novel approach for early diagnosis of pediatric septic shock and its mortality // Am. J. Respir. Crit. Care Med. 2013. Vol. 187. N. 9. P. 967–976.
  146. Mtaweh H., Trakas E.V., Su E. et al. Advances in monitoring and management of shock // Pediatr. Clin. North Am. 2013. Vol. 60. N. 3. P. 641–654.
  147. Parker M.J., Parshuram C.S. Sodium bicarbonate use in shock and cardiac arrest: attitudes of pediatric acute care physicians // Crit. Care Med. 2013. Vol. 41. P. 2188–2195.
  148. Pinsky M.R. Is there a role for â-blockade in septic shock? JAMA 310:1677–1678, 2013.
  149. PRISM Investigators: Early, goal-directed therapy for septic shock: a patient-level meta-analysis // N. Engl. J. Med. 2017. Vol. 376. N. 23. P. 2223–2234.
  150. Prowle J.R., Pearse R.M. Is it the end of the road for synthetic starches in critical illness? // BMJ. 2013. Vol. 346. P. f1805.
  151. Ramar K., Gajic O. Early recognition and treatment of severe sepsis // Am. J. Respir. Crit. Care Med. 2013. Vol. 188. P. 7–8.
  152. Ranieri V.M., Thompson B.T., Barie P.S. et al. Drotrecogin alfa (activated) in adults with septic shock // N. Engl. J. Med. 2012. Vol. 366. P. 2055–2064.
  153. Rhodes A., Evans L.E., Alhazzani W. et al. Surviving Sepsis campaign: international guidelines for management of sepsis and septic shock: 2016 // Intensive Care Med. 2017. Vol. 43. N. 3. P. 304–377.
  154. Schortgen F., Clabault K., Katsahian S. et al. Fever control using external cooling in septic shock // Am. J. Respir. Crit. Care Med. 2012. Vol. 185. P. 1088–1095.
  155. Scott H.F., Brou L., Deakyne S.J. et al. Lactate clearance and normalization and prolonged organ dysfunction in pediatric sepsis // J. Pediatr. 2016. Vol. 170. P. 149–155.
  156. Singer M., Deutschman C.S., Seymour C.W. et al. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3) // JAMA. 2016. Vol. 315. N. 8. P. 801–810.
  157. Stevenson E.K., Rubenstein A.R., Radin G.T. et al. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis // Crit. Care Med. 2014. Vol. 42. N. 3. P. 625–631.
  158. Vasu T.S., Cavallazzi R., Hirani A. et al. Norepinephrine or dopamine for septic shock: a systematic review of randomized clinical trials // J. Intensive Care Med. 2011. Vol. 27. P. 172–178.
  159. Venkatesh B., Finfer S., Cohen J. et al. Adjunctive glucocorticoid therapy in patients with septic shock // N. Engl. J. Med. 2018. Vol. 378. N. 9. P. 797–808.
  160. Vincent J.L., De Backer D. Circulatory shock // N. Engl. J. Med. 2013. Vol. 369. P. 1726–1734.
  161. Wong H.R. Genetics and genomics in pediatric septic shock // Crit. Care Med. 2012. Vol. 40. N. 5. P. 1618–1626.
  162. Westwood M., Ramaekers B., Whiting P. et al. Procalcitonin testing to guide antibiotic therapy for the treatment of sepsis in intensive care settings and for suspected bacterial infection in emergency department settings: a systematic review and cost-effectiveness analysis // Health Technol. Assess. 2015. Vol. 19. N. 96. P. XIX–XXV.
  163. Wong H.R., Salisbury S., Xiao Q. et al. The pediatric sepsis biomarker risk model // Crit. Care. 2012. Vol. 16. N. 5. P. R174.
  164. Zarychanski R., Abou-Setta A.M., Turgeon A.F. et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation // JAMA. 2013. Vol. 309. P. 678–688.
  165. ARISE Investigators and ANZICS Clinical Trials Group: Goal-directed resuscitation for patients with early septic shock, N Engl J Med 371:1496–1506, 2014.
  166. Asfar P, Meziani F, Hamel JF, et al: High versus low blood-pressure target in patients with septic shock, N Engl J Med 370:1583–1592, 2014.
  167. Caironi P, Tognoni G, Masson S, et al: Albumin replacement in patients with severe sepsis or septic shock, N Engl J Med 370:1412–1421, 2014.
  168. Chernick V, West J: The functional basis of respiratory disease. In Chernick V, Boat TF, Wilmott RW, et al, editors: Kendig’s disorders of the respiratory tract in children, ed 7, Philadelphia, 2006, Saunders, pp 29–64.
  169. De Caen A, et al: Airway management. In Nichols DG, Ackerman AD, Carcillo JA, et al, editors: Rogers’ textbook of pediatric intensive care, ed 4, Philadelphia, 2008, Lippincott Williams & Wilkins, pp 303–322.
  170. De Luca D, Piastra M, Chidini G, et al: The use of the Berlin definition for acute respiratory distress syndrome during infancy and early childhood: multicenter evaluation and expert consensus, Intensive Care Med 39:2083–2091, 2013.
  171. Holst LB, Haase N, Wetterslev J, et al: Lower versus higher hemoglobin threshold for transfusion in septic shock, N Engl J Med 371:1381–1390, 2014.
  172. Kilpatrick FA, Wilson W: Arterial and capillary blood gas analysis. In Barnhart S, Czervinske M, editors: Perinatal and pediatric respiratory care, Philadelphia, 1995, Saunders, pp 114–129.
  173. Leaver SK, Evans TW: Acute respiratory distress syndrome, BMJ 335:389–394, 2007.
  174. Lumb AM: Pulmonary ventilation. In Nunn’s applied respiratory physiology, ed 6, Philadelphia, 2005, Elsevier/Butterworth Heinemann, pp 76–91.
  175. ProCESS Investigators: A randomized trial of protocol-based care for early septic shock, N Engl J Med 370:1683–1692, 2014.
  176. Ranieri VN, Rubenfeld GD, Thompson BT, et al: ARDS definition task force: acute respiratory distress syndrome—the Berlin definition, JAMA 307:2526–2533, 2012.
  177. Rochwerg B, Alhazzani W, Sindi A, et al: Fluid resuscitation in sepsis, Ann Intern Med 161:347–355, 2014.
  178. Vender J, Clemency M: Oxygen delivery systems, inhalational therapy and respiratory therapy. In Benumof J, editor: Airway management: principles and practice, Philadelphia, 1996, Mosby, pp 205–227.
  179. Wheeler AP, Bernard GR: Acute lung injury and the acute respiratory distress syndrome: a clinical review, Lancet 369:1553–1564, 2007.
  180. Wratney A, Hamel D, Cheifetz I: Inhaled gases. In Nichols DG, Ackerman AD, Carcillo JA, et al, editors: Rogers’ textbook of pediatric intensive care, ed 4, Philadelphia, 2008, Lippincott Williams & Wilkins, pp 532–543
  181. Albuali WH, Singh RN, Frasier DD, et al: Have changes in ventilation practices improved outcome in children with acute lung injury?, Pediatr Crit Care Med 8:324–330, 2007.
  182. Bronicki RA, Anas NG: Cardiopulmonary interactions, Pediatr Crit Care Med 10:313–322, 2009.
  183. Brower RG, Lanken PN, MacIntyre N, National Heart, Lung, and Blood Institute ARDS Clinical Trials Network, et al: Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome, N Engl J Med 351:327–336, 2004.
  184. Campbell RS, Davis BR: Pressure-controlled versus volume-controlled ventilation: does it matter?, Respir Care 47:416–424, 2002.
  185. Chu DK, Kim LHY, Youg PJ, et al: Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis, Lancet 391:1693–1704, 2018.
  186. Combes A, Hajage D, Capellier G, et al: Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome, N Engl J Med 378(21):1965–1974, 2018.
  187. Goligher EC, Ferguson ND, Brochard LJ: Clinical challenges inmechanical ventilation, Lancet 387:1856–1866, 2016.
  188. Greenough A, Dimitriou G, Prendergast M, et al: Synchronized mechanical ventilation for respiratory support in newborn infants, Cochrane Database Syst Rev (1):CD000456, 2008.
  189. Leme AC, Hajjar LA, Volpe MS, et al: Effect of intensive vs moderate alveolar recruitment strategies added to lung-protective ventilation on postoperative pulmonary complications, JAMA 317(4):1422–1432, 2017.
  190. Mac Sweeney R, McAuley DF: Acute respiratory distress syndrome, Lancet 388: 2416–2430, 2016.
  191. Marraro GA: Innovative practices of ventilatory support with pediatric patients, Pediatr Crit Care Med 4:8–17, 2004.
  192. Meade MO, Cook DJ, Guyatt GH, et al: Ventilation strategy using low tidal volumes, recruitment maneuvers, and high positive end-expiratory pressure for acute lung injury and acute respiratory distress syndrome, JAMA 299:637–645, 2008.
  193. Mercat A, Richard JCM, Vielle B, et al: Positive end-expiratory pressure setting in adults with acute lung injury and acute respiratory distress syndrome, JAMA
  194. Newth CJ, Venkataraman S, Willson DF, et al: Weaning and extubation readiness in pediatric patients, Pediatr Crit Care Med 10:1–11, 2009.
  195. Papazian L, Forel JM, Gacouin A, et al: Neuromuscular blockers in early acute respiratory distress syndrome, N Engl J Med 363(12):1107–1116, 2010.
  196. Pearse RM, Young JD: Steroids to prevent postextubation laryngeal oedema, Lancet 369:1060–1061, 2007.
  197. Pinhu L, Whitehead T, Evans T, et al: Ventilator-associated lung injury, Lancet 361:332–340, 2003.
  198. Priestley MA, Helfaer MA: Approaches in the management of acute respiratory failure in children, Curr Opin Pediatr 16:293–298, 2004.
  199. Randolph A: Management of acute lung injury and acute respiratory distress syndrome in children, Crit Care Med 37:2448–2454, 2009.
  200. Reade MC, Eastwood GM, Bellomo R, et al: Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium, JAMA 315(14):1460–1468, 2016.
  201. Sarnaik AP, Daphtary K, Meert KL, et al: Pressure controlled ventilation in children with status asthmaticus, Pediatr Crit Care Med 5:133–138, 2004.
  202. Schweickert WD, Pohlman MC, Pohlman AS, et al: Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomized controlled trial, Lancet 373:1874–1882, 2009.
  203. Siemieniuk RAC, Chu DK, Kim LHY, et al: Oxygen therapy for acutely ill medical patients: a clinical practice guideline, BMJ 363:4169, 2018.
  204. Spoletini G, Garpestad E, Hill NS: High-flow nasal oxygen or noninvasive ventilation for postextubation hypoxemia: flow vs pressure?, JAMA 315(13):1340–1342, 2016.
  205. Srinivasan R, Asselin J, Gildengorin G, et al: A prospective study of ventilator-associated pneumonia in children, Pediatrics 123:1108–1115, 2009.
  206. Thompson BT, Chambers RC, Liu KD: Acute respiratory distress syndrome, N Engl J Med 377(6):562–572, 2017.
  207. Xu XP, Zhang XC, Hu SL, et al: Noninvasive ventilation in acute hypoxemic nonhypercapnic respiratory failure: a systematic review and meta-analysis, Crit Care Med 45(7):e727–e733, 2017.
  208. Allemann Y., Stuber T., de Marchi S.F. et al. Pulmonary artery pressure and cardiac function in children and adolescents after rapid ascent to 3,450 m // Am. J. Physiol. Heart. Circ. Physiol. 2012. Vol. 302. N. 12. P. H2646–H2653.
  209. Alvaro R., Alvarez J., Kwiatkowski K. et al. Small preterm infants (<1500 g) have only a sustained decrease in ventilation in response to hypoxia // Pediatr. Res. 1992. Vol. 32. P. 403–406.
  210. Asano K., Mazzeo R.S., McCullough R.E. et al. Relation of sympathetic activation in man at 4300 meters altitude // Aviat. Space Environ. Med. 1997. Vol. 68. P. 104–110.
  211. Bailey D.M., Bartsch P., Knauth M. et al. Emerging concepts in acute mountain sickness and high-altitude cerebral edema: from the molecular to the morphological // Cell Mol. Life Sci. 2009. Vol. 66. N. 22. P. 3583–3594.
  212. Bartsch P., Mairbaurl H., Swenson E.R. et al. High altitude pulmonary oedema // Swiss Med. Wkly. 2003. Vol. 133. N. 27/28. P. 377–384.
  213. Bartsch P., Swenson E.R. Acute high-altitude illness // N. Engl. J. Med. 2013. Vol. 368. P. 2294–2302.
  214. Berger M.M., Hesse C., Dehnert C. et al. Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema // Am. J. Respir. Crit. Care Med. 2005. Vol. 172. N. 6. P. 763–767.
  215. Bloch J., Duplain H., Rimoldi S.F. et al. Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters // Pediatrics. 2009. Vol. 123. N. 1. P. 1–5.
  216. Burtscher M., Netzer N., Strohl K. et al. Hypoxia-related altitude illnesses // J. Travel. Med. 2013. Vol. 20. N. 4. P. 247–255.
  217. Carpenter T.C., Stenmark K.R. Predisposition of infants with chronic lung disease to respiratory syncytial virus-induced respiratory failure: a vascular hypothesis // Pediatr. Infect. Dis. J. 2004. Vol. 23. Suppl. 1. P. S33–S40.
  218. Claster S., Godwin M.J., Embury S.H. Risk of altitude exposure in sickle cell disease // West J. Med. 1981. Vol. 135. P. 364–367.
  219. Das B.B., Wolfe R.R., Chan K.C. et al. High-altitude pulmonary edema in children with underlying cardiopulmonary disorders and pulmonary hypertension living at altitude // Arch. Pediatr. Adolesc. Med. 2004. Vol. 158. N. 12. P. 1170–1176.
  220. Dehnert C., Berger M.M., Mairbaurl H. et al. High altitude pulmonary edema: a pressure-induced leak // Respir. Physiol. Neurobiol. 2007. Vol. 158. N. 2/3. P. 266–273.
  221. Drastic new rules coming very soon for visitors to Machu Picchu, Andean Air Mail and Peruvian Times, March 12, 2014.
  222. Durmowicz A.G. Pulmonary edema in 6 children with down syndrome during travel to moderate altitudes // Pediatrics. 2001. Vol. 108. N. 2. P. 443–447.
  223. Durmowicz A.G., Noordeweir E., Nicholas R., Reeves J.T. Inflammatory processes may predispose children to high-altitude pulmonary edema // J. Pediatr. 1997. Vol. 130. P. 838–840.
  224. Eldridge M.W., Podolsky A., Richardson R.S. et al. Pulmonary hemodynamic response to exercise in subjects with prior high-altitude pulmonary edema // J. Appl. Physiol. 1996. Vol. 81. N. 2. P. 911–921.
  225. Endom E.E., Hackett P., Gallagher S.A. High altitude disease: unique pediatric considerations // Post T.W. (ed.). UpTodate. Waltham: MA, 2017.
  226. Evans A.M., Dipp M. Hypoxic pulmonary vasoconstriction: cyclic adenosine diphosphateribose, smooth muscle ca(2+) stores and the endothelium // Respir. Physiol. Neurobiol. 2002. Vol. 132. N. 1. P. 3–15.
  227. Fagenholz P.J., Gutman J.A., Murray A.F. et al. Treatment of high altitude pulmonary edema at 4240 m in Nepal // High Alt. Med. Biol. 2007. Vol. 8. N. 2. P. 139–146.
  228. Fagenholz P.J., Gutman J.A., Murray A.F. et al. Chest ultrasonography for the diagnosis and monitoring of high-altitude pulmonary edema // Chest. 2007. Vol. 131. N. 4. P. 1013–1018.
  229. Fulco C.S., Beidleman B.A., Muza S.R. Effectiveness of preacclimatization strategies for high-altitude exposure // Exerc. Sport Sci. Rev. 2013. Vol. 41. N. 1. P. 55–63.
  230. Gabry A.L., Ledoux X., Mozziconacci M., Martin C. Highaltitude pulmonary edema at moderate altitude (<2,400 m; 7,870 feet): a series of 52 patients // Chest. 2003. Vol. 123. P. 49–53.
  231. Garlick V., O’Connor A., Shubkin C.D. High-altitude illness in the pediatric population: a review of the literature on prevention and treatment // Curr. Opin. Pediatr. 2017. Vol. 29. N. 4. P. 503–509.
  232. Gertsch J.H., Lipman G.S., Holck P.S. et al. Prospective, double-blind, randomized, placebo-controlled comparison of acetazolamide versus ibuprofen for prophylaxis against high altitude headache: the headache evaluation at altitude trial (HEAT) // Wilderness Environ. Med. 2010. Vol. 21. N. 3. P. 236–243.
  233. Gluecker T., Capasso P., Schnyder P. et al. Clinical and radiologic features of pulmonary edema // Radiographics. 1999. Vol. 19. N. 6. P. 1507–1531.
  234. Grunig E., Mereles D., Hildebrandt W. et al. Stress doppler echocardiography for identification of susceptibility to high altitude pulmonary edema // J. Am. Coll. Cardiol. 2000. Vol. 35. N. 4. P. 980–987.
  235. Hackett P.H., Roach R.C. High altitude cerebral edema // High Alt. Med. Biol. 2004. Vol. 5. N. 2. P. 136–146.
  236. Hackett P.H., Yarnell P.R., Hill R. et al. High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology // JAMA. 1998. Vol. 280. N. 22. P. 1920–1925.
  237. Hackett P.H. High altitude cerebral edema and acute mountain sickness: a pathophysiology update // Adv. Exp. Med. Biol. 1999. Vol. 474. P. 23–45.
  238. Imray C. Acetazolamide for the prophylaxis of acute mountain sickness // BMJ. 2012. Vol. 345. P. e7077.
  239. Jackson S.J., Varley J., Sellers C. et al. Incidence and predictors of acute mountain sickness among trekkers on mount Kilimanjaro // High Alt. Med. Biol. 2010. Vol. 11. N. 3. P. 217–222.
  240. Jensen K.M., Sevick C.J., Seewald L.A. et al. Greater risk of hospitalization in children with Down’s syndrome and OSA at higher elevation // Chest. 2015. Vol. 147. P. 1344–1351.
  241. Jin B., Luo X.P., Ni H.C., Shi H.M. Phosphodiesterase type 5 inhibitors for high-altitude pulmonary hypertension // Clin. Drug. Investig. 2010. Vol. 30. N. 4. P. 259.
  242. Kallenberg K., Bailey D.M., Christ S. et al. Magnetic resonance imaging evidence of cytotoxic cerebral edema in acute mountain sickness // J. Cereb. Blood Flow Metab. 2007. Vol. 27. N. 5. P. 1064–1071.
  243. Katz D., Shore S., Bandle B. et al. Sudden infant death syndrome and residential altitude // Pediatrics. 2015. Vol. 135. N. 6. P. e1442–e1449.
  244. Kohler M., Kriemler S., Wilhelm E.M. et al. Children at high altitude have less nocturnal periodic breathing than adults // Eur. Respir. J. 2008. Vol. 32. N. 1. P. 189–197.
  245. Kriemler S., Burgi F., Wick C. et al. Prevalence of acute mountain sickness at 3500 m within and between families: a prospective cohort study // High Alt. Med. Biol. 2014. Vol. 15. N. 1. P. 28–38.
  246. Kriemler S., Radtke T., Burgi F. et al. Short-term cardiorespiratory adaptation to high altitude in children compared with adults // Scand. J. Med. Sci. Sports. 2016. Vol. 26. N. 2. P. 147–155.
  247. Lane P.A., Githens J.H. Splenic syndrome at mountain altitudes in sickle cell trait: its occurrence in nonblack persons // JAMA. 1985. Vol. 253. P. 2252–2254.
  248. Luks A.M., McIntosh S.E., Grissom C.K. et al. Wilderness medical society practice guidelines for the prevention and treatment of acute altitude illness: 2014 update // Wilderness Environ. Med. 2014. Vol. 25. N. 4. P. S4–S14.
  249. Lhasa Statistics Bureau. Lhasa statistics yearbook 2010. Beijing: China Statistics Press, 2015.
  250. Luks A.M., Swenson E.R. Medication and dosage considerations in the prophylaxis and treatment of high-altitude illness // Chest. 2008. Vol. 133. N. 3. P. 744–755.
  251. MacInnis M.J., Koehle M.S., Rupert J.L. Evidence for a genetic basis for altitude illness: 2010 update // High Alt. Med. Biol. 2010. Vol. 11. N. 4. P. 349–368.
  252. Macinnis M.J., Wang P., Koehle M.S. et al. The genetics of altitude tolerance: the evidence for inherited susceptibility to acute mountain sickness // J. Occup. Environ. Med. 2011. Vol. 53. N. 2. P. 159–168.
  253. Maggiorini M., Brunner-La Rocca H.P., Peth S. et al. Both tadalafil and dexamethasone may reduce the incidence of high-altitude pulmonary edema: a randomized trial // Ann. Intern. Med. 2006. Vol. 145. N. 7. P. 497–506.
  254. Mahoney B.S., Githens J.H. Sickling crisis and altitude: occurrence in the colorado patient population // Clin. Pediatr. (Phila.). 1979. Vol. 18. P. 431–438.
  255. Meier D., Collet T.H., Locatelli I. et al. Does this patient have acute mountain sickness? // JAMA. 2017. Vol. 318. N. 18. P. 1810–1819.
  256. Nepal tourism statistics 2013. Government of Nepal Ministry of Culture, Tourism & Civil Aviation Planning & Evaluation, Division Statistical Section Singha Durbar; Kathmandu, July 2014.
  257. Nerin M.A., Palop J., Montano J.A. et al. Acute mountain sickness: influence of fluid intake // Wilderness Environ. Med. 2006. Vol. 17. N. 4. P. 215–220.
  258. Niermeyer S., Shaffer E.M., Thilo E. et al. Arterial oxygenation and pulmonary arterial pressure in healthy neonates and infants at high altitude // J. Pediatr. 1993. Vol. 123. N. 5. P. 767–772.
  259. Niermeyer S. Cardiopulmonary transition in the high altitude infant // High Alt. Med. Biol. 2003. Vol. 4. N. 2. P. 225–239.
  260. Niermeyer S. Going to high altitude with a newborn infant // High Alt. Med. Biol. 2007. Vol. 8. N. 2. P. 117–123.
  261. Otto C., Hamilton D.R., Levine B.D. et al. Into thin air: extreme ultrasound on mt Everest // Wilderness Environ. Med. 2009. Vol. 20. N. 3. P. 283–289.
  262. Pollard A.J., Niermeyer S., Barry P. et al. Children at high altitude: an international consensus statement by an ad hoc committee of the international society for mountain medicine, March 12, 2001 // High Alt. Med. Biol. 2001. Vol. 2. N. 3. P. 389–403.
  263. Qi Y., Niu W., Zhu T. et al. Synergistic effect of the genetic polymorphisms of the renin-angiotensin-aldosterone system on high-altitude pulmonary edema: a study from Qinghai-tibet altitude // Eur. J. Epidemiol. 2008. Vol. 23. N. 2. P. 143–152.
  264. Rexhaj E., Garcin S., Rimoldi S.F. et al. Reproducibility of acute mountain sickness in children and adults: a prospective study // Pediatrics. 2011. Vol. 127. N. 6. P. e1445–e1448.
  265. Roach R.C., Bartsch P., Oelz O. et al. The Lake Louise Acute Mountain Sickness Scoring System // Sutton J.R., Houston C.S., Coates G. (eds). Hypoxia and molecular medicine. Burlington: Queen City Press, 1993. P. 272–274.
  266. Roach R.C., Icenogle M., Hinghofer-Szalkay H. et al. Exercise exacerbates acute mountain sickness at simulated high altitude // J. Appl. Physiol. 2000. Vol. 88. N. 2. P. 581–585.
  267. Roach R.C., Lawley J.S., Hackett P.H. High-altitude physiology // Auerbach P.S. (ed.). Wilderness medicine. Ed. 7. St Louis: Elsevier, 2016.
  268. Sagoo R.S., Hutchinson C.E., Wright A. et al. Magnetic resonance investigation into the mechanisms involved in the development of high-altitude cerebral edema // J. Cereb. Blood Flow Metab. 2017. Vol. 37. N. 1. P. 319–331.
  269. Sanchez del Rio M., Moskowitz M.A. High altitude headache: lessons from headaches at sea level // Adv. Exp. Med. Biol. 1999. Vol. 474. P. 145–153.
  270. Sartori C., Allemann Y., Duplain H. et al. Salmeterol for the prevention of high-altitude pulmonary edema // N. Engl. J. Med. 2002. Vol. 346. N. 21. P. 1631–1636.
  271. Schneider M., Bernasch D., Weymann J. et al. Acute mountain sickness: influence of susceptibility, preexposure, and ascent rate // Med. Sci. Sports Exerc. 2002. Vol. 34. N. 12. P. 1886–1891.
  272. Schoonman G.G., Sandor P.S., Nirkko A.C. et al. Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3 T magnetic resonance imaging study // J. Cereb. Blood Flow Metab. 2008. Vol. 28. N. 1. P. 198–206.
  273. Schwartz K. The tricky business of treating altitude sickness. New York Times; Dec 8, 2015.
  274. Scoggin C.H., Hyers T.M., Reeves J.T. et al. High-altitude pulmonary edema in the children and young adults of Leadville, Colorado // N. Engl. J. Med. 1977. Vol. 297. P. 1269–1272.
  275. Southard A., Niermeyer S., Yaron M. Language used in Lake Louise Scoring System underestimates symptoms of acute mountain sickness in 4- to 11-year-old children // High Alt. Med. Biol. 2007. Vol. 8. N. 2. P. 124–130.
  276. Steinacker J.M., Tobias P., Menold E. et al. Lung diffusing capacity and exercise in subjects with previous high altitude pulmonary oedema // Eur. Respir. J. 1998. Vol. 11. N. 3. P. 643–650.
  277. Sui G.J., Liu Y.H., Cheng X.S. et al. Subacute infantile mountain sickness // J. Pathol. 1988. Vol. 155. P. 161–170.
  278. Swenson E.R. Carbonic anhydrase inhibitors and hypoxic pulmonary vasoconstriction // Respir. Physiol. Neurobiol. 2006. Vol. 151. N. 2/3. P. 209–216.
  279. Theis M.K., Honigman B., Yip R. et al. Acute mountain sickness in children at 2835 meters // Am. J. Dis. Child. 1993. Vol. 147. N. 2. P. 143–145.
  280. Tuggy M.L., Sarjeant P., Litch J.A. et al. Acclimatization of genetically related adults and children // Wilderness Environ. Med. 2000. Vol. 11. N. 4. P. 292–295.
  281. Vivona M.L., Matthay M., Chabaud M.B. et al. Hypoxia reduces alveolar epithelial sodium and fluid transport in rats: reversal by ?-adrenergic agonist treatment // Am. J. Respir. Cell Mol. Biol. 2001. Vol. 25. N. 5. P. 554–561.
  282. Wilson M.H., Imray C.H. The cerebral venous system and hypoxia // J. Appl. Physiol. 2016. Vol. 120. N. 2. P. 244–250.
  283. Xu Y., Liu Y., Liu J., Qian G. Meta-analysis of clinical efficacy of sildenafil, a phosphodiesterase type-5 inhibitor on high-altitude hypoxia and its complications // High Alt. Med. Biol. 2014. Vol. 15. N. 1. P. 46–51.
  284. Yaron M., Niermeyer S., Lindgren K.N., Honigman B. Evaluation of diagnostic criteria and incidence of acute mountain sickness in preverbal children // Wilderness Environ. Med. 2002. Vol. 13. N 1. P. 21–26.
  285. Yaron M., Niermeyer S., Lindgren K.N. et al. Physiologic response to moderate altitude exposure among infants and young children // High Alt. Med. Biol. 2003. Vol. 4. N. 1. P. 53–59.
  286. Yaron M., Niermeyer S. Travel to high altitude with young children: an approach for clinicians // High Alt. Med. Biol. 2008. Vol. 9. N. 4. P. 265–269.
  287. Yu-Jing S., Ming-Wu F., Wen-Quan N. et al. Endothelial nitric oxide synthase gene polymorphisms associated with susceptibility to high altitude pulmonary edema in Chinese railway construction workers at Qinghai-Tibet over 4 500 meters above sea level // Chin. Med. Sci. J. 2010. Vol. 25. N. 4. P. 215–222.
  288. Bowman S.M., Aitken M.E., Robbins J.M. et al. Trends in US pediatric drowning hospitalizations, 1993–2008 // Pediatrics. 2012. Vol. 129. P. 275–281.
  289. Boyd C., Levy A., McProud T. et al. Fatal and nonfatal drowning outcomes related to dangerous underwater breath-holding behaviors—New York State, 1988–2011 // MMWR Morb. Mortal Wkly Rep. 2015. Vol. 64. N. 19. P. 518–521.
  290. Centers for Disease Control and Prevention, National Center for Health Statistics. Compressed mortality file 1999-2015, Series 20 No 2U, 2016. Vital Statistics Cooperative Program. URL: http://wonder.cdc.gov/cmf-icd10.html.
  291. Committee on Injury, Violence, and Poison Prevention: Policy statement—prevention of drowning // Pediatrics. 2010. Vol. 126. P. 178–185.
  292. De Caen A.R., Berg M.D., Chameides L. et al. Part 12. Pediatric advanced life support: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care // Circulation. 2015. Vol. 132. Suppl. 2. P. S526–S542.
  293. Felton H., Myers J., Liu G. et al. Unintentional, non-fatal drowning of children: US trends and racial/ethnic disparities // BMJ Open. 2015. Vol. 5. P. e008444.
  294. Kieboom J.K., Verkade H.J., Burgerhof J.G. et al. Outcome after resuscitation beyond 30 minutes in drowned children with cardiac arrest and hypothermia: death nationwide retrospective cohort study // BMJ. 2015. Vol. 350. P. h418.
  295. The Lancet. Drowning: a silent killer // Lancet. 2017. Vol. 38. P. 1859.
  296. Moler F.W., Hutchison J.S., Nadkarni V.M. et al. THAPCA trial investigators: targeted temperature after pediatric cardiac arrest due to drowning: outcomes and complications // Pediatr. Crit. Care Med. 2016. Vol. 17. P. 712–720.
  297. Moler F.W., Silverstein F.S., Holubkov R. et al. Therapeutic hypothermia after out-ofhospital cardiac arrest in children // N. Engl. J. Med. 2015. Vol. 372. P. 1898–1908.
  298. Quan L., Bierens J.J., Lis R. et al. Prediciting outcome of drowning at the scene: a systematic review and meta-analyses // Resuscitation. 2016. Vol. 104. P. 63–75.
  299. Quan L., Mack C.D., Schiff M.A. Association of water temperature and submersion duration and drowning outcome // Resuscitation. 2014. Vol. 85. P. 790–794.
  300. Suominen P.K., Vahatalo R. Neurologic long term outcome after drowning in children // Scand. J. Trauma Resusc. Emerg. Med. 2012. Vol. 20. P. 55.
  301. Suominen P.K., V?h?talo R., Sintonen H. et al. Health-related quality of life after a drowning incident as a child // Resuscitation. 2011. Vol. 82. N. 10. P. 1318–1322.
  302. US Coast Guard. Recreational boating statistics—2015.
  303. World Health Organization. Global report on drowning: preventing a leading killer. Geneva, 2014. WHO Department for Management of NCDS, Disability, Violence and Injury Prevention.
  304. Ali S.N., O’Toole G., Tyler M. Milk bottle burns // J. Burn Care Rehabil. 2004. Vol. 25. P. 461–462.
  305. Anderson R.R., Donelan M., Hivnor C. et al. Laser treatment of traumatic scars with an emphasis on ablative fractional laser resurfacing: consensus report // JAMA. Dermatol. 2014. Vol. 150. P. 187–193.
  306. Arnoldo B., Purdue G.F., Kowalske K. et al. Electrical injuries: a 20-year review // J. Burn. Care Rehabil. 2004. Vol. 25. P. 479–484.
  307. Bracco D., Eggimann P. Prophylaxis with systemic antibiotics in patients with severe burns // BMJ. 2010. Vol. 340. P. 487–488.
  308. Chen E.H., Sareen A. Do children require ECG evaluation and inpatient telemetry after household electrical exposures? // Ann. Emerg. Med. 2007. Vol. 49. P. 64–67.
  309. Ciszkowski C., Madadi P., Phillips M.S. et al. Codeine, ultrarapid-metabolism genotype, and postoperative death // N. Engl. J. Med. 2009. Vol. 361. P. 827–828.
  310. Collier M.L., Ward R.S., Saffle J.R. et al. Home treadmill friction injuries: a five-year review // J. Burn. Care Rehabil. 2004. Vol. 25. P. 441–444.
  311. Enoch S., Roshan A., Shah M. Emergency and early management of burns and scalds // BMJ. 2009. Vol. 338. P. 937–941.
  312. Finnerty C.C., Jeschke M.G., Branski L.K. et al. Hypertrophic scarring: the greatest unmet challenge after burn injury // Lancet. 2016. Vol. 388. P. 1427–1436.
  313. Greene M.A. Comparison of the characteristics of fire and non-fire households in the 2004–2005 survey of fire department-attended and unattended fires // Inj. Prev. 2012. Vol. 18. P. 170–175.
  314. Hart D.W., Wolf S.E., Ramzy P.I. et al. Anabolic effects of oxandrolone after severe burn // Ann. Surg. 2001. Vol. 233. P. 556–564.
  315. Hermanns-Clausen M., Weinmann W., Auwarter V. et al. Drug dosing error with drops: severe clinical course of codeine intoxication in twins // Eur. J. Pediatr. 2009. Vol. 168. P. 819–824.
  316. Herndon D.N., Hart D.W., Wolf S.E. et al. Reversal of catabolism by beta-blockade after severe burns // N. Engl. J. Med. 2001. Vol. 345. P. 1223–1229.
  317. Herndon D.N., Tompkins R.G. Support of the metabolic response to burn injury // Lancet. 2004. Vol. 363. P. 1895–1902.
  318. Hohlfeld J., de Buys Roessingh A., Hiti-Burri N. et al. Tissue engineered fetal skin constructs for paediatric burns // Lancet. 2006. Vol. 366. P. 840–842.
  319. Jeschke M.G., Herndon D.N. Burns in children: standard and new treatments // Lancet. 2014. Vol. 383. P. 1168–1176.
  320. Juurlink D.N., Buckley N.A., Stanbrook M.B. et al. Hyperbaric oxygen for carbon monoxide poisoning // Cochrane Database Syst. Rev. 2005. CD002041.
  321. Kai-Yang L., Zhao-Fan X., Luo-Man Z. et al. Epidemiology of pediatric burns requiring hospitalization in China: a literature review of retrospective studies // Pediatrics. 2008. Vol. 122. P. 132–142.
  322. Kelly L.E., Rieder M., van den Anker J. et al. More codeine fatalities after tonsillectomy in north American children // Pediatrics. 2012. Vol. 129. N. 5. P. e1343–e1347.
  323. Kraft R., Herndon D.N., Al-Mousawi A.M. et al. Burn size and survival probability in paediatric patients in modern burn care: a prospective observational cohort study // Lancet. 2012. Vol. 379. P. 1013–1020.
  324. Lowell G., Quinlan K., Gottleib L.J. Preventing unintentional scald burns: moving beyond tap water // Pediatrics. 2008. Vol. 122. P. 799–804.
  325. Monstrey S., Hoeksema H., Verbelen J. et al. Assessment of burn depth and burn wound healing potential // Burns. 2008. Vol. 34. P. 761–769.
  326. Musgrave M.A., Fingland R., Gomez M. et al. The use of inhaled nitric oxide as adjuvant therapy in patients with burn injuries and respiratory failure // J. Burn Care Rehabil. 2000. Vol. 21. P. 551–557.
  327. Niazi Z.B., Essex T.J., Papini R. et al. New laser doppler scanner, a valuable adjunct in burn depth assessment // Burns. 1993. Vol. 19. P. 485–489.
  328. Orgill D.P. Excision and skin grading of thermal burns // N. Engl. J. Med. 2009. Vol. 360. P. 893–900.
  329. Porter C., Tompkins R.G., Finnerty C.C. et al. The metabolic stress response to burn trauma: current understanding and therapies // Lancet. 2016. Vol. 388. P. 1417–1426.
  330. Prelack K., Dylewski M., Sheridan R.L. Practical guidelines for nutritional management of burn injury and recovery // Burns. 2007. Vol. 33. P. 14–24.
  331. Sanghavi P., Bhalla K., Das V. Fire-related deaths in India in 2001: a retrospective analysis of data // Lancet. 2009. Vol. 373. P. 1282–1288.
  332. Sheridan R.L., Hinson M., Liang M.H. et al. Long-term outcomes of children surviving massive burns // JAMA. 2000. Vol. 283. P. 69–73.
  333. Sheridan R.L. Fire-related inhalation injury // N. Engl. J. Med. 2016. Vol. 375. N. 5. P. 464–469.
  334. Sheridan R.L. Thermal injuries // McInerny T.K., Adam H.M., Campbell D.E. (eds). American academy of pediatrics pediatric textbook of pediatric care. Elk Grove Village: American Academy of Pediatrics, 2008.
  335. Singer A.J., Dagum A.B. Current management of acute cutaneous wounds // N. Engl. J. Med. 2008. Vol. 359. P. 1037–1046.
  336. Stoddard F.J., Usher C.T., Abrams A.J. Psychopharmacology in pediatric critical care // Child Adolesc. Psychiatr. Clin. N. Am. 2006. Vol. 15. P. 611–655.
  337. Tompkins R.G. Survival of children with burn injuries // Lancet. 2012. Vol. 379. P. 983–984.
  338. Volinsky J., Hanson J., Lustig J. Lightning burns // Arch. Pediatr. Adolesc. Med. 1994. Vol. 148. P. 529–530.
  339. Walker A. Emergency department management of house fire burns and carbon monoxide poisoning in children // Curr. Opin. Pediatr. 1996. Vol. 8. P. 239–242.
  340. Wasiak J., Cleland H., Campbell F. et al. Dressings for superficial and partial thickness burns (review) // Cochrane Database Syst. Rev. 2013. CD002106.
  341. Wiechman S.A., Patterson D.R. Psychosocial aspects of burn injuries // BMJ. 2004. Vol. 329. P. 391–393.
  342. Wolf S.E., Thomas S.J., Dasu M.R. et al. Improved net protein balance, lean mass, and gene expression changes with oxandrolone treatment in the severely burned // Ann. Surg. 2003. Vol. 237. P. 801–810.
  343. Brown DJA, Brugger H, Boyd J, et al. Accidental hypothermia, N Engl J Med 367: 1930-1938, 2012.
  344. Bruen KJ, Ballard JR, Morris SE, et al. Reduction of the incidence of amputation in frostbite injury with thrombolytic therapy. Arch Surg. 2007;142:546-551,.
  345. Crowson AN, Magro CM. Idiopathic perniosis and its mimics: a clinical and histological study of 38 cases. Hum Pathol. 1997;28(4):478-484,.
  346. Gunther C, Berndt N, Wolf C, Lee-Kirsch M. Familial chilblain lupus due to a novel mutation in the exonuclease III domain of 3' repair exonuclease 1 (TREX1). JAMA Dermatol. 2015;151(4):426-431,.
  347. Hallam MJ, Cubison T, Dheansa B, et al. Managing frostbite. BMJ. 2010;341:1151-1156,.
  348. Kieboom JK, Verkade HJ, Burgerhof JG, et al. Outcome after resuscitation beyond 30 minutes in drowned children with cardiac arrest and hypothermia: Dutch nationwide retrospective cohort study. BMJ. 2015;350:h418,.
  349. Shephard RJ. Metabolic adaptations to exercise in the cold: an update. Sports Med. 1993;16:266-289,.
  350. Souwer IH, Bor JHJ, Smits P, Lagro-Janssen ALM. Nifedipine vs placebo for treatment of chronic chilblains: a randomized controlled trial. Ann Family Med. 2016;14(5):453-459,.
  351. Twomey JA, Peltier GL, Zera RT. An open-label study to evaluate the safety and efficacy of tissue plasminogen activator in treatment of severe frostbite. J Trauma. 2005;59:1350-1354.
  352. Bickman L: A common factors approach to improving mental health services, Ment Health Serv Res 7(1):1–4, 2005.
  353. Elder JP, Ayala GX, Harris S: Theories and intervention approaches to health-behavior change in primary care, Am J Prev Med 17(4):275–284, 1999.
  354. Erickson SJ, Gerstle M, Feldstein SW: Brief interventions and motivational interviewing with children, adolescents, and their parents in pediatric health care settings: a review, Arch Pediatr Adolesc Med 159(12):1173–1180, 2005.
  355. Guilamo-Ramos V, Jaccard J, Dittus P, Collins S: Parent-adolescent communication about sexual intercourse: an analysis of maternal reluctance to communicate, Health Psychol 27(6):760–769, 2008.
  356. Jaccard J, Dodge T, Dittus P: Parent-adolescent communication about sex and birth control: a conceptual framework, New Dir Child Adolesc Dev 97:9–41, 2002.
  357. Prochaska JO, Velicer WF: The transtheoretical model of health behavior change, Am J Health Promot 12(1):38–48, 1997.
  358. Wissow L, Anthony B, Brown J, et al: A common factors approach to improving the mental health capacity of pediatric primary care, Adm Policy Ment Health 35(4):305–318, 2008.
  359. Wissow LS, Gadomski A, Roter D, et al: Improving child and parent mental health in primary care: a cluster-randomized trial of communication skills training, Pediatrics 121(2):266–275, 2008.
  360. Wyatt KD, List B, Brinkman WB, et al: Shared decision making in pediatrics: a systematic review and meta-analysis, Acad Pediatr 15(6):573–583, 2015.
  361. Agency for Healthcare Research and Quality (AHRQ): Pediatric Quality Measures Program (PQMP) Centers of Excellence grant awards fact sheet.
  362. American Academy of Pediatrics (AAP): ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents.
  363. American Academy of Pediatrics (AAP): Urinary tract infection: clinical practice guideline for the diagnosis and management of the initial UTI in febrile infants and children 2 to 24 months.
  364. American Board of Internal Medicine Foundation: Choosing Wisely Campaign.
  365. Britto MT, Fuller SC, Kaplan HC, et al: Using a network organizational architecture to support the development of learning health systems, BMJ Qual Saf 2018. doi:10.1136/bmjqs-2017-007219. PMID: 29438072.
  366. Courtlandt CD, Noonan L, Field LG: Model for improvement. Part 1. A framework for health care quality, Pediatr Clin North Am 56:757–778, 2009.
  367. Crandall WV, Margolis PA, Kappelman MD, et al: Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease, Pediatrics 129(4):e1030–e1041, 2012.
  368. Deming WE: The new economics for industry, government, education, ed 2, 2000, MIT Press.
  369. Donabedian A: Evaluating the quality of medical care, Milbank Mem Fund Q 44(Suppl 3):166–206, 1966.
  370. Eggleston EM, Finkelstein JA: Finding the role of health care in population health, JAMA 311(8):797–798, 2014.
  371. American Medical Association, Council on Scientific Affairs (CSA): Report 11 of CSA (I-99). Full text: school violence.
  372. Bauman S, Toomey RB, Walker JL: Associations among bullying, cyberbullying, and suicide in high school students, J Adolesc 36:341–350, 2013.
  373. Centers for Disease Control and Prevention: Youth Risk Behavior Surveillance, 2014.
  374. Englander E: Bullying and cyberbullying: what every educator needs to know, Cambridge, MA, 2013, Harvard Education Press.
  375. Espelage DL, Swearer SM: Research on school bullying and victimization: what have we learned and where do we go from here? School Psychol Rev 32:365–383, 2003.
  376. Gini G, Pozzoli T: Bullied children and psychosomatic problems: a meta-analysis, Pediatrics 132:720–729, 2013.
  377. American Academy of Pediatrics, Section on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics. 2005;115:496–506.
  378. Brazelton TB, Nugent JK. The neonatal behavioral assessment scale. Åd 3. London: MacKeith Press, 1995.
  379. Chaudron LH, Szilagyi PG, Kitzman HJ, et al. Detection of postpartum depressive symptoms by screening at well-child visits. Pediatrics. 2004;113(3):551–558.
  380. Crockenberg S, Leerkes E. Infant social and emotional development in family context. Zeanah CH, ed. Handbook of infant mental health. Ed. 2. New York: Guilford Press, 2000:60–91.
  381. Currie ML, Rademacher R. The pediatrician’s role in recognizing and intervening in postpartum depression, Pediatr Clin North Am. 2004;51:785–801.
  382. De Onis M, Garza C, Onyango AW, et al. Comparison of the WHO child growth standards and the CDC 2000 growth charts. J Nutr. 2007;137(1):144–148.
  383. Hodnett ED. Caregiver support for women during childbirth. Cochrane Database Syst Rev. 2002; (1):CD000199.
  384. Kennell JH, Klaus MH. Bonding: recent observations that alter perinatal care. Pediatr Rev. 1998;19:4–12.
  385. Philipp BL, Merewood A. The Baby Friendly way: the best breastfeeding start. Pediatr Clin North Am. 2004;51:761–783.
  386. Sims M, Sims TL, Bruce MA. Race, ethnicity, concentrated poverty, and low birth weight disparities. J Natl Black Nurses Assoc. 2008;19(1):12–18.
  387. Swain JE, Lorberbaum JP, Kose S, et al. Brain basis of early parent-infant interactions: psychology, physiology, and in vivo functional neuroimaging studies. J Child Psychol Psychiatry. 2007;48(3–4):262–287.
  388. Antovich DM, Graf Estes K. Learning across languages: bilingual experience supports dual language statistical word segmentation. Dev Sci. 2017 Feb 3. doi:10.1111/desc.12548. PMID: 28156032.
  389. Goodman SH, Garber J. Evidence-based interventions for depressed mothers and their young children. Child Dev. 2017;88(2):368–377.
  390. James HE, Perszyk AA, MacGregor TL, Aldana PR. The value of head circumference measurement after 36 months of age: a clinical report and review of practice patterns. J Neurosurg Pediatr. 2015;16(2):186–194. PMID: 25932781.
  391. Parsons CE, Young KS, Jegindoe Elmholdt EM, et al. Interpreting infant emotional expressions: parenthood has differential effects on men and women. Q J Exp Psychol (Hove). 2017;70(3):554–564. PMID: 26822551.
  392. Paul IA, Schaefer EW, Miller JR, et al. Weight change nomograms for the first month after birth. Pediatrics. 2016;138(6).
  393. Seehagen S, Konrad C, Herbert J, et al. Timely sleep facilitates declarative memory consolidation in infants. Proc Natl Acad Sci USA. 2015;112(5):1625–1629.
  394. Williams JA, Zimmerman FJ, Bell JF. Norms and trends of sleep time among US children and adolescents. JAMA Pediatr. 2013;167:55–60.
  395. Wisner KL, Sit DKY, McShea MC, et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. JAMA Psychiatry. 2013;70(5):490–498.
  396. Barr RG, Rajabali F, Aragon M, et al. Education about crying in normal infants is associated with a reduction in pediatric emergency room visits for crying complaints. J Dev Behav Pediatr. 2015;36(4):252–257.
  397. Bechtel K, Le K, Martin KD, et al. Impact of an educational intervention on caregivers beliefs about infant crying and knowledge of shaken baby syndrome. Acad Pediatr. 2011;11(6):481–486.
  398. American Psychiatric Association: . Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington:, American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  399. Bern E.M., O’’Brien R.F: . Is it an eating disorder, gastrointestinal disorder, or both? // Curr. Opin. Pediatr. 2013. Vol. 25. N. (4. P. ):463–470, 2013.
  400. Bryaaynt-Waugh R: . Feeding and eating disorders in children //, Curr. Opin. Psychiatry. 2013. Vol. 26. N. (6. P. ):537–542, 2013.
  401. Bulik C.M., Kleiman S.C., Yilmaz Z: . Genetic epidemiology of eating disorders //, Curr. Opin. Psychiatry. 2016. Vol. 29. N. (6. P. ):340–345, 2016.
  402. Chamay-Weber C., Combescure C., Lanza L, . et al: . Screening obese adolescents for binge eating disorder in primary care: the adolescent binge eating scale //, J. Pediatr. 2017. Vol. 185. P. :68–72, 2017.
  403. Forsberg S., Lock J: . Family-based treatment of child and adolescent eating disorders //, Child Adolesc. Psychiatr. Clin. N. Am. 2015. Vol. 24. N. (3. P. ):617–629, 2015.
  404. Garber A.K., Sawyer S.M., Golden N.H, . et al: . A systematic review of approaches to refeeding in patients with anorexia nervosa //, Int. J. Eat. Disord. 2016. Vol. 49. N. (3. P. ):293–310, 2016.
  405. Golden N.H., Katzman D.K., Sawyer S.M, . et al: . Medical management of restrictive eating disorders in adolescents and young adults //, J. Adolesc. Health. 2015. Vol. 56. N. (4. P. ):370–375, 2015.
  406. Kelly N.R., Shank L.M., Bakalar J.L., Tanofsky-Kraff M: . Pediatric feeding and eating disorders: current state of diagnosis and treatment //, Curr. Psychiatry Rep. 2014. Vol. 16. N. (5. P. ):446, 2014.
  407. Keski-Rahkonen A., Mustelin L: . Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors //, Curr. Opin. Psychiatry. 2016. Vol. 29. N. (6. P. ):340–345, 2016.
  408. Kurz S., van Dyck Z., Dremmel D, . et al: . Variants of early-onset restrictive eating disturbances in middle childhood //, Int. J. Eat. Disord. 2016. Vol. 49. N. (1. P. ):102–106, 2016.
  409. M?rild K., St?rdal K., Bulik C.M, . et al: . Celiac disease and anorexia nervosa: a nationwide study //, Pediatrics. 2017. Vol. 139. N. (5. P. ):e2016467, 2017.
  410. Mairs R., Nicholls D: . Assessment and treatment of eating disorders in children and adolescents //, Arch. Dis. Child. 2016. Vol. 101. N. (12. P. ):1168–1175, 2016.
  411. Munro C., Randell L., Lawrie S.M: . An integrative bio-psycho-social theory of anorexia nervosa //, Clin. Psychol. Psychother. 2017. Vol. 24. N. (1. P. ):1–21, 2017.
  412. Sachs K.V., Harnke B., Mehler P.S., Krantz M.J: . Cardiovascular complications of anorexia nervosa: a systematic review //, Int. J. Eat. Disord. 2016. Vol. 49. N. (3. P. ):238–248, 2016.
  413. Spaulding-Barclay M.A., Stern J., Mehler P.S: . Cardiac changes in anorexia nervosa //, Cardiol. Young. 2016. Vol. 26. P. :623–628, 2016.
  414. Thomas J.J., Brigham K.S., Sally S.T, . et al: . Case 18-2017: an 11-year-old girl with difficulty eating after a choking incident //, N. Engl. J. Med. 2017. Vol. 376. N. (24. P. ):2377–2386, 2017.
  415. Wolfe B.E., Dunne J.P., Kells M.R: . Nursing care considerations for the hospitalized patient with an eating disorder //, Nurs. Clin. North. Am. 2016. Vol. 51. N. (2. P. ):213–235, 2016.
  416. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington:, American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  417. Barlow J., Bergman H., Kornor H, . et al: . Group-based parent training programmes for improving emotional and behavioral adjustment in young children , // Cochrane Database Syst. Rev. 2016. (8):CD003680, 2016. doi:10.1002/14651858.
  418. Blair R.J.R., Leibenluft E., Pine D.S: . Conduct disorder and callous-unemotional traits in youth //, N. Engl. J. Med. 2014. Vol. 371. N. (23. P. ):2207–2214, 2014.
  419. Comer J.S., Chow C., Chan P.T, . et al: . Psychosocial treatment efficacy for disruptive behavior problems in very young children: a meta-analytic examination //, J. Am. Acad. Child Adolesc. Psychiatry. 2013. Vol. 52. P. :26–36, 2013.
  420. Correll C.U., Kratochvil C.J., March J.S: . Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics //, J. Clin. Psychiatry. 2011. Vol. 72. N. (5. P. ):655–670, 2011.
  421. Eyberg S.M., Nelson M.M., Boggs S.R: . Evidence-based psychosocial treatments for children and adolescents with disruptive behavior //, J. Clin. Child Adolesc. Psychol. 2008. Vol. 37. N. (1. P. ):215–237, 2008.
  422. Furlong M., McGilloway S., Bywater T, . et al: . The Cochrane Library. Behavioural and cognitive-behavioural group-based parenting programmes for early-onset conduct problems in children aged 3-12 years //, Cochrane Database Syst. Rev. 2012. (2):CD008225, 2012. doi:10.1002/14651858.
  423. Kendler K.S., Aggen S.H., Patrick C.J: . Familial influences on conduct disorder reflect 2 genetic factors and 1 shared environmental factor //, JAMA Psychiatry. 2013. Vol. 70. P. :78–86, 2013.
  424. Knapp P., Chait A., Pappadopulos E, . et al:et al. Treatment of maladaptive aggression in youth: CERT guidelines. I. Engagement, assessment, and management //, Pediatrics. 2012. Vol. 129. P. :e1542–e1576, 2012.
  425. Lamont J.H., Devore C.D., Allison M, . et al: . AAP Policy Statement: out-of-school suspension and expulsion //, Pediatrics. 2013. Vol. 131. P. :e1000–e1007, 2013.
  426. Lavigne J.V., LeBailly S.A., Gouze K.R, . et al: . Predictors and correlates of completing behavioral parent training for the treatment of oppositional defiant disorder in pediatric primary care //, Behav. Ther. 2010. Vol. 41. P. :198–211, 2010.
  427. Lavigne J.V., LeBailly S.A., Gouze K.R, . et al: . Treating oppositional defiant disorder in primary care: a comparison of three models //, J. Pediatr. Psychol. 2008. Vol. 33. N. (5. P. ):449–461, 2008.
  428. Lochman J.E., Powell N.P., Boxmeyer C.L, . et al: . Cognitive-behavioral therapy for externalizing disorders in children and adolescents //, Child Adolesc. Psychiatr. Clin. N. Am. 2011. Vol. 20. P. :305–318, 2011.
  429. Loy J.H., Merry S.N., Hetrick S.E, . et al: . Atypical antipsychotics for disruptive behavior disorders in children and youths //, Cochrane Database Syst. Rev. 2012. (8):CD008559, 2012. doi:10.1002/14651858.
  430. Montgomery P., Bjornstad G.J., Dennis J.A: . Media-based behavioural treatments for behavioural problems in children //, Cochrane Database Syst. Rev. 2006. (1):CD002206, 2006. doi:10.1002/14651858.
  431. Malhotra K., Shim R., Baltrus P, . et al: . Racial/ethnic disparities in mental health service utilization among youth participating in negative externalizing behaviors //, Ethn. Dis. 2015. Vol. 25. N. (2. P. ):123–129, 2015.
  432. Oesterle S., Hawkins J.D., Kuklinski M.R, . et al:et al. Effects of communities that care on males’’ and females’’ drug use and delinquency 9 years after baseline in a community-randomized trial //, Am. J. Community Psychol. 2015. Vol. 56. N. (3–4. P. ):217–228, 2015.
  433. Perrin E.C., Sheldrick R.C., McMenamy J.M, . et al: . Improving parenting skills for families of young children in pediatric settings: a randomized clinical trial //, JAMA Pediatr. 2014. Vol. 168. N. (1. P. ):16–24, 2014.
  434. Rosato N.S., Correll C.U., Pappadopulos E, . et al: . Treatment of maladaptive aggression in youth: CERT guidelines II. Treatments and ongoing management //, Pediatrics. 2012. Vol. 129. P. :e1577–e1586, 2012.
  435. Shannon B.J., Raichle M.E., Snyder A.Z, . et al:et al. Premotor functional connectivity predicts impulsivity in juvenile offenders //, Proc. Natl. Acad. Sci. USA. 2011. Vol. 108. P. :11241–11245, 2011.
  436. Barkley R.A: . Defiant children: a clinician’’s manual for assessment and parent training, . New York, : Guilford Press, 2013, Guilford Press.
  437. DiMario F.J., Burleson J.A: . Behavior profile of children with severe breath-holding spells , // J. Pediatr. 1993. Vol. 122. N. (3. P. ):488–491, 1993.
  438. Wakschlag L.S., Choi S.W., Carter A.S, . et al: . Defining the developmental parameters of temper loss in early childhood: implications for developmental psychopathology //, J. Child Psychol. Psychiatry. 2012. Vol. 53. N. (11. P. ):1099–1108., 2012
  439. Cook E.C., Pflieger J.C., Connell A.M., Connell C.M: . Do specific transitional patterns of antisocial behavior during adolescence increase risk for problems in young adulthood?, ? // J. Abnorm. Child Psychol. 2015. Vol. 43. N. (1. P.):95–106, 2015.
  440. Dishion T.J., Patterson G.R., Dishion T.J., Patterson G.R: . The development and ecology of problem behavior: linking etiology, prevention, and treatment. // In Cicchetti D., ed.itor: Handbook for developmental psychopathology, . Ed. 3, . New York:, Wiley, 2016, Wiley.
  441. Evans A.D., Lee K: . Emergence of lying in very young children //, Dev. Psychol. 2013. Vol. 49. N. (10. P. ):1958, 2013.
  442. Awasthi S., Peto R., Read S. et al. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial // Lancet. 2013. Vol. 381. P. 1469–1476.
  443. Ballew C., Bowman B.A., Sowell A.L. et al. Serum retinol distributions in residents of the United States: third National Health and Nutrition Examination Survey, 1988–1994 // Am. J. Clin. Nutr. 2001. Vol. 73. P. 586–593.
  444. Darlow B.A., Graham P.J. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants // Cochrane Database Syst. Rev. 2011. CD000501.
  445. DeKlotz C.M.C., Roby K.D., Friedlander S.F. Dietary supplements, isotretinoin, and liver toxicity in adolescents: a retrospective case series // Pediatrics. 2017. Vol. 140. N. 4. P. e20152940.
  446. Erhardt J. Biochemical methods for the measurement of vitamin A deficiency disorders (VADD) // Sight Life Mag. 2003. Vol. 2. P. 5–7.
  447. Fernandes T.F., Figueiroa J.N., Grande de Arruda I.K. et al. Effect of infant illness of maternal supplementation with 400,000 IU vs 200,000 IU of vitamin A // Pediatrics. 2012. Vol. 129. P. e960–e966.
  448. Grune T., Lietz G., Palou A. et al. Beta-carotene is an important vitamin A source for humans // J. Nutr. 2010. Vol. 140. P. 2268S–2285S.
  449. Haider B.A., Bhutta Z.A. Neonatal vitamin A supplementation: time to move on // Lancet. 2015. Vol. 385. P. 1268–1270.
  450. Hodges J.K., Tan L., Green M.H., Ross A.C. Vitamin A supplementation redirects the flow of retinyl esters from peripheral to central organs of neonatal rats raised under vitamin A-marginal conditions // Am. J. Clin. Nutr. 2017. Vol. 105. N. 5. P. 1110–1121.
  451. Office of Dietary Supplements, National Institutes of Health. Vitamin A fact sheet. URL: http://ods.od.nih.gov/factsheets/VitaminA-HealthProfessional/.
  452. Penniston K.L., Tanumihardjo S.A. The acute and chronic toxic effects of vitamin A // Am. J. Clin. Nutr. 2006. Vol. 83. P. 191–201.
  453. Raiten D.J., Sakr Ashour F.A., Ross A.C. et al; INSPIRE Consultative Group. Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE) // J. Nutr. 2015. Vol. 145. N. 5. P. 1039S–1108S.
  454. Ross A.C. Vitamin A // Ross A.C., Caballero B., Cousins R.J. et al. (eds). Modern nutrition in health and disease. Ed. 11. Baltimore: Lippincott, Williams & Wilkins, 2013. P. 260–277.
  455. Rubin L.P., Ross A.C., Stephensen C.B. et al. Metabolic effects of inflammation on vitamin A and carotenoids in humans and animal models // Adv. Nutr. 2017. Vol. 8. N. 2. P. 197–212.
  456. Saari J.C. Vitamin A and vision // Asson-Batres M.A., Rochette-Egly C. (eds). The biochemistry of retinoid signaling. II. Vol. 81. Subcellular biochemistry. Netherlands, 2016. P. 231–259.
  457. Shah P., Isley W.L. Ketoacidosis during a low-carbohydrate diet // N. Engl. J. Med. 2006. Vol. 354. N. 1. P. 97–98.
  458. Sommer A. Vitamin A deficiency and clinical disease: an historical overview // J. Nutr. 2008. Vol. 138. P. 1835–1839.
  459. Tanumihardjo S. Vitamin A. biomarkers of nutrition for development // Am. J. Clin. Nutr. 2011. Vol. 94. P. 658S–665S.
  460. Tanumihardjo S.A. Assessing vitamin A status: past, present and future // J. Nutr. 2004. Vol. 134. P. 290S–293S.
  461. Tanumihardjo S.A., Ball A.M., Kaliwile C., Pixley K.V. The research and implementation continuum of biofortified sweet potato and maize in Africa // Ann. NY Acad. Sci. 2017. Vol. 1390. P. 88–103.
  462. Tanumihardjo S.A., Russell R.M., Stephensen C.B. et al. Biomarkers of nutrition for development (bond)-vitamin: a review // J. Nutr. 2016. Vol. 146. P. 1816S–1848S.
  463. Tielsch J.M. Vitamin A supplements in newborns and child survival // BMJ. 2008. Vol. 336. P. 1385–1386.
  464. US Food and Drug Administration. iPLEDGE Information. URL: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm094307.htm.
  465. Villamor E., Fawzi W.W. Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes // Clin. Microbiol. Rev. 2005. Vol. 18. P. 446–464.
  466. Beshlawi I., Al Zadjali S., Bashir W. et al. Thiamine responsive megaloblastic anemia: the puzzling phenotype // Pediatr. Blood Cancer. 2014. Vol. 61. P. 528–531.
  467. Dabar G., Harmouche C., Habr B. et al. Shoshin beriberi in critically-ill patients: case series // Nutr. J. 2015. Vol. 14. P. 51.
  468. Frank L.L. Thiamin in clinical practice // JPEN J. Parenter. Enteral Nutr. 2015. Vol. 39. P. 503–520.
  469. Qureshi U.A., Sami A., Altaf U. et al. Thiamine responsive acute life threatening metabolic acidosis in exclusively breast-fed infants // Nutrition. 2016. Vol. 32. P. 213–216.
  470. Tabarki B., Alfadhel M., AlShahwan S. et al. Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone // Eur. J. Paediatr. Neurol. 2015. Vol. 19. P. 547–552.
  471. Wani N.A., Qureshi U.A., Jehangir M. et al. Infantile encephalitic beriberi: magnetic resonance imaging findings // Pediatr. Radiol. 2016. Vol. 46. P. 96–103.
  472. Ygberg S., Naess K., Eriksson M. et al. Biotin and thiamine responsive basal ganglia disease: a vital differential diagnosis in infants with severe encephalopathy // Eur. J. Paediatr. Neurol. 2016. Vol. 20. P. 457–461.
  473. Foley A.R., Menezes M.P., Pandraud A. et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2 // Brain. 2014. Vol. 137. P. 44–56.
  474. Nichols E.K., Talley L.E., Birungi N. et al. Suspected outbreak of riboflavin deficiency among populations reliant on food assistance: a case study of drought-stricken Karamoja, Uganda, 2009–2010 // PLoS ONE. 2013. Vol. 8. P. e62976.
  475. Sherwood M., Goldman R.D. Effectiveness of riboflavin in pediatric migraine prevention // Can. Fam. Physician. 2014. Vol. 60. P. 244–246.
  476. Swaminathan S., Thomas T., Kurpad A.V. B-vitamin interventions for women and children in low-income populations // Curr. Opin. Clin. Nutr. Metab. Care. 2015. Vol. 18. P. 295–306.
  477. Brown T.M. Pellagra: an old enemy of timeless importance // Psychosomatics. 2010. Vol. 51. P. 93–97.
  478. Lanska D.J. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins // Handb. Clin. Neurol. 2010. Vol. 95. P. 445–476.
  479. Piqu?-Duran E., P?rez-Cejudo J.A., Cameselle D. et al. Pellagra: a clinical, histopathological, and epidemiological study of 7 cases // Actas Dermosifiliogr. 2012. Vol. 103. P. 51–58.
  480. Steffen C. Pellagra // Skinmed. 2012. Vol. 10. P. 174–179.
  481. Wan P., Moat S., Anstey A. Pellagra: a review with emphasis on photosensitivity // Br. J. Dermatol. 2011. Vol. 164. P. 1188–1200.
  482. Derakhshanfar H., Amree A.H., Alimohammadi H. et al. Results of double blind placebo controlled trial to assess the effect of vitamin B6 on managing of nausea and vomiting in pediatrics with acute gastroenteritis // Glob. J. Health Sci. 2013. Vol. 5. P. 197–201.
  483. Salam R.A., Zuberi N.F., Bhutta Z.A. Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes // Cochrane Database Syst. Rev. 2015. CD000179.
  484. Ueland P.M., Ulvik A., Rios-Avila L. et al. Direct and functional biomarkers of vitamin B6 status // Annu. Rev. Nutr. 2015. Vol. 35. P. 33–70.
  485. Alfadhel M., Almuntashri M., Jadah R.H. et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases // Orphanet. J. Rare. Dis. 2013. Vol. 8. P. 83.
  486. Ito T., Nishie W., Fujita Y. et al. Infantile eczema caused by formula milk // Lancet. 2013. Vol. 381. P. 1958.
  487. Kassem H., Wafaie A., Alsuhibani S. et al. Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment // AJNR Am. J. Neuroradiol. 2014. Vol. 35. P. 1900–1995.
  488. Tabarki B., Al-Shafi S., Al-Shahwan S. et al. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings // Neurology. 2013. Vol. 80. P. 261–267.
  489. De-Regil L.M., Pe?a-Rosas J.P., Fern?ndez-Gaxiola A.C. et al. Effects and safety of periconceptional oral folate supplementation for preventing birth defects // Cochrane Database Syst. Rev. 2015. CD007950.
  490. Gildestad T., Bj?rge T., Vollset S.E. et al. Folic acid supplements and risk for oral clefts in the newborn: a population-based study // Br. J. Nutr. 2015. Vol. 114. P. 1456–1463.
  491. Hodgetts V.A., Morris R.K., Francis A. et al. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis // BJOG. 2015. Vol. 4. P. 478–490.
  492. Pfeiffer C.M., Sternberg M.R., Fazili Z. et al. Folate status and concentrations of serum folate forms in the US population: National Health and Nutrition Examination Survey 2011–2 // Br. J. Nutr. 2015. Vol. 113. P. 1965–1977.
  493. Sur?n P., Roth C., Bresnahan M. et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children // JAMA. 2013. Vol. 309. P. 570–577.
  494. Williams J., Mai C.T., Mulinare J. et al. Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011 // MMWR Morb. Mortal Wkly Rep. 2015. Vol. 64. P. 1–5.
  495. Bahadir A., Reis P.G., Erduran E. Oral vitamin B12 treatment is effective for children with nutritional vitamin B12 deficiency // J. Paediatr. Child Health. 2014. Vol. 50. P. 721–725.
  496. Benson J., Phillips C., Kay M. et al. Low vitamin B12 levels among newly-arrived refugees from Bhutan, Iran and Afghanistan: a multicentre Australian study // PLoS ONE. 2013. Vol. 8. P. e57998.
  497. Berry N., Sagar R., Tripathi B.M. Catatonia and other psychiatric symptoms with vitamin B12 deficiency // Acta Psychiatr. Scand. 2003. Vol. 108. P. 156–159.
  498. Cuffe K., Stauffer W., Painter J. et al. Update: Vitamin B12 deficiency among Bhutanese refugees resettling in the United States, 2012 // MMWR Morb. Mortal Wkly Rep. 2014. Vol. 63. P. 607.
  499. Demir N., Do?an M., Ko? A. et al. Dermatological findings of vitamin B12 deficiency and resolving time of these symptoms // Cutan. Ocul. Toxicol. 2014. Vol. 33. P. 70–73.
  500. Duong M.C., Mora-Plazas M., Mar?n C. et al. Vitamin B-12 deficiency in children is associated with grade repetition and school absenteeism, independent of folate, iron, zinc, or vitamin A status biomarkers // J. Nutr. 2015. Vol. 145. P. 1541–1548.
  501. Goraya J.S., Kaur S., Mehra B. Neurology of nutritional vitamin B12 deficiency in infants: case series from India and literature review // J. Child Neurol. 2015. Vol. 30. P. 1831–1837.
  502. Hannibal L., Lysne V., Bjorke-Monsen A.L. et al. Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency // Frontiers Mol. Biosci. 2016. Vol. 3. N. 27. P. 1–16.
  503. Hunt A., Harrington D., Robinson S. Vitamin B12 deficiency // BMJ. 2014. Vol. 349. P. g5226.
  504. Lam J.R., Schneider J.L., Zhao W. et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency // JAMA. 2013. Vol. 310. P. 2435–2442.
  505. Kvestad I., Taneja S., Kumar T. et al. Vitamin B12 and folic acid improve gross motor and problem-solving skills in young north Indian children: a randomized placebo-controlled trial // PLoS ONE. 2015. Vol. 10. P. e0129915.
  506. Pawlak R., Lester S.E., Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature // Eur. J. Clin. Nutr. 2014. Vol. 68. P. 541–548.
  507. Pawlak R., Parrott S.J., Raj S. et al. How prevalent is vitamin B(12) deficiency among vegetarians? // Nutr. Rev. 2013. Vol. 71. P. 110–117.
  508. Rahmandar M.H., Bawcom A., Romano M.E., Hamid R. Cobalamin C deficiency in an adolescent with altered mental status and anorexia // Pediatrics. 2014. Vol. 134. N. 6. P. e1709–e1714.
  509. Stabler S.P. Clinical practice. Vitamin B12 deficiency // N. Engl. J. Med. 2013. Vol. 368. P. 149–160.
  510. Strand T.A., Taneja S., Ueland P.M. et al. Cobalamin and folate status predicts mental development scores in North Indian children 12–18 mo of age // Am. J. Clin. Nutr. 2013. Vol. 97. P. 310–317.
  511. Torsvik I.K., Ueland P.M., Markestad T. et al. Motor development related to duration of exclusive breastfeeding, B vitamin status and B12 supplementation in infants with a birth weight between 2000–3000 g, results from a randomized intervention trial // BMC Pediatr. 2015. Vol. 15. P. 218.
  512. Wang Z.P., Shang X.X., Zhao Z.T. Low maternal vitamin B(12) is a risk factor for neural tube defects: a meta-analysis // J. Matern. Fetal. Neonatal. Med. 2012. Vol. 25. P. 389–394.
  513. Bansal P.G., Toteja G.S., Suman R. Plasma vitamin C status of adolescent girls in a slum of Delhi // Indian Pediatr. 2014. Vol. 51. P. 932–933.
  514. Carr A.C., Bozonet S.M., Vissers M.C. A randomised cross-over pharmacokinetic bioavailability study of synthetic versus kiwifruit-derived vitamin C // Nutrients. 2013. Vol. 5. P. 4451–4461.
  515. Cove?as R., Gonz?lez-Fuentes J., Rivas-Infante E. et al. Developmental study of vitamin C distribution in children’s brainstems by immunohistochemistry // Ann. Anat. 2015. Vol. 201. P. 65–78.
  516. Fain O. Musculoskeletal manifestations of scurvy // Joint Bone. Spain. 2005. Vol. 72. P. 124–128.
  517. Garaiova I., Muchov? J., Nagyov? Z. et al. Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study // Eur. J. Clin. Nutr. 2015. Vol. 69. P. 373–379.
  518. German Nutrition Society (DGE). New reference values for vitamin C intake // Ann. Nutr. Metab. 2015. Vol. 67. P. 13–20.
  519. Gulko E., Collins L.K., Murphy R.C. et al. MRI findings in pediatric patients with scurvy // Skeletal. Radiol. 2015. Vol. 44. P. 291–297.
  520. Ma N.S., Thompson C., Weston S. Scurvy as a manifestation of food selectivity in children with autism // J. Autism Dev. Disord. 2016. Vol. 46. P. 1464–1470.
  521. McEvoy C.T., Schilling D., Clay N. et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial // JAMA. 2014. Vol. 311. P. 2074–2082.
  522. Pysz K., Leszczy?ska T., Kope? A. et al. Intake of vitamin C, ?-carotene, and polyphenolic compounds by children and adolescents from orphanages // J. Am. Coll. Nutr. 2016. Vol. 35. P. 75–85.
  523. Seya M., Handa A., Hasegawa D. et al. Scurvy: from a selective diet in children with developmental delay // J. Pediatr. 2016. Vol. 177. P. 331.
  524. Vitoria I., L?pez B., G?mez J. et al. Improper use of a plant-based vitamin C–deficient beverage causes scurvy in an infant // Pediatrics. 2016. Vol. 137. N. 2. P. e20152781.
  525. Capelli S., Donghi V., Maruca K. et al. Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets // Bone. 2015. Vol. 79. P. 143–149.
  526. Czech-Kowalska J., Czekuc-Kryskiewicz E., Pludowski P. et al. The clinical and biochemical predictors of bone mass in preterm infants // PLoS ONE. 2016. Vol. 11. P. e0165727.
  527. Elidrissy A.T. The return of congenital rickets, are we missing occult cases? // Calcif. Tiss. Int. 2016. Vol. 99. P. 227–236.
  528. Fernandez-Cooke E., Cruz-Rojo J., Gallego C. et al. Tumor-induced rickets in a child with a central giant cell granuloma: a case report // Pediatrics. 2015. Vol. 135. P. e1518–e1523.
  529. Imel E.A., Zhang X., Ruppe M.D. et al. Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of krn23 // J. Clin. Endocrinol. Metab. 2015. Vol. 100. P. 2565–2573.
  530. Ketha H., Wadams H., Lteif A. et al. Iatrogenic vitamin d toxicity in an infant: a case report and review of literature // J. Steroid Biochem. Mol. Biol. 2015. Vol. 148. P. 14–18.
  531. Martineau A.R., Jolliffe D.A., Hooper R.L. et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data // BMJ. 2017. Vol. 256. P. i6583.
  532. Munns C.F., Shaw N., Kiely M. et al. Global consensus recommendations on prevention and management of nutritional rickets // J. Clin. Endocrinol. Metab. 2016. Vol. 101. P. 394–415.
  533. Paterson C.R., Ayoub D. Congenital rickets due to vitamin d deficiency in the mothers // Clin. Nutr. (Edinburgh). 2015. Vol. 34. P. 793–798.
  534. Razali N.N., Hwu T.T., Thilakavathy K. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets // J. Pediatr. Endocrinol. Metab. 2015. Vol. 28. P. 1009–1017.
  535. Reid I.R. What disease are causally linked to vitamin D deficiency? // Arch. Dis. Child. 2016. Vol. 101. P. 185–189.
  536. Heyne D., Sauter F.M., Ollendick T.H, . et al: . Developmentally sensitive cognitive behavioral therapy for adolescent school refusal: rationale and case illustration //, Clin. Child Fam. Psychol. Rev. 2014. Vol. 17. N. (2. P. ):191–215, 2014.
  537. Lochman J.E., Powell N.P., Whidby J.M., FitzGerald D.P: . Aggression in children. // In Kendall P.C., (editor).: Child and adolescent therapy: cognitive-behavioral procedures, . New York: Guilford Press, 2012,. Guilford Press, P.pp 27–60.
  538. Olweus D: . School bullying: development and some important challenges , // Annu. Rev. Clin. Psychol. 2013. Vol. 9. P. :751–780, 2013.
  539. Pepler D.J., Madsen K.C., Webster C.D., Levene K.S., (editors): . The development and treatment of girlhood aggression,: Psychology Press, 2014, Psychology Press.
  540. Widom C.S., Wilson H.W: . Intergenerational transmission of violence. //In Lindert J., Levav I, . (editors).: Violence and mental health, : Springer Netherlands, 2015, . Springer Netherlands, P.pp 27–45.
  541. Ahima RS, Antwi DA: Brain regulation of appetite and satiety, Endocrinol Metab Clin North Am 37:811–823, 2008.
  542. American Heart Association: Dietary recommendations for children and adolescents: a guide for practitioners, Pediatrics 117:544–559, 2006.
  543. Anzman-Frasca S, Stifter CA, Birch LL: Temperament and childhood obesity risk: a review of the literature, J Dev Behav Pediatr 33(9):732–745, 2012.
  544. August GP, Caprios S, Fennoy I, et al: Prevention and treatment of pediatric obesity: an Endocrine Society clinical practice guideline based on expert opinion, J Clin Endocrinol Metab 93:4576–4599, 2008.
  545. Block JP, Condon SK, Kleinman K, et al: Consumers’ estimation of calorie content at fast food restaurants: cross sectional observational study, BMJ 346:14, 2013.
  546. Bocca G, Corpeleijn E, Stolk RP, et al: Results of a multidisciplinary treatment program in 3-year-old to 5-year-old overweight or obese children, Arch Pediatr Adolesc Med 166:1109–1115, 2012.
  547. Bochukova EG, Huang N, Keogh J, et al: Large, rare chromosomal deletions associated with severe early-onset obesity, Nature 463:666–670, 2010.
  548. Bond DS, Vithiananthan S, Nash JM, et al: Improvement of migraine headaches in severely obese patients after bariatric surgery, Neurology 76:1135–1138, 2011.
  549. Boutelle KN, Norman GJ, Rock CL, et al: Guided self-help for the treatment of pediatric obesity, Pediatrics 131(5):e1435–e1442, 2013.
  550. Boutelle KN, Cafri G, Crow SJ: Parent predictors of child weight change in family based behavioral obesity treatment, Obesity (Silver Spring) 20(7):1539–1543, 2012.
  551. Brara SM, Koebnick C, Porter AH, et al: Pediatric idiopathic intracranial hypertension and extreme childhood obesity, J Pediatr 161:602–607, 2012.
  552. Bray GA, Fr?hbeck G, Ryan DH, Wilding JPH: Management of obesity, Lancet 387: 1947–1965, 2016.
  553. Carlsson LMS, Peltonen M, Ahlin S, et al: Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects, N Engl J Med 367:695–704, 2012.
  554. Casazza K, Fontaine KR, Astrup A, et al: Myths, presumptions, and facts about obesity, N Engl J Med 368:446–454, 2013.
  555. Cecchini M, Sassi F, Lauer JA, et al: Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness, Lancet 376:1775–1784, 2010.
  556. Centers for Disease Control and Prevention: Recommended community strategies and measurements to prevent obesity in the United States, MMWR Recomm Rep 58:1–29, 2009.
  557. Centers for Disease Control and Prevention: Differences in prevalence of obesity among black, white, and Hispanic adults—United States, 2006–2008, MMWR Morb Mortal Wkly Rep 58:740–744, 2009.
  558. Centers for Disease Control and Prevention: Effect of switching from whole to low-fat/fat-free milk in public schools—New York City, 2004–2009, MMWR Morb Mortal Wkly Rep 59:70–73, 2010.
  559. Centers for Disease Control and Prevention: CDC grand rounds: childhood obesity in the United States, MMWR Morb Mortal Wkly Rep 60:42–46, 2011.
  560. Centers for Disease Control and Prevention: Obesity prevalence among low-income, preschool-aged children—New York City and Los Angeles County, 2003–2011, MMWR Morb Mortal Wkly Rep 62:17–22, 2013.
  561. Claussnitzer M, Dankel SN, Kim KH, et al: FTO obesity variant circuitry and adipocyte browning in humans, N Engl J Med 373(10):895–906, 2015.
  562. Courcoulas AP, Christian NJ, Belle SH, et al: Weight change and health outcomes at 3 years after bariatric surgery among individuals with severe obesity, JAMA 310:2416–2424, 2013.
  563. Billard C, Fluss J, Pinton F. Specific language impairment versus Landau-Kleffner syndrome. Epilepsia. 2009;50(Suppl 7):21–24.
  564. Boyle J. Speech and language delays in preschool children. BMJ. 2011;343:d5181.
  565. Clegg J, Hollis C, Mawhood L, et al. Developmental language disorder—a follow-up in later adult life: cognitive, language and psychosocial outcomes. J Child Psychol Psychiatry. 2005;46:128–149.
  566. Cohen NJ, Barwick MA, Horodezky NB, et al. Language, achievement, and cognitive processing in psychiatrically disturbed children with previously identified and unsuspected language impairments. J Child Psychol Psychiatry. 1998;39:865–877.
  567. De Fosse L, Hodge SM, Makris N, et al. Language-association cortex asymmetry in autism and specific language impairment. Ann Neurol. 200456:757–766.
  568. Dehaene-Lambertz G, Montavont A, Jobert A, et al. Language or music, mother or Mozart? Structural and environmental influences on infants’ language networks. Brain Lang. 2010;114:53–65.
  569. Elbro C, Dalby M, Maarbjerg S. Language-learning impairments: a 30-year follow-up of language-impaired children with and without psychiatric, neurological and cognitive difficulties. Int J Lang Commun Disord. 2011;46:437–448.
  570. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433–440.
  571. Flapper BCT, Schoemaker MM. Developmental coordination disorder in children with specific language impairment: co-morbidity and impact on quality of life. Res Dev Disabil. 2013;34:756–763.
  572. Herbert MR, Kenet T. Brain abnormalities in language disorders and in autism, Pediatr Clin North Am 54:563–583, 2007. Hua A, Major N: Selective mutism. Curr Opin Pediatr. 2016;28:114–120.
  573. Johnson CJ, Beitchman JH, Young A, et al. Fourteen-year follow-up of children with and without speech/language impairments: speech/language stability and outcomes. J Speech Lang Hear Res. 1999;42:744–760.
  574. Kennedy CR, McCann DC, Campbell MJ, et al. Language ability after early detection of permanent childhood hearing impairment. N Engl J Med. 2006;354:2131–2140.
  575. May L, Byers-Heinlein K, Gervain J, et al. Language and the newborn brain: does prenatal language experience shape the neonate neural response to speech? Front Psychol. 2011;2:222.
  576. McCormack J, Harrison LJ, McLeod S, et al. A nationally representative study of the association between communication impairment at 4–5 years and children’s life activities at 7-9 years. J Speech Lang Hear Res. 2011;54:1328–1348.
  577. Peterson RL, Pennington BF. Developmental dyslexia. Lancet. 2012;379(9830):1997–2007.
  578. Reilly S, Onslow M, Packman A, et al. Predicting stuttering onset by the age of 3 years: a prospective, community cohort study. Pediatrics. 2009;123:270–277.
  579. Rice ML. Toward epigenetic and gene regulation models of specific language impairment: looking for links among growth, genes, and impairments. J Neurodev Disord. 2012;4:27–41.
  580. Roberts JE, Rosenfeld RM, Zeisel SA. Otitis media and speech and language: a metaanalysis of prospective studies. Pediatrics. 2004;113(3 Pt 1):e238–e248.
  581. Schum R. Language screening in the pediatric office setting. Pediatr Clin North Am 200754:425–436.
  582. Simms MD, Jin X. Autism, language disorder, social (pragmatic) communication disorder, and DSM-V. Pediatr Rev. 2015;38:355–362.
  583. Siu AL. Screening for speech and language delay and disorders in children aged 5 years or younger: US Preventive Services Task Force Recommendation Statement. Pediatrics. 2015;136:e448–e462.
  584. Stefanatos G. Changing perspectives on Landau-Kleffner syndrome. Clin Neuropsychol. 2011;25:963–988.
  585. Tager-Flusberg H, Caronna E. Language disorders: autism and other pervasive developmental disorders. Pediatr Clin North Am. 2007;54:469–481.
  586. Tierney CD, Kurtz M, Souders H. Clear as mud: another look at autism, childhood apraxia of speech and auditory processing. Curr Opin Pediatr. 2012;24:394–399.
  587. US Preventive Services Task Force: Screening for speech and language delay in preschool children: recommendation statement. Pediatrics. 2006117:497–501.
  588. Wake M, Tobin S, Girolametto L, et al. Outcomes of population based language promotion for slow to talk toddlers at ages 2 and 3 years: Let’s Learn Language cluster randomised controlled trial. BMJ. 2011;343:d4741.
  589. Wallace IF, Berkman ND, Watson LR, et al. Screening for speech and language delay in children 5 years old and younger: a systematic review. Pediatrics. 2015;136(2):e448–e462.
  590. Ward D. The aetiology and treatment of developmental stammering in childhood. Arch Dis Child. 200893:68–71.
  591. Whitehouse AJO, Robinson M, Zubrick SR. Late talking and the risk for psychosocial problems during childhood and adolescence. Pediatrics. 2011;128:e324–e332.
  592. Yew SG, O’Kearney R. Emotional and behavioural outcomes later in childhood and adolescence for children with specific language impairments: meta-analyses of controlled prospective studies. J Child Psychol Psychiatry. 2013;54(5):516–524.
  593. Zhang X, Tomblin JB. The association of intervention receipt with speech-language profiles and social-demographic variables. Am J Speech Lang Pathol. 2000;9:345–357.
  594. Zumach A, Gerritis E, Chenault M, et al. Long-term effects of early-life otitis media on language development. J Speech Lang Hear Res. 2010;53:34–43.
  595. American Academy of Pediatrics, Committee on Children with Disabilities: Pediatrician’s role in the development and implementation of an Individualized Education Plan (IEP) and/or an Individual Family Service Plan (IFSP), Pediatrics 104:124–127, 1999.
  596. American Association on Intellectual and Developmental Disabilities: Definition, classification, and systems of supports, Washington, DC, 2010, AAIDD.
  597. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed 5, Arlington, VA, 2013, American Psychiatric Publishing.
  598. Battaglia A, Hoyme HE, Dallapiccola B, et al: Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation, Pediatrics 121:404–410, 2008.
  599. Cleary MA, Green A: Developmental delay: when to suspect and how to investigate for an inborn error of metabolism, Arch Dis Child 90(11):1128–1132, 2005.
  600. Council on Children with Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children with Special Needs Project Advisory Committee: Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening, Pediatrics 118:405–420, 2006.
  601. Curry CJ, Stevenson RE, Aughton D, et al: Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics, Am J Med Genet 72:468–477, 1977.
  602. De Ligt J, Willemsen MH, van Bon BW, et al: Diagnostic exome sequencing in persons with severe intellectual disability, N Engl J Med 367:2012.
  603. Gecz J, Haan E: New mutations and sporadic intellectual disability, Lancet 380(9854):1630–1631, 2012.
  604. Johnson CP, Walker WO Jr, Palomo-Gonzales SA, et al: Mental retardation: diagnosis, management, and family support, Curr Probl Pediatr Adolesc Health Care 36:123–171, 2006.
  605. Martin CL, Ledbetter DH: Chromosomal microarray testing for children with unexplained neurodevelopmental disorders, JAMA 317(24):2545–2546, 2017.
  606. Maulik PK, Mascarenhas MN, Mathers CD, et al: Prevalence of intellectual disability: a meta-analysis of population-based studies, Res Dev Disabil 32(2):419–436, 2011.
  607. Michelson DJ, Shevell MI, Sherr EH, et al: Evidence report. Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Neurology 77(17):1629–1635, 2011.
  608. Moeschler JB, Shevell M, American Academy of Pediatrics Committee on Genetics: Comprehensive evaluation of the child with intellectual disability or global developmental delays, Pediatrics 134:e903–e918, 2014.
  609. Rauch A, Wieczorek D, Graf E, et al: Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study, Lancet 380(9854):1674–1682, 2012.
  610. Robertson J, Emerson E, Hatton C, et al: Efficacy of community-based rehabilitation for children with or at significant risk of intellectual disabilities in low- and middle-income countries: a review, J Appl Res Intellect Disabil 25(2):143–154, 2012.
  611. Saha S, Barnett AG, Foldi C, et al: Advanced paternal age is associated with impaired neurocognitive outcomes during infancy and childhood, PLoS Med 6:e40, 2009.
  612. Shapiro BK, Batshaw ML: Developmental delay and intellectual disability. In Batshaw ML, Pellegrino L, Roizen NJ, editors: Children with disabilities, ed 7, Baltimore, 2013, Paul H Brookes, pp 291–306.
  613. Shevell M, Ashwal S, Donley D, et al: Practice parameter: evaluation of the child with global developmental delay, Neurology 60:367–380, 2003.
  614. Stevenson RE, Schwartz CE: X-linked intellectual disability: unique vulnerability of the male genome, Dev Disabil Res Rev 15:361–368, 2009.
  615. Sundaram S, Huq AH, Hsia T, et al: Exome sequencing and diffusion tensor imaging in developmental disabilities, Pediatr Res 75(3):443–447, 2014.
  616. Tarailo-Graovac M, Shyr C, Ross CJ, et al: Exome sequencing and the management of neurometabolic disorders, N Engl J Med 374(23):2246–2255, 2016.
  617. Tarini BA, Zikmund-Fisher BJ, Saal HM, et al: Primary care providers’ initial evaluation of children with global developmental delay: a clinical vignette study, J Pediatr 167:1404–1408, 2015.
  618. Tarpey PS, Smith R, Pleasance E, et al: A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation, Nat Genet 41(5):535–543, 2009.
  619. Valente EM, Ferraris A, Dallapiccola B: Genetic testing for paediatric neurological disorders, Lancet 7:1113–1126, 2008.
  620. Van Karnebeek CD, Scheper FY, Abeling NG, et al: Etiology of mental retardation in children referred to a tertiary care center: a prospective study, Am J Ment Retard 110(4):253–267, 2005.
  621. Van Karnebeek CD, Shevell M, Zschocke J, et al: The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource, Mol Genet Metab 111:428–438, 2014.
  622. Van Karnebeek CD, Stockler S: Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review, Mol Genet Metab 105:368–381, 2012.
  623. Vissers LE, de Ligt J, Gilissen C, et al: A de novo paradigm for mental retardation, Nat Genet 42(12):1109–1112, 2010.
  624. World Health Organization: Definition: intellectual disability.
  625. World Health Organization: Mental retardation. Â International Statistical Classification of Diseases and Related Health Problems, 10th revision, Geneva, 2011, WHO.
  626. American Academy of Pediatrics, Committee on Children with Disabilities: Pediatrician’s role in the development and implementation of an Individualized Education Plan (IEP) and/or an Individual Family Service Plan (IFSP), Pediatrics 104:124–127, 1999.
  627. American Association on Intellectual and Developmental Disabilities: Definition, classification, and systems of supports, Washington, DC, 2010, AAIDD.
  628. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed 5, Arlington, VA, 2013, American Psychiatric Publishing.
  629. Battaglia A, Hoyme HE, Dallapiccola B, et al: Further delineation of deletion 1p36 syndrome in 60 patients: a recognizable phenotype and common cause of developmental delay and mental retardation, Pediatrics 121:404–410, 2008.
  630. Cleary MA, Green A: Developmental delay: when to suspect and how to investigate for an inborn error of metabolism, Arch Dis Child 90(11):1128–1132, 2005.
  631. Council on Children with Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children with Special Needs Project Advisory Committee: Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening, Pediatrics 118:405–420, 2006.
  632. Curry CJ, Stevenson RE, Aughton D, et al: Evaluation of mental retardation: recommendations of a Consensus Conference: American College of Medical Genetics, Am J Med Genet 72:468–477, 1977.
  633. De Ligt J, Willemsen MH, van Bon BW, et al: Diagnostic exome sequencing in persons with severe intellectual disability, N Engl J Med 367:2012.
  634. Gecz J, Haan E: New mutations and sporadic intellectual disability, Lancet 380(9854): 1630–1631, 2012.
  635. Johnson CP, Walker WO Jr, Palomo-Gonzales SA, et al: Mental retardation: diagnosis, management, and family support, Curr Probl Pediatr Adolesc Health Care 36:123–171, 2006.
  636. Martin CL, Ledbetter DH: Chromosomal microarray testing for children with unexplained neurodevelopmental disorders, JAMA 317(24):2545–2546, 2017.
  637. Maulik PK, Mascarenhas MN, Mathers CD, et al: Prevalence of intellectual disability: a meta-analysis of population-based studies, Res Dev Disabil 32(2):419–436, 2011.
  638. Michelson DJ, Shevell MI, Sherr EH, et al: Evidence report. Genetic and metabolic testing on children with global developmental delay: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society, Neurology 77(17):1629–1635, 2011.
  639. Moeschler JB, Shevell M, American Academy of Pediatrics Committee on Genetics: Comprehensive evaluation of the child with intellectual disability or global developmental delays, Pediatrics 134:e903–e918, 2014.
  640. Rauch A, Wieczorek D, Graf E, et al: Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study, Lancet 380(9854):1674–1682, 2012.
  641. Robertson J, Emerson E, Hatton C, et al: Efficacy of community-based rehabilitation for children with or at significant risk of intellectual disabilities in low- and middle-income countries: a review, J Appl Res Intellect Disabil 25(2):143–154, 2012.
  642. Saha S, Barnett AG, Foldi C, et al: Advanced paternal age is associated with impaired neurocognitive outcomes during infancy and childhood, PLoS Med 6:e40, 2009.
  643. Shapiro BK, Batshaw ML: Developmental delay and intellectual disability. In Batshaw ML, Pellegrino L, Roizen NJ, editors: Children with disabilities, ed 7, Baltimore, 2013, Paul H Brookes, pp 291–306.
  644. Shevell M, Ashwal S, Donley D, et al: Practice parameter: evaluation of the child with global developmental delay, Neurology 60:367–380, 2003.
  645. Stevenson RE, Schwartz CE: X-linked intellectual disability: unique vulnerability of the male genome, Dev Disabil Res Rev 15:361–368, 2009.
  646. Sundaram S, Huq AH, Hsia T, et al: Exome sequencing and diffusion tensor imaging in developmental disabilities, Pediatr Res 75(3):443–447, 2014.
  647. Tarailo-Graovac M, Shyr C, Ross CJ, et al: Exome sequencing and the management of neurometabolic disorders, N Engl J Med 374(23):2246–2255, 2016.
  648. Tarini BA, Zikmund-Fisher BJ, Saal HM, et al: Primary care providers’ initial evaluation of children with global developmental delay: a clinical vignette study, J Pediatr 167:1404–1408, 2015.
  649. Tarpey PS, Smith R, Pleasance E, et al: A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation, Nat Genet 41(5):535–543, 2009.
  650. Valente EM, Ferraris A, Dallapiccola B: Genetic testing for paediatric neurological disorders, Lancet 7:1113–1126, 2008.
  651. Van Karnebeek CD, Scheper FY, Abeling NG, et al: Etiology of mental retardation in children referred to a tertiary care center: a prospective study, Am J Ment Retard 110(4):253–267, 2005.
  652. Van Karnebeek CD, Shevell M, Zschocke J, et al: The metabolic evaluation of the child with an intellectual developmental disorder: diagnostic algorithm for identification of treatable causes and new digital resource, Mol Genet Metab 111:428–438, 2014.
  653. Van Karnebeek CD, Stockler S: Treatable inborn errors of metabolism causing intellectual disability: a systematic literature review, Mol Genet Metab 105:368–381, 2012.
  654. Vissers LE, de Ligt J, Gilissen C, et al: A de novo paradigm for mental retardation, Nat Genet 42(12):1109–1112, 2010.
  655. World Health Organization: Definition: intellectual disability.
  656. World Health Organization: Mental retardation. In International Statistical Classification of Diseases and Related Health Problems, 10th revision, Geneva, 2011, WHO.
  657. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Ed. 5. Washington: American Psychiatric Association, 2013.
  658. Arora M., Reichenberg A., Willfors C. et al. Fetal and postnatal metal dysregulation in autism // Nat. Commun. 2017. Vol. 8. P. 15493. doi:10.1038/ncomms15493.
  659. Broder-Fingert S., Feinberg E., Silverstein M. Music therapy for children with autism spectrum disorders // JAMA. 2017. Vol. 318. N. 6. P. 523–524.
  660. Brown H.K., Ray J.G., Wilton A.S. et al. Association between serotonergic antidepressant use during pregnancy and autism spectrum disorder in children // JAMA. 2017. Vol. 317. N. 15. P. 1544–1552.
  661. Buie T., Campbell D.B., Fuchs G.J. et al. Evaluation, diagnosis and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report // Pediatrics. 2010. Vol. 125. S1–S18.
  662. Cuomo B.M., Vaz S., Lee E.A.I. et al. Effectiveness of sleep-based interventions for children with autism spectrum disorder: a meta-synthesis // Pharmacotherapy. 2017. Vol. 37. N. 5. P. 555–578.
  663. Dawson G., Rogers S., Munson J. et al. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model // Pediatrics. 2010. Vol. 125. P. e17.
  664. Dove D., Warren Z., McPheeters M.L. et al. Medications for adolescents and young adults with autism spectrum disorders: a systematic review // Pediatrics. 2012. Vol. 130. P. 717–726.
  665. Estes A., Munson J., Rogers S.J. et al. Long-term outcomes of early intervention in 6-year-old children with autism spectrum disorder // J. Am. Acad. Child Adolesc. Psychiatry. 2015. Vol. 54. P. 580.
  666. Gabriels R.L., Pan Z., Dechant B. et al. Randomized controlled trial of therapeutic horseback riding in children and adolescents with autism spectrum disorder // J. Am. Acad. Child Adolesc. Psychiatry. 2015. Vol. 54. N. 7. P. 541–549.
  667. Hazlett H.C., Hongbin G., Munsell B.C. et al. Early brain development in infants at high risk for autism spectrum disorder // Nature. 2017. Vol. 542. P. 348–353.
  668. Johnson C.P., Myers S.M. American Academy of Pediatrics Council on Children with Disabilities: Identification and evaluation of children with autism spectrum disorders // Pediatrics. 2007. Vol. 120. P. 1183.
  669. Kasari C., Gulsrud A.C., Wong C. et al. Randomized controlled caregiver mediated joint engagement intervention for toddlers with autism // J. Autism. Dev. Disord. 2010. Vol. 40. P. 1045.
  670. Kasari C., Gulsrud A., Freeman S. et al. Longitudinal follow-up of children with autism receiving targeted interventions on joint attention and play // J. Am. Acad. Child Adolesc. Psychiatry. 2012. Vol. 51. P. 487.
  671. Kasari C., Rotheram-Fuller E., Locke J., Gulsrud A. Making the connection: randomized controlled trial of social skills at school for children with autism spectrum disorders // J. Child Psychol. Psychiatry. 2012. Vol. 53. P. 431.
  672. Kaufmann W.E., Kidd S.A., Andrews H.F. et al. Autism spectrum disorders in fragile X syndrome: cooccurring conditions and current treatment // Pediatrics. 2017. Vol. 139. N. S3. S194–S206.
  673. Klein N., Kemper K.J. Integrative approaches to caring for children with autism // Curr. Probl. Pediatr. Adolesc. Health Care. 2016. Vol. 46. P. 195.
  674. Lai M.C., Lombardo M.V., Baron-Cohen S. Autism // Lancet. 2014. Vol. 383. P. 896–910.
  675. Lord C., Elsabbagh M., Baird G., Veenstra-Vanderweele J. Autism spectrum disorder // Lancet. 2018. Vol. 392. P. 508–518.
  676. Malow B.A., Katz T., Reynolds A. et al. Sleep difficulties and medications in children with autism spectrum disorders: a registry study // Pediatrics. 2016. Vol. 137. S98–S104.
  677. McGuire K., Fung L.K., Hagopian L. et al. Irritability and problem behavior in autism spectrum disorder: a practice pathway for pediatric primary care // Pediatrics. 2016. Vol. 137. S136–S148.
  678. Miller M., Iosif A.M., Hill M. et al. Response to name in infants developing autism spectrum disorder: a prospective study // J. Pediatr. 2017. Vol. 183. P. 141–146.
  679. Myers S.M., Johnson C.P. American Academy of Pediatrics Council on Children with Disabilities: Management of children with autism spectrum disorders // Pediatrics. 2007. Vol. 120. P. 1162.
  680. Parker K.J., Oztan O., Libove R.A. et al. Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism // Proc. Natl. Acad. Sci. USA. 2017. Vol. 114. N. 30. P. 8119–8124.
  681. Pickles A., LeCouteur A., Leadbitter K. et al. Parent-mediated social communication therapy for young children with autism (PACT): long-term follow-up of a randomized controlled trial // Lancet. 2016. Vol. 388. P. 2501–2509.
  682. Pierce K., Courchesne E., Bacon E. To screen or not to screen universally for autism is not the questions: why the task force got it wrong // J. Pediatr. 2016. Vol. 176. P. 182–194.
  683. Sathe N., Andrews J.C., McPheeters M.L., Warren Z.E. Nutritional and dietary interventions for autism spectrum disorder: a systematic review // Pediatrics. 2017. Vol. 139. N. 6. P. e20170346.
  684. Schaefer G.B., Mendelsohn N.J. Professional Practice and Guidelines Committee: Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions // Genet. Med. 2013. Vol. 15. P. 399.
  685. Schendel D.E., Overgaard M., Christiansen J. et al. Association of psychiatric and neurologic comorbidity with mortality among persons with autism spectrum disorder in a Danish population // JAMA Pediatr. 2016. Vol. 170. N. 3. P. 243–250.
  686. Schreibman L., Dawson G., Stahmer A.C. et al. Naturalistic developmental behavioral interventions: empirically validated treatments for autism spectrum disorder // J. Autism Dev. Disord. 2015. Vol. 45. P. 2411.
  687. Shen M.D., Kim S.H., McKinstry R.G. et al. Increased extra-axial cerebrospinal fluid in high-risk infants who later develop autism // Biol. Psychiatry. 2017. Vol. 82. N. 3. P. 186–193.
  688. Siegel M., Beaulieu A.A. Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice // J. Autism Dev. Disord. 2012. Vol. 42. N. 8. P. 1592–1605.
  689. Sigafoos J., Waddington H. 6 year follow-up supports early autism intervention // Lancet. 2016. Vol. 388. P. 2454–2455.
  690. Taylor L.E., Swerdfeger A.L., Eslick G.D. Vaccines are not associated with autism: an evidence based meta-analysis of case-control and cohort studies // Vaccine. 2014. Vol. 32. P. 3623–3629.
  691. Vasa R.A., Mazurek M.O., Mahajan R. et al. Assessment and treatment of anxiety in youth with autism spectrum disorders // Pediatrics. 2016. Vol. 137. S115–S123.
  692. Volkmar F., Siegel M., Woodbury-Smith M., American Academy of Child and Adolescent Psychiatry (AACAP) Committee on Quality Issues (CQI) et al. Practice parameter for the assessment and treatment of children and adolescents with autism spectrum disorders // J. Am. Acad. Child Adolesc. Psychiatry. 2014. Vol. 53. N. 2. P. 237–257.
  693. Warren Z., McPheeters M.L., Sathe N. et al. A systematic review of early intensive intervention for autism spectrum disorders // Pediatrics. 2011. Vol. 127. P. e1303–e1311.
  694. Warren Z., Veenstra-VanderWeele J., Stone W. et al. Therapies for children with autism spectrum disorders. Rockville: Agency for Healthcare Research and Quality, 2011. P. 102.
  695. Weitlauf A.S., McPheeters M.L., Peters B. et al. Therapies for children with autism spectrum disorder: behavioral interventions update. Rockville: Agency for Healthcare Research and Quality, 2014. Comparative Effectiveness Review N. 137.
  696. Weitlauf A.S., Sathe N., McPheeters M.L., Warren Z.E. Interventions targeting sensory challenges in autism spectrum disorder: a systematic review // Pediatrics. 2017. Vol. 139. N. 6. P. e2017347.
  697. De Ruyter JC, Olthof MR, Seidell JC, et al: A trial of sugar-free or sugar-sweetened beverages and body weight in children, N Engl J Med 367:1397–1406, 2012.
  698. Dunn W, Schwimmer JB: The obesity epidemic and nonalcoholic fatty liver disease in children, Curr Gastroenterol Rep 10:67–72, 2008.
  699. Ebbeling CB, Feldman HA, Chomitz VR, et al: A randomized trial of sugar-sweetened beverages and adolescent body weight, N Engl J Med 367:1407–1416, 2012.
  700. Farley TA: The role of government in preventing excess calorie consumption, JAMA 308:1093–1094, 2012.
  701. Flegal KM, Kit BK, Orpana H, et al: Association of all-cause mortality with overweight and obesity using standard body mass index categories, JAMA 309:71–80, 2013.
  702. Ford AL, Bergh C, S?dersten P, et al: Treatment of childhood obesity by retraining eating behaviour: randomized controlled trial, BMJ 340:b5388, 2010.
  703. Fothergill E, Guo J, Howlard L, et al: Persistent metabolic adaptation 6 years after “the biggest loser” competition, Obesity (Silver Spring) 24(8):1612–1619, 2016.
  704. Franks PW, Hanson RL, Knowler WC, et al: Childhood obesity, other cardiovascular risk factors, and premature death, N Engl J Med 362:485–492, 2010.
  705. Gahagan S, Uauy R, Roseboom TJ: Developmental origins of pediatric obesity, Int J Pediatr 309863:2012.
  706. Glaser Pediatric Research Network Obesity Study Group: Metformin extended-release treatment of adolescent obesity, Arch Pediatr Adolesc Med 164:116–123, 2010.
  707. Global Burden of Disease 2015 Obesity Collaborators: Health effects of overweight and obesity in 195 countries over 25 years, N Engl J Med 377:13–24, 2017.
  708. Golden NH, Schneider M, Wood C: Preventing onesity and eating disorders in adolescents, Pediatrics 138(3):e10161649, 2016.
  709. Gortmaker SL, Swinburn BA, Levy D, et al: Changing the future of obesity: science, policy, and action, Lancet 378:838–846, 2011.
  710. Gulati AK, Kaplan DW, Daniels SR: Clinical tracking of severely obese children: a new growth chart, Pediatrics 130:1136–1140, 2012.
  711. Heymsfield SB, Wadden TA: Mechanisms, pathophysiology, and management of obesity, N Engl J Med 376(3):254–266, 2017.
  712. Ho M, Garnett SP, Baur L, et al: Effectiveness of lifestyle interventions in child obesity: systematic review with meta-analysis, Pediatrics 130:e1647–e1671, 2012.
  713. Ibaez L, Lopez-Bermejo A, Diaz M, et al: Pubertal metformin therapy to reduce total, visceral, and hepatic adiposity, J Pediatr 156:98–102, 2010.
  714. Inge TH, Jenkins TM, Xanthakos SA, et al: Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis, Lancet 5(3):165–173, 2017.
  715. Jacquemont S, Reymond A, Zufferey F, et al: Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus, Nature 478:97–102, 2011.
  716. Johnson BS, Kanters S, Bandayrel K, et al: Comparison of weight loss among named diet programs in overweight and obese adults—a meta analysis, JAMA 312:923–932, 2014.
  717. Kaisari P, Yannakoulia M, Panagiotakos DB: Eating frequency and overweight and obesity in children and adolescents: a meta-analysis, Pediatrics 131:958–967, 2013.
  718. Karra E, O’Daly OG, Choudhury AI, et al: A link between FTO, ghrelin, and impaired brain food-cue responsivity, J Clin Invest 123(8):3539–3551, 2013.
  719. Kelly AS: The harsh reality of severe obesity, J Pediatr 163:6–8, 2013.
  720. Khera R, Murad MH, Chandar AK, et al: Association of pharmacological treatments for obesity with weight loss and adverse events, JAMA 315(22):2424–2434, 2016.
  721. Komaroff AL: The microbiome and risk for obesity and diabetes, JAMA 317(4):355–356, 2017.
  722. Kohnen P, Cl?ment K, Wiengand S, et al: Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist, N Engl J Med 375(3):240–246, 2016.
  723. Larder R, O’Rahilly S: Guts over glory—why diets fail, Nat Med 18:666–668, 2012.
  724. Lee IM, Djouss? L, Sesso HD, et al: PA and weight gain prevention, JAMA 303: 1173–1179, 2010.
  725. Leung CW, Blumenthal SJ, Hoffnagle EE, et al: Associations of food stamp participation with dietary quality and obesity in children, Pediatrics 131:463–472, 2013.
  726. Ludwig J, Sanbonmatsu L, Gennetian L, et al: Neighborhoods, obesity, and diabetes—a randomized social experiment, N Engl J Med 365:1509–1518, 2011.
  727. Maggard-Gibbons M, Maglione M, Livhits M, et al: Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes, JAMA 309: 2250–2260, 2013.
  728. Manco M, Dallapiccola B: Genetics of pediatric obesity, Pediatrics 130:123–133, 2012.
  729. Marcus CL, Brooks LJ, Draper KA, et al: Diagnosis and management of childhood obstructive sleep apnea syndrome, Pediatrics 130(3):e714–e755, 2012.
  730. Markwald RR, Melanson EL, Smith MR, et al: Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain, Proc Natl Acad Sci USA 110:5695–5700, 2013.
  731. Martin RM, Patel R, Kramer MS, et al: Effects of promoting longer-term and exclusive breastfeeding on adiposity and insulin-like growth factor-1 at age 11.5 years, JAMA 309:1005–1012, 2013.
  732. Mead E, Atkinson G, Richter B, et al: Drug interventions for the treatment of obesity in children and adolescents (review), Cochrane Database Syst Rev (11):CD012436, 2016.
  733. The Medical Letter: Two new drugs for weight loss, Med Lett Drugs Ther 54:69–72, 2012.
  734. The Medical Letter: Diet, drugs, and surgery for weight loss, Med Lett 57:21–28, 2015.
  735. Murray R, Battista M: Managing the risk of childhood overweight and obesity in primary care practice, Curr Probl Pediatr Adolesc Health Care 39:145–166, 2009.
  736. Nader P, Huang TK, Gahagan S, et al: Next steps in obesity prevention: altering early life systems to support healthy parents, infants and toddlers, Child Obes 8(3):195–204, 2012.
  737. Nadler EP, Brotman LM, Miyoshi T, et al: Morbidity in obese adolescents who meet the adult National Institutes of Health criteria for bariatric surgery, J Pediatr Surg 44:1869–1876, 2009.
  738. O’Brien PE, Sawyer SM, Laurie C, et al: Laparoscopic adjustable gastric banding in severely obese adolescents, JAMA 303:519–526, 2010.
  739. Ogden CL, Carroll MD, Kit BK, et al: Prevalence of obesity and trends in body mass index among US children and adolescents, 1999–2010, JAMA 307:483–490, 2012.
  740. Page KA, Chan O, Arora J, et al: Effects of fructose vs glucose on regional cerebral blood flow in brain regions involved with appetite and reward pathways, JAMA 309:63–70, 2013.
  741. Asghari G, Yuzbashian E, Mirmiran P, et al. Dietary Approaches to Strop Hypertension (DASH) dietary pattern is associated with reduced incidence of metabolic syndrome in children and adolescents. J Pediatr. 2016;174:178–184.
  742. Auerbach BJ, Wolf FM, Hikida A, et al. Fruit juice and change in BMI: a meta-analysis. Pediatrics. 2017;139(4):e20162454.
  743. Azad MB, Abou-Setta AM, Chauhan BF, et al. Nonnutritive sweeteners and cardiometabolic health: a systematic review and meta-analysis of randomized trials. CMAJ. 2017;189:E929–E939.
  744. Bhutta ZA, Salam RA: Global nutrition epidemiology and trends. Ann Nutr Metab. 2012;61(Suppl 1):19S–27S.
  745. Boulton J, Hashem KM, Jenner KH, et al. How much sugar is hidden in drinks marketed to children? A survey of fruit juices, juice drinks and smoothies. BMJ Open. 2016;6:e010330.
  746. Chumpatazi BP, Shulman RJ: Dietary carbohydrates and childhood functional abdominal pain. Ann Nutr Metab. 2016;69(Suppl 1):8–17.
  747. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ. 2000;320(7244):1240–1243.
  748. Gidding SS, Dennison BA, Birch LL, et al. American Heart Association: Dietary recommendations for children and adolescents: a guide for practitioners. Pediatrics. 2006;117:544–559.
  749. Goldman TR: Health policy brief: Final 2015–20 guidelines for Americans. Health Aff. 2016.
  750. Grummer-Strawn LM, Reinold C, Krebs NF: Use of World Health Organization and CDC growth charts for children aged 0–59 months in the United States, MMWR Recomm Rep. 2010;59:1–15.
  751. Gulati AK, Kaplan DW, Daniels SR: Clinical tracking of severely obese children: a new growth chart. Pediatrics. 2012;130(6):1136–1140.
  752. Heyman MB, Abrams SA: Fruit juice in infants, children, and adolescents: current recommendations. Pediatrics. 2017;139(6):e20170967.
  753. Institutes of Medicine (IOM). Dietary reference intakes for calcium and vitamin D. Washington: DC, 2011. National Academies Press.
  754. Institute of Medicine (IOM). Dietary reference intakes. the essential guide to nutrient requirements. Washington: DC, 2006. National Academies Press.
  755. Keast DR, Fulgoni VL 3rd, Nicklas TA, et al. Food sources of energy and nutrients among children in the United States: National Health and Nutrition Examination Survey 2003–2006. Nutrients. 2013;5(1):283–301.
  756. Kellings S, Isom K, editors. Academy of Nutrition and Dietetics pocket guide to bariatric surgery, ed. 2. Chicago, 2015. Academy of Nutrition and Dietetics.
  757. Kleinman RE, editor. Pediatric nutrition handbook, ed 7. Elk Grove Village, IL, 2013. American Academy of Pediatrics.
  758. National Center for Health Statistics: CDC growth charts. www.cdc.gov/GrowthCharts/ .
  759. Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of high body mass index in US children and adolescents, 2007-2008. JAMA. 2010;303(3):242–249.
  760. Roy SM, Spivack JG, Faith MS è äð.: Infant BMI or weight-for-length and obesity risk in early childhood. Pediatrics. 2016;137(5):pii e20153492.
  761. Skinner AC, Skelton JA: Prevalence and trends in obesity and severe obesity among children in the United States. 1999-2012. JAMA Pediatr. 2014;168(6):561–566.
  762. Thomas DT, Erdman KA, Burke LM: Position of the Academy of Nutrition and Dietetics, Dietitians of Canada, and the American College of Sports Medicine: Nutrition and athletic performance. J Acad Nutr Diet. 2016;116(3):501–528.
  763. US Department of Agriculture: MyPlate. www.choosemyplate.gov/ .
  764. US Department of Health and Human Services: 2008 Physical Activity Guidelines for Americans.
  765. US Department of Health and Human Services: 2015–2020 Dietary Guidelines for Americans.
  766. Vos MB, Kaar JL, Welsh JA è äð.: Added sugars and cardiovascular disease risk in children, Circulation 2017;135(19):e1017–e1034.
  767. Williams CL: Dietary fiber in childhood. J Pediatr. 2006;149:S121–S130.
  768. Zeevi D, Korem T, Zmora N, et al. Personalized nutrition by prediction of glycemic responses. Cell. 2015;163:1079–1094.
  769. Zemel BS, Pipan M, Stallings VA, et al. Growth charts for children with Down syndrome in the United States. Pediatrics. 2015;136(5):e1204–e1211.
  770. American Academy of Pediatrics. Breast-feeding and the use of human milk // Pediatrics. 2012. Vol. 129. P e827–e841.
  771. American Academy of Pediatrics, Committee on Nutrition. Pediatric nutrition handbook. Ed. 7. Elk Grove Village: American Academy of Pediatrics, 2014.
  772. Anstey E.H., Chen J., Elam-Evans L.D., Perrine C.G. Radical and geographic differences in breastfeeding—United States, 2011–2015 // MMWR. 2017. Vol. 66. N. 27. P 723–727.
  773. Asghari G., Yuzbashian E., Mirmiran P. et al. Dietary Approaches to Stop Hypertension (DASH) dietary pattern is associated with reduced incidence of metabolic syndrome in children and adolescents // J. Pediatr. 2016. Vol. 174. P. 178–184.
  774. Baranski M., Srednicka-Tober D., Volakakis N. et al. Higher antioxidant and lower cadmium concentrations and lower incidence of pesticide residues in organically grown crops: a systematic literature review and meta-analysis // J. Nutr. 2014. Vol. 112. P. 794–811.
  775. Bass J.L., Gartley T., Kleinman R. Unintended consequences of current breastfeeding initiatives // JAMA Pediatr. 2016. Vol. 170. N. 10. P. 923–924.
  776. Chiu Y.H., Williams P.L., Gillman M.W. et al. Association between pesticide residue intake from consumption of fruits and vegetables and pregnancy outcomes among women undergoing infertility treatment with assisted reproductive technology // JAMA Intern. Med. 2017. doi:10.1001/jamainternmed.2017.5038.
  777. Crinnion W.J. Organic foods contain higher levels of certain nutrients, lower levels of pesticides, and may provide health benefits for the consumer // Altern. Med. Rev. 2010. Vol. 15. N. 1. P. 4–12.
  778. Di Noia J. Defining powerhouse fruits and vegetables: a nutrient density approach // Prev. Chronic Dis. 2014. Vol. 11. P. 130390.
  779. Emond A., Ingram J., Johnson D et al. Randomised controlled trial of early frenotomy in breastfed infants with mild-moderate tongue-tie // Arch. Dis. Child Fetal. Neonatal. Ed. 2014. Vol. 99. N. 3. F189–F195.
  780. Flaherman V.J., Aby J., Burgos A.E. et al. Effect of early limited formula on duration and exclusively of breastfeeding in at-risk infants: an RCT // Pediatrics. 2013. Vol. 131. N. 6. P. 1059–1065.
  781. Flaherman V.J., Schaefer E.W., Kuzniewicz M.W. et al. Early weight loss nomograms for exclusively breastfed newborns // Pediatrics. 2015. Vol. 135. N. 1. P. e16–e23.
  782. Forman J., Silverstein J. Organic foods: health and environmental advantages and disadvantages // Pediatrics. 2012. Vol. 130. N. 5. P. e1406–e1415.
  783. Gidding S.S., Dennison B.A., Birch L.L. et al. Dietary recommendations for children and adolescents: a guide for practitioners // Pediatrics. 2006. Vol. 117. N. 2. P. 544–559.
  784. Grummer-Strawn L.M., Reinold C., Krebs N.F. Use of World Health Organization and CDC growth charts for children aged 0-59 mo in the United States // MMWR Recomm. Rep. 2010. Vol. 59. RR–9. P. 1–15.
  785. Heyman M.B., Abrams S.A., Section on Gastroenterology, Hepatology, and Nutrition, Committee on Nutrition. Fruit juice in infants, children, and adolescents: current recommendations // Pediatrics. 2017. Vol. 139. N. 6. P. e20170967.
  786. Jaafar S.H., Ho J.J., Jahanfar S. et al. Effect of restricted pacifier use in breastfeeding term infants for increasing duration of breastfeeding (review) // Cochrane Database Syst. Rev. 2016. CD007202.
  787. Landrigan P.J., Benbrook C. GMOs, herbicides, and public health // N. Engl. J. Med. 2015. Vol. 373. N. 8. P. 693–695.
  788. Lillycrop K.A., Hoile S.P., Grenfell L., Burdge G.C. DNA methylation, ageing and the influence of early life nutrition // Proc. Nutr. Soc. 2014. Vol. 73. N. 3. P. 413–421.
  789. Lozoff B., Castillo M., Clark K.M. et al. Iron-fortified vs low-iron infant formula // Arch. Pediatr. Adolesc. Med. 2012. Vol. 166. N. 3. P. 208–215.
  790. May A.L., Dietz W.H., The Feeding Infants and Toddlers Study 2008. Opportunities to assess parental, cultural, and environmental influences on dietary behaviors and obesity prevention among young children // J. Am. Diet. Assoc. 2010. Vol. 110. Suppl. 12. S11–S15.
  791. Metayer C., Dahl G., Wiemels J., Miller M. Childhood leukemia: a preventable disease // Pediatrics. 2016. Vol. 138. N. 1. P. e20154268.
  792. Mitka M. New dietary guidelines place added sugars in the crosshairs // JAMA. 2016. Vol. 315. N. 14. P. 1440–1442.
  793. National Academies: Dietary Reference Intakes. The essential guide to nutrient requirements. Washington: National Academies Press, 2006.
  794. Neltner T., Maffini M., Lovell S., Harvey M. Lead in food: a hidden health threat // Environmental Defense Fund. June 15. 2017.
  795. Nguyen T., Dennison B.A., Fan W. et al. Variation in formula supplementation of breastfed newborn infants in New York hospitals // Pediatrics. 2017. Vol. 140. N. 1. P. e20170142.
  796. Peres K.G., Nascimento G.G., Peres M.A. et al. Impact of prolonged breastfeeding on dental caries: a population-based birth cohort study // Pediatrics. 2017. Vol. 140. N. 1. P. e20162943.
  797. Perrine C.G., Galuska D.A., Dohack J.L. et al. Vital signs: Improvements in maternity care policies and practices that support breastfeeding—United States, 2007–2013 // MMWR. 2015. Vol. 64. N. 39. P. 1112–1117.
  798. Power R.F., Murphy J.F. Tongue-tie and frenotomy in infants with breastfeeding difficulties: achieving a balance // Arch. Dis. Child. 2015. Vol. 100. N. 5. P. 489–494.
  799. Roe L.S., Meengs J.S., Birch L.L., Rolls B.J. Serving a variety of vegetables and fruit as a snack increased intake in preschool children // Am. J. Clin. Nutr. 2013. Vol. 98. N. 3. P. 693–699.
  800. Srednicka-Tober D., Bara?ski M., Seal C. et al. Composition differences between organic and conventional meet: a systematic literature review and meta-analysis // Br. J. Nutr. 2016. Vol. 115. N. 6. P. 994–1011.
  801. Friedli N., Stanga Z., Sobotka L. et al. Revisiting the refeeding syndrome: results of a systematic review // Nutrition. 2017. Vol. 31. P. 151–160.
  802. Pulani C.D., Zettle S., Srinath A. Refeed syndrome // Pediatr. Rev. 2016. Vol. 37. P. 516–523.
  803. Rytter M.J.H., Babirekere-Iriso E., Namusoke H. et al. Risk factors for death in children during inpatient treatment of severe acute malnutrition: a prospective cohort study // Am. J. Clin. Nutr. 2017. Vol. 105. P. 494–502.
  804. Srednicka-Tober D., Bara?ski M., Seal C. et al. Higher PUFA and n-3 PUFA, conjugated linolenic acid, ?-tocopherol and iron, but lower iodine and selenium concentrations in organic milk; a systematic literature review and meta- and redundancy analyses // Br. J. Nutr. 2016. Vol. 115. N. 6. P. 1043–1060.
  805. US Department of Agriculture, US Department of Health and Human Services. Dietary guidelines for Americans. Ed. 8. Washington: US Government Printing Office, 2015.
  806. Daniels S.R., Hassink S.G. COMMITTEE ON NUTRITION: The role of the pediatrician in primary prevention of obesity // Pediatrics. 2015. Vol. 136. N. 1. P. e275–292.
  807. US Preventive Services Task Force. Recommendation statement: Primary care interventions to support breastfeeding // JAMA. 2016. Vol. 316. N. 16. P. 1688–1693.
  808. Bartels R.H., Bourdon C., Potani I. et al. Pancreatic enzyme replacement therapy in children with severe acute malnutrition: a randomized controlled trial // J. Pediatr. 2017. Vol. 190. P. 85–92.
  809. Beddington J., Asaduzzaman M., Clark M. et al. Achieving food security in the face of climate change: Final Report from the Commission on Sustainable Agriculture and Climate Change. Copenhagen, 2012.
  810. Black M.M., Walker S.P., Fernald L.C.H. et al. Early childhood development coming of age: science through the life course // Lancet. 2017. Vol. 389. P. 77–90.
  811. Black R.E., Victora C.G., Walker S.P. et al. Maternal and child undernutrition and overweight in low- and middle-income countries // Lancet. 2013. Vol. 382. P. 427–451.
  812. Carvalho N.F., Kenney R.D., Carrington P.H. et al. Severe nutritional deficiencies in toddlers resulting from health food milk alternatives // Pediatrics. 2001. Vol. 107. N. 4. P. e–46.
  813. Community-based therapeutic care (CTC): a field manual. Oxford: Valid International, 2006.
  814. Gillespie S., Hodge J., Yosef S., Pandya-Lorch R. (eds). Nourishing millions: stories of change in nutrition. Washington: International Food Policy Research Institute, 2016.
  815. Global Burden of Disease 2015 SDG Collaborators. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015 // Lancet. 2016. Vol. 388. P. 1813–1850.
  816. Global Panel on Agriculture and Food Systems for Nutrition. Food systems and diets: facing the challenges of the 21st century. London, 2016.
  817. Imdad A., Mayo-Wilson E., Herzer K. et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age // Cochrane Database of Systematic Reviews. 2017. Iss. 3. CD008524. Doi: 10.1002/14651858.CD008524.pub3.
  818. International Food Policy Research Institute. Global Nutrition Report 2016: from promise to impact—ending malutrition by 2030. Washington, 2016.
  819. Million M., Diallo A., Raoult D. Gut microbiota and malnutrition // Microb. Pathog. 2017. Vol. 106. P. 127–138.
  820. Myers S.S., Smith M.R., Guth S. et al. Climate change and global food systems: potential impacts on food security and undernutrition // Annu. Rev. Public Health. 2017. Vol. 38. P. 259–277.
  821. Prado E.L., Sebayang S.K., Apriatni M. et al. Maternal multiple micronutrient supplementation and other biomedical and socioenvironmental influences on children’s cognition at age 9-12 years in Indonesia: follow-up of the SUMMIT randomized trial // Lancet. 2017. Vol. 5. P. e217–e228.
  822. Prendergast A.J., Kelly P. Interactions between intestinal pathogens, enteropathy and malnutrition in developing countries // Curr. Opin. Infect. Dis. 2016. Vol. 29. P. 229–236.
  823. Shatrugna V., Srivatsan R. The right to food security // BMJ. 2012. Vol. 345. P. e8273.
  824. Trehan I., Goldbach H.S., LaGrone L.N. et al. Antibiotics as part of the management of severe acute malnutrition // N. Engl. J. Med. 2013. Vol. 368. P. 425–435.
  825. United Nations Department of Economic and Social Affairs. The Millennium Development Goals Report 2015. New York, 2015.
  826. UNICEF/WHO/World Bank Group. Joint child malnutrition estimates—levels and trends. 2018.
  827. Van der Kam S., Roll S., Swarthout T. et al. Effect of short-term supplementation with ready-to-use therapeutic food or micronutrients for children after illness for prevention of malnutrition: a randomized controlled trial in Uganda // PLoS Med. 2016. Vol. 13. N. 2. P. e1001951.
  828. Vygen S.B., Roberfroid D., Captier V. et al. Treatment of severe acute malnutrition in infants aged ?6 months in Niger // J. Pediatr. 2013. Vol. 162. P. 515–521.
  829. Watts N., Adger W.N., Agnolucci P. et al. Health and climate change: policy responses to protect public health // Lancet. 2015. Vol. 386. P. 1861–1914.
  830. Williams V., Jayashree M. Muehrcke lines in an infant // J. Pediatr. 2017. Vol. 189. P. 234.
  831. World Health Organization. Pocket book of hospital care for children: guidelines for the management of common illnesses. Geneva, 2013.
  832. Pal A, Barber TM, van de Bunt M, et al: PTEN mutations as a cause of constitutive insulin sensitivity and obesity, N Engl J Med 367:1002–1010, 2012.
  833. Pan L, Freedman DS, Sharma AJ, et al: Trends in obesity among participants aged 2-4 years in the Special Supplemental Nutrition Program for Women, Infants, and Children—United States, 2000–2014, MMWR 65(45):1256–1260, 2016.
  834. Patwari PP, Rand CM, Berry-Kravis EM, et al: Monozygotic twins discordant for ROHHAD phenotype, Pediatrics 128:e711–e715, 2011.
  835. Paz-Priel I, Cooke DW, Chen AR: Cyclophosphamide for rapid-onset obesity, hypothalamic dysfunction, hypoventilation, and autonomic dysregulation syndrome, J Pediatr 158(2):337–339, 2011.
  836. Perkins E, Murphy SK, Murtha AP, et al: Insulin-like growth factor 2/H19 methylation at birth and risk of overweight and obesity in children, J Pediatr 161:31–39, 2012.
  837. Puzziferri N, Roshek TB III, Mayo HG, et al: Long-term follow-up after bariatric surgery—a systematic review, JAMA 312:934–942, 2014.
  838. Rand CM, Patwari PP, Rodikova EA, et al: Rapid-onset obesity with hypothalamic dysfunction, hypoventilation, and autonomic dysregulation: analysis of hypothalamic and autonomic candidate genes, Pediatr Res 70:375–378, 2011.
  839. Reinehr T: Predicting weight loss of obese adolescents in lifestyle interventions by genetic screening: a promising approach for researchers and clinicians?, J Pediatr 161:382–384, 2012.
  840. Renn T, Volkov P, Daveg?rdh C, et al: A six months exercise intervention influences the genome-wide DNA methylation pattern in human adipose tissue, PLoS Genet 9:e1003572, 2013.
  841. Sacher PM, Kolotourou M, Chadwick PM, et al: Randomized controlled trial of the MEND program: a family-based community intervention for childhood obesity, Obesity (Silver Spring) 18:S62–S68, 2010.
  842. Sacks FM, Bray GA, Carey VJ, et al: Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates, N Engl J Med 360:859–872, 2009.
  843. Savoye M, Nowicka P, Shaw M, et al: Long-term results of an obesity program in an ethnically diverse pediatric population, Pediatrics 127(3):402–410, 2011.
  844. Scharf RJ, Demmer RT, DeBoer MD: Longitudinal evaluation of milk type consumed and weight status in preschoolers, Arch Dis Child 98:335–340, 2013.
  845. Schauer PR, Kashyap SR, Wolski K, et al: Bariatric surgery versus intensive medical therapy in obese patients with diabetes, N Engl J Med 366:1567–1576, 2012.
  846. Spyropoulos C, Kehagias I, Panagiotopoulos S, et al: Revisional bariatric surgery, Arch Surg 145:173–177, 2010.
  847. Styne DM, Arslanian SA, Connor EL, et al: Pediatric obesity—assessment, treatment, and prevention: an Endocrine Society clinical practice guideline, J Clin Endocrinol Metab 102(3):1–49, 2017.
  848. Swinburn B, Sacks G, Ravussin E: Increased food energy supply is more than sufficient to explain the US epidemic of obesity, Am J Clin Nutr 90:1453–1456, 2009.
  849. Taveras EM, Rifas-Shiman SL, Belfort MB, et al: Weight status in the first 6 months of life and obesity at 3 years of age, Pediatrics 123:1177–1183, 2009.
  850. US Department of Agriculture: Dietary guidelines for Americans, 2005. www.health.gov/dietaryguidelines/dga2005/document/html/chapter2.htm.
  851. US Preventive Services Task Force: Recommendation statement: Screening for obesity in children and adolescents, JAMA 317(23):2417–2426, 2017.
  852. Van Cauter E, Knutson K: Sleep and the epidemic of obesity in children and adults, Eur J Endocrinol 159:S59–S66, 2008.
  853. Van Cleave J, Gortmaker SL, Perrin JM: Dynamics of obesity and chronic health conditions among children and youth, JAMA 303:623–630, 2010.
  854. Vandanmagsar B, Youm YH, Ravussin A, et al: The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance, Nat Med 17(2):179–188, 2011.
  855. Vanselow MS, Pereira MA, Neumark-Sztainer D, et al: Adolescent beverage habits and changes in weight over time: finding from Project EAT, Am J Clin Nutr 90: 1489–1495, 2009.
  856. Wabitsch M, Funcke JB, Lennerz B, et al: Biologically inactive leptin and early-onset extreme obesity, N Engl J Med 372(1):48–54, 2015.
  857. Waters E, de-Silva-Sanigorski A, Hall BJ, et al: Interventions for preventing obesity in children, Cochrane Database Syst Rev (12):CD001871, 2011.
  858. Weiss R, Kaufman F: Metabolic complications of childhood obesity: identifying and mitigating the risk, Diabetes Care 31:S310–S316, 2008.
  859. Weng SF, Redsell SA, Swift JA, et al: Systematic review and meta-analyses of risk factors for childhood overweight identifiable during infancy, Arch Dis Child 97(12): 1019–1026, 2012.
  860. Wilfley DE, Stein RI, Saelens BE, et al: Efficacy of maintenance treatment approaches for childhood overweight: a randomized controlled trial, JAMA 298:1661–1673, 2007.
  861. Willett WC, Ludwig DS: Science souring on sugar, BMJ 346:7, 2013.
  862. Wojcicki JM: Peptide YY in children: a review, J Pediatr Endocrinol Metab 25:227–232, 2012.
  863. Yang J, Loos RJF, Powell JE, et al: FTO genotype is associated with phenotypic variability of body mass index, Nature 490:267–272, 2012.
  864. Yanovski SZ: Naltrexone extended-release plus bupropion extended-release for treatment of obesity, JAMA 313(12):1213–1214, 2015.
  865. Yanovski SZ, Yanovski JA: Long-term drug treatment for obesity—a systematic and clinical review, JAMA 311:74–84, 2014.
  866. American Psychiatric Association: . Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington:, American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  867. Bennardi M., McMahon E., Corcoran P, . et al: . Risk of repeated self-harm and associated factors in children, adolescents and young adults , // BMC Psychiatry. 2016. Vol. 16. P. :421, 2016.
  868. Dickstein D.P., Puzia M.H., Cushman G.K, . et al: . Self-injurious implicit attitudes among adolescent suicide attempters versus those engaged in nonsuicidal self-injury //, J. Child Psychol. Psychiatry. 2015. Vol. 56. N. (10. P.):1127–1136, 2015.
  869. Laukkanen E., Rissanen M.L., Tolmunen T, . et al: . Adolescent self-cutting elsewhere than on the arms reveals more serious psychiatric symptoms //, Eur. Child Adolesc. Psychiatry. 2013. Vol. 22. P. :501–510, 2013.
  870. Lewis S.P., Heath N.L: . Nonsuicidal self-injury among youth //, J. Pediatr. 2015. Vol. 166. N. (3. P. ):526–530, 2015.
  871. Swanson E.N., Owens E.B., Hinshaw S.P: . Pathways to self-harmful behaviors in young women with and without ADHD: a longitudinal examination of mediating factors //, J. Child Psychol. Psychiatry. 2014. Vol. 55. N. (5. P. ):505–515, 2014.
  872. Whitlock J.L., Powers J.L., Eckenrode J: . The virtual cutting edge: the internet and adolescent self-injury //, Dev. Psychol. 2006. Vol. 42. N. (3. P. ):407–417, 2006.
  873. Aberg K.A., Liu Y., Buksz?r J, . et al: . A comprehensive family-based replication study of schizophrenia genes , // JAMA Psychiatry. 2013. Vol. 70. P. :573–581, 2013.
  874. Abidi S: . Psychosis in children and youth: focus on early-onset schizophrenia //, Pediatr. Rev. 2013. Vol. 34. P. :296–306, 2013.
  875. Ahn K., Gotay N., Andersen T.M, . et al:et al. High rate of disease-related copy number variations in childhood onset schizophrenia //, Mol. Psychiatry. 2014. Vol. 19. N. (5. P. ):568–572, 2014.
  876. American Academy of Child and Adolescent Psychiatry: AACAP official action. Practice parameters for the assessment and treatment of children and adolescents with schizophrenia Àìåðèêàíñêàÿ àêàäåìèÿ äåòñêîé è ïîäðîñòêîâîé ïñèõèàòðèè: îôèöèàëüíîå äåéñòâèå ÀÀÄÏÏ. Practice parameters for the assessment and treatment of children and adolescents with schizophrenia//, J. Am. Acad. Child Adolesc. Psychiatry. 2000. Vol. 39. P. :1580–1582, 2000.
  877. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington, : American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  878. Calkins M.E., Moore T.M., Merikangas K.R, . et al: . The psychosis spectrum in a young U.S. community sample: findings from the Philadelphia Neurodevelopmental Cohort //, World Psychiatry. 2014. Vol. 13. N. (3. P. ):296–305, 2014.
  879. Chapman M.R., Vause H.E: . Anti-NMDA receptor encephalitis: diagnosis, psychiatric-presentation, and treatment //, Am. J. Psychiatry. 2011. Vol. 168. P. :245–251, 2011.
  880. Correll C.U., Manu P., Olshanskiy V, . et al: . Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents //, JAMA. 2009. Vol. 302. N. (16. P. ):1765–1773, 2009.
  881. Cross-Disorder Group of the Psychiatric Genomics Consortium: Identification of risk loci shared effects on five major psychiatric disorders: a genome-wide analysis //, Lancet. 2013. Vol. 381. P. :1371–1378, 2013.
  882. De Hert M., Vancampfort D., Correll C.U, . et al: . Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluation //, Br. J. Psychiatry. 2011. Vol. 199. N. (2. P. ):99–105, 2011.
  883. Guha S., Rees E., Darvasi A, . et al: . Implications of a rare deletion at distal 16p11.2 in schizophrenia //, JAMA Psychiatry. 2013. Vol. 70. P. :253–260, 2013.
  884. Gur R.C., Calkins M.E., Satterthwaite T.D, . et al: . Neurocognitive growth charting in psychosis spectrum youths //, JAMA Psychiatry. 2014. Vol. 71. N. (4. P. ):366–374, 2014.
  885. Hart S.J., Bizzell J., McMahon M.A, . et al: . Altered fronto-limbic activity in children and adolescents with familial high risk for schizophrenia //, Psychiatry Res. 2013. Vol. 212. P. :19–27, 2013.
  886. Harvey R.C., James A.C., Shields G.E: . A systematic review and network meta-analysis to assess the relative efficacy of antipsychotics for the treatment of positive and negative symptoms in early-onset schizophrenia //, CNS Drugs. 2016. Vol. 30. N. (1. P. ):27–39, 2016.
  887. Jackson J.R: . Neurologic and psychiatric manifestations of celiac disease and gluten sensitivity //, Psychiatr. Q. 2012. Vol. 83. N. (1. P. ):91–102, 2012.
  888. Kayser M.S., Titulaer M.J., Gresa-Arribas N, . et al: . Frequency and characteristics of isolated psychiatric episodes in anti-N-methyl-D-aspartate receptor encephalitis //, JAMA Neurol. 2013. Vol. 70. P. :1133–1139, 2013.
  889. Kendall T: . Treating negative symptoms of schizophrenia //, BMJ. 2012. Vol. 344. P. :e664, 2012.
  890. Kendall T., Hollis C., Stafford M, . et al: . Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance //, BMJ. 2013. Vol. 346. P. :F150, 2013.
  891. Kumar A., Datta S.S., Wright S.D, . et al: . Atypical antipsychotics for psychosis in adolescents //, Cochrane Database Syst. Rev. 2013. (10):CD009582, 2013.
  892. Larson M.K., Walker E.F., Compton M.T: . Early signs, diagnosis, therapeutics of the prodromal phase of schizophrenia and related psychotic disorders //, Expert Rev. Neurother. 2010. Vol. 10. P. :1347–1359, 2010.
  893. Laurens K., Hobbs M.J., Sunderland M, . et al: . Psychotic-like experiences in a community sample of 8000 children 9-11 years: an item response theory analysis //, Psychol. Med. 2012. Vol. 42. N. (7. P. ):1495–1506, 2012.
  894. Lauterbach M.D., Stanislawski-Zygaj A.L., Benjamin S: . The differential diagnosis of childhood- and adult-onset disorders that include psychosis //, J. Neuropsychiatry Clin. Neurosci. 2008. Vol. 20. N. (4. P. ):409–418, 2008.
  895. Leroy A., Corfiotti C., Nguyen The Tich S., et al: . Catatonia associated with a SCN2A-related disorder in a 4-year-old child //. Pediatrics. 2018. Vol. 142. N. (5. P. ):e20181231, 2018.
  896. Leucht S., Cipriani A., Spineli L, . et al: . Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis //, Lancet. 2013. Vol. 382. P. :951–962, 2013.
  897. Lieberman J.A., Dixon L.B., Goldman H.H: . Early detection and intervention in schizophrenia: a new therapeutic model //, JAMA. 2013. Vol. 310. P. :689–690, 2013.
  898. MacCabe J.H., Wicks S., L?fving S, . et al: . Decline in cognitive performance between ages 13 and 18 yr and the risk of psychosis in adulthood //, JAMA Psychiatry. 2013. Vol. 70. P. :261–270, 2013.
  899. Marshall M., Rathbone J: . Early intervention for psychosis //, Cochrane Database Syst. Rev. 2011. (6):CD004718, 2011.
  900. Maziade M: . At risk for serious mental illness: screening children of patients with mood disorders or schizophrenia //, N. Engl. J. Med. 2017. Vol. 376. N. (10. P. ):910–912, 2017.
  901. The Medical Letter: Drugs for psychotic disorders //, Med. Lett. 2016. Vol. 58. N. (1510. P. ):160–164, 2016.
  902. The Medical Letter: Cariprazine (vraylar) for schizophrenia and bipolar I disorder //, Med. Lett. 2016. Vol. 58. N. (1493. P. ):51–53, 2016.
  903. Mitchell A.J., Delaffon V., Vancampfort D, . et al: . Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices //, Psychol. Med. 2012. Vol. 42. N. (1. P. ):125–147, 2012.
  904. National Institute for Health and Clinical Excellence: Psychosis and schizophrenia in children and young people overview. Íàöèîíàëüíûé èíñòèòóò çäðàâîîõðàíåíèÿ è ñîâåðøåíñòâà ìåäèöèíñêîé ïîìîùè: îáçîð ïñèõîçîâ è øèçîôðåíèè ó äåòåé è ìîëîäåæè, 2017 ã.
  905. Nemeth G., Laszlovszky I., Czobor P, . et al: . Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomized, double-blind, controlled trial //, Lancet. 2017. Vol. 389. P. :1103–1112, 2017.
  906. Olfson M., Gerhard T., Huang C, . et al: . Comparative effectiveness of second-generation antipsychotic medications in early-onset schizophrenia //, Schizophr. Bull. 2012. Vol. 38. N. (4. P. ):845–853, 2012.
  907. Owen M.J., Sawa A., Mortensen P.B: . Schizophrenia //, Lancet. 2016. Vol. 388. P. :86–97, 2016.
  908. Pagsberg A.K., Tarp S., Glintborg D, . et al: . Acute antipsychotic treatment of children and adolescents with schizophrenia-spectrum disorders: a systematic review and network meta-analysis //, J. Am. Acad. Child Adolesc. Psychiatry. 2017. Vol. 56. N. (3. P. ):191–202, 2017.
  909. Par?s A: . Schizophrenia, primary negative symptoms, and soft outcomes in psychiatry //, Lancet. 2017. Vol. 389. P. :1077–1080, 2017.
  910. Salgado H., Martins-Correia L: . Williams syndrome and psychosis: a case report //, J. Med. Case Rep. 2014. Vol. 8. P. :49, 2014.
  911. Sarkar S., Grover S: . Antipsychotics in children and adolescents with schizophrenia: a systematic review and meta-analysis //, Indian J. Pharmacol. 2013. Vol. 45. N. (5. P. ):439–446, 2013.
  912. Sedel F., Baumann N., Turpin J.C, . et al: . Psychiatric manifestations revealing inborn errors of metabolism in adolescent and adults //, J. Inherit. Metab. Dis. 2007. Vol. 30. P. :631–641, 2007.
  913. Sethi K., Lee Y.H., Daugherty L.E, . et al: . ROHHADNET syndrome presenting as major behavioral changes in a 5-year-old obese girl //, Pediatrics. 2016. Vol. 134. N. (2. P. ):e586–e589, 2016.
  914. Siegel M.S., Smith W.E: . Psychiatric features in children with genetic syndromes: toward functional phenotypes //, Child Adolesc. Psychiatric Clin. North Am. 2010. Vol. 19. P. :229–261, 2010.
  915. Stafford M.R., Jackson H., Mayo-Wilson E, . et al: . Early interventions to prevent psychosis systematic review and meta-analysis //, BMJ. 2013. Vol. 346. P. :f185, 2013.
  916. Schizophrenia Working Group of the Psychiatric Genomics Consortium: Biological insights from 108 schizophrenia-associated genetic loci //, Nature. 2014. Vol. 511. P. :421–427, 2014.
  917. Stentebjerg-Olesen M., Pagsberg A.K., Fink-Jensen A, . et al: . Clinical characteristics and predictors of outcome of schizophrenia-spectrum psychosis in children and adolescents: a systematic review //, J. Child Adolesc. Psychopharmacol. 2016. Vol. 26. N. (5. P. ):410–427, 2016.
  918. US Food and Drug Administration: Olanzapine: Drug safety communication—FDA warns about rare but serious skin reactions Óïðàâëåíèå ïî ñàíèòàðíîìó íàäçîðó çà êà÷åñòâîì ïèùåâûõ ïðîäóêòîâ è ìåäèêàìåíòîâ ÑØÀ: îëàíçàïèí. Èíôîðìàöèÿ î áåçîïàñíîñòè ëåêàðñòâ — óïðàâëåíèå ïî ñàíèòàðíîìó íàäçîðó çà êà÷åñòâîì ïèùåâûõ ïðîäóêòîâ è ìåäèêàìåíòîâ ïðåäóïðåæäàåò î ðåäêèõ, íî ñåðüåçíûõ êîæíûõ ðåàêöèÿõ.
  919. Van Os J: . Antipsychotic drugs for prevention of relapse //, Lancet. 2012. Vol. 379. P. :2030–2031, 2012.
  920. Wandinger K.P., Saschenbrecker S., Stoecker W., Dalmau J: . Anti-NMDA-receptor encephalitis: a severe multistage, treatable disorder presenting with psychosis //, J. Neuroimmunol. 2011. Vol. 231. P. :86–91, 2011.
  921. Won H., de la Torre-Ubieta L., Stein J.L, . et al: . Chromosome conformation elucidates regulatory relationships in developing human brain //, Nature. 2016. Vol. 538. P. :523–527, 2016.
  922. Xu B., Ionita-Laza I., Roos J.L, . et al: . De novo gene mutations highlight patterns of genetic and neural complexity in schizophrenia //, Nat. Genet. 2012. Vol. 44. P. :1365–1369, 2012.
  923. American Psychiatric Association: . Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington, : American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  924. Caraballo R., Koutroumanidis M., Panayiotopoulos C.P, . et al:et al. Idiopathic childhood occipital epilepsy of Gastaut: a review and differentiation from migraine and other epilepsies , // J. Child Neurol. 2009. Vol. 24. P. :1536–1542, 2009.
  925. Devinsky O: . Postictal psychosis: common, dangerous, and treatable //, Epilepsy Curr. 2008. Vol. 8. P. :31–34, 2008.
  926. Elliott B., Joyce E., Shorvon S: . Delusions, illusions and hallucinations in epilepsy. 2. Complex phenomena and psychosis //, Epilepsy Res. 2009. Vol. 85. N. (2–3. P. ):172–186, 2009.
  927. Farooq S., Sherin A: . Interventions for psychotic symptoms concomitant with epilepsy (review) //, Cochrane Database Syst. Rev. 2008. (4):CD006118, 2008.
  928. Kanner A.M, ., Dunn D.W: . Diagnosis and management of depression and psychosis in children and adolescents with epilepsy //, J. Child Neurol. 2004. Vol. 19. :S65–S72, 2004.
  929. Consoli A., Benmiloud M., Wachtel L, . et al:et al. Electroconvulsive therapy in adolescents with the catatonia syndrome: efficacy and ethics , // J. ECT. 2010. Vol. 26. N. (4. P. ):259–265, 2010.
  930. Cornic F., Consoli A., Cohen D: . Catatonic syndrome in children and adolescents //, Psychiatr. Ann. 2007. Vol. 37. P. :19–26, 2007.
  931. Dhossche D.M., Wachtel L.E: . Catatonia is hidden in plain sight among different pediatric disorders: a review article //, Pediatr. Neurol. 2010. Vol. 43. N. (5. P ):307–315, 2010.
  932. Dhossche D.M., Wilson C.M.D., Wachtel L.E: . Catatonia in childhood and adolescence: implications for the DSM-5 //, Prim. Psychiatry. 2010. Vol. 17. P. :35–39, 2010.
  933. Francis A: . Catatonia: diagnosis, classification, and treatment //, Curr. Psychiatry Rep. 2010. Vol. 12. P. :180–185, 2010.
  934. Peralta V., Campos M.S., Garcia de Jalon E, . et al:et al. DSM-IV catatonia signs and criteria in first-episode, drug-na?ve, psychotic patients: psychometric validity and response to antipsychotic medication //, Schizophr. Res. 2010. Vol. 118. P. :168–175, 2010.
  935. Tandon R., Heckers S., Bustillo J, . et al:et al. Catatonia in DSM-5 //, Schizophr. Res. 2013. Vol. 150. N. (1. P. ):26–30, 2013.
  936. Weder N.D., Muralee S., Penland H, . et al:et al. Catatonia: a review // , Ann. Clin. Psychiatry. 2008. Vol. 20. N. (2. P. ):97–107, 2008.
  937. McGee R., Williams S., Poulton R: . Hallucinations in nonpsychotic children , // J. Am. Acad. Child Adolesc. Psychiatry. 2000. Vol. 39. P. :12–13, 2000.
  938. Pao M., Lohman C., Gracey D, . et al:et al. Visual, tactile, and phobic hallucinations: recognition and management in the emergency department //, Pediatr. Emerg. Care. 2004. Vol. 20. P. :30–34, 2004.
  939. Schreier A., Wolke D., Thomas K, . et al:et al. Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years //, Arch. Gen. Psychiatry. 2009. Vol. 66. P. :527–536, 2009.
  940. Sosland M., Edelsohn G: . Hallucinations in children //, Curr. Psychiatry. Rep. 2005. Vol. 7. P. :180–188, 2005.
  941. Wong S., Bewley A: . Patients with delusional infestation (delusional parasitosis) often require prolonged treatment as recurrence of symptoms after cessation of treatment is common: an observational study //, Br. J. Dermatol. 2011. Vol. 165. P. :893–896, 2011.
  942. Chau K, Lau E, Greenberg S, et al. Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938. J Pediatr. 2015;166(1):74–78.
  943. Gelfand AA. Infant colic. Semin Pediatr Neurol. 2016;23(1):79–82.
  944. Harb T, Matsuyama M, David M, Hill RJ. Infant colic — what works: a systematic review of interventions for breast-fed infants. J Pediatr Gastroenterol Nutr. 2016;62(5):668–686.
  945. Radesky JS, Zuckerman B, Silverstein M, et al. Inconsolable infant crying and maternal postpartum depressive symptoms. Pediatrics. 2013;131(6):e1857–e1864.
  946. Sung V, Collett S, de Gooyer T, et al. Probiotics to prevent or treat excessive infant crying: systemic review and meta-analysis. JAMA Pediatr. 2013;167(12):1150–1157.
  947. American Academy of Pediatrics. Council on Communications and Media: media and young minds. Pediatrics. 2016;138(5):e20162591.
  948. Berry D et al. Early childcare, executive functioning, and the moderating roles of early stress physiology. Dev Psychol. 2014;50(4):1250–1261.
  949. Centers for Disease Control and Prevention (CDC). WHO growth standards are recommended for use in the U.S. for infants and children 0 to 2 years of age.
  950. Dubois J et al. The early development of brain white matter: a review of imaging studies in fetuses, newborns, and infants. Neuroscience. 2014;276:48–71.
  951. Fraiberg S. The magic years. New York: Scribner, 1959.
  952. Lin LY et al. Effects of television exposure on developmental skills among young children. Infant Behav Dev. 2015;38:20–26.
  953. Shonkoff JP. Capitalizing on advances in science to reduce the health consequences of early childhood adversity. JAMA Pediatr. 2016;170(10):1003–1007.
  954. Zimmerman FJ, Gilkerson J, Richards JA, et al. Teaching by listening: the importance of adult-child conversations to language development. Pediatrics. 2009;124:342.
  955. American Academy of Pediatrics. Council on Communications and Media: media and young minds. Pediatrics. 2016138(5):e20162591.
  956. Black MM, et al. Early childhood development coming of age: science through the life course. Lancet. 2017;389:77–90.
  957. Blewitt P, Langan R. Learning words during shared book reading: the role of extratextual talk designed to increase child engagement. J Exp Child Psychol. 2016;150:404–410.
  958. Bureau JF, et al. Correlates of child-father and child-mother attachment in the preschool years. Attach Hum Dev. 2017;19(2):130–150.
  959. Alfano CA, Lau S, Balderas J, et al. The impact of military deployment on children: placing developmental risk in context. Clin Psychol Rev. 2016;43:17–29.
  960. American Academy of Pediatrics Committee on Psychosocial Aspects of Child and Family Health: The pediatrician and childhood bereavement. Pediatrics. 2000;105(2):445–447. (Reaffirmed March 2013).
  961. Children’s Grief Education Association: Navigating children’s grief.
  962. Cohen GJ, Weitzman CC; Committee on Psychosocial Aspects of Child and Family Health; Section on Developmental and Behavioral Pediatrics. Helping children and families deal with divorce and separation. Pediatrics. 2016;138(6).
  963. Gaab EM, Owens GR, MacLeod RD. Siblings caring for and about pediatric palliative care patients. J Palliat Care. 2014;17(1):62–67.
  964. Miller PJ, Rosengren KS, Gutierrez IT. Children’s understanding of death: toward a contextualized and integrated account. Monogr Soc Res Child Dev. 2014;79.
  965. Schonfeld DJ, Demaria T; Committee on Psychosocial Aspects of Child and Family Health, Disaster Preparedness Advisory Council. Supporting the grieving child and family. Pediatrics. 2016;138(3).
  966. Schonfeld DJ, Demaria T, Disaster Preparedness Advisory Council and Committee on Psychosocial Aspects of Child and Family Health. Providing psychosocial support to children and families in the aftermath of disasters and crises. Pediatrics. 2015;136(4):e1120–e1130.
  967. Snaman JM, Kaye EC, Torres C, et al. Helping parents live with the hole in their heart: the role of health care providers and institutions in the bereaved parents’ grief journeys. Cancer. 2016;122(17):2757–2765.
  968. Weiner L, McDonnell DG, Latella L, et al. Cultural and religious considerations in pediatric palliative care. Palliat Support Care. 2013;11(1):47–67.
  969. Bertisch S. Restless legs syndrome. Ann Intern Med. 2015;163(9):ITC1–ITC11.
  970. Brockmann PE, Schaefer C, Poets A, et al. Diagnosis of obstructive sleep apnea in children: A systematic review. Sleep Med Rev. 2013;17(5):331–340.
  971. Bruni O, Alonso-Alconada D, Besag F, et al. Current role of melatonin in pediatric neurology: clinical recommendations. Eur J Paediatr Neurol. 2015;19(2):122–133.
  972. De Bruin EJ, van Run C, Staaks J, Meijer AM. Effects of sleep manipulation on cognitive functioning of adolescents: a systematic review. Sleep Med Rev. 2017;32:45–47.
  973. Garcia-Borreguero D, Cano-Pumarega I. New concepts in the management of restless legs syndrome. BMJ. 2017;356:j104.
  974. Honeker SM, Meltzer LJ. Sleep in pediatric primary care: a review of the literature. Sleep Med Rev. 2016;25:31–39.
  975. Khan Z, Trotti LM. Central disorders of hypersomnolence. Contemp Rev Sleep Med. 2015;148(1):262–273.
  976. Maski K, Owens J. Insomnia, parasomnias and narcolepsy in children; clinical features, diagnosis and management. Lancet Neurol. 2016;15:1170–1181.
  977. Meltzer LJ, Mindell JA. Systematic review and meta-analysis of behavioral interventions for pediatric insomnia. J Pediatr Psychol. 2014;39:932–948.
  978. Mindell J, Owens J. A clinical guide to pediatric sleep; diagnosis and management of sleep problems. Åd. 3. Wolters Kluwer, 2015.
  979. Paruthi S, Brooks LJ, D’Ambrosio C, et al. Recommended amount of sleep for pediatric populations: a consensus statement of the American Academy of Sleep Medicine. J Clin Sleep Med. 2016;12:785–786.
  980. Pizza F, Franceschini C, Peltola H, et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain. 2013;136:3787–3795.
  981. Price AM, Wake M, Ukoumunne OC, Hiscock H. Five-year follow-up of harms and benefits of behavioral infant sleep intervention: randomized trial. Pediatrics. 2012;130:9.
  982. Scammell TE. Narcolepsy. N Engl J Med. 2015;373(27):2654–2662.
  983. Szakacs Z, Dauvilliers Y, Mikhaylov V, et al. Safety and efficiency of pitolisant and cataplexy in patients with narcolepsy: a randomizes, double-blind, placebo-controlled trial. Lancet Neurol. 2017;16:200–207.
  984. Van Maanen A, Meijer AM, Smits MG, et al. Effects of melatonin and bright light treatment in childhood chronic sleep onset insomnia with late melatonin onset: a randomized controlled study. Sleep. 2017;40(2):1–11.
  985. Wheaton AG, Ferro GA, Croft JB. School start times for middle school and high school students — United States, 2011–2012 school year. MMWR Morb Mortal Wkly Rep. 2015;64(30):809–813.
  986. Williams JA, Zimmerman FJ, Bell JF. Norms and trends of sleep time among US children and adolescents. JAMA Pediatr. 2013;167(1):55–60.
  987. Wilt TJ, MacDonald R, Brasure M, et al. Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians. Ann Intern Med. 2016;165(2):103–112.
  988. American Academy of Child and Adolescent Psychiatry: Practice parameters for the psychiatric assessment of infants and toddlers //, J. Am. Acad. Child Adolesc. Psychiatry. 1997. Vol. 36. P. :21S-36S, 1997.
  989. American Academy of Child and Adolescent Psychiatry: Practice parameters for the psychiatric assessment of children and adolescents //, J. Am. Acad. Child Adolesc. Psychiatry. 1997. Vol. 36. P. :4S-20S, 1997.
  990. American Psychiatric Association: . Diagnostic and statistical manual of mental disorders., Ed. 5, . Washington: American Psychiatric Association, DC, 2013, American Psychiatric Association.
  991. Angold A., Costello E.J., Messer S.C, . et al: . Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents //, Int. J. Meth. Psych. Res. 1995. Vol. 5. P. :237-249, 1995.
  992. Birmaher B., Khetarpal S., Brent D, . et al: . The Screen for Child Anxiety Related Emotional Disorders (SCARED): scale construction and psychometric characteristics //, J. Am. Acad. Child Adolesc. Psychiatry. 1997. Vol. 36. P. :545-553, 1997.
  993. Boris N.W., Zeanah C.H: . Research diagnostic criteria for infants and preschool children: the process and empirical support //, J. Am. Acad. Child Adolesc. Psychiatry. 2003. Vol. 42. P. :1504-1512, 2003.
  994. Bourdon K.H., Goodman R., Rae D.S, . et al: . The Strengths and Difficulties Questionnaire: U.S. normative data and psychometric properties //, J. Am. Acad. Child Adolesc. Psychiatry. 2005. Vol. 44. P. :557-564, 2005.
  995. Chun T.H., Mace S.E., Katz E.R, . et al: . Executive summary: Evaluation and management of children and adolescents with acute mental health or behavioral problems. Part I. Common clinical challenges of patients with mental health and/or behavioral emergencies //, Pediatrics. 2016. Vol. 138. N. (3. P. ):e20161571, 2016.
  996. Chun T.H., Mace S.E., Katz E.R, . et al: . Executive summary: Evaluation and management of children with acute mental health or behavioral problems. Part II. Recognition of clinically challenging mental health related conditions presenting with medical or uncertain symptoms //, Pediatrics. 2016. Vol. 138. N. (3. P. ):e20161574, 2016.
  997. Cohen E., MacKenzie R.G., Yates G.L: . HEADSS, a psychosocial risk assessment instrument: implications for designing effective intervention programs for runaway youth //, J. Adolesc. Health. 1991. Vol. 12. P. :539-544, 1991.
  998. Copeland W.E., Wolke D., Shanahan L, . et al: . Adult functional outcomes of common childhood psychiatric problems-a prospective, longitudinal study //, JAMA Psychiatry. 2015. Vol. 72. N. (9. P. ):892-899, 2015.
  999. Faulstich M.E., Carey M.P., Ruggiero L, . et al: . Assessment of depression in childhood and adolescence: an evaluation of the Center for Epidemiologic Studies Depression Scale for Children (CES-DC) //, Am. J. Psychiatry. 1986. Vol. 143. P. :1024-1027, 1986.
  1000. Finny G.R., Minagar A., Heilman K.M: . Assessment of mental status //, Neurol. Clin. 2016. Vol. 34. P. :1-16, 2016.
  1001. Gleason M.M., Goldson E., Yogman M.W: . Addressing early childhood emotional and behavioral problems //, Pediatrics. 2016. Vol. 138. N. (6. P. ):e20163023, 2016.
  1002. Jellinek M.S., Murphy J.M., Little M, . et al.: Use of the Pediatric Symptom Checklist to screen for psychosocial problems in pediatric primary care: a national feasibility study //, Arch. Pediatr. Adolesc. Med. 1999. Vol. 153. P. :254-260, 1999.
  1003. American Academy of Pediatrics. Committee on Children with Disabilities: The pediatrician’s role in development and implementation of an Individual Education Plan (IEP) and/or an Individual Family Service Plan (IFSP) // Pediatrics. 1999. Vol. 104. P. 124–127.
  1004. Anderson P.J., Reidy N. Assessing executive function in preschoolers // Neuropsychol. Rev. 2012. Vol. 22. P. 345–360.
  1005. Cuevas K., Bell M.A. Infant attention and early childhood executive function // Child Dev. 2014. Vol. 85. N. 2. P. 397–404.
  1006. Eicher J.D., Montgomery A.M., Akshoomoff N. et al. Dyslexia and language impairment associated genetic markers influence cortical thickness and white matter in typically developing children // Brain Imaging Behav. 2016. Vol. 10. P. 272–282.
  1007. Gioia G.A., Isquith P.K., Guy S.C., Kenworthy L. Behavior rating inventory of executive function. Ed. 2 (BRIEF2). Professional manual. Lutz: Psychological Assessment Resources, 2015.
  1008. Griffin J.A., McCardle P., Freund L.S. Executive function in preschool-age children, integrating measurement, neurodevelopment, and translational research. Washington: American Psychological Association, 2016.
  1009. Ransom D.M., Vaughan C.G., Pratson L. Academic effects of concussion in children and adolescents // Pediatrics. 2015. Vol. 135. N. 6.
  1010. Swillen A., McDonald-McGinn D.M. Developmental trajectories in 22q11.2 deletion // Am. J. Med. Genet. C. Semin. Med. Genet. 2015. Vol. 169. N. 2. P. 172–181.
  1011. Zelazo P.D., Carlson S.M. Hot and cool executive function in childhood and adolescence: development and plasticity // Child Dev. Perspect. 2012. Vol. 6. N. 4. P. 354–360.
  1012. American Academy of Pediatrics/American Heart Association: AAP/AHA clarification of statement on cardiovascular evaluation and monitoring of children and adolescents with heart disease receiving medications for ADHD: 2008, J Dev Behav Pediatr 29(4):335, 2008.
  1013. Atkinson M, Hollis C: NICE guideline: attention deficit hyperactivity disorder, Arch Dis Child Educ Pract Ed 95:24–27, 2010.
  1014. Babcock T, Ornstein CS: Comorbidity and its impact in adult patients with attention-deficit/hyperactivity disorder: a primary care perspective, Postgrad Med 121:73–82, 2009.
  1015. Barbaresi W, et al: Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study, Pediatrics 131(4):637–644, 2013.
  1016. Barkley RA, Fischer M, Smallish L, et al: Young adult outcome of hyperactive children: adaptive functioning in major life activities, J Am Acad Child Adolesc Psychiatry 45:192–202, 2006.
  1017. Bouchard MF, Bellinger DC, Wright RO, et al: Attention-deficit hyperactivity disorder and urinary metabolites of organophosphate pesticides, Pediatrics 125:e1270–e1277, 2010.
  1018. Brookes KJ, Mill J, Guindalini C, et al: A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy, Arch Gen Psychiatry 63:74–81, 2006.
  1019. Caspi A, Langley K, Milne B, et al: A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder, Arch Gen Psychiatry 65:203–210, 2008.
  1020. Centers for Disease Control and Prevention: Percentage of children and teens aged 4–17 years ever diagnosed with attention-deficit/hyperactivity disorder (ADHD) by sex and urbanization of county residence—National Health Interview Survey, 2013–2015, MMWR Morb Mortal Wkly Rep 66(23):625, 2016.
  1021. Chan E, Fogler JA, Hammerness PG: Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review, JAMA 315(18):1997–2008, 2016.
  1022. Chang Z, Quinn PD, Hur K, et al: Association between medication use for attention-deficit/hyperactivity disorder and risk of motor vehicle crashes, JAMA Psychiatry 74(6):597–603, 2017.
  1023. Cohen SC, Mulqueen JM, Ferracioli-Oda E, et al: Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials, J Am Acad Child Adolesc Psychiatry 54(9):728–736, 2015.
  1024. Dalsgaard S, Leckman JF, Mortensen PB, et al: Effect of drugs on the risk of injuries in children with attention deficit hyperactivity disorder: a prospective cohort study, Lancet Psychiatry 2:702–709, 2015.
  1025. Eigenmann PA, Haenggeli CA: Food colourings, preservatives, and hyperactivity, Lancet 370:1524–1525, 2007.
  1026. Faraone SV: Attention deficit hyperactivity disorder and premature death, Lancet 385:2132–2133, 2015.
  1027. Franke AG, Gransmark P, Agricola A, et al: Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: a double-blind, randomized controlled trial, Eur Neuropsychopharmacol 27:248–260, 2017.
  1028. Friedland S, Walkup JT: Meta-assurance: no tic exacerbation caused by stimulants, J Am Acad Child Adolesc Psychiatry 54(9):706–708, 2015.
  1029. Gloss D, Varma JK, Pringsheim T, Nuwer MR: Practice advisory: the utility of EEG theta/beta power ratio in ADHD diagnosis, Neurology 97:1–5, 2016.
  1030. Gould MS, Walsh BT, Munfakh JL, et al: Sudden death and use of stimulant medications in youths, Am J Psychiatry 166:992–1101, 2009.
  1031. Greenhill L, Kollins S, Abikoff H, et al: Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD, J Am Acad Child Adolesc Psychiatry 45:1284–1293, 2006.
  1032. Hammerness P, Wilens T, Mick E, et al: Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder, J Pediatr 155:84–89, 2009.
  1033. Harpin VA: Medication options when treating children and adolescents with ADHA: interpreting the NICE guidance 2006, Arch Dis Child Educ Pract Ed 93:58–66, 2008.
  1034. Hartanto TA, Krafft CE, Iosif AM, Schweitzer JB: A trial-by-trial analysis reveals more intense physical activity is associated with better cognitive control performance in attention-deficit/hyperactivity disorder, Child Neuropsychol 22(5):618–626, 2016.
  1035. Jones K, Daley D, Hutchings J, et al: Efficacy of the Incredible Years Programme as an early intervention for children with conduct problems and ADHD: long-term follow-up, Child Care Health Dev 34:380–390, 2008.
  1036. Kendall T, Taylor E, Perez A, et al: Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance, BMJ 337:751–754, 2008.
  1037. Knight M: Stimulant-drug therapy for attention-deficit disorder (with or without hyperactivity) and sudden cardiac death, Pediatrics 119:154–155, 2007.
  1038. Kollins S, Greenhill L, Swanson J, et al: Rationale, design, and methods of the Preschool ADHA Treatment Study (PATS), J Am Acad Child Adolesc Psychiatry 45:1275–1283, 2006.
  1039. Langberg JM, Brinkman WB, Lichtenstein PK, et al: Interventions to promote the evidence-based care of children with ADHD in primary-care settings, Expert Rev Neurother 9:477–487, 2009.
  1040. Man KKC, Chan EW, Ip P, et al: Prenatal antidepressant use and risk of attention-deficit/hyperactivity disorder in offspring: population based cohort study, BMJ 357:j2350, 2017.
  1041. McCann D, Barrett A, Cooper A, et al: Food additives and hyperactive behaviour in 3-year-old and 8/9-year-old children in the community: a randomized, double-blind, placebo-controlled trial, Lancet 370:1560–1567, 2007.
  1042. The Medical Letter: Guanfacine extended-release (Intuniv) for ADHD, Med Lett Drugs Ther 52:82, 2010.
  1043. The Medical Letter: Drugs for ADHD, Med Lett Drugs Ther 57:37–40, 2015.
  1044. The Medical Letter: Two new amphetamines for ADHD, Med Lett Drugs Ther 58(1497):80–81, 2016.
  1045. Mosholder AD, Gelperin K, Hammad TA, et al: Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs in children, Pediatrics 123:611–616, 2009.
  1046. Newcorn JH: Managing ADHD and comorbidities in adults, J Clin Psychiatry 70(2):e40, 2009.
  1047. Newcorn JH, Kratochvil CJ, Allen AJ, et al: Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response, Am J Psychiatry 165:721–730, 2008.
  1048. Newcorn JH, Sutton VK, Weiss MD, et al: Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the integrated Data Exploratory Analysis (IDEA) study, J Am Acad Child Adolesc Psychiatry 48:511–518, 2009.
  1049. Nutt DJ, Fone K, Asherson P, et al: Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology, J Psychopharmacol 21:10–41, 2007.
  1050. Okie S: ADHD in adults, N Engl J Med 354:2637–2641, 2006.
  1051. Pelsser LM, Frankena K, Toorman J, et al: Effects of restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial, Lancet 377:494–503, 2011.
  1052. Perrin JM, Friedman RA, Knilans TK: Cardiovascular monitoring and stimulant drugs for attention-deficit/hyperactivity disorder, Pediatrics 122:451–453, 2008.
  1053. Safren SA, Sprich S, Mimiaga MJ, et al: Cognitive behavioral therapy vs relaxation with educational support for medication—adults with ADHD and persistent symptoms, JAMA 304:875–880, 2010.
  1054. Shaw P: Quantifying the benefits and risks of methylphenidate as treatment for childhood attention-deficit/hyperactivity disorder, JAMA 315(18):1953–1954, 2016.
  1055. Shin JY, Roughhead EE, Park BJ, Pratt NL: Cardiovascular safety of methylphenidate among children and young people with attention-deficit/hyperactivity disorder (ADHD): nationwide self-controlled case series study, BMJ 353:i2550, 2016.
  1056. Shum SBM, Pang MYC: Children with attention deficit hyperactivity disorder have impaired balance function: involvement of somatosensory, visual, and vestibular systems, J Pediatr 155:245–249, 2009.
  1057. Silk TJ, Vance A, Rinehart N, et al: Dysfunction in the fronto-parietal network in attention deficit hyperactivity disorder (ADHD): an fMRI study, Brain Imaging Behav 2:2008, 1931.
  1058. Smith AK, Mick E, Faraone SV: Advances in genetic studies of attention-deficit/hyperactivity disorder, Curr Psychiatry Rep 11:143–148, 2009.
  1059. Sowell ER, Thompson PM, Welcome SE, et al: Cortical abnormalities in children and adolescents with attention-deficit disorder, Lancet 362:1699–1707, 2008.
  1060. Spencer TJ: ADHD and comorbidity in childhood, J Clin Psychiatry 67(Suppl 8):27–31, 2006.
  1061. Thapar A, Cooper M: Attention deficit hyperactivity disorder, Lancet 387:1240–1248, 2016.
  1062. Thomas PE, Carlo WE, Decker JA, et al: Impact of the American Heart Association scientific statement on screening electrocardiograms and stimulant medications, Arch Pediatr Adolesc Med 165(2):166–170, 2011.
  1063. Verkuijl N, Perkins M, Fazel M: Childhood attention-deficit/hyperactivity disorder, BMJ 350:h2168, 2015.
  1064. Wilens TE, Prince JB, Spencer TJ, et al: Stimulants and sudden death: What is a physician to do? Pediatrics 118:1215–1219, 2006.
  1065. Ferrer E, Shaywitz BA, Holahan JM, et al: Uncoupling of reading and IQ over time: empirical evidence for a definition of dyslexia. Psychol Sci. 2010;21(1):93–101.
  1066. Ferrer E, Shaywitz BA, Holahan JM, et al: Achievement gap in reading is present as early as first grade and persists through adolescence. J Pediatr. 2015;167:1121–1125.
  1067. Herrera-Araujo D, Shaywitz BA, Holahan JM, et al: Evaluating willingness to pay as a measure of the impact of dyslexia in adults. J Benefit Cost Anal. 2017;8(1):4–48.
  1068. Hulme C, Snowling MJ: Reading disorders and dyslexia. Curr Opin Pediatr. 2016;28:731–735.
  1069. National Reading Panel: Teaching children to read: an evidence based assessment of the scientific research literature on reading and its implications for reading instruction, NIH Pub No 00-4754, Bethesda, MD, 2000, US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Child Health and Human Development.
  1070. Romberg F, Shaywitz BA, Shaywitz SE: How should medical schools respond to students with dyslexia? AMA J Ethics. 2016;18(10):975–984.
  1071. First Step Act, 2018, 115th Congress (2017–2018), Public Law No: 115-391, “The term dyslexia means an unexpected difficulty in reading for an individual who has the intelligence to be a much better reader, most commonly caused by a difficulty in the phonological processing (the appreciation of the individual sounds of spoken language), which affects the ability of an individual to speak, read, and spell.”
  1072. Shaywitz SE: Shaywitz DyslexiaScreen. Shaywitz DyslexiaScreen — ýòî ýôôåêòèâíûé, íàäåæíûé è óäîáíûé äëÿ ïîëüçîâàòåëÿ òåñò íà äèñëåêñèþ äëÿ äåòñêîãî ñàäà è ïåðâîãî êëàññà øêîë. Ýòîò ñêðèíèíã ïîçâîëÿåò îïðåäåëÿòü ó÷åíèêîâ ãðóïïû ðèñêà ðàçâèòèÿ äèñëåêñèè. Äîñòóïåí îò Pearson Clinical.
  1073. Shaywitz SE, Shaywitz BA: Dyslexia (specific reading disability). Biol Psychiatry. 2005;57:1301–1309.
  1074. Shaywitz BA, Weiss LG, Saklofske DH, Shaywitz SE: Translating scientific progress in dyslexia into 21st century diagnosis and interventions. In Weiss LG, Saklofske DH, Holdnack JA, Prifitera A, editors. WISC-V Clinical use and interpretation: a scientist-practitioner perspective. San Diego: Elsevier, 2016. Ð. 269–286.
  1075. Shaywitz S, Shaywitz B, Wietecha L, et al: Effect of atomoxetine treatment on reading and phonological skills in children with dyslexia or attention-deficit/hyperactivity disorder and comorbid dyslexia in a randomized, placebo-controlled trial. J Child Adolesc Psychopharmacol. 2017;27(1):19–28.
  1076. Ðåøåíèå Ñåíàòà ÑØÀ 576: Îáðàùåíèå ê Êîíãðåññó, øêîëàì, îáðàçîâàòåëüíûì ó÷ðåæäåíèÿì â øòàòå è íà ìåñòíîì óðîâíå ïðèçíàòü çíà÷èòåëüíûå îáðàçîâàòåëüíûå ïîñëåäñòâèÿ äèñëåêñèè, êîòîðûå äîëæíû áûòü ðåøåíû, Âàøèíãòîí, îêðóã Êîëóìáèÿ, 2016; 114 Êîíãðåññ, 2-ÿ ñåññèÿ.
  1077. Bartelet D, Ansari D, Vaessen A, Blomert L: Cognitive subtypes of mathematics learning difficulties in primary education, Res Dev Disabil 35(3):657–670, 2014.
  1078. Chodura S, Kuhn JT, Holling H: Interventions for children with mathematical difficulties: a meta-analysis, Z Psychol 223(2):129–144, 2015.
  1079. Docherty SJ, Davis OSP, Kovas Y, et al: Genome-wide association study identifies multiple loci associated with mathematics ability and disability, Genes Brain Behav 9:234–247, 2010.
  1080. Geary DC: Mathematical cognition deficits in children with learning disabilities and persistent low achievement: a five-year prospective study, J Educ Psychol 104(1):206–223, 2012.
  1081. Kaufman L, Mazzocco MM, Dowker A, et al: Dyscalculia from a developmental and differential perspective, Front Psychol 4:1–5, 2013.
  1082. Kucian K: Developmental dyscalculia and the brain. In Berch DB, Geary DC, Koepke KM, editors: Development of mathematical cognition: neural substrates and genetic influences, New York, 2016, Elsevier, pp 165–193.
  1083. Mazzocco M: Mathematics awareness month: why should pediatricians be aware of mathematics and numeracy? J Dev Behav Pediatr 37:251–253, 2016.
  1084. Mazzocco MM, Quintero AI, Murphy MM, McCloskey M: Genetic syndromes as model pathways to mathematical learning difficulties: fragile X, Turner and 22q deletion syndromes. In Berch DB, Geary DC, Koepke KM, editors: Development of mathematical cognition: neural substrates and genetic influences, New York, 2016, Elsevier, pp 325–357.
  1085. Petrill SA, Kovas Y: Individual differences in mathematics ability: a behavioral genetic approach. In Berch DB, Geary DC, Koepke KM, editors: Development of mathematical cognition: neural substrates and genetic influences, New York, 2016, Elsevier, pp 299–324.
  1086. Shin MS, Bryant DP: A synthesis of mathematical and cognitive performances of students with mathematics learning disabilities, J Learn Disabil 48:96–112, 2015.
  1087. Andrews JE, Lombardino LJ: Strategies for teaching handwriting to children with writing disabilities, Perspect Lang Learn Educ 21:114–126, 2014.
  1088. Berninger VW: Preventing written expression disabilities through early and continuing assessment and intervention for handwriting and/or spelling problems: research into practice. In Swanson HL, Harris KR, Graham S, editors: Handbook of learning disabilities, New York, 2003, The Guilford Press, pp 35–363.
  1089. Berninger VW: Process assessment of the learner (PAL): research-based reading and writing lessons, San Antonio, TX, 2003, Psychological Corporation.
  1090. Berninger VW: Interdisciplinary frameworks for schools: best professional practices for serving the needs of all students, Washington, DC, 2015, American Psychological Association.
  1091. Berninger VW, May MO: Evidence-based diagnosis and treatment for specific learning disabilities involving impairments in written and/or oral language, J Learn Disabil 44(2):167–183, 2011.
  1092. Dockrell JE: Developmental variations in the production of written text: challenges for students who struggle with writing. In Stone CA, Silliman ER, Ehren BJ, Wallach GP, editors: Handbook of language and literacy, ed 2, New York, 2014, The Guilford Press, pp 505–523.
  1093. Dockrell JE, Lindsay G, Connelly V: The impact of specific language impairment on adolescents’ written text, Except Child 75(4):427–446, 2009.
  1094. Graham S, Harris KR: Writing better: effective strategies for teaching students with learning difficulties, Baltimore, 2005, Paul H Brookes Publishing.
  1095. Katusic SK, Colligan RC, Weaver AL, Barbaresi WJ: The forgotten learning disability: epidemiology of written-language disorder in a population-based birth cohort (1976-1982), Rochester, Minnesota, Pediatrics 123(5):1306–1313, 2009.
  1096. Paul R, Norbury C: Language disorders from infancy through adolescence: listening, speaking, reading, writing, and communicating, St Louis, 2012, Elsevier.
  1097. Silliman ER, Berninger VW: Cross-disciplinary dialogue about the nature of oral and written language problems in the context of developmental, academic, and phenotypic profiles, Top Lang Disord 31:6–23, 2011.
  1098. Stoeckel RE, Colligan RC, Barbaresi WJ, et al: Early speech-language impairment and risk for written language disorder: a population-based study, J Dev Behav Pediatr 34(1):38–44, 2013.
  1099. Sun L, Wallach GP: Language disorders are learning disabilities: challenges on the divergent and diverse paths to language learning disability, Top Lang Disord 34:25–38, 2014.
  1100. Williams GJ, Larkin RF, Blaggan S: Written language skills in children with specific language impairment, Int J Lang Commun Disord 48(2):160–171, 2013
  1101. Robins D.L: . Screening for autism spectrum disorders in primary care settings //, Autism. 2008. Vol. 12. P. :537-556, 2008.
  1102. Sveen T.H., Berg-Nielsen T.S., Lydersen S., Wichstrom L: . Screening for persistent psychopathology in 4-year-old children //, Pediatrics. 2016. Vol. 138. N. (4. P. ):e20151648, 2016.
  1103. Swanson J., Schuck S., Mann M: . Categorical and dimensional definitions and evaluations of symptoms of ADHD: the SNAP and SWAN ratings scales.
  1104. Weitzman C., Wegner L., the Section on Developmental and Behavioral Pediatrics, Committee on Psychosocial Aspects of Child and Family Health, Council on Early childhood, and Society for Developmental and Behavioral Medicine: . Promoting optimal development: screening for behavioral and emotional problems //, Pediatrics. 2015. Vol. 135. N. (2. P. ):384-395, 2015.
  1105. American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, North American Association for the Study of Obesity: Consensus development conference on antipsychotic drugs and obesity and diabetes , // Diabetes Care 2004. Vol. 27. P. :596-601, 2004.
  1106. American Academy of Child Adolescent Psychiatry: Practice parameter for the use of atypical antipsychotic medications in children and adolescents, 2014.
  1107. Ames D., Carr-Lopez S.M., Gutierrez M.A, . et al.: Detecting and managing adverse effects of antipsychotic medications: current state of play //, Psychiatr. Clin. North. Am. 2016. Vol. 39. P. :275-311, 2016.
  1108. Anagnostou E., Hansen R: . Medical treatment overview: traditional and novel psycho-pharmacological and complementary and alternative medications //, Curr. Opin. Pediatr. 2011. Vol. 23. P. :621-627, 2011.
  1109. Berry N., Pradhan S., Sagar R., et al: . Neuroleptic malignant syndrome in an adolescent receiving olanzapine-lithium combination therapy //, Pharmacotherapy. 2003. Vol. 23. P. :255-259, 2003.
  1110. Bridge J.A., Iyengar S., Salary C.B., et al: . Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials //, JAMA. 2007. Vol. 297. P. :1683-1696, 2007.
  1111. Cooper W.O., Habel L.A., Sox C.M, . et al: . ADHD drugs and serious cardiovascular events in children and young adults //, N. Engl. J. Med. 2011. Vol. 365. N. (20. P. ):1896-1904, 2011.
  1112. Correll C.U., Kratochvil C.H., March J.S: . Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics //, J. Clin. Psychiatry. 2011. Vol. 72. N. (5. P. ):655-670, 2011.
  1113. DeHert M., Dobbelaere M., Sheridan E.M, . et al: . Metabolic and endocrine adverse effects of second-generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice //, Eur. Psychiatry. 2011. Vol. 26. N. (3. P. ):144-158, 2011.
  1114. Giusti C.F., Amorim S.R., Guerra R.A, . et al: . Endocrine disturbances related to the use of lithium //, Arq. Bras. Endocrinol. Metabol. 2012. Vol. 56. P. :153-158, 2012.
  1115. Gopalakrishna G., Ithman M.H., Lauriello J: . Update on new and emerging treatments for schizophrenia //, Psychiatr. Clin. North Am. 2016. Vol. 39. P. :217-238, 2016.
  1116. McKnight R.F., Adida M., Budge K, . et al: . Lithium toxicity profile: a systematic review and meta-analysis //, Lancet. 2012. Vol. 379. P. :721-728, 2012.
  1117. Neuhut R., Lindenmayer J.P., Silva R: . Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a review //, J. Child Adolesc. Psychopharmacol. 2009. Vol. 19. P. :415-422, 2009.
  1118. Olfson M., Blanco C., Liu S.M, . et al: . National trends in the office-based treatment of children, adolescents, and adults with antipsychotics //, Arch. Gen. Psychiatry. 2012. Vol. 69. P. :1247-1256, 2012.
  1119. Punja S., Shamseer L., Hartling L, . et al: . Amphetamines for ADHD in children and adolescents //, Cochrane Database Syst. Rev. 2016. (2):CD009996, 2016. 10.1002/14651858.CD009996.pub2.
  1120. Ray W.A., Chung C.P., Murray K.T, . et al.: Atypical antipsychotic drugs and the risk of sudden cardiac death //, N. Engl. J. Med. 2009. Vol. 360. P. :225-235, 2009.
  1121. Reichow B., Volkmar F.R., Bloch M.H: . Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders //, J. Autism Dev. Disord. 2014. Vol. 43. P. :2435-2441, 2014.
  1122. Seida J.C., Schouten J.R., Boylan K, . et al:et al. Antipsychotics for children and young adults: a comparative effectiveness review //, Pediatrics. 2012. Vol. 129. P. :e771-e784, 2012.
  1123. Siegel M., Beaulieu A.A: . Psychotropic medications in children with autism spectrum disorders: a systematic review and synthesis for evidence-based practice //, J. Autism Dev. Disord. 2012. Vol. 42. P. :1592-1605, 2012.
  1124. Shaw R.J., DeMaso D.R: . Clinical manual of pediatric psychosomatic medicine: mental health consultation with physically ill children and adolescents, . Washington: American Psychiatric Press, DC, 2006, American Psychiatric Press.
  1125. Shin J.Y., Roughead E.E., Park B.J, . et al: . Cardiovascular safety of methylphenidate among children and young people with ADHD: nationwide self controlled case series study //, BMJ. 2016. Vol. 353. P. :i2550, 2016.
  1126. Sonnier L., Barzman D: . Pharmacologic management of acutely agitated pediatric patients //, Paediatr. Drugs. 2011. Vol. 13. P. :1-10, 2011.
  1127. Storebo O.J., Ramstad E., Krogh H.B, . et al:et al. Methylphenidate for children and adolescents with ADHD //, Cochrane Database Syst. Rev. 2015. (11):CD009885, 2015. 10.1002/14651858.CD009885.pub2.
  1128. Strawn J.R., Keck P.E E.Jr., Caroff S.N: . Neuroleptic malignant syndrome //, Am. J. Psychiatry. 2007. Vol. 164. P. :870-878, 2007.
  1129. Weiden P.J: . Redefining medication adherence in the treatment of schizophrenia //, Psychiatr Clin. N. Am. 2016. Vol. 39. P. :122-216, 2016.
  1130. Choe DE, Olson SL, Sameroff AJ. The interplay of externalizing problems and physical and inductive discipline during childhood. Dev Psychol. 2013;49(11):2029–2039.
  1131. McCardle P. Bilingualism: research and policy. Grigorenko EL, editor. The global context for new directions for child and adolescent development. Wiley Periodicals. 2015;147:41–48.
  1132. Milteer RM, Ginsburg KR. Council on Communications and Media. The importance of play in promoting healthy child development and maintaining strong parent-child bond: focus on children in poverty. Pediatrics. 2012;129(1):e204–e213.
  1133. Ribner A, Fitzpatrick C, Blair C. Family socioeconomic status moderates associations between television viewing and school readiness skills. J Dev Behav Pediatr. 2017;38(3):233–239.
  1134. Tandon PS, et al. The relationship between physical activity and diet and young children’s cognitive development: a systematic review. Prev Med Rep. 2016;3:379–390.
  1135. Ashcraft AM, Murray PJ. Talking to parents about adolescent sexuality. Pediatr Clin North Am. 2017;64(2):305–320.
  1136. Brenner JS. Council on Sports Medicine and Fitness: Sports specialization and intensive training in young athletes. Pediatrics. 2016;138(3):e20162148, 106–113.
  1137. Lubans L, Richards J, Hillman C, et al. Physical activity for cognitive and mental health in youth: a systematic review of mechanisms. Pediatrics. 2016;138(3):e20161642.
  1138. Olson KR, Durwood L, DeMeules M, McLaughlin KA. Mental health of transgender children who are supported in their identities. Pediatrics. 2016;137(3):e20153223.
  1139. Theall KP, Shirtcliff EA, Dismukes AR, et al. Association between neighborhood violence and biological stress in children. JAMA Pediatr. 2017;171(1):53–60.
  1140. US Centers for Disease Control and Prevention. Youth physical activity guidelines toolkit.
  1141. Gladden RM, Vivolo-Kantor AM, Hamburger ME, Lumpkin CD: Bullying surveillance among youths: uniform definitions for public health and recommended data elements. Version 1.0, Centers for Disease Control and Prevention, US Department of Education 2014. Atlanta.
  1142. Kowalski RM, Limber SP: Psychological, physical, and academic correlates of cyberbullying and traditional bullying, J Adolesc Health 53:S13–S20, 2013.
  1143. Leff SS, Waasdorp TE: Effect of aggression and bullying on children and adolescents: implications for prevention and intervention, Curr Psychiatry Rep 15(3):343, 2013.
  1144. Moore M, Petrie C, Braga A, et al, editors: Deadly lessons: understanding lethal school violence (website), 2003, National Research Council.
  1145. National Center for Education Statistics: Indicators of school crime and safety, 2012.
  1146. National Academies of Science, Engineering and medicine. Preventing bullying through science, policy and practice, Washington, DC, 2016, National Academies Press.
  1147. Peskin MF, Tortolero SR, Markham CM: Bullying and victimization among black and hispanic adolescents, Adolescence 14:703–722, 2016.
  1148. Vaillancourt T, Brittain HL, McDougall P, Duku E: Longitudinal links between childhood peer victimization, internalizing and externalizing problems, and academic functioning: developmental cascades, J Abnorm Child Psychol 41:1203–1215, 2013.
  1149. Vreeman RC, Carroll AC: A systematic review of school-based interventions to prevent bullying, Arch Pediatr Adolesc Med 161(1):78–88, 2007.
  1150. Èíòåðàêòèâíûé ïëàí èñïîëüçîâàíèÿ ñåìåéíûõ ìåäèà Àìåðèêàíñêîé àêàäåìèè ïåäèàòðèè
  1151. Áîñòîíñêàÿ äåòñêàÿ áîëüíèöà: êîîïåðàòèâ ïî ïðåäîòâðàùåíèþ òðàâëè è èíòåðíåò-òðàâëè è çàùèòå èíòåðåñîâ èõ æåðòâ.
  1152. American Academy of Pediatrics, Council on Communications and Media: Virtual violence, Pediatrics 138(2), 2016.
  1153. Brockmyer JF. Playing violent video games and desensitization to violence, Child Adolesc Psychiatr Clin North Am 24(1):65–77, 2015.
  1154. Calvert SL, Appelbaum M, Dodge KA, et al: The American psychological association task force assessment of violent video games: science in the service of public interest, Am Psychologist 72(2):126–143, 2017.
  1155. Lenhart A, Kahne J, Middaugh E, et al: Teens, video games and civics, Washington, DC, 2008, Pew Internet & American Life Project.
  1156. Media Violence Commission, International Society for Research on Aggression (ISRA): Report of the media violence commission, Aggress Behav 38(5):335–341, 2012.
  1157. Moreno MA, Kota R, et al: The facebook influence model: a concept mapping approach, Cyberpsychol Behav Soc Netw, 2013.
  1158. Prot S, Gentile DA: Applying risk and resilience models to predicting the effects of media violence on development, Adv Child Dev Behav 46:215–244, 2014.
  1159. Akbulut-Yuksel M: War during childhood: the long run effects of warfare on health, J Health Econ 53:117–130, 2017.
  1160. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, ed 5, Washington, DC, 2013, American Psychiatric Association.
  1161. Attanayake V, McKay R, Joffres M, et al: Prevalence of mental disorders among children exposed to war: a systematic review of 7,920 children, Med Confl Surviv 25:4–19, 2009.
  1162. Betancourt TS, Khan KT: The mental health of children affected by armed conflict: protective processes and pathways to resilience, Int Rev Psychiatry 20:317–328, 2008.
  1163. Bhutta ZA, Yousafzai AK, Zipursky A: Pediatrics, war, and children, Curr Probl Pediatr Adolesc Health Care 40:20–35, 2010.
  1164. Burnett MW, Callahan CW: American pediatricians at war: a legacy of service, Pediatrics 129(Suppl 1):S33–S49, 2012.
  1165. Dimitry L: A systematic review on the mental health of children and adolescents in areas of armed conflict in the middle east, Child Care Health Dev 38:153–161, 2012.
  1166. Drury J, Williams R: Children and young people who are refugees, internally displaced persons or survivors or perpetrators of war, mass violence and terrorism, Curr Opin Psychiatry 25:277–284, 2012.
  1167. Edwards MJ, Lustik M, Eichelberger MR, et al: Blast injury in children: an analysis from Afghanistan and Iraq, 2002–2010, J Trauma Acute Care Surg 73:1278–1283, 2012.
  1168. Hagan JF Jr: American academy of pediatrics, Committee on psychosocial aspects of child and family health, Task force on terrorism: psychosocial implications of disaster or terrorism on children: a guide for the pediatrician, Pediatrics 116:787–795, 2005.
  1169. Holman EA, Garfin DR, Silver RC: Media’s role in broadcasting acute stress following the Boston marathon bombings, Proc Natl Acad Sci USA 111:93–98, 2014.
  1170. Lavi T, Green O, Dekel R: The contribution of personal and exposure characteristics to the adjustment of adolescents following war, J Adolesc 36:21–30, 2013.
  1171. Lavi T, Itzhaky L, Menachem M, et al: Adolescents on the front line: exposure to shelling via television and the parental role, Psychiatry 79:85–94, 2016.
  1172. Masten AS, Narayan AJ: Child development in the context of disaster, war, and terrorism: pathways of risk and resilience, Annu Rev Psychol 63:227–257, 2012.
  1173. Pfefferbaum B, Seale TW, Brandt EN Jr, et al: Media exposure in children one hundred miles from a terrorist bombing, Ann Clin Psychiatry 15:1–8, 2003.
  1174. Ramo-Fern?ndez L, Schneider A, Wilker S, et al: Epigenetic alterations associated with war trauma and childhood maltreatment, Behav Sci Law 33:701–721, 2015.
  1175. Shenoda S, Kadir A, Goldhagen J: Children and armed conflict, Pediatrics 136:e309–e311, 2015.
  1176. Slone M, Mann S: Effects of war, terrorism and armed conflict on young children: a systematic review, Child Psychiatry Hum Dev 47:950–965, 2016.
  1177. Vindevogel S, De Schryver M, Broekaert E, et al: Challenges faced by former child soldiers in the aftermath of war in Uganda, J Adolesc Health 52:757–764, 2013.
  1178. Werner EE: Children and war: risk, resilience, and recovery, Dev Psychopathol 24:553–558, 2012.
  1179. Wexler ID, Branski D, Kerem E: War and children, JAMA 296:579–581, 2006.
  1180. Wiesel E: Without conscience, N Engl J Med 352:1511–1513, 2005.
  1181. Centers for Disease Control and Prevention: Sexually transmitted diseases treatment guidelines, MMWR Recomm Rep 64(3):1–137, 2015.
  1182. Edinburgh L, Pape-Blabolil J, Harpin SB, Saewyc E: Assessing exploitation experiences of girls and boys seen at a child advocacy center, Child Abuse Negl 46:47–59, 2015.
  1183. Greenbaum J, Crawford-Jakubiak J, Committee on Child Abuse and Neglect: Child sex trafficking and commercial sexual exploitation: health care needs of victims, Pediatrics 135(3):566–574, 2015.
  1184. Hemmings S, Jakobowitz S, Abas M, et al: Responding to the health needs of survivors of human trafficking: a systematic review, BMC Health Serv Res 16:320–328, 2016.
  1185. International Labor Organization: Global estimate of forced labour, 2012.
  1186. Kimberlin W, Brady MT, Jackson MA, Long SS: Red book: 2015 report of the Committee on Infectious Diseases, ed 30, Elk Grove Village, IL, 2015, American Academy of Pediatrics.
  1187. Lederer L, Wetzel C: The health consequences of sex trafficking and their implications for identifying victims in healthcare facilities, Ann Health Law 23:61–91, 2014.
  1188. Ottisova L, Hemmings S, Howard LM, et al: Prevalence and risk of violence and the mental, physical and sexual health problems associated wtih human trafficking: an updated systematic review, Epidemiol Psychiatr Sci 2016. doi:10.1017/S2045796016000135. CJO 2016.
  1189. United Nations Commission on Human Rights: Protocol to prevent, suppress and punish trafficking in persons especially women and children, supplementing the United Nations Convention against Transnational Organized Crime, 2000.
  1190. Zimmerman C, Borland R: Caring for trafficked persons: guidance for health providers, 2009, International Organization for Migration.
  1191. Zimmerman C, Watts C: World Health Organization ethical and safety recommendations for interviewing trafficked women. 2003
  1192. Berkowitz CD: Physical abuse of children, N Engl J Med 376(17):1659–1666, 2017.
  1193. Dubowitz H, Bennett S: Physical abuse and neglect of children: key health issues, Lancet 2(369):1891–1899, 2007.
  1194. Dubowitz H, DePanfilis D, editors: The handbook for child protection, Thousand Oaks, CA, 2000, Sage Publications.
  1195. Dubowitz H, Leventhal JM: Child maltreatment, Pediatr Clin North Am 61(5):2014.
  1196. Dubowitz H: World perspectives on child abuse, Denver, 2016, The International Society for the Prevention of Child Abuse and Neglect.
  1197. Farrell CA, Fleegler EW, Monuteaux MC, et al: Community poverty and child abuse fatalities in the United States, Pediatrics 139(5):2016.
  1198. Fisher-Owens SA, Lukefahr JL, Tate AR, et al: Oral and dental aspects of child abuse and neglect, Pediatrics 140(2):2017.
  1199. Gilbert R, Kemp A, Thoburn J, et al: Child maltreatment. 2. Recognizing and responding to child maltreatment, Lancet 373:167–180, 2009.
  1200. Jenny C, editor: Child abuse and neglect: diagnosis, treatment, and evidence, 2010, Elsevier Health Sciences.
  1201. Jonson-Reid M, Kohl PL, Drake B: Child and adult outcomes of chronic child maltreatment, Pediatrics 129(5):839–845, 2012.
  1202. Kondis JS, Muenzer J, Luhmann JD: Missed fractures in infants presenting to the emergency department with fussiness, Pediatr Emerg Care 33(8):538–543, 2017.
  1203. Leventhal JM, Edwards GA: Flawed theories to explain child physical abuse—what are the medical-legal consequences?, JAMA 318(14):1317–1318, 2017.
  1204. Scott DA: The landscape of child maltreatment, Lancet 373:101–102, 2009.
  1205. Sege RD, Amaya-Jackson L: Clinical considerations related to the behavioral manifestations of child maltreatment, Pediatrics 139(4):2017.
  1206. Spies EL, Klevens J: Fatal abusive head trauma among children aged <5 years—United States, 1999–2014, MMWR Morb Mortal Wkly Rep 65(20):505–509, 2016.
  1207. Afifi TO, Mota NP, Dasiewicz P, et al: Physical punishment and mental disorders: results from a nationally representative US sample, Pediatrics 130(2):184–192, 2012.
  1208. Barnes PM, Norton CM, Dunstan FD, et al: Abdominal injury due to child abuse, Lancet 366:234–235, 2005.
  1209. Bhardwaj G, Chowdhury V, Jacobs MB, et al: A systematic review of the diagnostic accuracy of ocular signs in pediatric abusive head trauma, Ophthalmology 117(5):983–992, e17, 2010.
  1210. Bronicki LM, Stevenson RE, Spranger JW: Beyond osteogenesis imperfecta: causes of fractures during infancy and childhood, Am J Med Genet C Semin Med Genet 169C:314–327, 2015.
  1211. Chester DL, Jose RM, Aldlyami E, et al: Non-accidental burns in children—are we neglecting neglect?, Burns 32(2):222–228, 2006.
  1212. Christian CW, Block R: Committee on child abuse and neglect: abusive head trauma in infants and children, Pediatrics 123:1409–1411, 2009.
  1213. Clement JG, Blackwell SA: Is current bite mark analysis a misnomer?, Forensic Sci Int 201:33–37, 2010.
  1214. Curcoy AI, Trenchs V, Moraled M, et al: Do retinal hemorrhages occur in infants with convulsions?, Arch Dis Child 94:873–875, 2009.
  1215. Di Pietro MA, Brody AS, Cassady CI, et al: Diagnostic imaging of child abuse, Pediatrics 123:1430–1435, 2009.
  1216. Forester BR, Petrou M, Lin D, et al: Neuroimaging evaluation of non- accidental head trauma with correlations to clinical outcomes: a review of 57 cases, J Pediatr 154:573–577, 2009.
  1217. Global Initiative to End All Corporal Punishment of Children: Ending legalised violence against children, Global Report 2012.
  1218. Guenther E, Powers A, Srivastava R, Bonkowsky JL: Abusive head trauma in children presenting with an apparent life-threatening event, J Pediatr 157:821–825, 2010.
  1219. Hymel KP, Makoroff KL, Laskey AL, et al: Mechanisms, clinical presentations, injuries, and outcomes from inflicted versus non-inflicted head trauma during infancy: results of a prospective, multi-centered, comparative study, Pediatrics 119:922–929, 2007.
  1220. Ibrahim NG, Wood J, Margulies S, Christian CW: Influence of age and fall type on head injuries in infants and toddlers, Int J Dev Neurosci 30(3):201–206, 2012.
  1221. Jenny C, Hymel KP, Ritzen A, et al: Analysis of missed cases of abusive head trauma, JAMA 281(7):621–626, 1999.
  1222. Kemp AM, Dunstan F, Nuttall D, et al: Patterns of bruising in preschool children: a longitudinal study, Arch Dis Child 100:426–431, 2015.
  1223. Leventhal JM, Gaither JR: Incidence of serious injuries due to physical abuse in the United States: 1997 to 2009, Pediatrics 130(5):e847–e852, 2012.
  1224. Levin AV: Retinal hemorrhage in abusive head trauma, Pediatrics 126(5):961–970, 2012.
  1225. Lindberg DM, Shapiro RA, Blood EA, et al: ExSTRA investigators: utility of hepatic transaminases in children with concern for abuse, Pediatrics 131(2):268–275, 2013.
  1226. Lindberg DM, Shapiro RA, Laskey AL, et al: ExSTRA investigators: prevalence of abusive injuries in siblings and household contacts of physically abused children, Pediatrics 130(2):193–201, 2012.
  1227. Maguire S, Mann M: Systematic reviews of bruising in relation to child abuse-what have we learnt: an overview of review updates, Evid Based Child Health 8(2):255–263, 2013.
  1228. Maguire S: Which injuries may indicate child abuse?, Arch Dis Child Educ Pract Ed 95:170–177, 2010.
  1229. Maguire SA, Upadhyaya M, Evans A, et al: A systematic review of abusive visceral injuries in childhood: their range and recognition, Child Abuse Negl 37(7):430–445, 2013.
  1230. Maguire SA, Watts PO, Shaw AD, et al: Retinal haemorrhages and related findings in abusive and non-abusive head trauma: a systematic review, Eye (Lond) 27(1):28–36, 2013.
  1231. Mash C, Frazier T, Nowacki A, et al: Development of a risk-stratification tool for medical child abuse in failure to thrive, Pediatrics 128(6):e1467–e1473, 2011.
  1232. Pierce MC, Kaczor K, Aldridge S, et al: Bruising characteristics discriminating physical child abuse from accidental trauma, Pediatrics 125:67–74, 2010.
  1233. Prosser I, Lawson Z, Evans A, et al: A timetable for the radiologic features of fracture healing in young children, AJR Am J Roentgenol 198(5):1014–1020, 2012.
  1234. Ravichandiran N, Schuh S, Bejuk M, et al: Delayed identification of pediatric abuse related fractures, Pediatrics 125:60–66, 2010.
  1235. Reesu GV, Brown NL: Inconsistency in opinions of forensic odontologists when considering bite mark evidence, Forensic Sci Int 266:263–270, 2016.
  1236. Ross AH, Abel SM, Radisch D: Pattern of injury in child fatalities resulting from child abuse, Forensic Sci Int 188:99–102, 2009.
  1237. Runyan DK, Shankar V, Hassan F, et al: International variations in harsh child discipline, Pediatrics 126:e701–e711, 2010.
  1238. Saperia J, Lakhanpaul M, Kemp A, et al: When to suspect child maltreatment: summary of NICE guidelines, BMJ 339:b2689, 2009.
  1239. Schilling S, Wood JN, Levine MA, et al: Vitamin D status in abused and nonabused children younger than 2 years old with fractures, Pediatrics 127(5):835–841, 2011.
  1240. Servaes S, Brown SD, Choudhary AK, et al: The etiology and significance of fractures in infants and young children: a critical multidisciplinary review, Pediatr Radiol 46(5):591–600, 2016.
  1241. Thackeray JD, Scribano PV, Lindberg DM: Yield of retinal examination in suspected physical abuse with normal neuroimaging, Pediatrics 125:e1066–e1071, 2010.
  1242. Tung GA, Kumarson RC, Richardson RC, et al: Comparison of accidental and nonaccidental traumatic head injury in children on noncontrast computed tomography, Pediatrics 118:626–633, 2006.
  1243. Zimmerman S, Makoroff K, Care M, et al: Utility of follow-up skeletal surveys in suspected child physical abuse evaluations, Child Abuse Negl 29(10):1075–1083, 2005.
  1244. Dubowitz H: Neglect in children, Pediatr Ann 42(4):73–77, 2013.
  1245. Mills R, Alati R, O’Callaghan M, et al: Child neglect and cognitive function at 14 years of age: findings from a birth cohort, Pediatrics 127:4–10, 2011.
  1246. Naughton AM, Maguire SA, Mann MK, et al: Emotional, behavioral, and developmental features indicative of neglect or emotional abuse in preschool children: a systematic review, JAMA Pediatr 10:1–7, 2013.
  1247. Butchart A, Kahane T, Harvey AP, et al: Preventing child maltreatment: a guide to taking action and generating evidence, Geneva, 2006, WHO and International Society for the Prevention of Child Abuse and Neglect.
  1248. Dubowitz H, Feigelman S, Lane W: Pediatric primary care to help prevent child maltreatment: the safe environment for every kid (SEEK) model, Pediatrics 123:858–864, 2009.
  1249. Dubowitz H, Lane WG, Semiatin JN, Magder LS: The SEEK model of pediatric primary care: can child maltreatment be prevented in a low-risk population?, Acad Pediatr 12(4):259–268, 2012.
  1250. Flaherty EG, Stirling J: Committee on child abuse and neglect: the pediatrician’s role in child maltreatment prevention, Pediatrics 126(4):833–841, 2010.
  1251. Lane WG: Prevention of child maltreatment, Pediatr Clin North Am 61:873–888, 2014.
  1252. Macmillan HL, Wathen CN, Barlow J, et al: Interventions to prevent child maltreatment and associated impairment, Lancet 373(9659):250–266, 2009.
  1253. Jenny C: Supporting paediatricians who work in child maltreatment, Lancet 373:105–197, 2009.
  1254. Lane WG, Dubowitz H: Primary care pediatricians’ experience, comfort and competence in the evaluation and management of child maltreatment: do we need child abuse experts?, Child Abuse Negl 33:76–83, 2009.
  1255. Anda RF, Felitti VJ, Bremner JD, et al: The enduring effects of abuse and related adverse experiences in childhood: a convergence of evidence from neurobiology and epidemiology, Eur Arch Psychiatry Clin Neurosci 256:174–186, 2006.
  1256. Campbell JA, Walker RJ, Egede LE: Associations between adverse childhood experiences, high-risk behaviors, and morbidity in adulthood, Am J Prev Med 50:344–352, 2015.
  1257. Giovanelli A, Reynolds AJ, Mondi CF, Ou S: Adverse childhood experiences and adult well-being in a low-income, urban cohort, Pediatrics 137:e20154016, 2015.
  1258. Sege RD, Siegel BS, AAP Council on Child Abuse and Neglect, AAP Committee on Psychosocial Aspects of Child and Family Health: Effective discipline to raise healthy children, Pediatrics 142:e3112, 2018.
  1259. Turner RJ, Thomas CS, Brown TH: Childhood adversity and adult heath: evaluating intervening mechanisms, Soc Sci Med 156:114–124, 2016.
  1260. American Academy of Pediatrics Policy Statements
  1261. Centers for Disease Control and Prevention, National Center for Health Statistics. CDC growth charts (website).
  1262. De Onis M, Garza C, Onyango AW, et al. Comparison of the WHO child growth standards and the CDC 2000 growth charts. J Nutr. 2007;137:144–148.
  1263. Foote JM, Kirouac N, Lipman TH. PENS position statement on linear growth measurement of children. J Pediatr Nurs. 2015;30(2):425–426.
  1264. Grummer-Strawn LM, Reinold C, Krebs NF. Centers for Disease Control and Prevention: Use of World Health Organization and CDC growth charts for children aged 0–59 months in the United States. MMWR Recomm Rep. 2010;59(RR–9):1–15.
  1265. Guo SS, Roche AF, Chumlea WC, et al. Growth in weight, recumbent length and head circumference for preterm low-birthweight infants during the first three years of life using gestation-adjusted ages. Early Hum Dev. 1997;47:305–325.
  1266. Guo SS, Wholihan K, Roche AF, et al. Weight-for-length reference data for preterm, low birth weight infants. Arch Pediatr Adolesc Med. 1996;150:964–970.
  1267. Himes JH, Roche AF, Thissen D, Moore WM. Parent-specific adjustments for evaluation of recumbent length and stature of children. Pediatrics. 1985;75(2):304–313.
  1268. Hochberg Z, Albertsson-Wikland K. Evo-devo of infantile and childhood growth. Pediatr Res. 2008;64:2–7.
  1269. Horton WA, Rotter JI, Rimoin DL, et al. Standard growth curves for achondroplasia. J Pediatr. 1978;93:435–438.
  1270. Kelly A, Winer KK, Kalkwarf H, et al. Age-based reference ranges for annual height velocity in US children. J Clin Endocrinol Metab. 2014;99(6):2104–2112.
  1271. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. National Center for Health Statistics. Vital Health Stat. 2002;11(246).
  1272. Lyon AJ, Preece MA, Grant DB. Growth curve for girls with Turner syndrome. Arch Dis Child. 1985;60(10):932–935.
  1273. Mahoney CP. Evaluating the child with short stature. Pediatr Clin North Am. 1987;34:825.
  1274. Mei Z, Ogden CL, Flegal KM, et al. Comparison of the prevalence of shortness, underweight, and overweight among US children aged 0 to 59 months using the CDC 2000 and the WHO 2006 growth charts. J Pediatr. 2008;153:622–628.
  1275. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002;109:45–60.
  1276. Olsen IE, Groveman SA, Lawson ML, et al. New intrauterine growth curves based on United States data. Pediatrics. 2010;125(2):e214–e224.
  1277. Tanner JM, Davies PSW. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr. 1985;107:317–329.
  1278. Van Buuren S, van Wouwe JP. WHO child growth standards in action. Arch Dis Child. 2008;93:549–551.
  1279. Wendel D, Weber D, Leonard MB, et al. Body composition estimation using skinfolds in children with and without health conditions affecting growth and body composition. Ann Hum Biol. 2017;44(2):108–120.
  1280. Wilkins L. The diagnosis and treatment of endocrine disorders in childhood and adolescence. Springfield: Charles C. Thomas IL, 1957.
  1281. Âñåìèðíàÿ îðãàíèçàöèÿ çäðàâîîõðàíåíèÿ. ÂÎÇ: ñòàíäàðòû ðîñòà äåòåé (âåá-ñàéò)
  1282. Zemel BS, Pipan M, Stallings VA, et al. Growth charts for children with Down syndrome in the United States. Pediatrics. 2015;136(5):e1204–e1211.
  1283. AAP: èíèöèàòèâà «Ñêðèíèíã â êëèíè÷åñêîé ïðàêòèêå»: öåíòð òåõíè÷åñêîé ïîìîùè è ðåñóðñîâ ñêðèíèíãà (STAR)
  1284. CDC: ïðîãðàììà «Èçó÷è ïðèçíàêè è äåéñòâóé çàðàíåå».
  1285. Ìèíèñòåðñòâî çäðàâîîõðàíåíèÿ è ñîöèàëüíûõ ñëóæá ÑØÀ, Óïðàâëåíèå ïî äåëàì äåòåé è ñåìåé: ñ ðîæäåíèÿ è äî 5 ëåò. Ñìîòðè, êàê ÿ ðàñòó!
  1286. Adams RC, Tapia C. Council on Children with Disabilities. Early intervention, IDEA Part C services, and the medical home: collaboration for best practice and best outcomes. Pediatrics. 2013;132(4):e1073–e1088.
  1287. American Academy of Pediatrics, Council on Children with Disabilities; Section on Developmental Behavioral Pediatrics; Bright Futures Steering Committee; Medical Home Initiatives for Children with Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Pediatrics. 2006;118:405–420. (Reaffirmed Pediatrics 125(2):e444–e445, 2010.)
  1288. Glascoe FP. Evidence-based early detection of developmental-behavioral problems in primary care: what to expect and how to do it. J Pediatr Health Care. 2015;29(1):46–53.
  1289. Guevara JP, Gerdes M, Localio R, et al. Effectiveness of developmental screening in an urban setting. Pediatrics. 2013;131:30–37.
  1290. Hagan JF, Shaw JS, Duncan PM. Bright futures: guidelines for health supervision of infants, children, and adolescents. Åd. 4. Elk Grove Village, IL, American Academy of Pediatrics,2017.
  1291. Johnson CP, Myers SM; American Academy of Pediatrics Council on Children with Disabilities. Identification and evaluation of children with autism spectrum disorders. Pediatrics. 2007;120(5):1183–1215.
  1292. Lipkin PH, Okamoto J; Council on Children with Disabilities; Council on School Health. The Individuals with Disabilities Education Act (IDEA) for children with special educational needs. Pediatrics. 2015;136(6):e1650–e1662.
  1293. Noritz GH, Murphy NA; Neuromotor Screening Expert Panel. Motor delays: early identification and evaluation. Pediatrics. 2013;131(6):e2016–e2027.
  1294. Radecki L, Sand-Loud N, O’Connor KG, et al. Trends in the use of standardized tools for developmental screening in early childhood: 2011;2002–2009. Pediatrics. 128(1):14–19.
  1295. Sheldrick RC, Garfinkel D. Is a positive developmental-behavioral screening score sufficient to justify referral? A review of evidence and theory. Acad Pediatr. 2017;17(5):464–470.
  1296. Weitzman C, Wegner L; Section on Developmental and Behavioral Pediatrics; Committee on Psychosocial Aspects of Child and Family Health; Council on Early Childhood; Society for Developmental and Behavioral Pediatrics; American Academy of Pediatrics. Promoting optimal development: screening for behavioral and emotional problems. Pediatrics. 2015;135(2):384–395.
  1297. Abner KS, Gordon RA, Kaestner R, et al. Does child-care quality mediate associations between type of care and development? J Marriage Family. 2013;75:1203–1217.
  1298. Administration for Children and Families, US Department of Health and Human Services. Caring for Our Children Basics. Foundations for Early Care and Education, 2015.
  1299. American Academy of Pediatrics (AAP), American Public Health Association, National Resource Center for Health and Safety in Child Care and Early Education: Stepping stones to caring for our children: national health and safety performance standards–guidelines for early care and education programs. Ed. 3. Elk Grove Village, IL, 2013. AAP.
  1300. Bradley RH, Vandell DL. Child care and the well-being of children. Arch Pediatr Adolesc Med. 2007;161:669–676.
  1301. Brotmen LM, Dawson-McClure S, Kamboukos D, et al. Effects of Parentcorps in prekindergarten on child mental health and academic performance. JAMA Pediatr. 2016;170(12):1149–1155.
  1302. Burchinal MR, Kainz K, Cai Y. How well do our measures of quality predict child outcomes? A meta-analysis and coordinated analysis of data from large-scale studies of early childhood settings. In Zaslow M, Martinez-Beck I, Tout K, eds. Quality measurement in early childhood settings. Baltimore, MD: Paul H Brookes Publishing, 2011. Ð. 11–32.
  1303. Child Care Aware of America: Child care in America: 2012 state fact sheets. Arlington: VA, 2012. Child Care Aware of America.
  1304. Child Care Aware of America: Parents and the high cost of child care 2016 report, Arlington, VA, 2013, Child Care Aware of America.
  1305. Curby TW, LoCasale-Crouch J, Konold TR, et al. The relations of observed pre-K classroom quality profiles to children’s achievement and social competence. Early Educ Dev. 2009;20(2):346–372.
  1306. De Schipper JC, Van Ijzendoorn MH, Tavecchio LWC. Stability in center day care: relations with children’s well-being and problem behavior in day care. Soc Dev. 2004;13(4):531–550.
  1307. Fass S. Paid leave in the states: a critical support for low-wage workers and their families. New York, 2009. National Center for Children in Poverty.
  1308. Galtry J, Callister P. Assessing the optimal length of parental leave for child and parental well-being: how can research inform policy? J Fam Issues. 2005;26(2):219–246.
  1309. Guendelman S, Kosa JL, Pearl M, et al. Juggling work and breastfeeding: effects of maternity leave and occupational characteristics. Pediatrics. 2009;123:e38–e46.
  1310. Iruka IU, Forry N. Patterns of quality in center and home-based programs and predictors to children’s preschool and kindergarten outcomes. Ïðåäñòàâëåíî íà ïðîõîäÿùåì ðàç â äâà ãîäà ñîáðàíèè Îáùåñòâà èññëåäîâàíèé â îáëàñòè ðàçâèòèÿ ðåáåíêà â àïðåëå 2013 ã.Ñèýòë.
  1311. Johnston K, Brinamen CF. The consultation relationship–from transactional to transformative: hypothesizing about the nature of change. Infant Ment Health J. 2012;33(3):226–233.
  1312. Kiehl EM, White MA. Maternal adaptation during childbearing in Norway, Sweden and the United States. Scand J Caring Sci. 2003;17:96–103.
  1313. Laughlin L. Maternity leave and employment patterns: 2006–2008. Current Population Reports P70–128, Washington: DC, 2011. US Census Bureau.
  1314. Laughlin L. Who’s minding the kids? Child care arrangements: spring 2011 Current Population Reports P70–135. Washington: DC, 2013. U.S. Census Bureau.
  1315. LoCasale-Crouch J, Konold T, Pianta R, et al. Observed classroom quality profiles in state-funded pre-kindergarten programs and associations with teacher, program, and classroom characteristics. Early Child Res Q. 2007;22(1):3–17.
  1316. Maxwell KL, Sosinsky L, Tout K, Hegseth D. Coordinated monitoring systems for early care and education. OPRE Research Brief #2016–19, Washington, DC, 2016, Office of Planning, Research and Evaluation, Administration for Children and Families, U.S. Department of Health and Human Services.
  1317. Morrissey TW. Multiple child-care arrangements and young children’s behavioral outcomes. Child Dev. 2009;80(1):59–76.
  1318. Nafstad P, Brunekreef B, Skrondal A, et al. Early respiratory infections, asthma, and allergy: 10-year follow-up of the Oslo Birth Cohort. Pediatrics. 2005;116:e255–e262.
  1319. National Center on Child Care Quality Improvement, Office of Child Care, Administration for Children and Families, US Department of Health and Human Services: Child-staff ratios and maximum group size requirements in 2011.
  1320. National Center on Child Care Quality Improvement, Office of Child Care Administration for Children and Families, U.S. Department of Health and Human Services: Research Brief 1. Trends in child care licensing regulations and policies for 2011.
  1321. National Center. Research Brief #2: Trends in family child care home licensing requirements and policies for 2011.
  1322. National Center. Research Brief #3, Trends in group child care home licensing regulations and policies for 2011.
  1323. National Institute of Child Health and Human Development (NICHD). Early Child Care Research Network: Child-care effect sizes for the NICHD study of early child care and youth development. Am Psychol. 2006;61:99–116.
  1324. National Survey of Early Care and Education Project Team. Early care and education usage and households’ out-of-pocket costs: tabulations from the National Survey of Early Care and Education (NSECE). OPRE Report #2016–09, Washington, DC, 2016, Office of Planning, Research and Evaluation, Administration for Children and Families, US Department of Health and Human Services.
  1325. Office of Child Care, Administration for Children and Families, US Department of Health & Human Services. National early care and education profile, 2013.
  1326. Office of Child Care, Administration for Children and Families, US Department of Health and Human Services. Child Care and Development Block Grant (CCDBG) Act of 2014. Plain language summary of statutory changes. Washington: DC, 2014.
  1327. Perry DF, Dallas Allen M, Brennan EM, et al. The evidence base for mental health consultation in early childhood settings: a research synthesis addressing children’s behavioral outcomes. Early Educ Dev. 2010;21(6):795–824.
  1328. Phillips DA, Fox NA, Gunnar MR. Same place, different experiences: bringing individual differences to research in child care. Child Dev Perspect. 2011;5(1):44–49.
  1329. Robins PK. Welfare reform and child care: evidence from 10 experimental welfare-to-work programs. Eval Rev. 2007;31(5):440–468.
  1330. Sosinsky LS. Parental selection of child care quality: income, demographic risk and beliefs about harm of maternal employment to children (dissertation). Dissertation Abstracts Int B Sci Eng. 2005;66(3B):1762.
  1331. Sosinsky LS, Kim S-K. A profile approach to child care quality, quantity, and type of setting: Parent selection of infant child care arrangements. Appl Dev Sci. 2013;17(1):39–56.
  1332. Sosinsky LS, Ruprecht K, Horm D, et al. Including relationship-based care practices in infant-toddler care: implications for practice and policy. Brief prepared for the Office of Planning, Research and Evaluation, Administration for Children and Families, US Department of Health and Human Services, 2016.
  1333. Tran H, Weinraub M. Child care effects in context: quality, stability, and multiplicity in nonmaternal child care arrangements during the first 15 months of life. Dev Psychol. 2006;42(3):566–582.
  1334. US Census Bureau, Housing and Household Economic Statistics Division, Fertility and Family Statistics Branch. Who’s minding the kids? Child care arrangements
  1335. American Academy of Pediatrics, Section on Radiology: Diagnostic imaging of child abuse, Pediatrics 123:1430–1435, 2009.
  1336. Anderst JD, Carpenter SL, Abshire TC: Section on Hematology/oncology and committee on child abuse and neglect: evaluation for bleeding disorders in suspected child abuse, Pediatrics 131:e1314, 2013.
  1337. Carpenter SL, Abshire TC, Anderst JD, et al: Section on Hematology/oncology and committee on child abuse and neglect: evaluating for suspected child abuse: conditions that predispose to bleeding, Pediatrics 131(4):1357–1373, 2013.
  1338. Christian CW, Block R: Committee on child abuse and neglect: abusive head trauma in infants and children, Pediatrics 123(5):1409–1411, 2009.
  1339. Christian CW, Sege RD: Committee on child abuse and neglect, Committee on injury, Violence, and poison prevention, Council on community pediatrics: child fatality review, Pediatrics 126(3):592–596, 2010.
  1340. Flaherty EG, Stirling J: Committee on child abuse and neglect: the pediatrician’s role in child maltreatment prevention, Pediatrics 126(4):833–841, 2010.
  1341. Hibbard R, Barlow J, MacMillan H, et al: American academy of child and adolescent psychiatry, Child maltreatment and violence committee: psychological maltreatment, Pediatrics 130(2):372–378, 2012.
  1342. Hibbard R, Desch L: American academy of pediatrics committee on child abuse and neglect: maltreatment of children with disabilities, Pediatrics 119:1018–1025, 2007.
  1343. Hymel KP: Committee on child abuse and neglect: distinguishing sudden infant death syndrome from child abuse fatalities, Pediatrics 118:421–427, 2006.
  1344. Jenny C: Committee on child abuse and neglect: evaluating infants and young children with multiple fractures, Pediatrics 118:1299–1303, 2006.
  1345. Kellogg N: Committee on child abuse and neglect: oral and dental aspects of child abuse and neglect, Pediatrics 116(6):1565–1568, 2005.
  1346. Kellogg ND: Committee on child abuse and neglect: evaluation of suspected child physical abuse, Pediatrics 119:1232–1241, 2007.
  1347. Levin AV, Christian CW: Committee on child abuse and neglect, Section on ophthalmology: the eye examination in the evaluation of child abuse, Pediatrics 126(2):376–380, 2010.
  1348. Sege RD, Amaya-Jackson L, American Academy of Pediatrics, Committee on Child Abuse and Neglect, Council on Foster Care, Adoption, and Kinship Care: Clinical considerations related to the behavioral manifestations of child maltreatment, Pediatrics 139:e20170100, 2017.
  1349. Stirling J: Committee on child abuse and neglect: beyond munchausen syndrome by proxy: identification and treatment of child abuse in a medical setting, Pediatrics 119(5):1026–1030, 2007.
  1350. Stirling J, Committee on Child Abuse and Neglect, Section on Adoption and Foster Care: Understanding the behavioral and emotional consequences of child abuse, Pediatrics 122:667–673, 2008.
  1351. Thackeray JD, Hibbard R, Dowd MD, Committee on Child Abuse and Neglect, Committee on Injury, Violence, and Poison Prevention: Intimate partner violence: the role of the pediatrician, Pediatrics 125(5):1094–1100, 2010.
  1352. Forrest CB, Crandall WV, Bailey LC, et al: Effectiveness of anti-TNF alpha for Crohn disease: research in a pediatric learning health system, Pediatrics 134(1):37–44, 2014.
  1353. Goldstein MM, Blumenthal D: Building an information technology infrastructure, J Law Med Ethics 36(4):709–715, 2008.
  1354. Guidelines for consumer-focused public reporting (PowerPoint file).
  1355. Guyatt GH, Oxman AD, Vist GE, et al: GRADE: an emerging consensus on rating quality of evidence and strength of recommendations, BMJ 336:924–926, 2008.
  1356. Harbaugh N Jr: Pay for performance: quality-and-value-based reimbursement, Pediatr Clin North Am 56:997–1007, 2009.
  1357. Huang X, Rosenthal MB: Transforming specialty practice—the patient-centered medical neighborhood, N Engl J Med 370:1376–1379, 2014.
  1358. Institute of Medicine, Committee on the Learning Health Care System in America: Best Care and Lower Cost: The Path to Continuously Learning Health Care in America, Washington, DC, 2012, National Academies Press.
  1359. Institute of Medicine, Committee on Quality Health Care in America: Crossing the quality chasm: a new health system for the 21st century, Washington, DC, 2001, National Academies Press.
  1360. Institute of Medicine: IHI Triple Aim Initiative.
  1361. Kaiser Family Foundation: Health expenditure and financing: health expenditure indicators, OECD Health Statistics (database), 2017.
  1362. Kavanagh BP: The GRADE system for rating clinical guidelines, PLoS Med 6(9):e1000094, 2009.
  1363. Kurtin P, Stucky E: Standardize to excellence: improving the quality and safety of care with clinical pathways, Pediatr Clin North Am 56:893–904, 2009.
  1364. Mandel KE, Muething SE, Schoettker PJ, et al: Transforming safety and effectiveness in pediatric hospital care locally and nationally, Pediatr Clin North Am 56:905–918, 2009.
  1365. Mangione-Smith R, DeCristofaro AH, Setodji CM, et al: The quality of ambulatory care delivered to children in the United States, N Engl J Med 357(15):1515–1523, 2007.
  1366. Margolis P, Provost LP, Schoettker PJ, et al: Quality improvement, clinical research, and quality improvement research—opportunities for integration, Pediatr Clin North Am 56:831–841, 2009.
  1367. McDonald KM: Approach to improving quality: the role of quality measurement and a case study of the agency for healthcare research and quality pediatric quality indicators, Pediatr Clin North Am 56:815–829, 2009.
  1368. McGlynn EA, Asch SM, Adams J, et al: The quality of health care delivered to adults in the United States, N Engl J Med 348(26):2635–2645, 2003.
  1369. Miles P: Health information systems and physician quality: role of the American Board of Pediatrics maintenance of certification in improving children’s health care, Pediatrics 123:S108–S110, 2009.
  1370. Miles PV: Maintenance of certification: the role of the American Board of Pediatrics in improving children’s health care, Pediatr Clin North Am 56:987–994, 2009.
  1371. Miller FG, Emanuel EJ: Quality-improvement research and informed consent, N Engl J Med 358:765–767, 2008.
  1372. National Institute of Health: Frequently asked questions about implementation science.
  1373. Patient-Centered Outcomes Research Institute
  1374. Pollack MM, Alexander SR, Clark N, et al: Improved outcomes from tertiary center pediatric intensive care: a statewide comparison of tertiary and nontertiary care facilities, Crit Care Med 19(2):150–159, 1991.
  1375. Pollack MM, Ruttimann UE, Getson PR: Pediatric Risk of Mortality (PRISM) score, Crit Care Med 16:1110–1116, 1988.
  1376. Porter ME: What is value in health care? N Engl J Med 363(26):2477–2481, 2010.
  1377. Porter ME, Lee TH: The strategy that will fix health care, Harv Bus Rev 91(10):50–70, 2013.
  1378. Porter ME, Pabo EA, Lee TH: Redesigning primary care: a strategic vision to improve value by organizing around patients’ needs, Health Aff (Millwood) 32(3):516–525, 2013.
  1379. Randolph G, Esporas M, Provost L, et al: Model for improvement. Part 2. Measurement and feedback for quality improvement efforts, Pediatr Clin North Am 56:779–798, 2009.
  1380. Robert Wood Johnson Foundation: Pay for performance improving health care quality and changing provider behavior; but challenges persist.
  1381. American Academy of Pediatrics, Committee on Bioethics and Committee on Hospital Care: Palliative care for children, Pediatrics 106:351–357, 2000. (Reaffirmed February 2007).
  1382. American Academy of Pediatrics, Committee on Bioethics: Clinical report: forgoing medically provided nutrition and hydration in children, Pediatrics 124(2):813–822, 2009. (Reaffirmed January 2014).
  1383. American Academy of Pediatrics, Committee on Bioethics: Informed consent in decision-making in pediatric practice, Pediatrics 138(2):e20161484, 2016.
  1384. American Academy of Pediatrics, Council on Foster Care, Adoption, and Kinship Care.
  1385. Brodzinsky DM: The modern adoptive families study: an introduction. The Donaldson Adoption Institute, 2015.
  1386. Brodzinsky DM: Children’s understanding of adoption: developmental and clinical implications, Prof Psychol Res Pr 42:200–207, 2011.
  1387. Child Welfare Information Gateway: Foster care statistics 2014, Washington, DC, 2016, US Department of Health and Human Services, Children’s Bureau.
  1388. Committee on Psychosocial Aspects of Child and Family Health, Committee on Early Childhood, Adoption, and Dependent Care, and Section on Developmental and Behavioral Pediatrics, et al: Early childhood adversity, toxic stress, and the role of the pediatrician: translating developmental science into lifelong health, Pediatrics 129:e224, 2012.
  1389. Eckerle JK, Howard CR, Chandy JC: Infections in internationally adopted children, Pediatr Clin North Am 60(2):487–505, 2013.
  1390. Evan B, Donaldson Adoption Institute: Beyond Culture Camp: promoting healthy identity in adoption.
  1391. Hague Conference on Private International Law: Hague Convention on Protection of Children and Co-operation in Respect of Intercountry Adoption.
  1392. Howard JA: Untangling the Web: The Internet’s transformative impact on adoption, New York, 2012, Evan B Donaldson Adoption Institute.
  1393. Jones VF, Schulte EE, Committee on Early Childhood and Council on Foster Care, Adoption, and Kinship Care: The pediatrician’s role in supporting adoptive families, Pediatrics 130:e1040–e1049, 2012.
  1394. Jones VF, Schulte EE, Council on Foster Care, Adoption, and Kinship Care: Comprehensive health evaluation of the newly adopted child, Pediatrics 129:e214, 2012.
  1395. Mason PW, Johnson DE, Albers Prock L, editors: Adoption medicine: caring for children and families, 2014, American Academy of Pediatrics Council on Foster Care, Adoption, and Kinship Care.
  1396. Medical evaluation for infectious diseases for internationally adopted, refugee, and immigrant children. In Kimberlin DW, Brady MT, Jackson MA, Long SS, editors: Red book: 2015 report of the committee on infectious diseases, ed 30, Elk Grove Village, IL, 2015, American Academy of Pediatrics, p 194.
  1397. Office of Children’s Issues: FY2014 Annual Report on Intercountry Adoption.
  1398. Perrin EC, Siegel BS, Committee on Psychosocial Aspects of Child and Family Health of the American Academy of Pediatrics: Promoting the well-being of children whose parents are gay or lesbian, Pediatrics 131:e1374–e1383, 2013.
  1399. Rosman EA, Johnson CE, Callahan NM, editors: Adoption Factbook V, Alexandria, VA, 2011, National Council for Adoption.
  1400. US Department of Health and Human Services. The National Survey of Adoptive Parents (NSAP).
  1401. AAP District II Task Force on Health Care for Children in Foster Care, District II Committee on Early Childhood, Adoption, and Dependent Care: Fostering health: health care for children and adolescents in foster care, Elk Grove, IL, 2005, AAP. [Available through the American Academy of Pediatrics Bookstore.
  1402. Adoption and Foster Care Analysis and Reporting System (AFCARS): Report #23 FY 2016 data.
  1403. Ahrens KR, DuBois DL, Garrison M, et al: Qualitative exploration of relationships with important non-parental adults in the loves of youth in foster care, Child Youth Serv Rev 33:1012–1023, 2011.
  1404. American Academy of Pediatrics, Council on Foster Care, Adoption, and Kinship Care, Committee on Adolescence, Council on Early Childhood: Policy statement: health care issues for children and adolescents in foster and kinship care, Pediatrics 136:e1132–e1140, 2015.
  1405. American Academy of Pediatrics Trauma Toolbox for Primary Care.
  1406. Casey Family Programs: Improving family foster care: findings from the northwest foster care alumni study, Seattle, WA, 2005, pp 1–64.
  1407. Courtney M, et al: The transition to adulthood for youth “aging out” of the foster care system. In Osgood DW, Foster EM, Flanagan C, editors: On your own without a net: the transitions to adulthood for vulnerable populations, Chicago, 2005, University of Chicago Press.
  1408. Dozier M, Lindheim O, Lewis E: Effects of a foster parent training program on young children’s attachment behaviors: preliminary evidence from a randomized trial, Child Adolesc Social Work J 26:321–332, 2009.
  1409. Dozier M, Peloso E, Lewis E, et al: Effects of an attachment-based intervention on the cortisol production of infants and toddlers in foster care, Dev Psychopathol 20:845–859, 2008.
  1410. Leslie LK, Gordon JN, Meneken L, et al: The physical, developmental, and mental health needs of young children in child welfare by initial placement type, J Dev Behav Pediatr 26:177–185, 2005.
  1411. Leve LD, Harold GT, Chamberlain P, et al: Practitioner review: children in foster care—vulnerabilities and evidence-based interventions that promote resilience processes, J Child Psychol Psychiatry 53:1197–1211, 2012.
  1412. Awasthi S., Peto R., Read S. et al. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial // Lancet. 2013. Vol. 381. P. 1469–1476.
  1413. Ballew C., Bowman B.A., Sowell A.L. et al. Serum retinol distributions in residents of the United States: third National Health and Nutrition Examination Survey, 1988–1994 // Am. J. Clin. Nutr. 2001. Vol. 73. P. 586–593.
  1414. Darlow B.A., Graham P.J. Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birthweight infants // Cochrane Database Syst. Rev. 2011. CD000501.
  1415. DeKlotz C.M.C., Roby K.D., Friedlander S.F. Dietary supplements, isotretinoin, and liver toxicity in adolescents: a retrospective case series // Pediatrics. 2017. Vol. 140. N. 4. P. e20152940.
  1416. Erhardt J. Biochemical methods for the measurement of vitamin A deficiency disorders (VADD) // Sight Life Mag. 2003. Vol. 2. P. 5–7.
  1417. Fernandes T.F., Figueiroa J.N., Grande de Arruda I.K. et al. Effect of infant illness of maternal supplementation with 400,000 IU vs 200,000 IU of vitamin A // Pediatrics. 2012. Vol. 129. P. e960–e966.
  1418. Grune T., Lietz G., Palou A. et al. Beta-carotene is an important vitamin A source for humans // J. Nutr. 2010. Vol. 140. P. 2268S–2285S.
  1419. Haider B.A., Bhutta Z.A. Neonatal vitamin A supplementation: time to move on // Lancet. 2015. Vol. 385. P. 1268–1270.
  1420. Hodges J.K., Tan L., Green M.H., Ross A.C. Vitamin A supplementation redirects the flow of retinyl esters from peripheral to central organs of neonatal rats raised under vitamin A-marginal conditions // Am. J. Clin. Nutr. 2017. Vol. 105. N. 5. P. 1110–1121.
  1421. Office of Dietary Supplements, National Institutes of Health. Vitamin A fact sheet.
  1422. Penniston K.L., Tanumihardjo S.A. The acute and chronic toxic effects of vitamin A // Am. J. Clin. Nutr. 2006. Vol. 83. P. 191–201.
  1423. Raiten D.J., Sakr Ashour F.A., Ross A.C. et al; INSPIRE Consultative Group. Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE) // J. Nutr. 2015. Vol. 145. N. 5. P. 1039S–1108S.
  1424. Ross A.C. Vitamin A // Ross A.C., Caballero B., Cousins R.J. et al. (eds). Modern nutrition in health and disease. Ed. 11. Baltimore: Lippincott, Williams & Wilkins, 2013. P. 260–277.
  1425. Rubin L.P., Ross A.C., Stephensen C.B. et al. Metabolic effects of inflammation on vitamin A and carotenoids in humans and animal models // Adv. Nutr. 2017. Vol. 8. N. 2. P. 197–212.
  1426. Saari J.C. Vitamin A and vision // Asson-Batres M.A., Rochette-Egly C. (eds). The biochemistry of retinoid signaling. II. Vol. 81. Subcellular biochemistry. Netherlands, 2016. P. 231–259.
  1427. Shah P., Isley W.L. Ketoacidosis during a low-carbohydrate diet // N. Engl. J. Med. 2006. Vol. 354. N. 1. P. 97–98.
  1428. Sommer A. Vitamin A deficiency and clinical disease: an historical overview // J. Nutr. 2008. Vol. 138. P. 1835–1839.
  1429. Tanumihardjo S. Vitamin A. biomarkers of nutrition for development // Am. J. Clin. Nutr. 2011. Vol. 94. P. 658S–665S.
  1430. Tanumihardjo S.A. Assessing vitamin A status: past, present and future // J. Nutr. 2004. Vol. 134. P. 290S–293S.
  1431. Tanumihardjo S.A., Ball A.M., Kaliwile C., Pixley K.V. The research and implementation continuum of biofortified sweet potato and maize in Africa // Ann. NY Acad. Sci. 2017. Vol. 1390. P. 88–103.
  1432. Tanumihardjo S.A., Russell R.M., Stephensen C.B. et al. Biomarkers of nutrition for development (bond)-vitamin: a review // J. Nutr. 2016. Vol. 146. P. 1816S–1848S.
  1433. Tielsch J.M. Vitamin A supplements in newborns and child survival // BMJ. 2008. Vol. 336. P. 1385–1386.
  1434. US Food and Drug Administration. iPLEDGE Information.
  1435. Villamor E., Fawzi W.W. Effects of vitamin A supplementation on immune responses and correlation with clinical outcomes // Clin. Microbiol. Rev. 2005. Vol. 18. P. 446–464.
  1436. Beshlawi I., Al Zadjali S., Bashir W. et al. Thiamine responsive megaloblastic anemia: the puzzling phenotype // Pediatr. Blood Cancer. 2014. Vol. 61. P. 528–531.
  1437. Dabar G., Harmouche C., Habr B. et al. Shoshin beriberi in critically-ill patients: case series // Nutr. J. 2015. Vol. 14. P. 51.
  1438. Frank L.L. Thiamin in clinical practice // JPEN J. Parenter. Enteral Nutr. 2015. Vol. 39. P. 503–520.
  1439. Qureshi U.A., Sami A., Altaf U. et al. Thiamine responsive acute life threatening metabolic acidosis in exclusively breast-fed infants // Nutrition. 2016. Vol. 32. P. 213–216.
  1440. Tabarki B., Alfadhel M., AlShahwan S. et al. Treatment of biotin-responsive basal ganglia disease: open comparative study between the combination of biotin plus thiamine versus thiamine alone // Eur. J. Paediatr. Neurol. 2015. Vol. 19. P. 547–552.
  1441. Wani N.A., Qureshi U.A., Jehangir M. et al. Infantile encephalitic beriberi: magnetic resonance imaging findings // Pediatr. Radiol. 2016. Vol. 46. P. 96–103.
  1442. Ygberg S., Naess K., Eriksson M. et al. Biotin and thiamine responsive basal ganglia disease: a vital differential diagnosis in infants with severe encephalopathy // Eur. J. Paediatr. Neurol. 2016. Vol. 20. P. 457–461.
  1443. Foley A.R., Menezes M.P., Pandraud A. et al. Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2 // Brain. 2014. Vol. 137. P. 44–56.
  1444. Nichols E.K., Talley L.E., Birungi N. et al. Suspected outbreak of riboflavin deficiency among populations reliant on food assistance: a case study of drought-stricken Karamoja, Uganda, 2009–2010 // PLoS ONE. 2013. Vol. 8. P. e62976.
  1445. Sherwood M., Goldman R.D. Effectiveness of riboflavin in pediatric migraine prevention // Can. Fam. Physician. 2014. Vol. 60. P. 244–246.
  1446. Swaminathan S., Thomas T., Kurpad A.V. B-vitamin interventions for women and children in low-income populations // Curr. Opin. Clin. Nutr. Metab. Care. 2015. Vol. 18. P. 295–306.
  1447. Brown T.M. Pellagra: an old enemy of timeless importance // Psychosomatics. 2010. Vol. 51. P. 93–97.
  1448. Lanska D.J. Chapter 30: historical aspects of the major neurological vitamin deficiency disorders: the water-soluble B vitamins // Handb. Clin. Neurol. 2010. Vol. 95. P. 445–476.
  1449. Piqui-Duran E., P?rez-Cejudo J.A., Cameselle D. et al. Pellagra: a clinical, histopathological, and epidemiological study of 7 cases // Actas Dermosifiliogr. 2012. Vol. 103. P. 51–58.
  1450. Steffen C. Pellagra // Skinmed. 2012. Vol. 10. P. 174–179.
  1451. Wan P., Moat S., Anstey A. Pellagra: a review with emphasis on photosensitivity // Br. J. Dermatol. 2011. Vol. 164. P. 1188–1200.
  1452. Derakhshanfar H., Amree A.H., Alimohammadi H. et al. Results of double blind placebo controlled trial to assess the effect of vitamin B6 on managing of nausea and vomiting in pediatrics with acute gastroenteritis // Glob. J. Health Sci. 2013. Vol. 5. P. 197–201.
  1453. Salam R.A., Zuberi N.F., Bhutta Z.A. Pyridoxine (vitamin B6) supplementation during pregnancy or labour for maternal and neonatal outcomes // Cochrane Database Syst. Rev. 2015. CD000179.
  1454. Ueland P.M., Ulvik A., Rios-Avila L. et al. Direct and functional biomarkers of vitamin B6 status // Annu. Rev. Nutr. 2015. Vol. 35. P. 33–70.
  1455. Alfadhel M., Almuntashri M., Jadah R.H. et al. Biotin-responsive basal ganglia disease should be renamed biotin-thiamine-responsive basal ganglia disease: a retrospective review of the clinical, radiological and molecular findings of 18 new cases // Orphanet. J. Rare. Dis. 2013. Vol. 8. P. 83.
  1456. Ito T., Nishie W., Fujita Y. et al. Infantile eczema caused by formula milk // Lancet. 2013. Vol. 381. P. 1958.
  1457. Kassem H., Wafaie A., Alsuhibani S. et al. Biotin-responsive basal ganglia disease: neuroimaging features before and after treatment // AJNR Am. J. Neuroradiol. 2014. Vol. 35. P. 1900–1995.
  1458. Tabarki B., Al-Shafi S., Al-Shahwan S. et al. Biotin-responsive basal ganglia disease revisited: clinical, radiologic, and genetic findings // Neurology. 2013. Vol. 80. P. 261–267.
  1459. De-Regil L.M., Pe?a-Rosas J.P., Fern?ndez-Gaxiola A.C. et al. Effects and safety of periconceptional oral folate supplementation for preventing birth defects // Cochrane Database Syst. Rev. 2015. CD007950.
  1460. Gildestad T., Bj?rge T., Vollset S.E. et al. Folic acid supplements and risk for oral clefts in the newborn: a population-based study // Br. J. Nutr. 2015. Vol. 114. P. 1456–1463.
  1461. Hodgetts V.A., Morris R.K., Francis A. et al. Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis // BJOG. 2015. Vol. 4. P. 478–490.
  1462. Pfeiffer C.M., Sternberg M.R., Fazili Z. et al. Folate status and concentrations of serum folate forms in the US population: National Health and Nutrition Examination Survey 2011–2 // Br. J. Nutr. 2015. Vol. 113. P. 1965–1977.
  1463. Suran P., Roth C., Bresnahan M. et al. Association between maternal use of folic acid supplements and risk of autism spectrum disorders in children // JAMA. 2013. Vol. 309. P. 570–577.
  1464. Williams J., Mai C.T., Mulinare J. et al. Updated estimates of neural tube defects prevented by mandatory folic acid fortification—United States, 1995–2011 // MMWR Morb. Mortal Wkly Rep. 2015. Vol. 64. P. 1–5.
  1465. Bahadir A., Reis P.G., Erduran E. Oral vitamin B12 treatment is effective for children with nutritional vitamin B12 deficiency // J. Paediatr. Child Health. 2014. Vol. 50. P. 721–725.
  1466. Benson J., Phillips C., Kay M. et al. Low vitamin B12 levels among newly-arrived refugees from Bhutan, Iran and Afghanistan: a multicentre Australian study // PLoS ONE. 2013. Vol. 8. P. e57998.
  1467. Berry N., Sagar R., Tripathi B.M. Catatonia and other psychiatric symptoms with vitamin B12 deficiency // Acta Psychiatr. Scand. 2003. Vol. 108. P. 156–159.
  1468. Cuffe K., Stauffer W., Painter J. et al. Update: Vitamin B12 deficiency among Bhutanese refugees resettling in the United States, 2012 // MMWR Morb. Mortal Wkly Rep. 2014. Vol. 63. P. 607.
  1469. Demir N., Do?an M., Ko? A. et al. Dermatological findings of vitamin B12 deficiency and resolving time of these symptoms // Cutan. Ocul. Toxicol. 2014. Vol. 33. P. 70–73.
  1470. Duong M.C., Mora-Plazas M., Mar?n C. et al. Vitamin B-12 deficiency in children is associated with grade repetition and school absenteeism, independent of folate, iron, zinc, or vitamin A status biomarkers // J. Nutr. 2015. Vol. 145. P. 1541–1548.
  1471. Goraya J.S., Kaur S., Mehra B. Neurology of nutritional vitamin B12 deficiency in infants: case series from India and literature review // J. Child Neurol. 2015. Vol. 30. P. 1831–1837.
  1472. Hannibal L., Lysne V., Bjorke-Monsen A.L. et al. Biomarkers and algorithms for the diagnosis of vitamin B12 deficiency // Frontiers Mol. Biosci. 2016. Vol. 3. N. 27. P. 1–16.
  1473. Hunt A., Harrington D., Robinson S. Vitamin B12 deficiency // BMJ. 2014. Vol. 349. P. g5226.
  1474. Lam J.R., Schneider J.L., Zhao W. et al. Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency // JAMA. 2013. Vol. 310. P. 2435–2442.
  1475. Kvestad I., Taneja S., Kumar T. et al. Vitamin B12 and folic acid improve gross motor and problem-solving skills in young north Indian children: a randomized placebo-controlled trial // PLoS ONE. 2015. Vol. 10. P. e0129915.
  1476. Pawlak R., Lester S.E., Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature // Eur. J. Clin. Nutr. 2014. Vol. 68. P. 541–548.
  1477. Pawlak R., Parrott S.J., Raj S. et al. How prevalent is vitamin B(12) deficiency among vegetarians? // Nutr. Rev. 2013. Vol. 71. P. 110–117.
  1478. Rahmandar M.H., Bawcom A., Romano M.E., Hamid R. Cobalamin C deficiency in an adolescent with altered mental status and anorexia // Pediatrics. 2014. Vol. 134. N. 6. P. e1709–e1714.
  1479. Stabler S.P. Clinical practice. Vitamin B12 deficiency // N. Engl. J. Med. 2013. Vol. 368. P. 149–160.
  1480. Strand T.A., Taneja S., Ueland P.M. et al. Cobalamin and folate status predicts mental development scores in North Indian children 12–18 mo of age // Am. J. Clin. Nutr. 2013. Vol. 97. P. 310–317.
  1481. Torsvik I.K., Ueland P.M., Markestad T. et al. Motor development related to duration of exclusive breastfeeding, B vitamin status and B12 supplementation in infants with a birth weight between 2000–3000 g, results from a randomized intervention trial // BMC Pediatr. 2015. Vol. 15. P. 218.
  1482. Wang Z.P., Shang X.X., Zhao Z.T. Low maternal vitamin B(12) is a risk factor for neural tube defects: a meta-analysis // J. Matern. Fetal. Neonatal. Med. 2012. Vol. 25. P. 389–394.
  1483. Bansal P.G., Toteja G.S., Suman R. Plasma vitamin C status of adolescent girls in a slum of Delhi // Indian Pediatr. 2014. Vol. 51. P. 932–933.
  1484. Carr A.C., Bozonet S.M., Vissers M.C. A randomised cross-over pharmacokinetic bioavailability study of synthetic versus kiwifruit-derived vitamin C // Nutrients. 2013. Vol. 5. P. 4451–4461.
  1485. Cove?as R., Gonz?lez-Fuentes J., Rivas-Infante E. et al. Developmental study of vitamin C distribution in children’s brainstems by immunohistochemistry // Ann. Anat. 2015. Vol. 201. P. 65–78.
  1486. Fain O. Musculoskeletal manifestations of scurvy // Joint Bone. Spain. 2005. Vol. 72. P. 124–128.
  1487. Garaiova I., Muchov? J., Nagyov? Z. et al. Probiotics and vitamin C for the prevention of respiratory tract infections in children attending preschool: a randomised controlled pilot study // Eur. J. Clin. Nutr. 2015. Vol. 69. P. 373-379.
  1488. German Nutrition Society (DGE). New reference values for vitamin C intake // Ann. Nutr. Metab. 2015. Vol. 67. P. 13–20.
  1489. Gulko E., Collins L.K., Murphy R.C. et al. MRI findings in pediatric patients with scurvy // Skeletal. Radiol. 2015. Vol. 44. P. 291–297.
  1490. Ma N.S., Thompson C., Weston S. Scurvy as a manifestation of food selectivity in children with autism // J. Autism Dev. Disord. 2016. Vol. 46. P. 1464–1470.
  1491. McEvoy C.T., Schilling D., Clay N. et al. Vitamin C supplementation for pregnant smoking women and pulmonary function in their newborn infants: a randomized clinical trial // JAMA. 2014. Vol. 311. P. 2074–2082.
  1492. Pysz K., Leszczy?ska T., Kope? A. et al. Intake of vitamin C, ?-carotene, and polyphenolic compounds by children and adolescents from orphanages // J. Am. Coll. Nutr. 2016. Vol. 35. P. 75–85.
  1493. Seya M., Handa A., Hasegawa D. et al. Scurvy: from a selective diet in children with developmental delay // J. Pediatr. 2016. Vol. 177. P. 331.
  1494. Vitoria I., L?pez B., G?mez J. et al. Improper use of a plant-based vitamin C–deficient beverage causes scurvy in an infant // Pediatrics. 2016. Vol. 137. N. 2. P. e20152781.
  1495. Capelli S., Donghi V., Maruca K. et al. Clinical and molecular heterogeneity in a large series of patients with hypophosphatemic rickets // Bone. 2015. Vol. 79. P. 143–149.
  1496. Czech-Kowalska J., Czekuc-Kryskiewicz E., Pludowski P. et al. The clinical and biochemical predictors of bone mass in preterm infants // PLoS ONE. 2016. Vol. 11. P. e0165727.
  1497. Elidrissy A.T. The return of congenital rickets, are we missing occult cases? // Calcif. Tiss. Int. 2016. Vol. 99. P. 227–236.
  1498. Fernandez-Cooke E., Cruz-Rojo J., Gallego C. et al. Tumor-induced rickets in a child with a central giant cell granuloma: a case report // Pediatrics. 2015. Vol. 135. P. e1518–e1523.
  1499. Imel E.A., Zhang X., Ruppe M.D. et al. Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of krn23 // J. Clin. Endocrinol. Metab. 2015. Vol. 100. P. 2565–2573.
  1500. Ketha H., Wadams H., Lteif A. et al. Iatrogenic vitamin d toxicity in an infant: a case report and review of literature // J. Steroid Biochem. Mol. Biol. 2015. Vol. 148. P. 14–18.
  1501. Martineau A.R., Jolliffe D.A., Hooper R.L. et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data // BMJ. 2017. Vol. 256. P. i6583.
  1502. Munns C.F., Shaw N., Kiely M. et al. Global consensus recommendations on prevention and management of nutritional rickets // J. Clin. Endocrinol. Metab. 2016. Vol. 101. P. 394–415.
  1503. Paterson C.R., Ayoub D. Congenital rickets due to vitamin d deficiency in the mothers // Clin. Nutr. (Edinburgh). 2015. Vol. 34. P. 793–798.
  1504. Razali N.N., Hwu T.T., Thilakavathy K. Phosphate homeostasis and genetic mutations of familial hypophosphatemic rickets // J. Pediatr. Endocrinol. Metab. 2015. Vol. 28. P. 1009–1017.
  1505. Reid I.R. What disease are causally linked to vitamin D deficiency? // Arch. Dis. Child. 2016. Vol. 101. P. 185–189.
  1506. Newton RR, Litrownik AJ, Landsverk JA: Children and youth in foster care: disentangling the relationship between problem behaviors and number of placements, Child Abuse Negl 24:1363–1374, 2000.
  1507. Nicoll A, Thompson KH, Pecora PJ, et al: In their own words: alumni of foster care talk about preparation for independent living. In Maluccio AN, Canali C, Vechiatto T, editors: Improving outcomes for children and families: finding and using international evidence, London, 2011, Jessica Kingsley, pp 98–110.
  1508. Pecora PJ: Maximizing education achievement of youth in foster care and alumni: factors associated with success, Child Youth Serv Rev 34:1121–1129, 2012.
  1509. Rubin DM, Downes KJ, O’Reilly ALR, et al: Impact of kinship care on behavioral well-being for children in out-of-home care, Arch Pediatr Adolesc Med 162:550–556, 2008.
  1510. Rubin DM, O’Reilly AL, Luan X, et al: The impact of placement stability on behavioral well-being for children in foster care, Pediatrics 119:336–344, 2007.
  1511. Sakai C, Lin H, Flores G: Health outcomes and family services in kinship care, Arch Pediatr Adolesc Med 165:159–165, 2011.
  1512. Simms MD, Dubowitz H, Szilagyi MA: Health care needs of children in the foster care system, Pediatrics 106:909–918, 2000.
  1513. Smithgall C, Gladden RM, Yang D, et al: Behavior problems and educational disruptions among children in out-of-home care in Chicago, 2005.
  1514. Szilagyi MA, Rosen DS, Rubin D, et al: Technical report: health care issues for children and adolescents in foster and kinship care, Pediatrics 136:e1143–e1156, 2015.
  1515. Winokur M, Crawford G, Longobardi R, Valentine D: Matched comparison of children in kinship care and foster care on child welfare outcomes, Fam Soc 89:338–346, 2008.
  1516. American Academy of Pediatrics, Committee on Bioethics: Children as hematopoietic stem cell donors, Pediatrics 125:2392–2404, 2010.
  1517. American Academy of Pediatrics, Committee on Bioethics: Committee on Genetics; The American College of Medical Genetics; and Genomics, Social, Ethical and Legal Issues Committee, Pediatrics 131(3):620–622, 2013.
  1518. American Academy of Pediatrics, Committee on Bioethics: Conflicts between religious or spiritual beliefs and pediatric care: informed refusal, exemptions, and public funding, Pediatrics 132(5):962–965, 2013.
  1519. American Academy of Pediatrics, Committee on Bioethics: Ethical controversies in organ donation after circulatory death, Pediatrics 131(5):1021–1026, 2013.
  1520. American Academy of Pediatrics, Committee on Bioethics: Ethics and the care of critically ill infants and children, Pediatrics 98:149–152, 1996.
  1521. Academy of Pediatrics, Committee on Bioethics Policy Statement: Guidance on forgoing life-sustaining medical treatment, Pediatrics 140(3):109–117, 2017.
  1522. American Academy of Pediatrics, Committee on Fetus and Newborn: Noninitiation or withdrawal of intensive care for high-risk newborns, Pediatrics 119(2):401–403, 2007.
  1523. American Academy of Pediatrics: Council on School Health and Committee on Bioethics: policy statement—honoring do-not-attempt-resuscitation requests in schools, Pediatrics 125:1073–1077, 2010.
  1524. Bosslet GT, Pope TM, Rubenfeld GD, et al: An official ATS/AACN/ACCP/ESICM/SCCM policy statement: responding to requests for potentially inappropriate treatments in intensive care units, Am J Respir Crit Care Med 191(11):1318–1330, 2015.
  1525. Brouwer M, Kaczor C, Battin MP, et al: Should pediatric euthanasia be legalized?, Pediatrics 141(2):e20171343, 2017.
  1526. Costeloe K: Euthanasia in neonates: should it be available?, BMJ 334:912–913, 2007.
  1527. Diekema DS, Botkin JR: Clinical report—forgoing medically provided nutrition and hydration in children, Pediatrics 124:813–822, 2009.
  1528. Diekema DS: Adolescent refusal of lifesaving treatment: are we asking the right questions?, Adolesc Med State Art Rev 22(2):213–228, 2011.
  1529. Diekema DS: Parental refusals of medical treatment: the harm principle as threshold for state intervention, Theor Med Bioeth 25(4):243–264, 2004.
  1530. Ethical conduct of clinical research involving children, Washington, DC, 2004, National Academy Press.
  1531. Fallat ME, Hertweck P, Ralston SJ: Surgical and ethical challenges in disorders of sexual development, Adv Pediatr 59(1):283–302, 2012.
  1532. American Academy of Child and Adolescent Psychiatry: Practice parameter for psychodynamic psychotherapy with children , // J. Am. Acad. Child Adolesc. Psychiatry. 2012. Vol. 51. N. (5. P. ):541-557, 2012.
  1533. Archer J., Bower P., Gilbody S, . et al: . Collaborative care for people with depression and anxiety, // Cochrane Database Syst Rev. 2012. 10.1002/14651858.CD006525.pub2.
  1534. Bernstein A., Chorpita B.F., Daleiden E.L, . et al: . Building an evidence-informed service array: considering evidence-based programs as well as their practice elements //, J. Consult. Clin. Psychol. 2015. Vol. 83. N. (6. P. ):1085-1096, 2015.
  1535. Chorpita B.F., Daleiden E.L., Weisz J.R: . Identifying and selecting the common elements of evidence based interventions: a distillation and matching model //, Ment Health Serv. Res. 2005. Vol. 7. N. (1. P. ):5-20, 2005.
  1536. Chorpita B.F., Weisz J.R., Daleiden E.L, . et al: . Long-term outcomes for the child STEPS randomized effectiveness trial: a comparison of modular and standard treatment designs with usual care //, J. Consult. Clin. Psychol. 2013. Vol. 81. N. (6. P. ):999-1009, 2013.
  1537. Chorpita B.F., Weisz J.R: . MATCH-ADTC: Modular approach to therapy for children with anxiety, depression, trauma, or conduct problems, . Satellite Beach, FL: PracticeWise,, 2009, PracticeWise.
  1538. Gosselin G., DeMaso D.R: . The adolescent unit. // In Sharpstein S., ed.itor: Textbook on hospital psychiatry, . Washington: American Psychiatric Press, DC, 2009,. American Psychiatric Press, P.pp 55-69.
  1539. Huibers M.J.H., Beurskens A., Bleijenberg G, . et al: . Psychosocial interventions by general practitioners //, Cochrane Database Syst. Rev. 2009. 10.1002/14651858.CD003494.pub2.
  1540. Kolko D.J., Campo J., Kilbourne A.M, . et al: . Collaborative care outcomes for pediatric behavioral health problems: a cluster randomized trial //, Pediatrics. 2014. Vol. 133. N. (4. P. ):e981-e992, 2014.
  1541. Linehan M.M., Korslund K.E., Harned M.S, . et al: . Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis //, JAMA Psych. 2015. Vol. 72. N. (5. P. ):475-482, 2015.
  1542. MacPherson H.A., Cheavens J.S., Fristad M.A: . Dialectical behavior therapy for adolescents: Theory, treatment, adaptations, and empirical outcomes //, Clin. Child Fam. Psychol. Rev. 2013. Vol. 16. P. :59-80, 2013.
  1543. McGarry J., McNicholas F., Buckley H, . et al: . The clinical effectiveness of a brief consultation and advisory approach compared to treatment as usual in child and adolescent mental health services //, Clin. Child Psychol. Psychiatry. 2008. Vol. 13. N. (3. P. ):365-376, 2008.
  1544. Park A.L., Tsai K.H., Guan K, . et al:et al. Service use findings from the child STEPS effectiveness trial: additional support for modular designs //, Adm. Policy Ment. Health. 2016. Vol. 43. N. (1. P. ):135-140, 2016.
  1545. Richardson L.P., Ludman E., McCauley E, . et al:et al. Collaborative care for adolescents with depression in primary care - a randomized clinical trial //, JAMA. 2014. Vol. 312. N. (8. P. ):809-816, 2014.
  1546. Rotheram-Borus M.J., Swendeman D., Chorpita B.F: . Disruptive innovations for designing and diffusing evidence-based interventions //, Am. Psychol. 2012. Vol. 67. N. (6. P. ):463-476, 2012.
  1547. Schleider J.L., Weisz J.R: . Little treatments, promising effects? Meta-analysis of single session interventions for youth psychiatric problems //, J. Am. Acad. Child Adolesc. Psychiatry. 2017. Vol. 56. N. (2. P. ):107-115, 2017.
  1548. Society of Clinical Child and Adolescent Psychology: Effective child psychotherapy: evidence-based mental health treatment for children and adolescents.
  1549. Sterling S., Kline-Simon A.H., Satre D.D, . et al:et al. Implementation of screening, brief intervention, and referral to treatment for adolescents in pediatric primary care: a cluster randomized trial //, JAMA Pediatr. 2015. Vol. 169. N. (1. P. ):e153145, 2015.
  1550. Weisz J.R., Kazdin A.E: . Evidence-based psychotherapies for children and adolescents., ed 2, New York: Guilford Press, 2010, Guilford Press.
  1551. Weisz J.R., Kuppens S., Ng M.Y, . et al:et al. What five decades of research tell us about the effects of youth psychological therapy: a multilevel meta-analysis and implications for science and practice //, Am. Psychologist. 2017. Vol. 72. P. :79-117, 2017.
  1552. Woltmann E., Grogan-Kaylor A., Perron B, . et al: . Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis //, Am. J. Psychiatry. 2012. Vol. 169. P. :790-804, 2012.
  1553. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . ed Ed 5, . Washington: American Psychiatric PublishingDC, 2013, . American Psychiatric Publishing, P.pp 309-327.
  1554. Bujoreanu S., Randall E., Thomson K., Ibeziako P: . Characteristics of medically hospitalized pediatric patients with somatoform diagnoses , // Hosp. Pediatr. 2014. Vol. 4. P. :283, 2014.
  1555. Ibeziako P., Choi C., Randall E., Bujoreanu S: . Bullying victimization in medically hospitalized pediatric patients with somatic symptom and related disorders: prevalence and associated factors //, Hosp. Pediatr. 2016. Vol. 6. N. (5. P. ):290-296, 2016.
  1556. Ibeziako P., Rohan J., Bujoreanu S, . et al:et al. Medically hospitalized patients with eating disorders and somatoform disorders in pediatrics: what are their similarities and differences and how can we improve their care? // Hosp. Pediatr. 2016. Vol. 6. N. (12. P. ):730-737, 2016.
  1557. Kozlowska K., Palmer D.M., Brown K.J, . et al:et al. Conversion disorder in children and adolescents: a disorder of cognitive control //, J. Neuropsychol. 2015. Vol. 9. N. (1. P. ):87-108, 2015.
  1558. Plioplys S., Doss J., Siddarth P, . et al: . A multisite controlled study of risk factors in pediatric psychogenic nonepileptic seizures //, Epilepsia. 2014. Vol. 55. N. (11. P. ):1739-1747, 2014.
  1559. Rask C.U., Ornbol E., Fink P.K., Mette Skovgaard A: . Functional somatic symptoms and consultation patterns in 5-to-7- year-olds //, Pediatrics. 2013. Vol. 132. P. :e459-e467, 2013.
  1560. Shelby G.D., Shirkey K.C., Sherman A.L, . et al: . Functional abdominal pain in childhood and long-term vulnerability to anxiety disorders //, Pediatrics. 2013. Vol. 132. N. (3. P. ):475-482, 2013.
  1561. Thomson K., Randall E., Ibeziako P., Bujoreanu S: . Somatoform disorders and trauma in medically admitted pediatric patients: prevalence and psychosocial characteristics //, Psychosomatics. 2014. Vol. 55. N. (6. P. ):630-639, 2014.
  1562. Wilson A.C., Moss A., Palermo T.M., Fales J.L: . Pain and catastrophizing are associated with pain, somatic symptoms, and pain-related disability among early adolescents //, J. Pediatr. Psychol. 2014. Vol. 39. N. (4. P. ):418-426, 2014.
  1563. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . Eed. 5, . Washington: American Psychiatric PublishingDC, 2013, . American Psychiatric PublishingP., pp 309-327.
  1564. Bujoreanu S., Randall E., Thomson K., Ibeziako P: . Characteristics of medically hospitalized pediatric patients with somatoform diagnoses , // Hosp. Pediatr. 2014. Vol. 4. P. :283, 2014.
  1565. Ibeziako P., Choi C., Randall E., Bujoreanu S: . Bullying victimization in medically hospitalized pediatric patients with somatic symptom and related disorders: prevalence and associated factors //, Hosp. Pediatr. 2016. Vol. 6. N. (5. P. ):290-296, 2016.
  1566. Ibeziako P., Rohan J., Bujoreanu S, . et al:et al. Medically hospitalized patients with eating disorders and somatoform disorders in pediatrics: what are their similarities and differences and how can we improve their care? // Hosp. Pediatr. 2016. Vol. 6. N. (12. P. ):730-737, 2016.
  1567. Kozlowska K., Palmer D.M., Brown K.J, . et al: . Conversion disorder in children and adolescents: a disorder of cognitive control //, J. Neuropsychol. 2015. Vol. 9. N. (1. P. ):87-108, 2015.
  1568. Plioplys S., Doss J., Siddarth P, . et al: . A multisite controlled study of risk factors in pediatric psychogenic nonepileptic seizures //, Epilepsia. 2014. Vol. 55. N. (11. P. ):1739-1747, 2014.
  1569. Rask C.U., Ornbol E., Fink P.K., Mette Skovgaard A: . Functional somatic symptoms and consultation patterns in 5-to7- year-olds //, Pediatrics. 2013. Vol. 132. P. :e459-e467, 2013.
  1570. Shelby G.D., Shirkey K.C., Sherman A.L, . et al: . Functional abdominal pain in childhood and long-term vulnerability to anxiety disorders //, Pediatrics. 2013. Vol. 132. N. (3. P. ):475-482, 2013.
  1571. Thomson K., Randall E., Ibeziako P., Bujoreanu S: . Somatoform disorders and trauma in medically admitted pediatric patients: prevalence and psychosocial characteristics //, Psychosomatics. 2014. Vol. 55. N. (6. P. ):630-639, 2014.
  1572. Wilson A.C., Moss A., Palermo T.M., Fales J.L: . Pain and catastrophizing are associated with pain, somatic symptoms, and pain-related disability among early adolescents //, J. Pediatr. Psychol. 2014. Vol. 39. N. (4. P. ):418-426, 2014.
  1573. Alioto A., Yacob D., Yardly H.L, . et al:et al. Inpatient treatment of rumination syndrome: outcomes and lessons learned , // Clin. Pract. Pediatr. Psychol. 2015. Vol. 3. N. (4. P. ):304-313, 2015.
  1574. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington:, American Psychiatric PublishingDC, 2013, American Psychiatric Publishing.
  1575. Chial H.J., Camilleri M., Williams D.E, . et al:et al. Rumination syndrome in children and adolescents: diagnosis, treatment, and prognosis //, Pediatrics. 2003. Vol. 111. N. (1. P. ):158-162, 2003.
  1576. Ellis C.R., Schnoes C.J. Eating disorder, rumination. 2006.
  1577. Green A.D., Alioto A., Mousa H, . et al: . Severe pediatric rumination syndrome: successful interdisciplinary inpatient management //, J. Pediatr. Gastroenterol. Nutr. 2011. Vol. 52. N. (4. P. ):414-418, 2011.
  1578. Matson J.L., Hattier M.A., Belva B, . et al: . Pica in persons with developmental disabilities: approaches to treatment //, Res. Dev. Disabil. 2013. Vol. 34. P. :2564-2571, 2013.
  1579. Williams D.E., McAdam D: . Assessment, behavioral treatment, and prevention of pica: clinical guidelines and recommendations for practitioners // , Res. Dev. Disabil. 2012. Vol. 33. P. :2050-2057, 2012
  1580. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington:, American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  1581. Bloch M.H., Panza K.E., Landeros-Weisenberger A, . et al: . Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders , // J. Am. Acad. Child Adolesc. Psychiatry. 2009. Vol. 48. N. (9. P. ):884-893, 2009.
  1582. Bonnet C., Roubertie A., Doummar D, . et al: . Developmental and benign movement disorders in childhood //, Mov. Disord. 2010. Vol. 25. N. (10. P. ):1317-1334, 2010.
  1583. Cavanna A.E., Seri S: . Tourette’’s syndrome //, BMJ. 2013. Vol. 347. P. :f4964, 2013.
  1584. Dutta N., Cavanna A.E: . The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review //, Funct. Neurol. 2013. Vol. 28. N. (1. P. ):7-12, 2013.
  1585. Grados M.A: . The genetics of obsessive-compulsive disorder and Tourette syndrome: an epidemiological and pathway-based approach for gene discovery //, J. Am. Acad. Child Adolesc. Psychiatry. 2010. Vol. 49. N. (8. P. ):810-819, 819.e1-819.e2, 2010.
  1586. Hollis C., Pennant M., Cuenca J, . et al: . Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis //, Health Technol. Assess. 2016. Vol. 20. N. (4. P. ):1-450, 2016.
  1587. Leckman J.F: . Tic disorders //, BMJ. 2012. Vol. 344. P. :10-11, 2012.
  1588. Leckman J., Bloch M.H., Smith M.E, . et al: . Neurobiological substrates of Tourette’’s disorder //, J. Child Adolesc. Psychopharmacol. 2010. Vol. 20. P. :237-247, 2010.
  1589. McGuire J.F., Piacentini J., Brennan E.A, . et al: . A meta-analysis of behavior therapy for Tourette syndrome //, J. Psychiatr. Res. 2014. Vol. 50. P. :106-112,. 2014.
  1590. Murphy T.K., Lewin A.B., Storch E.A, . et al: . Practice parameter for the assessment and treatment of children and adolescents with chronic tic disorders //, J. Am. Acad. Child Adolesc. Psychiatry. 2013. Vol. 52. N. (12. P. ):1341-1359, 2013.
  1591. Murphy T.K., Storch E.A., Lewin A.B, . et al:et al. Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections //, J. Pediatr. 2012. Vol. 160. P. :314-319, 2012.
  1592. Piacentini J., Woods D.W., Scahill L, . et al: . Behavior therapy for children with Tourette disorder: a randomized controlled trial //, JAMA. 2010. Vol. 303. N. (19. P.):1929-1937, 2010.
  1593. Sukholdolsky D.G., Smith S.D., McCauley S.A, . et al:et al. Behavioral interventions for anger, irritability, and aggression in children and adolescents //, J. Child Adolesc. Psychopharmacol. 2016. Vol. 26. N. (1. P. ):58-64, 2016.
  1594. Swedo S.E., Leckman J.F., Rose N.R: . From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome) //, Pediatr. Therapeut. 2012. Vol. 2. P. :113, 2012.
  1595. Weisman H., Qureshi I.A., Leckman J.F, . et al: . Systematic review: pharmacological treatment of tic disorders-efficacy of antipsychotic and alpha-2 adrenergic agonist agents //, Neurosci. Biobehav. Rev. 2013. Vol. 37. N. (6. P. ):1162-1171, 2013.
  1596. Whittington C., Pennant M., Kendall T, . et al: . Practitioner review: treatments for Tourette syndrome in children and young people-a systematic review //, J. Child Psychol. Psychiatry. 2016. Vol. 57. N. (9. P. ):988-1004, 2016.
  1597. Zinner S.H., Mink J.W: . Movement disorders I: tics and stereotypies //, Pediatr. Rev. 2010. Vol. 31. N. (6. P. ):223-233, 2010.
  1598. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington:, American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  1599. Bloch M.H., Panza K.E., Landeros-Weisenberger A, . et al: . Meta-analysis: treatment of attention-deficit/hyperactivity disorder in children with comorbid tic disorders , // J. Am. Acad. Child Adolesc. Psychiatry. 2009. Vol. 48. N. (9. P. ):884-893, 2009.
  1600. Bonnet C., Roubertie A., Doummar D, . et al: . Developmental and benign movement disorders in childhood //, Mov. Disord. 2010. Vol. 25. N. (10. P. ):1317-1334, 2010.
  1601. Cavanna A.E., Seri S: . Tourette’’s syndrome //, BMJ. 2013. Vol. 347. P. :f4964, 2013. 325-327.
  1602. Dutta N., Cavanna A.E: . The effectiveness of habit reversal therapy in the treatment of Tourette syndrome and other chronic tic disorders: a systematic review //, Funct. Neurol. 2013. Vol. 28. N. (1. P. ):7-12, 2013.
  1603. Grados M.A: . The genetics of obsessive-compulsive disorder and Tourette syndrome: an epidemiological and pathway-based approach for gene discovery //, J. Am. Acad. Child Adolesc. Psychiatry. 2010. Vol. 49. N. (8. P. ):810-819, 819.e1-819.e2, 2010.
  1604. Hollis C., Pennant M., Cuenca J, . et al: . Clinical effectiveness and patient perspectives of different treatment strategies for tics in children and adolescents with Tourette syndrome: a systematic review and qualitative analysis //, Health Technol. Assess. 2016. Vol. 20. N. (4. P. ):1-450, 2016.
  1605. Leckman J.F: . Tic disorders //, BMJ. 2012. Vol. 344. P. :10-11, 2012.
  1606. Leckman J., Bloch M.H., Smith M.E, . et al: . Neurobiological substrates of Tourette’’s disorder //, J. Child Adolesc. Psychopharmacol. 2010. Vol. 20. P. :237-247, 2010.
  1607. MñGuire J.F., Piacentini J., Brennan E.A, . et al: . A meta-analysis of behavior therapy for Tourette syndrome // J. Psychiatr. Res. 2014. Vol. 50. P. :106-112, 2014.
  1608. Murphy T.K., Lewin A.B., Storch E.A, . et al: . Practice parameter for the assessment and treatment of children and adolescents with chronic tic disorders //, J. Am. Acad. Child Adolesc. Psychiatry. 2013. Vol. 52. N. (12. P. ):1341-1359, 2013.
  1609. Murphy T.K., Storch E.A., Lewin A.B, . et al: . Clinical factors associated with pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections //, J. Pediatr. 2012. Vol. 160. P. :314-319, 2012.
  1610. Piacentini J., Woods D.W., Scahill L, . et al: . Behavior therapy for children with Tourette disorder: a randomized controlled trial //, JAMA. 2010. Vol. 303. N. (19. P. ):1929-1937, 2010.
  1611. Sukholdolsky D.G., Smith S.D., McCauley S.A, . et al:et al. Behavioral interventions for anger, irritability, and aggression in children and adolescents //, J. Child Adolesc. Psychopharmacol. 2016. Vol. 26. N. (1. P. ):58-64, 2016.
  1612. Swedo S.E., Leckman J.F., Rose N.R: . From research subgroup to clinical syndrome: modifying the PANDAS criteria to describe PANS (pediatric acute-onset neuropsychiatric syndrome) //, Pediatr. Therapeut. 2012. Vol. 2. P. :113, 2012.
  1613. Weisman H., Qureshi I.A., Leckman J.F, . et al: . Systematic review: pharmacological treatment of tic disorders - efficacy of antipsychotic and alpha-2 adrenergic agonist agents //, Neurosci. Biobehav. Rev. 2013. Vol. 37. N. (6. P. ):1162-1171, 2013.
  1614. Whittington C., Pennant M., Kendall T, . et al: . Practitioner review: treatments for Tourette syndrome in children and young people - a systematic review //, J. Child Psychol. Psychiatry. 2016. Vol. 57. N. (9. P. ):988-1004, 2016.
  1615. Zinner S.H., Mink J.W: . Movement disorders I: tics and stereotypies //, Pediatr. Rev. 2010. Vol. 31. N. (6. P. b):223-233, 2010.
  1616. American Psychiatric Association: . Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington:, American Psychiatric AssociationDC, 2013, American Psychiatric Association.
  1617. Brent D., Emslie G., Clarke G, . et al: . Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial , // JAMA. 2008. Vol. 299. P. :901-913, 2008.
  1618. Bridge J.A., Iyengar S., Salary C.B, . et al: . Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials //, JAMA. 2007. Vol. 297. N. (15. P. ):1683-1696, 2007.
  1619. Brunoni A.R., Moffa A.H., Sampaio-Junior B, . et al: . Trial of electrical direct-current therapy versus escitalopram for depression //, N. Engl. J. Med. 2017. Vol. 376. N. (26. P. ):2523-2532, 2017.
  1620. Cipriani A., Zhou X., Del Giovane C, . et al: . Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis //, Lancet. 2016. Vol. 388. P. :881-890, 2016.
  1621. Copeland W.E., Angold A., Costello E.J, . et al: . Prevalence, comorbidity, and correlates of DSM-5 proposed disruptive mood dysregulation disorder //, Am. J. Psychiatry. 2013. Vol. 170. P. :173-179, 2013.
  1622. Cox G.R., Callahan P., Churchill R, . et al: . Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents //, Cochrane Database Syst. Rev. 2012. (11):CD008324, 2012.
  1623. Ekers D., Webster L., Van Straten A, . et al: . Behavioral activation for depression: an update of meta-analysis of effectiveness and sub group analysis //, PLoS ONE. 2014. Vol. 9. N. (6. P. ):e100100, 2014
  1624. Emslie G.J., Kennard B.D., Mayes T.L, . et al: . Continued effectiveness of relapse prevention cognitive-behavioral therapy following fluoxetine treatment in youth with major depressive disorder //, J. Am. Acad. Child Adolesc. Psychiatry. 2015. Vol. 54. N. (12. P. ):991-998, 2015.
  1625. Forti-Buratti M.A., Saikia R., Wilkinson E.L, . et al: . Psychological treatments for depression in pre-adolescent children (12 years and younger): systematic review and meta-analysis of randomized controlled trials //, Eur. Child Adolesc. Psychiatry. 2016. Vol. 25. N. (10. P. ):1045-1054, 2016.
  1626. Gafney M.S., Barch D.M., Singer J, . et al: . Disrupted amygdala reactivity in depressed 4- to 6-year-old children //, J. Am. Acad. Child Adolesc. Psychiatry. 2013. Vol. 52. P. :737-746, 2013.
  1627. Gartlehner G., Hansen R.A., Morgan L.C, . et al: . Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder //, Ann. Intern. Med. 2011. Vol. 155. P. :772-785, 2011.
  1628. Gilbody S., House A., Sheldon T: . Screening and case finding instruments for depression //, Cochrane Database Syst. Rev. 2005. (4):CD002792, 2005.
  1629. Hetrick S.E., Cox G.R., Witt K.G, . et al: . Cognitive behavioural therapy (CBT), third-wave CBT and interpersonal therapy (IPT) based interventions for preventing depression in children and adolescents //, Cochrane Database Syst. Rev. 2016. (1):CD003380, 2016.
  1630. Hetrick S.E., McKenzie J.E., Cox G.R, . et al: . Newer generation antidepressants for depressive disorders in children and adolescents //, Cochrane Database Syst. Rev. 2012. (11):CD004851, 2012.
  1631. Kanter J.W., Puspitasari A.J: . Global dissemination and implementation of behavioral activation //, Lancet. 2016. Vol. 388. P. :843-844, 2016.
  1632. Kupfer D.J., Frank E., Phillips M.L: . Major depressive disorder: new clinical, neurobiological, and treatment perspectives //, Lancet. 2012. Vol. 379. P. :1045-1052, 2012..
  1633. Lewandowski R.E., Acri M.C., Hoagwood K.E, . et al: . Evidence for the management of adolescent depression //, Pediatrics. 2013. Vol. 132. P. :e996-e1009, 2013.
  1634. The Medical Letter: Drugs for depression //, Med. Lett. 2016. Vol. 58. N. (1498. P. ):85-90, 2016.
  1635. Merry S.N., Hetrick S.E., Cox G.R, . et al: . Psychological and educational interventions for preventing depressing in children and adolescents //, Cochrane Database Syst. Rev. 2011. (12):CD003380, 2011.
  1636. Merry S.N., Stasiak K: . Preventing depression in adolescents //, BMJ. 2012. Vol. 345. P. :e6720, 2012.
  1637. Perrin J.S., Merz S., Bennett D.M, . et al:et al. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder //, Proc. Natl. Acad. Sci. USA. 2012. Vol. 109. P. :5464-5468, 2012.
  1638. Perou R., Bitsko R.H., Blumberg S.J, . et al: . Centers for Disease Control and Prevention: mental health surveillance among children-United States, 2005-2011 //, MMWR Surveill. Summ. 2013. Vol. 62. (Suppl. 2. P. ):1-35, 2013.
  1639. Richards D.A., Ekers D., McMillian D, . et al: . Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a randomized, controlled, non-inferiority trial //, Lancet. 2016. Vol. 388. P. :871-880, 2016.
  1640. Roy A.K., Lopes V., Klein R.G: . Disruptive mood dysregulation disorder: a new diagnostic approach to chronic irritability in youth //, Am. J. Psychiatry. 2014. Vol. 171. P. :918-924, 2014.
  1641. Shinohara K., Honyashiki M., Iman H, . et al: . Behavioural therapies versus other psychological therapies for depression (review) //, Cochrane Database Syst. Rev. 2013. (Issue10):CD008696, 2013.
  1642. Stewart D.E., Vigod S: . Postpartum depression //, N. Engl. J. Med. 2016. Vol. 375. N. (22. P. ):2177-2186, 2016.
  1643. Thapar A., Collishaw S., Pine D.S, . et al: . Depression in adolescence //, Lancet. 2012. Vol. 379. P. :1056-1066, 2012.
  1644. Ttofi M.M: . Adolescent bullying linked to depression in early childhood //, BMJ. 2015. Vol. 350. P. :h2694, 2015.
  1645. Varigonda A.L., Jakubovski E., Taylor M.J, . et al: . Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors in pediatric major depressive disorder //, J. Am. Acad. Child Adolesc. Psychiatry. 2015. Vol. 54. N. (7. P. ):557-564, 2015.
  1646. Vitiello B., Ordonez A.E: . Pharmacologic treatment of children and adolescents with depression //, Expert Opin. Pharmacother. 2016. Vol. 17. N. (17. P. ):2273-2279, 2016.
  1647. Aas M., Aminoff S.R., Vik Lagerberg T, . et al: . Affective lability in patients with bipolar disorders is associated with high levels of childhood trauma , // Psychiatry Res. 2014. Vol. 218. N. (1-2. P. ):252-255, 2014.
  1648. American Psychiatric Association: Diagnostic and statistical manual of mental disorders, . Ed. 5, . Washington, : American Psychiatric Association DC, 2013, American Psychiatric Association.
  1649. Chen H., Mehta S., Aparasu R, . et al: . Comparative effectiveness of monotherapy with mood stabilizers vs second generation (atypical) antipsychotics for the treatment of bipolar disorder in children and adolescents //, Pharmacoepidemiol. Drug. Saf. 2014. Vol. 23. P. :299-308, 2014.
  1650. Cipriani A., Hawton K., Stockton S, . et al: . Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis //, BMJ. 2013. Vol. 346. P. :f3646-f3650, 2013.
  1651. Craddock N., Sklar P: . Genetics of bipolar disorder //, Lancet. 2013. Vol. 381. P. :1654-1662, 2013.
  1652. Detke H.C., DelBello M.P., Landry J, . et al: . Olanzapine/fluoxetine combination in children and adolescents with bipolar I depression: a randomized, double-blind, placebo-controlled trial //, J. Am. Acad. Child Adolesc. Psychiatry. 2015. Vol. 54. N. (3. P. ):217-224, 2015.
  1653. Findling R.L., Robb A., McNamara N.K, . et al: . Lithium in the acute treatment of bipolar I disorder: a double-blind, placebo-controlled study //, Pediatrics. 2015. Vol. 136. N. (5. P. ):885-894, 2015.
  1654. Findling R.L., Landbloom R.L., Szegedi A, . et al: . Asenapine for the acute treatment of pediatric manic or mixed episodes of bipolar I disorder //, J. Am. Acad. Child Adolesc. Psychiatry. 2015. Vol. 54. N. (12. P. ):1032-1041, 2015.
  1655. Frias A., Palma C., Farriols N: . Psychosical interventions in the treatment of youth diagnosed or at high-risk for pediatric bipolar disorder: a review of the literature //, Rev. Psiquiatr. Salud. Ment. 2015. Vol. 8. N. (3. P. ):146-156, 2015.
  1656. Fristad M.A., MacPherson H.A: . Evidence-based psychosocial treatments for child and adolescent bipolar spectrum disorders //, J. Clin. Child Adolesc. Psychol. 2014. Vol. 43. N. (3. P. ):339-355, 2014.
  1657. Geddes J.R., Miklowitz D.J: . Treatment of bipolar disorder //, Lancet. 2013. Vol. 381. P. :1672-1680, 2013.
  1658. Geller B., Luby J.L., Joshi P, . et al: . A randomized controlled trial of risperidone, lithium, or divalproex sodium for initial treatment of bipolar I disorder, manic or mixed phase, in children and adolescents //, Arch. Gen. Psychiatry. 2012. Vol. 69. N. (5. P. ):515-528, 2012.
  1659. Goldstein T.R., Ha W., Axelson D.A, . et al: . Predictors of prospectively examined suicide attempts among youth with bipolar disorder //, Arch. Gen. Psychiatry. 2012. Vol. 69. P. :1113-1122, 2012.
  1660. Grande I., Berk M., Birmaher B, . et al: . Bipolar disorder //, Lancet. 2016. Vol. 387. P. :1561-1572, 2016.
  1661. Khazanov G.K., Cui L., Merikangas K.R, . et al: . Treatment patterns of youth with bipolar disorder: results from the National Comorbidity Survey-Adolescent Supplement (NCS-A) //, J. Abnorm. Child Psychol. 2015. Vol. 43. N. (2. P. ):391-400, 2015.
  1662. Lee T: . Pediatric bipolar disorder //, Pediatr. Ann. 2016. Vol. 45. N. (10. P. ):e362-e366, 2016.
  1663. Malhi G.S: . Diagnosis of bipolar disorder: who is in a mixed state? //, Lancet. 2013. Vol. 381. P. :1599-1600, 2013.
  1664. The Medical Letter: Drugs for bipolar disorder //, Med Lett. 2016. Vol. 58. P. :103-106, 2016.
  1665. Miklowitz D.J., Axelson D.A., Birmaher B, . et al: . Family-focused treatment for adolescents with bipolar disorder: results of a 2-year randomized trial //, Arch. Gen. Psychiatry. 2008. Vol. 65. N. (9. P. ):1053-1061, 2008.
  1666. Miklowitz D.J., Schneck C.D., Singh M.K, . et al: . Early intervention for symptomatic youth at risk for bipolar disorder: a randomized trial of family-focused therapy //, J. Am. Acad. Child Adolesc. Psychiatry. 2013. Vol. 52. N. (2. P. ):121-131, 2013.
  1667. Papolos D.F., Bronsteen A: . Bipolar disorder in children: assessment in general pediatric practice //, Curr. Opin. Pediatr. 2013. Vol. 25. P. :419-426, 2013.
  1668. Parens E., Johnston J: . Controversies concerning the diagnosis and treatment of bipolar disorder in children //, Child Adolesc. Psychiatry Ment. Health. 2010. Vol. 4. N. (9):2010. doi: 10.1186/1753-2000-4-9.
  1669. Phillips M.L., Kupfer D.J: . Bipolar disorder diagnosis: challenges and future directions //, Lancet. 2013. Vol. 381. P. :1663-1670, 2013.
  1670. Serretti A., Fabbri C: . Shared genetics among major psychiatric disorders //, Lancet. 2013. Vol. 381. P. :1339-1341, 2013.
  1671. Vande Voort J.L., Singh A., Bernardi J, . et al: . Treatments and services provided to children diagnosed with bipolar disorder //, Child Psychiatry Hum. Dev. 2016. Vol. 47. N. (3. P. ):494-502, 2016.
  1672. Waugh M.J., Meyer T.D., Youngstrom E.A, . et al: . A review of self-rating instruments to identify young people at risk of bipolar spectrum disorders //, J. Affect. Disord. 2014. Vol. 160. P. :113-121, 2014.
  1673. Weinstein S.M., West A.E., Pavuluri M: . Psychosocial intervention for pediatric bipolar disorder: current and future directions //, Expert Rev. Neurother. 2013. Vol. 13. N. (7. P. ):843-850, 2013.
  1674. Bibliography Barrocas A.L., Hankin B.L., Young J.F, . et al:et al. Rates of nonsuicidal self-injury in youth: age, sex, and behavioral methods in a community sample , // Pediatrics. 2012. Vol. 130. P. :39–45, 2012.
  1675. Bj?rkenstam C., Kosidou K., Bj?rkenstam E: . Childhood adversity and risk of suicide: cohort study of 548 721 adolescents and young adults in Sweden //, BMJ. 2017. Vol. 357. P. :j1334, 2017.
  1676. Bohanna I., Wang X: . Media guidelines for the responsible reporting of suicide: a review of effectiveness //, Crisis. 2012. Vol. 33. N. (4. P. ):190–198, 2012.
  1677. Brent D.A., Brown C.H: . Effectiveness of school-based suicide prevention programmes //, Lancet. 2015. Vol. 385. P. :1489–1491, 2015.
  1678. Carter G., Milner A., McGill K, . et al: . Predicting suicidal behaviours using clinical instruments: systematic review and meta-analysis of positive predictive values for risk scales //, Br. J. Psychiatry. 2017. Vol. 210. N. (6. P. ):387–395, 2017.
  1679. Centers for Disease Control and Prevention: Injury Prevention & Control: Suicide rates by mechanism of injury—National Vital Statistics System, United States, 1999–2013 //, MMWR Morb. Mortal Wkly Rep. 2015. Vol. 64. N. (3. P. ):76, 2015.
  1680. Centers for Disease Control and Prevention: Injury Prevention & Control: CDC Grand Rounds—Preventing suicide through a comprehensive public health approach //, MMWR Morb. Mortal Wkly Rep. 2016. Vol. 65. N. (34. P. ):894–987, 2016.
  1681. Centers for Disease Control and Prevention: Injury Prevention & Control: Data & Statistics (WISQARS). Ten leading causes of death and injury.
  1682. Centers for Disease Control and Prevention: Injury Prevention & Control: Data & Statistics (WISQARS).
  1683. Centers for Disease Control and Prevention: National Center for Health Statistics, Data Briefs. Increase in suicide in the United States, 1999–2014.
  1684. Centers for Disease Control and Prevention: Youth risk behavioral surveillance—United States, 2015.
  1685. Gibbons R.D., Brown C.H., Hur K, . et al: . Suicidal thought and behavior with antidepressant treatment //, Arch Gen. Psychiatry. 2012. Vol. 69. P. :580–587, 2012.
  1686. Hawton K., Saunders K.E.A., O’’Connor R.C: . Self-harm and suicide in adolescents //, Lancet. 2012. Vol. 379. P. :2373-2380, 2012.
  1687. Hawton K., Witt K.G., Taylor Salisbury T.L, . et al: . Interventions for self-harm in children and adolescents //, Cochrane Database Syst. Rev. 2015. (12):CD012013, 2015.
  1688. Henderson A.F., Joseph A.P: . Motor vehicle accident or driver suicide? Identifying cases of failed driver suicide in the trauma setting //, Injury. 2012. Vol. 43. P. :18–21, 2012.
  1689. Horowitz L., Bridge J., Teach S, . et al: . Ask Suicide-Screening Questions (ASQ): a brief instrument for the pediatric emergency department //, Arch. Pediatr. Adolesc. Med. 2012. Vol. 166. P. :1170–1176, 2012.
  1690. Kaess M: . Suicide prevention //, BMJ. 2012. Vol. 345. P. :e35779, 2012.
  1691. The Lancet: Suicide prevention: creating a safer culture //, Lancet. 2016. Vol. 388. P. 1955:2016, 1955.
  1692. Lewis S.P., Heath N.L: . Non-suicidal self-injury among youth //, J. Pediatr. 2015. Vol. 166. N. (3. P. ):526–530, 2015.
  1693. Linehan M.M., Korslund K.E., Harned M.S, . et al: . Dialectical behavior therapy for high suicide risk in individuals with borderline personality disorder: a randomized clinical trial and component analysis //, JAMA Psychiatry. 2015. Vol. 72. N. (5. P. ):475–482, 2015.
  1694. Nock M.K., Green J.G., Hwang I, . et al: . Prevalence, correlates, and treatment of lifetime suicidal behavior among adolescents //, JAMA Psychiatry. 2013. Vol. 70. P. :300–310, 2013.
  1695. O’’Connor E., Gaynes B.N., Burda B.U, . et al: . Screening for and treatment of suicide risk relevant to primary care: a systematic review for the U.S. Preventive Services Task Force //, Ann. Intern. Med. 2013. Vol. 158. P. :741–754, 2013.
  1696. O’’Connor R.C., Nock M.K: . The psychology of suicidal behaviour //, Lancet Psychiatry. 2014. Vol. 1. P. :73–85, 2014.
  1697. O’’Connor R.C., Rasmussen S., Hawton K: . Distinguishing adolescents who think about self-harm from those who engage in self-harm //, Br. J. Psychiatry. 2012. Vol. 200. P. :330–335, 2012.
  1698. Sheftall A.H., Asti L., Horowitz L.M, . et al: . Suicide in elementary school-aged children and early adolescents //, Pediatrics. 2016. Vol. 138. N. (4.): doi: 10.1542/peds.2016-04362016.
  1699. Sinyor M., Cheung A.H: . Antidepressants and risk of suicide //, BMJ. 2015. Vol. 350. P. :h783, 2015.
  1700. Sisask M., V?rnik A: . Media roles in suicide prevention: a systematic review //, Int. J. Environ. Res. Public Health. 2012. Vol. 9. N. (1. P. ):123–138, 2012.
  1701. Suicide Prevention Resource Center: Best Practices Registry.
  1702. Suicide Prevention Resource Center: WICHE Center for Mental Health Program. Suicide prevention primer.
  1703. Sullivan E.M., Annest J.L., Simon T.R, . et al: . Suicide trends among persons aged 10-24 years—United States, 1994–2012 //, MMWR. 2015. Vol. 64. N. (8. P. ):201–205, 2015.
  1704. Turecki D., Brent D.A: . Suicide and suicidal behaviours //, Lancet. 2016. Vol. 387. P. :1227–1238, 2016.
  1705. Yip P.S., Caine E., Yousuf S, . et al: . Means restriction for suicide prevention //, Lancet. 2012. Vol. 379. N. (9834. P. ):2393–2399, 2012.
  1706. US Preventive Services Task Force: Suicide risk in adolescents, adults and older adults: screening, 2014.
  1707. Goodyear MDE, Eckenwiler LA, Ells C: Fresh thinking about the declaration of Helsinki, BMJ 337:1067–1068, 2008.
  1708. Goodyear MDE, Krieza-Jeric K, Lemmens T: The declaration of Helsinki, BMJ 335:624–626, 2007.
  1709. Greer DM, Wang HH, Robinson JD, et al: Variability of brain death policies in the United States, JAMA Neurol 73(2):213–218, 2016.
  1710. Himelstein BP: Palliative care for infants, children, adolescents, and their families, J Palliat Med 9(1):163–181, 2006.
  1711. Joffe S, Kodish E: Protecting the rights and interests of pediatric stem cell donors, Pediatr Blood Cancer 56:517–519, 2011.
  1712. Kimberly MB, Forte AL, Carroll JM, et al: Pediatric do-not-attempt-resuscitation orders and public schools: a national assessment of policies and laws, Am J Bioeth 5(1):59–65, 2005.
  1713. Kodish E, editor: Ethics and research with children: a case-based approach, New York, 2005, Oxford University Press.
  1714. Kodish E: Paediatric ethics: a repudiation of the Groningen protocol, Lancet 371(9616):892–893, 2008.
  1715. Kopelman LM: Are the 21-year-old Baby Doe rules misunderstood or mistaken?, Pediatrics 115(3):797–802, 2005.
  1716. Lo B: Euthanasia in The Netherlands: what lessons for elsewhere?, Lancet 380:869–870, 2012.
  1717. Mercurio MR: An adolescent’s refusal of medical treatment: implications of the Abraham Cheerix case, Pediatrics 120(6):1357–1358, 2007.
  1718. Nakagawa TA, et al: Clinical report—guidelines for the determination of brain death in infants and children: an update of the 1987 Task Force Recommendations, Pediatrics 128(3):e720–e740, 2011.
  1719. Nelson RM, Botkjin JR, Kodish ED, et al: Committee on Bioethics: ethical issues with genetic testing in pediatrics, Pediatrics 107:1451–1455, 2001. (Reaffirmed May 2009).
  1720. Nondiscrimination on the basis of handicap; procedures and guidelines relating to health care for handicapped infants—HHS. Final rules, Fed Regist 50:14879–14892, 1985.
  1721. President’s Council on Bioethics: The changing moral focus of newborn screening: an ethical analysis by the President’s Council on Bioethics, Washington, DC, 2008.
  1722. Quadri-Sheriff M, Hendrix KS, Downs SM, et al: The role of herd immunity in parents’ decision to vaccinate children: a systematic review, Pediatrics 130(3):522–530, 2012.
  1723. Sisk BA, DuBois J, Kodish E, et al: Navigating decisional discord: the pediatrician’s role when child and parents disagree, Pediatrics 139(6):e20170234, 2017.
  1724. Verhagen E, Sauer PJJ: The Groningen protocol—euthanasia in severely ill newborns, N Engl J Med 352(10):959–962, 2005.
  1725. Weise KL: What is the «rule of double effect»? In Thompson DR, Kummer HB, editors: Critical care ethics: a practice guide from the ACCM Ethics Committee, ed 2, 2009, Society of Critical Care Medicine.
  1726. Wilkinson D: Beyond resources: denying parental requests for futile treatment, Lancet 389:1866–1867, 2017.
  1727. World Medical Association: The physician’s pledge, 2017.
  1728. Sachdeva RC, Jain S: Making the case to improve quality and reduce costs in pediatric health care, Pediatr Clin North Am 56(4):731–743, 2009.
  1729. Sachdeva RC, Kuhn EM, Gall CM, et al: A need for development of diagnosis-specific severity of illness tools for risk adjustment [abstract], Crit Care Med 36(12 Suppl):A83, 2009.
  1730. Sauers-Ford HS, Simmons JM, Shah SS, H2O Study Team: Strategies to engage stakeholders in research to improve acute care delivery, J Hosp Med 11(2):123–125, 2016.
  1731. Scanlon MC, Harris JM II, Levy F, et al: Evaluation of the Agency for Healthcare Research and quality pediatric quality indicators, Pediatrics 121:e1723–e1731, 2008.
  1732. Schondelmeyer AC, Simmons JM, Statile AS, et al: Using quality improvement to reduce continuous pulse oximetry use in children with wheezing, Pediatrics 135(4):2015.
  1733. Sebastian S: Learning from big health care data, N Engl J Med 370:2161–2163, 2014.
  1734. Seid M, Dellal G, Peterson LE, et al: Co-designing a collaborative chronic care network (C3N) for inflammatory bowel disease: development of methods, JMIR Hum Factors 5(1):e8, 2018. PMID: 29472173.
  1735. Simpson LA, Fairbrother G: How health policy influences quality of care in pediatrics, Pediatr Clin North Am 56:1009–1021, 2009.
  1736. Siow E, Wypij D, Berry P, et al: The effect of continuity in nursing care on patient outcomes in the pediatric intensive care unit, J Nurs Adm 43(7/8):394–402, 2013.
  1737. Stapleton FB, Hendricks J, Hagan P, et al: Modifying the Toyota production system for continuous performance improvement in an academic children’s hospital, Pediatr Clin North Am 56:799–813, 2009.
  1738. Stimpfel AW, Lake ET, Barton S, et al: How differing shift lengths relate to quality outcomes in pediatrics, J Nurs Adm 43(2):95–100, 2013.
  1739. Stockwell DC, Kane-Gill SL: Developing a patient safety surveillance system to identify adverse events in the intensive care unit, Crit Care Med 38(6 Suppl):S117–S125, 2010.
  1740. Tchou MJ, Tang-Girdwood S, Wormser B, et al: Reducing electrolyte testing in hospitalized children by using quality improvement methods, Pediatrics 141(5):e20173187, 2018.
  1741. Trivedi AN, Zaslavsky AM, Schneider EC, et al: Trends in the quality of care and racial disparities in Medicare managed care, N Engl J Med 353:692–700, 2005.
  1742. Wegner SE, Antonelli RC, Turchi RM: The medical home—improving quality of primary care for children, Pediatr Clin North Am 56:953–964, 2009.
  1743. Wheeler DS, Giaccone MJ, Hutchinson N, et al: Hospital-wide quality improvement collaborative to reduce catheter-associated blood stream infections, Pediatrics 128(4):e995–e1004, 2011.
  1744. American Academy of Pediatrics, Council on Children with Disabilities and Medical Home Advisory Committee: Patient and family centered care coordination: a framework for integrating care for children and youth across multiple systems, Pediatrics 133(5):e1451–e1460, 2014.
  1745. American Academy of Pediatrics, Committee on Psychosocial Aspects of Child Family Health: Pediatrics and the psychosocial aspects of child and family health, Pediatrics 70:126–127, 1982.
  1746. American Academy of Pediatrics, Committee on Psychosocial Aspects of Child Family Health: The pediatrician and the «new morbidity,», Pediatrics 92:731–733, 1993.
  1747. American Academy of Pediatrics, Committee on Psychosocial Aspects of Child Family Health: The new morbidity revisited: a renewed commitment to the psychosocial aspects of pediatric care, Pediatrics 108:1227–1230, 2001.
  1748. Anda RF, Brown DW, Dube SR, et al: Adverse childhood experiences and chronic obstructive pulmonary disease in adults, Am J Prev Med 34(5):396–403, 2008.
  1749. Antonelli RC, McAllister JW, Popp J: Making care coordination a critical component of the pediatric health system: a multidisciplinary framework, The Commonwealth Fund, May 2009.
  1750. Berry JG, Hall M, Neff J, et al: Children with medical complexity and Medicaid: spending and cost savings, Health Aff 33(12):2199–2206, 2014.
  1751. Berwick DM, Nolan TW, Whittington J: The triple aim: care, health, and cost, Health Aff 27(3):759–769, 2008.
  1752. Booske BC, Athens JK, Kindig DA, et al: Different perspectives for assigning weights to determinants of health, 2010, University of Wisconsin: Population Health Institute.
  1753. Boyce WT, Ellis BJ: Biological sensitivity to context. I. An evolutionary–developmental theory of the origins and functions of stress reactivity, Dev Psychopathol 17:271–301, 2005.
  1754. Brown DW, Anda RF, Felitti VJ, et al: Adverse childhood experiences are associated with the risk of lung cancer: a prospective cohort study, BMC Public Health 10(1):20, 2010.
  1755. Brown DW, Anda RF, Tiemeier H, et al: Adverse childhood experiences and the risk of premature mortality, American J Prev Med 37(5):389–396, 2009.
  1756. Brown MJ, Thacker LR, Cohen SA: Association between adverse childhood experiences and diagnosis of cancer, PLoS ONE 8(6):e65524, 2013.
  1757. Öåíòðû ïî êîíòðîëþ è ïðîôèëàêòèêå çàáîëåâàíèé. Íàöèîíàëüíûé öåíòð ïðîôèëàêòèêè è êîíòðîëÿ òðàâìàòèçìà.
  1758. Chaturvedi S, DeBaun MR: Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: the last 40 years, Am J Hematol 91(1):5–14, 2016.
  1759. Child and Adolescent Health Measurement Initiative: 2010 National Survey of Children with Special Health Care Needs.
  1760. Child and Adolescent Health Measurement Initiative: 2011/12 National Survey of Children’s Health.
  1761. Cronholm PF, Forke CM, Wade R, et al: Adverse childhood experiences: expanding the concept of adversity, Am J Prev Med 49(3):354–361, 2015.
  1762. Danese A, McEwen BS: Adverse childhood experiences, allostasis, allostatic load, and age-related disease, Physiol Behav 106:29–39, 2012.
  1763. Danese A, Pariante CM, Caspi A, et al: Childhood maltreatment predicts adult inflammation in a life-course study, Proc Natl Acad Sci 104(4):1319–1324, 2007.
  1764. Dong M, Dube SR, Felitti VJ, et al: Adverse childhood experiences and self-reported liver disease: new insights into the causal pathway, Arch Intern Med 163:1949–1956, 2003.
  1765. Dong M, Giles WH, Felitti VJ, et al: Insights into causal pathways for ischemic heart disease: adverse childhood experiences study, Circulation 110(13):1761–1766, 2004.
  1766. Epel ES, Blackburn EH, Lin J, et al: Accelerated telomere shortening in response to life stress, PNAS 101(49):17312–17315, 2004.
  1767. Felitti VJ, Anda RF, Nordenberg D, et al: Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: the Adverse Childhood Experiences (ACE) Study, Am J Prev Med 14(4):245–258, 1998.
  1768. Finlekhor D, Shattuck A, Turner H, Hanby S: Improving the adverse childhood experiences study scale, JAMA Pediatr 167(1):70–75, 2013.
  1769. Fisher ES: Building a medical neighborhood for the medical home, N Engl J Med 359(12):1202–1205, 2008.
  1770. Garg A, Sandel M, Dworkin PH, et al: From medical home to health neighborhood: transforming the medical home into a community-based health neighborhood, J Pediatr 160(4):535–536.e1, 2012.
  1771. Garner AS, Shonkoff JP, Siegel BS, et al: Early childhood adversity, toxic stress, and the role of the pediatrician: translating developmental science into lifelong health, Pediatrics 129(1):e224–e231, 2012.
  1772. Gunnar M, Quevedo K: The neurobiology of stress and development, Ann Rev Psychol 58:145–173, 2007.
  1773. Haggerty RJ, Roghmann KJ, Pless IB: Child health and the community, New York, 1975, John Wiley & Sons.
  1774. Hunger SP, Lu X, Devidas M, et al: Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the Children’s Oncology Group, J Clin Oncol 30(14):1663–1669, 2012.
  1775. Jensen SKG, Berens AE, Nelson CA: Effects of poverty on interacting biological systems underlying child development, Lancet 1:225–238, 2017.
  1776. MacKenzie T, Gifford AH, Sabadosa KA, et al: Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: survival analysis of the Cystic Fibrosis Foundation Patient Registry, Ann Intern Med 161:233–241, 2014.
  1777. McGinnis JM, Williams-Russo P, Knickman JR: The case for more active policy attention to health promotion, Health Aff 21(2):78–93, 2002.
  1778. McGovern L, Miller G, Hughes-Cromwick P: Health Policy Brief: The relative contribution of multiple determinants to health outcomes, Health Affairs, August 21, 2014.
  1779. McPherson M, Arango P, Fox H, et al: A new definition of children with special health care needs, Pediatrics 102:137–140, 1998.
  1780. Millenium Development Goals.
  1781. Alessandrini E., Wright J. The continuing evolution of pediatric emergency care // JAMA Pediatr. 2015. Vol. 169. P. 523–524.
  1782. American Academy of Pediatrics; American College of Emergency Physicians; American College of Surgeons, Committee on Trauma; Emergency Medical Services for Children; Emergency Nurses Association; National Association of EMS Physicians; National Association of State EMS Officials: Joint policy statement: equipment for ground ambulances // Prehosp. Emerg. Care. 2014. Vol. 18. P. 92–97.
  1783. Brown K.M., Hirshon J.M., Alcorta R.A. et al. Implementation and evaluation of an evidence-based prehospital pain management protocol developed using the national prehospital model process // Prehosp. Emerg. Care. 2014. Vol. 18. Suppl. 1. P. 45–51.
  1784. Dudley N., Ackerman A., Brown K.M. et al. Patient- and family-centered care of children in the emergency department // Pediatrics. 2015. Vol. 135. P. e255–e272.
  1785. Fagbuyi D.B., Schonfeld D.J., American Academy of Pediatrics Disaster Preparedness Advisory Council: Medical countermeasures for children in public health emergencies, disasters, or terrorism // Pediatrics. 2016. Vol. 137. P. e20154273.
  1786. Gausche-Hill M., Ely M., Schmuhl P. et al. A national assessment of pediatric readiness of emergency departments // JAMA Pediatr. 2015. Vol. 169. N. 6. P. 527–534.
  1787. Gausche-Hill M., Krug S.E., American Academy of Pediatrics, Committee on Pediatric Emergency Medicine; American College of Emergency Physicians, Pediatric Committee; Emergency Nurses Association, Pediatric Committee: Joint policy statement—guidelines for care of children in the emergency department // Pediatrics. 2009. Vol. 124. P. 1233–1243. Ïîäòâåðæäåíî: Pediatrics. 2013. Vol. 132. P. e281.
  1788. Lerner E.B., Dayan P.S., Brown K. et al. Characteristics of the pediatric patients treated by the pediatric emergency care applied research Network’s affiliated EMS agencies // Prehosp. Emerg. Care. 2014. Vol. 18. P. 52–59.
  1789. Needle S., Wright J.L., American Academy of Pediatrics Disaster Preparedness Advisory Council, Committee on Pediatric Emergency Medicine: Ensuring the health of children in disasters // Pediatrics. 2015. Vol. 136. P. e1407–e1417.
  1790. Pellegrini C., Krug S.E., Wright J.L. Saving emergency medical services for children // Clin. Pediatr. Emerg. Med. 2014. Vol. 15. P. 3–8.
  1791. Sasser S.M., Hunt R.C., Faul M., Centers for Disease Control and Prevention. Guidelines for field triage of injured patients: recommendations of the national expert panel on field triage // MMWR. Recomm. Rep. 2012. Vol. 61. P. 1–20.
  1792. Schonfeld D.J., Demaria T., American Academy of Pediatrics Disaster Preparedness Advisory Council, Committee on Psychosocial Aspects of Child and Family Health. Providing psychosocial support to children and families in the aftermath of disasters and crises // Pediatrics. 2015. Vol. 136. P. e1120.
  1793. Shah M.I., Macias C.G., Dayan P.S. et al. An evidence-based guideline for pediatric prehospital seizure management using GRADE methodology // Prehosp. Emerg. Care. 2014. Vol. 1. Suppl. 1. P. 15–24.
  1794. Tzimenatos L., Kim E., Kuppermann N. The pediatric emergency care applied research network: a history of multicenter collaboration in the United States // Pediatr. Emerg. Care. 2015. Vol. 31. P. 70–76.
  1795. Wright J.L. Evidence-based guidelines for prehospital practice: a process whose time has come // Prehosp. Emerg. Care. 2014. Vol. 18. Suppl. 1. P. 1–2.
  1796. Ajizian S.J., Nakagawa T.A. Interfacility transport of the critically ill pediatric patient // Chest. 2007. Vol. 132. P. 1361–1367.
  1797. American Academy of Pediatrics. Section on transport medicine // Insoft R.M., Schwartz H.P., Romito J. (eds). Air and ground transport of neonatal and pediatric patients. Ed. 4. Chicago: American Academy of Pediatrics, 2016.
  1798. Institute of Medicine Committee on the Future of Emergency Care in the United States Health System. Emergency care for children: growing pains. Washington: National Academies Press, 2007.
  1799. Karlsen K.A., Trautman M., Price-Douglas W. et al. National survey of neonatal transport teams in the United States // Pediatrics. 2011. Vol. 128. P. 685–691.
  1800. King B.R., King T.M., Foster R.L. et al. Pediatric and neonatal transport teams with and without a physician: a comparison of outcomes and interventions // Pediatr. Emerg. Care. 2007. Vol. 23. P. 77–82.
  1801. King B.R., Woodward G.A. Pediatric critical care transport—the safety of the journey: a five-year review of vehicular collisions involving pediatric and neonatal transport teams // Prehosp. Emerg. Care. 2002. Vol. 6. P. 449–454.
  1802. Orr R.A., Felmet K.A., Han Y. et al. Pediatric specialized transport teams are associated with improved outcomes // Pediatrics. 2009. Vol. 124. P. 40–48.
  1803. Philpot C., Day S., Marcdante K. et al. Pediatric interhospital transport: diagnostic discordance and hospital mortality // Pediatr. Crit. Care Med. 2008. Vol. 9. P. 15–19.
  1804. Ramnarayan P., Thiru K., Parslow R.C. et al. Effect of specialist retrieval teams on outcomes in children admitted to paediatric intensive care units in England and Wales: a retrospective cohort study // Lancet. 2010. Vol. 376. P. 698–704.
  1805. Singh J.M., Gunz A.C., Dhanani S. et al. Frequency, composition, and predictors of in-transit critical events during pediatric critical care transport // Pediatr. Crit. Care Med. 2016. Vol. 17. P. 984–991.
  1806. Stroud M.H., Trautman M.S., Meyer K. et al. Pediatric and neonatal interfacility transport: results from a national consensus conference // Pediatrics. 2013. Vol. 132. P. 359–366.
  1807. Alessandrini E.A., Alpern E.R., Chamberlain J.M. et al. Developing a diagnosis-based severity classification system for use in emergency medical services for children // Acad. Emerg. Med. 2012. Vol. 19. P. 70–78.
  1808. Bradman K., Borland M., Pascoe E. Predicting patient disposition in a paediatric emergency department // J. Paediatr. Child Health. 2014. Vol. 50. P. E39–E44.
  1809. Chamberlain J.M., Joseph J.G., Pollack M.M. Differences in severity-adjusted pediatric hospitalization rates are associated with race/ethnicity // Pediatrics. 2007. Vol. 119. P. e1319–e1324.
  1810. Chamberlain J.M., Patel K.M., Pollack M.M. The association of emergency department care factors with admission and discharge decisions for pediatric patients // J. Pediatr. 2006. Vol. 149. P. 644–649.
  1811. Chamberlain J.M., Patel K.M., Pollack M.M. The pediatric risk of hospital admission score: a second-generation severity-of-illness score for pediatric emergency patients // Pediatrics. 2005. Vol. 115. P. 388–395.
  1812. Defining quality performance measures for pediatric emergency care. URL: www.children- snational.org/EMSC/PubRes/toolbox.aspx.
  1813. Donabedian A. The quality of care: how can it be assessed? // JAMA. 1988. Vol. 260. P. 1743–1748.
  1814. Gorelick M.H., Alessandrini E.A., Cronan K. et al. Revised pediatric emergency assessment tool (RePEAT): a severity index for pediatric emergency care // Acad. Emerg. Med. 2007. Vol. 14. P. 316–323.
  1815. Institute of Medicine. Crossing the quality chasm: a new health system for the 21st century. Washington: National Academy Press, 2001.
  1816. Institute of Medicine. The future of emergency care in the United States health system. Washington: National Academies Press, 2006.
  1817. Institute of Medicine. To err is human: building a safer health care system. Washington: National Academy Press, 2000.
  1818. MacKenzie E.J. Injury severity scales: overview and directions for future research // Am. J. Emerg. Med. 1984. Vol. 2. P. 537–549.
  1819. Pollack M.M., Holubkov R., Funai T. et al. Simultaneous prediction of new morbidity, mortality, and survival without new morbidity from pediatric intensive care: a new paradigm for outcomes assessment // Crit. Care Med. 2015. Vol. 43. P. 1699–1709.
  1820. Pollack M.M., Holubkov R., Funai T. et al. The pediatric risk of mortality score: update 2015 // Pediatr. Crit. Care Med. 2016. Vol. 17. P. 2–9.
  1821. Slater A., Shann F. The suitability of the pediatric index of mortality (PIM), PIM2, the pediatric risk of mortality (PRISM), and PRISM III for monitoring the quality of pediatric intensive care in Australia and New Zealand // Pediatr. Crit. Care Med. 2004. Vol. 5. P. 447–454.
  1822. Stang A.S., Straus S.E., Crotts J. et al. Quality indicators for high acuity pediatric conditions // Pediatrics. 2013. Vol. 132. P. 752–762.
  1823. Dick W.F. Anglo-American vs Franco-german emergency medical services system // Prehosp. Disaster Med. 2003. Vol. 18. P. 29–35.
  1824. Duke T., Kelly J., Weber M. et al. Hospital care for children in developing countries: clinical guidelines and the need for evidence // J. Trop. Pediatr. 2006. Vol. 52. P. 1–2.
  1825. Gausche M., Krug S.E., American Academy of Pediatrics, Committee on Pediatric Emergency Medicine, American College of Emergency Physicians, Pediatric Committee. Emergency: guidelines for care of children in the emergency department // Pediatrics. 2009. Vol. 124. P. 1233–1243.
  1826. Glomb N.W., Shah M.I., Cruz A.T. Prioritising minimum standards of emergency care for children in resource-limited settings // Paediatr. Int. Child Health. 2017. Vol. 37. N. 2. P. 116–120.
  1827. Gries A., Zink W., Berhard M. et al. Realistic assessment of the physician-staffed emergency services in Germany // Anaesthesist. 2006. Vol. 55. P. 1080–1086.
  1828. HINARI Access to Research Initiative. About HINARI. URL: http://www.who.int/hinari/about/en.
  1829. International Federation for Emergency Medicine: 2012 international standards of care for children in emergency departments.
  1830. International Federation for Emergency Medicine. About IFEM. URL: http://www.ifem. cc/about/about.htm.
  1831. Khan A.N., Rubin D.H. International pediatric emergency care: establishment of a new specialty in a developing country // Pediatr. Emerg. Care. 2003. Vol. 19. P. 181–184.
  1832. Molyneux E. Emergency care for children in resource-constrained countries // Trans. R. Soc. Trop. Med. Hyg. 2009. Vol. 103. P. 11–15.
  1833. Molyneux E. Triaging children—keep it simple, swift and safe // S. Afr. Med. J. 2012. Vol. 103. P. 158–159.
  1834. Molyneux E., Ahmad S., Roberston A. Improved triage and emergency care for children reduces inpatient mortality in a resource-constrained setting // Bull. World. Health Org. 2006. Vol. 84. P. 314–319.
  1835. Molyneux E., Langton J., Njiram’madzi J., Robertson A.M. Setting up and running a paediatric emergency department in a hospital in Malawi: 15 years on // BMJ. Paediatr. Open 2017. Vol. 1. doi:10.1136/bmjpo-2017-000014.
  1836. Moss W.J., Ramakrishnan M., Storms D. et al. Child health in complex emergencies // Bull. World Health Org. 2006. Vol. 84. P. 58–64.
  1837. Nielsen K., Mock C., Joshipura M. et al. Assessment of the status of prehospital care in 13 low- and middle-income countries // Prehosp. Emerg. Care. 2012. Vol. 16. P. 381–389.
  1838. Nolan T., Angos P., Cunha A.J.L.A. et al. Quality of hospital care for seriously ill children in less-developed countries // Lancet. 2001. Vol. 357. P. 106–110.
  1839. Norton R., Hyder A.A., Bishai D. et al. Unintentional injuries // Jamison D.T., Breman J.G., Measham A.R. et al. (eds). Disease control priorities in developing countries. Ed. 2. New York: Oxford University Press and the World Bank, 2006. P. 737–753.
  1840. Peden M., Oyegbite K., Ozannr-Smith J. (eds). World report on child injury prevention. Geneva: WHO Press, 2009. URL: www.who.int/violence_injury_prevention/child/injury/world_report/en/index.html.
  1841. Siddiqui E.U., Razzak J.A. Pediatric emergency medicine—an evolving sub-speciality in Pakistan // J. Coll Physicians Surg. Pak. 2008. Vol. 18. P. 135–136.
  1842. United Nations Children’s Fund: Progress for children: a world fit for children statistical review. Vol. N. 6. New York: UNICEF, 2007.
  1843. United States Agency for International Development. The first modern pediatric ER in the region opens in Georgia.
  1844. Walker D.M., Tolentino V.R., Teach S.J. Trends and challenges in international pediatric emergency medicine // Curr. Opin. Pediatr. 2007. Vol. 19. P. 247–252.
  1845. World Health Organization. Emergency triage assessment and treatment (ETAT): manual for participants. Geneva: WHO Press, 2005.
  1846. World Health Organization. Guidelines for essential trauma care. Geneva: WHO Press, 2004.
  1847. World Health Organization. Integrated management for emergency and essential surgical care (IMEESC) tool kit.
  1848. World Health Organization. Integrated management of childhood illness (IMCI). Geneva: WHO Press, 2007.
  1849. World Health Organization. Prehospital trauma care systems. Geneva: WHO Press, 2005.
  1850. Alpern E.R., Alessandrini E.A., Bell L.M. et al. Occult bacteremia from a pediatric emergency department: current prevalence, time to detection, and outcome // Pediatrics. 2000. Vol. 106. P. 505–511.
  1851. Balamuth F., Alpern E.R., Abaddessa M.F. et al. Improving recognition of pediatric severe sepsis in the emergency department: contributions of a vital sign-based electronic alert and bedside clinician identification // Ann. Emerg. Med. 2017. Vol. 70. N. 6. P. 759–768.
  1852. Children’s Hospital of Philadelphia Emergency Department Clinical Pathway Algorithms.
  1853. DeCaen A.R., Berg M.D., Chameides L. et al. Part 12. Pediatric advanced life support: 2015 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care // Circulation. 2015. Vol. 132. S526–S542.
  1854. Farah M.M., Tay K., Lavelle J. A general approach to ill and injured children // Shaw K.N., Bachur R.G. (eds). Fleischer and Ludwig’s textbook of pediatric emergency medicine. Philadelphia: LWW, 2015.
  1855. Jhaveri R., Byington C.L., Klein J.O. et al. Management of the non-toxic-appearing acutely febrile child: a 21st century approach // J. Pediatr. 2011. Vol. 159. P. 181–185.
  1856. Kleinman M.E., Chameides L., Schexnayder S.M. et al. Part 14. Pediatric advanced life support: 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care // Circulation. 2010. Vol. 122. S876–S908.
  1857. Klig J.E., O’Malley P.J. Pediatric office emergencies // Curr. Opin. Pediatr. 2007. Vol. 19. P. 591–596.
  1858. Lavelle J.M., Costarino A.T., Ludwig S. Recognition and management of the ill child // Compr. Ther. 1995. Vol. 21. N. 12. P. 711–718.
  1859. Pediatric Readiness Project; Readiness Toolkit.
  1860. American Academy of Pediatrics Committee on Pediatric Emergency Medicine. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery. Markenson D. Ventricular fibrillation and the use of automated external defibrillators on children // Pediatrics. 2007. Vol. 120. P. 1159–1161.
  1861. American Heart Association: AHA guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric advanced life support // Pediatrics. 2006. Vol. 117. P. e1005–e1028.
  1862. Arrich J., Holzer M., Havel C. et al. Hypothermia for neuroprotection in adults after cardiopulmonary resuscitation (review) // Cochrane Database Syst. Rev. 2012. CD004128.
  1863. Atkins D.L., Berger S., Duff J.P. et al. Part 11. Pediatric basic life support and cardiopulmonary resuscitation quality: 2015 American heart association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care // Circulation. 2015. Vol. 132. Suppl. 2. P. S519–S525.
  1864. Bae K., Shin S., Ro Y. et al. The effect of mild therapeutic hypothermia on good neurologic recovery after out-of-hospital arrest according to location of return of spontaneous circulation: a nationwide observational study // Resuscitation. Vol. 89. P. 129–136.
  1865. Belletti A., Benedetto U., Putzu A. et al. Vasopressors during cardiopulmonary resuscitation: a network meta-analysis of randomized trials // Crit. Care Med. 2018. Vol. 46. N. 5. P. e443–e451.
  1866. Berg M.D., Schexnayder S.M., Chameides L. et al. Pediatric basic life support: 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care // Pediatrics. 2010. Vol. 126. P. e1345–e1360.
  1867. Carcillo J.A., Kuch B.A., Han Y.Y. et al. Mortality and functional morbidity after use of PALS/APLS by community physicians // Pediatrics. 2009. Vol. 124. P. 500–508.
  1868. Doherty D.R., Parshuram C.S., Gaboury I. et al. Hypothermia therapy after pediatric cardiac arrest // Circulation. 2009. Vol. 119. P. 1492–1500.
  1869. Driver B.E., Prekker M.E., Klein L.R. et al. Effect of use of a bougie vs endotracheal tube and stylet on first-attempt intubation success among patients with difficult airways undergoing emergency intubation // JAMA. 2018. Vol. 319. N. 21. P. 2179–2189.
  1870. Dumas F., Rea T., Fahrenbruch C. et al. Chest compression alone cardiopulmonary resuscitation is associated with better long-term survival compared with standard cardiopulmonary resuscitation // Circulation. 2013. Vol. 127. P. 435–441.
  1871. Eelco F.M., Wijdicks M.D., Kramer A.A. et al. Comparison of the full outline of unresponsiveness score and the Glasgow coma scale in predicting mortality in critically ill patients // Crit. Care Med. 2015. Vol. 43. P. 439–444.
  1872. Eng Hock Ong M., Perkins G.D., Cariou A. Out-of-hospital cardiac arrest: prehospital management // Lancet. 2018. Vol. 391. P. 980–988.
  1873. Geocadin R.G., Wijdicks E., Armstrong M.J. et al. Practice guideline summary: reducing brain injury following cardiopulmonary resuscitation // Neurology. 2017. Vol. 88. P. 1–9.
  1874. Hassager C., Nagao K., Hildick-Smith D. Out-of-hospital cardiac arrest: in-hospital intervention strategies // Lancet. 2018. Vol. 391. P. 989–996.
  1875. Hegenbarth M.A. American academy of pediatrics committee on drugs: preparing for pediatric emergencies: drugs to consider // Pediatrics. 2008. Vol. 121. P. 433–443.
  1876. Horton M.A., Beamer C. Powered intraosseous insertion provides safe and effective vascular access for pediatric emergency patients // Pediatr. Emerg. Care. 2008. Vol. 24. P. 347–350.
  1877. Jabre P., Belpomme V., Azoulay E. et al. Family presence during cardiopulmonary resuscitation // N. Engl. J. Med. 2013. Vol. 368. P. 1008–1018.
  1878. Kleinman M.E., Chameides L., Schexnayder S.M. et al. Part 14. Pediatric advanced life support 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care // Circulation. 2010. Vol. 122. Suppl. 3. P. S876–S908.
  1879. Kleinman M.E., Chameides L., Schexnayder S.M. et al. Pediatric advanced life support. 2010 American heart association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care // Pediatrics. 2010. Vol. 126. P. e1361–e1399.
  1880. Kleinman M.E., de Caen A.R., Chameides L. et al. Pediatric basic and advanced life support. 2010 international consensus on cardiopulmonary resuscitation and emergency cardiovascular care science with treatment recommendations // Pediatrics. 2010. Vol. 126. P. e1261–e1318.
  1881. Lopez-Herce J., Alvarez A.C. Bystander CPR for paediatric out-of-hospital cardiac arrest // Lancet. 2010. Vol. 375. P. 1321–1322.
  1882. Markenson D., Pyles L., Neish S. et al. Ventricular fibrillation and use of automated external defibrillators on children // Pediatrics. 2007. Vol. 120. P. e1368–e1379.
  1883. Matos R.I., Watson S., Nadkarni V.M. et al. Duration of cardiopulmonary resuscitation and illness category impact survival and neurologic outcomes for in-hospital pediatric cardiac arrests // Circulation. 2013. Vol. 127. P. 442–451.
  1884. McNally B., Robb R., Mehta M. et al. Out-of-hospital cardiac arrest surveillance-cardiac arrest registry to enhance survival (CARES)—United States, October 1, 2005- December 31, 2010 // MMWR. 2011. Vol. 60. P. 1–19.
  1885. The Medical Letter. Intraosseous infusion for rapid vascular access // Med. Lett. Drugs Ther. 2012. Vol. 54. P. 50.
  1886. Mentzelopoulos S.D., Malachias S., Chamos C. et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest // JAMA. 2013. Vol. 310. P. 270–279.
  1887. Mentzelopoulos S.D., Zakynthinos S.G., Tzoufi M. et al. Vasopressin, epinephrine, and corticosteroids for in-hospital cardiac arrest // Arch. Intern. Med. 2009. Vol. 169. P. 15–24.
  1888. Moler F.W., Silverstein F.S., Holubkov R. et al. Therapeutic hypothermia after in-hospital cardiac arrest in children // N. Engl. J. Med. V. Vol. 376. N. 4. P. 318–328, X.
  1889. Morley P. New international guidelines on resuscitation // BMJ. 2010. Vol. 341. P. 902.
  1890. Myat A., Song K.J., Rea T. Out-of-hospital cardiac arrest: current concepts // Lancet. 2018. Vol. 391. P. 970–978.
  1891. Nagele P. Augmented CPR: rescue after the ResQ trial // Lancet. 2011. Vol. 377. P. 276–277.
  1892. Nielsen N., Wetterslev J., Cronberg T. et al. Targeted temperature management at 33°C versus 36°C after cardiac arrest // N. Engl. J. Med. 2013. Vol. 369. P. 2197–2206.
  1893. Nolan J.P., Soar J., Perkins G.D. Cardiopulmonary resuscitation // BMJ. 2012. Vol. 345. P. e6122.
  1894. Ogawa T., Akahane M., Koike S. et al. Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study // BMJ. 2011. Vol. 342. P. 321.
  1895. Padman R., Lawless S.T., Kettrick R.G. Noninvasive ventilation via bilevel positive airway pressure support in pediatric practice // Crit. Care Med. 1998. Vol. 26. P. 169–173.
  1896. Perkins G.D., Nolan J.P. Early adrenaline for cardiac arrest // BMJ. 2014. Vol. 348. P. 7.
  1897. Rea T.D., Fahrenbruch C., Calley L. et al. CPR with chest compression alone or with rescue breathing // N. Engl. J. Med. 2010. Vol. 363. N. 5. P. 423–432.
  1898. Rittenberger J.C, Callaway C.W. Temperature management and modern post-cardiac arrest care // N. Engl. J. Med. 2013. Vol. 369. P. 2262–2264.
  1899. Robinson S.M., Mackenzie-Ross S., Campbell Hewson G.L. et al. Psychological effect of witnessed resuscitation on bereaved relatives // Lancet. 1998. Vol. 352. P. 614–617.
  1900. Samson R.A., Berg R.A., Bingham R. et al. Use of automated external defibrillators for children: an update: an advisory statement from the pediatric advanced life support task force, International liaison committee on resuscitation // Circulation. 2003. Vol. 107. P. 3250–3255.
  1901. Scholefield B.R., Perkins G.D., Duncan H.P. et al. Should children who have a cardiac arrest be treated with therapeutic hypothermia? // BMJ. 2014. Vol. 348. P. 36–37.
  1902. Sharek P.J., Parast L.M., Leong K. et al. Effect of a rapid response team on hospitalwide mortality and code rates outside the ICU in a children’s hospital // JAMA. 2007. Vol. 298. P. 2267–2274.
  1903. Tsou P.Y., Kurbedin J., Chen Y.S. et al. Accuracy of point-of-care focused echocardiography in predicting outcome of resuscitation in cardiac arrest patients: a systematic review and meta-analysis // Resuscitation. 2017. Vol. 114. P. 92–99.
  1904. Valdes S.O., Donoghue A.J., Hoyme D.B. et al. Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation // Resuscitation. 2014. Vol. 85. P. 381–386.
  1905. Vilke G.M., Smith A.M., Ray L.U. et al. Airway obstruction in children aged less than 5 years: the prehospital experience // Prehosp. Emerg. Care. 2004. Vol. 8. P. 196–199.
  1906. American Academy of Pediatrics Committee on Pediatric Emergency Medicine, Council on Injury, Violence, and Poison Prevention, Section on Critical Care, Section on Orthopaedics, Section on Surgery, Section on Transport Medicine, Pediatric Trauma Society, and Society of Trauma Nurses, Pediatric Committee. Management of pediatric trauma // Pediatrics. 2016. Vol. 138. P. e20161569.
  1907. American College of Surgeons Committee on Trauma. Advanced trauma life support for doctors: student course manual. Ed. 9. Chicago: American College of Surgeons, 2012.
  1908. Balogh Z.J., Reumann M.K., Gruen R.L. et al. Advances and future directions for management of trauma patients with musculoskeletal injuries // Lancet. 2012. Vol. 380. P. 1109–1119.
  1909. Borse N.N., Gilchrist J., Dellinger A.M. et al. CDC childhood injury report: patterns of unintentional injuries among 0–19 year olds in the United states. 2000–2006. Atlanta, 2008. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Injury Prevention and Control, Division of Unintentional Injury Prevention. URL: http://www.cdc.gov/SafeChild/ChildhoodInjuryReport/b_Summary.html.
  1910. Bracken M.B. Steroids for acute spinal cord injury // Cochrane Database Syst Rev. 2012. CD001046.
  1911. Bulger E.M., May S., Kerby J.D. et al. Out-of-hospital hypertonic resuscitation after traumatic hypovolemic shock: a randomized, placebo controlled trial // Ann. Surg. 2011. Vol. 253. P. 431–441.
  1912. Carney N., Totten A.M., O’Reilly C. et al. Guidelines for the management of severe traumatic brain injury // Neurosurgery. 2017. Vol. 80. P. 6–15.
  1913. Chang M.C. et al. (eds). National trauma data bank pediatric annual report, 2016/American College of Surgeons. URL: https://www.facs.org/quality%20programs/trauma/ntdb/docpub.
  1914. Curry N., Davis P.W. What’s new in resuscitation strategies for the patient with multiple trauma? // Injury. 2012. Vol. 43. P. 1021–1028.
  1915. Davis D.H., Localio A.R., Stafford P.W. et al. Trends in operative management of pediatric splenic injury in a regional trauma system // Pediatrics. 2005. Vol. 115. P. 89–94.
  1916. Demetriades D., Karaiskakis M., Velmahos G.C. et al. Pelvic fractures in pediatric and adult trauma patients: are they different injuries? // J. Trauma. 2003. Vol. 54. P. 1146–1151.
  1917. Dreyfus J., Flood A., Cutler G. et al. Comparison of pediatric motor vehicle collision injury outcomes at level I trauma centers // J. Pediatr. Surg. 2016. Vol. 51. P. 1693–1699.
  1918. Feliz A., Shultz B., McKenna C. et al. Diagnostic and therapeutic laparoscopy in pediatric abdominal trauma // J. Pediatr. Surg. 2006. Vol. 41. P. 72–77.
  1919. Flynn J.M., Closkey R.F., Mahboubi S. et al. Role of magnetic resonance imaging in the assessment of pediatric cervical spine injuries // J. Pediatr. Orthop. 2002. Vol. 22. P. 573–577.
  1920. Fox J.C., Boysen M., Gharahbaghian L. et al. Test characteristics of focused assessment of sonography for trauma for clinically significant abdominal free fluid in pediatric blunt trauma // Acad. Emerg. Med. 2011. Vol. 18. P. 477–482.
  1921. Gruen R.L., Brohi K., Schreiber M. et al. Haemorrhage control in severely injured patients // Lancet. 2012. Vol. 380. P. 1099–1108.
  1922. Harris T., Thomas G.O.R., Brohi K. Early fluid resuscitation in severe trauma // BMJ. 2012. Vol. 345. P. e5752.
  1923. Hildebrand D.R., Ben-Sassi A., Ross N.P. et al. Modern management of splenic trauma // BMJ. 2014. Vol. 348. P. g1864.
  1924. Hoffman J.R., Mower W.R., Wolfson A.B. et al. Validity of a set of clinical criteria to rule out injury to the cervical spine in patients with blunt trauma // N. Engl. J. Med. 2000. Vol. 343. P. 94–99.
  1925. Holmes J.F., Gladman A., Chang C.H. Performance of abdominal ultrasonography in pediatric blunt trauma patients: a meta-analysis // J. Pediatr. Surg. 2007. Vol. 42. P. 1588–1594.
  1926. Holmes J.F., Lillis K., Monroe D. et al. Identifying children at very low risk of clinically important blunt abdominal injuries // Ann. Emerg. Med. 2013. Vol. 62. P. 107–116, e2.
  1927. Inaba K., Okoye O.T., Rosenheck R. et al. Prospective evaluation of the role of computed tomography in the assessment of abdominal stab wounds // JAMA Surg. 2013. Vol. 148. P. 810–816.
  1928. James I.A., Moukalled A., Yu E. et al. A systematic review of the need for MRI for the clearance of cervical spine injury in obtunded blunt trauma patients after normal cervical spine CT // J. Emerg. Trauma Shock. 2014. Vol. 7. P. 251–255.
  1929. Jansen J.O., Thomas R., Loudon M.A. et al. Damage control resuscitation for patients with major trauma // BMJ. 2009. Vol. 338. P. b1778.
  1930. Jansen J.O., Yule S.R., Loudon M.A. Investigation of blunt abdominal trauma // BMJ. 2008. Vol. 336. P. 938–942.
  1931. Karam O., Sanchez O., Chardot C. et al. Blunt abdominal trauma in children: a score to predict the absence of organ injury // J. Pediatr. 2009. Vol. 154. P. 912–917.
  1932. Kerrey B.T., Rogers A.J., Lee L.K. et al. A multicenter study of the risk of intra-abdominal injury in children after normal abdominal computed tomography scan results in the emergency department // Ann. Emerg. Med. 2013. Vol. 62. P. 319–326.
  1933. Kristoffersen K.W., Mooney D.P. Long-term outcome of nonoperative pediatric splenic injury management // J. Pediatr. Surg. 2007. Vol. 42. P. 1038–1042.
  1934. Kuppermann N., Holmes J.F., Dayan P.S. et al. Identification of children at very low risk of clinically important brain injuries after head trauma: a prospective cohort study // Lancet. 2009. Vol. 374. P. 1160–1170.
  1935. Lagisetty J., Slovis T., Thomas R. et al. Are routine pelvic radiographs in major pediatric blunt trauma necessary? // Pediatr. Radiol. 2012. Vol. 42. P. 853–858.
  1936. Mathen R., Inaba K., Munera F. et al. Prospective evaluation of multislice computed tomography versus plain radiographic cervical spine clearance in trauma patients // J. Trauma. 2007. Vol. 62. P. 1427–1431.
  1937. Matsushima K., Kulaylat A.N., Won E.J. et al. Variation in the management of adolescent patients with blunt abdominal solid organ injury between adult versus pediatric trauma centers: an analysis of a statewide trauma database // J. Surg. Res. 2013. Vol. 183. P. 808–813.
  1938. Morrison C.A., Carrick M.M., Norman M.A. et al. Hypotensive resuscitation strategy reduces transfusion requirements and severe postoperative coagulopathy in trauma patients with hemorrhagic shock: preliminary results of a randomized controlled trial // J. Trauma. 2011. Vol. 70. P. 652–663.
  1939. Nishijima D.K., Simel D.L., Wisner D.H. et al. Does this adult patient have a blunt intra-abdominal injury? // JAMA. 2012. Vol. 307. P. 1517–1527.
  1940. Pracht E.E., Tepas J.J., Langland-Orban B. et al. Do pediatric patients with trauma in Florida have reduced mortality rates when treated in designated trauma centers? // J. Pediatr. Surg. 2008. Vol. 43. P. 212–221.
  1941. Ramanathan R., Parrish D.W., Hartwich J.E. et al. Utility of admission serum lactate in pediatric trauma // J. Pediatr. Surg. 2015. Vol. 50. P. 588–603.
  1942. Sasser S.M., Hunt R.C., Faul M. et al. Guidelines for field triage of injured patients: recommendations of the National Expert Panel on Field Triage, 2011 // MMWR Recomm. Rep. 2012. Vol. 61. RR-1. P. 1–20.
  1943. Schonfeld D., Lee L.K. Blunt abdominal trauma in children // Curr. Opin. Pediatr. 2012. Vol. 24. P. 314–318.
  1944. Shah A., Guyette F., Suffoletto B. et al. Diagnostic accuracy of a single point-of-care prehospital serum lactate for predicting outcomes in pediatric trauma patients // Pediatr. Emerg. Care. 2013. Vol. 29. P. 715–719.
  1945. Suson K.D., Gupta A.D., Wang M.H. Bloody urine after minor trauma in a child: isolated renal injury versus congenital anomaly? // J. Pediatr. 2011. Vol. 159. P. 870.
  1946. US Department of Health and Human Services, Administration for Children and Families, Administration on Children, Youth and Families, Children’s Bureau. Child maltreatment 2015. URL: http://www.acf.hhs.gov/programs/cb/research-data-technology/statistics-research/child-maltreatment.
  1947. Van der Wilden G.M., Velmahos G.C., Emhoff T. et al. Successful nonoperative management of the most severe blunt liver injuries // Arch. Surg. 2012. Vol. 147. P. 423–428.
  1948. Viccellio P., Simon H., Pressman B.D. et al. A prospective multicenter study of cervical spine injury in children // Pediatrics. 2001. Vol. 108. N. 2. P. e20.
  1949. Wakai A., McCabe A., Roberts I. et al. Mannitol for acute traumatic brain injury // Cochrane Database Syst. Rev. 2013. CD001049.
  1950. Walther A.E., Falcone R.A., Pritts T.A. et al. Pediatric and adult trauma centers differ in evaluation, treatment, and outcomes for severely injured adolescents // J. Pediatr. Surg. 2016. Vol. 51. P. 1346–1350.
  1951. Warner K.J., Cuschieri J., Garland B. et al. The utility of early end-tidal capnography in monitoring ventilation status after severe injury // J. Trauma. 2009. Vol. 66. P. 26–31.
  1952. Wolf S.J., Bebarta V.S., Bonnett C.J. et al. Blast injuries // Lancet. 2009. Vol. 374. P. 405–415.
  1953. Yanchar N.L., Woo K., Brennan M. et al. Chest x-ray as a screening tool for blunt thoracic trauma in children // J. Trauma Acute. Care Surg. 2013. Vol. 75. P. 613–619.
  1954. Yen K., Kuppermann N., Lillis K. et al. Interobserver agreement in the clinical assessment of children with blunt abdominal trauma // Acad. Emerg. Med. 2013. Vol. 20. P. 426–432.
  1955. Zealley I.A., Chakraverty S. The role of interventional radiology in trauma // BMJ. 2010. Vol. 340. P. c497.
  1956. Brockmeyer DL, Ragel BT, Kestle JR. The pediatric cervical spine instability study. A pilot study assessing the prognostic value of four imaging modalities in clearing the cervical spine for children with severe traumatic injuries. Childs Nerv Syst. 2012;28(5):699-705.
  1957. Farrell CA, Hannon M, Lee LK. Pediatric spinal cord injury without radiographic abnormality in the era of advanced imaging. Curr Opin Pediatr. 2017;29:286-290.
  1958. Garton HJ, Hammer MR. Detection of pediatric cervical spine injury, Neurosurgery. 2008;62:700-708.
  1959. Inoue K, Kumada T, Fujii T, Kimura N. Progressive cervical spinal cord atrophy after a traffic accident. J Pediatr. 2017180:287.
  1960. Kemal NAS. Acute complications of spinal cord injuries. World J Orthop. 2015;6(1):17-23.
  1961. Lavy C, James A, Wilson-MacDonald J, et al. Cauda equina syndrome. BMJ. 2009;338:881-884.
  1962. Polk-Williams A, Carr BG, Blinman TA, et al. Cervical spine injury in young children: a National Trauma Data Bank Review. J Pediatr Surg. 2008;43:1718-1721.
  1963. Youngers EH, Zundel K, Gerhardstein D, et al. Comprehensive review of the ThinkFirst injury prevention programs: a 30-year success story for organized neurosurgery. Neurosurgery. 2017;81(3):416-421.
  1964. National Institutes of Health: History of Congressional Appropriations, Fiscal Years 2000–2016.
  1965. National Scientific Council on the Developing Child: Working Paper No. 3: Excessive stress disrupts the architecture of the developing brain, 2005.
  1966. Oza LLS, Hogan D, Chu Y, et al: Global, regional, and national causes of under-5-mortality in 2000–15: an updated systematic analysis with implications for the sustainable development goals, Lancet 388:3027–3034, 2016.
  1967. Shonkoff JP: Capitalizing on advances in science to reduce the health consequences of early childhood adversity, JAMA Pediatr 170(10):1003–1007, 2016.
  1968. Shonkoff JP, Boyce WT, McEwen BS: Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion. Îïóáëèêîâàíî îíëàéí 22 àâãóñòà 2016 ã.
  1969. Smith AK, Conneely KN, Kilaru V, et al: Differential immune system DNA methylation and cytokine regulation in post-traumatic stress disorder, Am J Med Genet B Neuropsychiatr Genet 156B(6):700–708, 2011.
  1970. Starfield B, Shi L: The medical home, access to care, and insurance: a review of evidence, Pediatrics 113(Suppl 4):1493–1498, 2004.
  1971. UNICEF, World Health Organization: A decade of tracking progress for maternal, newborn & child survival: the 2015 report, WHO Press.
  1972. US Census Bureau: World population by age and sex.
  1973. World Bank: Under-5 mortality rate, 2015.
  1974. World Factbook: Birthrate.
  1975. World Factbook: Infant mortality rates.
  1976. World Health Organization: Child mortality factsheet.
  1977. Adler NE, Glymour MM, Fielding J: Addressing social determinants of health and health inequalities, JAMA 316(16):1641–1642, 2016.
  1978. Adler NE, Stewart J: Health disparities across the lifespan: meaning, methods, and mechanisms, Ann N Y Acad Sci 1186(1):5–23, 2010.
  1979. American Academy of Pediatrics Council on Community Pediatrics: Poverty and child health in the United States, Pediatrics 137(4):e20160339, 2016.
  1980. Bush ML, Kaufman MR, McNulty BN: Disparities in access to pediatric hearing health care, Curr Opin Otolaryngol Head Neck Surg 25(5):359–365, 2017.
  1981. Centers for Disease Control and Prevention: Community Health and Program Services (CHAPS): health disparities among racial/ethnic populations, Atlanta, 2008, US Department of Health and Human Services.
  1982. Cheng TL, Jenkins R, Horn IB, et al: Starting early: a life-course perspective on child health disparities—research recommendations, Pediatrics 124(3):S257–S261, 2009.
  1983. Cheng TL, Solomon BS: Translating life course theory to clinical practice to address health disparities, Matern Child Health J 18(2):389–395, 2014.
  1984. Chin MH, Alexander-Young M, Burnet DL: Health care quality-improvement approaches to reducing child health disparities, Pediatrics 124(Suppl 3):S224–S236, 2009.
  1985. Choudhry S, Ung N, Avila PC, et al: Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma, Am J Respir Crit Care Med 171(6):535–536, 2005.
  1986. Coker TR, Elliott MN, Toomey SL, et al: Racial and ethnic disparities in ADHD diagnosis and treatment, Pediatrics 138(3):e20160407, 2016.
  1987. Collins JW Jr, David RJ, Symons R, et al: Low-income African-American mothers’ perception of exposure to racial discrimination and infant birth weight, Epidemiology 11(3):337–339, 2000.
  1988. Dickman SL, Himmelstein DU, Woolhandler S: Inequality and the health-care system in the USA, Lancet 389:1431–1440, 2017.
  1989. Dye BA, Thornton-Evans G: Trends in oral health by poverty status as measured by Healthy People 2010 objectives, Public Health Rep 125(6):817–830, 2010.
  1990. Edelstein BL, Chinn CH: Update on disparities in oral health and access to dental care for America’s children, Acad Pediatr 9(6):415–419, 2009.
  1991. Farrell CA, Fleegler EW, Monuteaux MC, et al: Community poverty and child abuse fatalities in the United States, Pediatrics 139(5):e20161616, 2017.
  1992. Flores G: Devising, implementing, and evaluating interventions to eliminate health care disparities in minority children, Pediatrics 124(Suppl 3):S214–S223, 2009.
  1993. Flores G, Lin H: Trends in racial/ethnic disparities in medical and oral health, access to care, and use of services in US children: has anything changed over the years? Int J Equity Health 12(1):10, 2013.
  1994. Flores G, Tomany-Korman SC: Racial and ethnic disparities in medical and dental health, access to care, and use of services in US children, Pediatrics 121(2):e286–e298, 2008.
  1995. Fuller B, Bridges M, Bein E, et al: The health and cognitive growth of Latino toddlers: at risk or immigrant paradox? Matern Child Health J 13(6):755, 2009.
  1996. Geronimus AT: The weathering hypothesis and the health of African-American women and infants: evidence and speculations, Ethn Dis 2(3):207–221, 1992.
  1997. Horn IB, Mitchell SJ, Joseph JG, Wissow LS: African-American parents’ perceptions of partnership with their child’s primary care provider, J Pediatr 159(2):262–267, 2011.
  1998. Hussey JM, Chang JJ, Kotch JB: Child maltreatment in the United States: prevalence, risk factors, and adolescent health consequences, Pediatrics 118(3):933–942, 2006.
  1999. Kester LM, Zimet GD, Fortenberry JD, et al: A national study of HPV vaccination of adolescent girls: rates, predictors, and reasons for non-vaccination, Matern Child Health J 17(5):879–885, 2013.
  2000. Love C, David RJ, Rankin KM, Collins JW Jr: Exploring weathering: effects of lifelong economic environment and maternal age on low birth weight, small for gestational age, and preterm birth in African-American and white women, Am J Epidemiol 172(2):127–134, 2010.
  2001. Lu PJ, Yankey D, Jeyarajah J, et al: HPV vaccination coverage of male adolescents in the United States, Pediatrics 136(5):839–849, 2015.
  2002. Mandell DS, Wiggins LD, Carpenter LA, et al: Racial/ethnic disparities in the identification of children with autism spectrum disorders, Am J Public Health 99(3):493–498, 2009.
  2003. Mustillo S, Krieger N, Gunderson EP, et al: Self-reported experiences of racial discrimination and Black–White differences in preterm and low-birthweight deliveries: the CARDIA Study, Am J Public Health 94(12):2125–2131, 2004.
  2004. Nelson AR, Stith AY, Smedley BD, editors: Unequal treatment: confronting racial and ethnic disparities in health care, Washington, DC, 2002, National Academies Press.
  2005. Nerenz DR, McFadden B, Ulmer C, editors: Race, ethnicity, and language data: standardization for health care quality improvement, Washington, DC, 2009, National Academies Press.
  2006. Ogden CL, Lamb MM, Carroll MD, Flegal KM: Obesity and socioeconomic status in children: United States 1988–1994 and 2005–2008, NCHS Data Brief No 51, Hyattsville, MD, 2010, National Center for Health Statistics.
  2007. Osypuk TL, Acevedo-Garcia D: Are racial disparities in preterm birth larger in hypersegregated areas? Am J Epidemiol 167(11):1295–1304, 2008.
  2008. Pachter LM: Child healthcare disparities: findings from the annual report and future directions, Acad Pediatr 10(2):87, 2010.
  2009. Pachter LM, Coll CG: Racism and child health: a review of the literature and future directions, J Dev Behav Pediatr 30(3):255, 2009.
  2010. Rice WS, Goldfarb SS, Brisendine AE, et al: Disparities in infant mortality by race among Hispanic and non-Hispanic infants, Matern Child Health J 21:1581–1588, 2017.
  2011. Robinson LR, Bitsko RH, Thompson RA, et al: CDC grand rounds: addressing health disparities in early childhood, MMWR Morb Mortal Wkly Rep 66(29):769–772, 2017.
  2012. Rogers R, Eagle TF, Sheetz A, et al: The relationship between childhood obesity, low socioeconomic status, and race/ethnicity: lessons from Massachusetts, Child Obes 11(6):691–695, 2015.
  2013. Rosenberg L, Palmer JR, Wise LA, et al: Perceptions of racial discrimination and the risk of preterm birth, Epidemiology 13(6):646–652, 2002.
  2014. Ruiz JM, Steffen P, Smith TB: Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature, Am J Public Health 103(3):e52–e60, 2013.
  2015. Shonkoff JP, Boyce WT, McEwen BS: Neuroscience, molecular biology, and the childhood roots of health disparities: building a new framework for health promotion and disease prevention, JAMA 301(21):2252–2259, 2009.
  2016. Smith LA, Oyeku SO, Homer C, Zuckerman B: Sickle cell disease: a question of equity and quality, Pediatrics 117(5):2006.
  2017. Strine TW, Mokdad AH, Barker LE, et al: Vaccination coverage of American Indian/Alaska Native children aged 19 to 35 months: findings from the National Immunization Survey, 1998–2000, Am J Public Health 93(12):2046–2049, 2003.
  2018. US Department of Health and Human Services: The Secretary’s Advisory Committee on National Health Promotion and Disease Prevention Objectives for 2020. Phase I report: recommendations for the framework and format of Healthy People 2020 [Internet]. Section IV: Advisory Committee findings and recommendations, 2010.
  2019. Walker AT, Smith PJ, Kolasa M: Reduction of racial/ethnic disparities in vaccination coverage, 1995–2011, MMWR Surveill Summ 63(Suppl 1):7–12, 2014.
  2020. Zuckerman KE, Mattox K, Donelan K, et al: Pediatrician identification of Latino children at risk for autism spectrum disorder, Pediatrics 132(3):445–453, 2013.
  2021. Zuckerman KE, Mattox KM, Sinche BK, et al: Racial, ethnic, and language disparities in early childhood developmental/behavioral evaluations: a narrative review, Clin Pediatr (Phila) 53(7):619–631, 2014.
  2022. Zuckerman KE, Sinche B, Cobian M, et al: Conceptualization of autism in the Latino community and its relationship with early diagnosis, J Dev Behav Pediatr 35(8):522–532, 2014.
  2023. Zuckerman KE, Sinche B, Mejia A, et al: Latino parents’ perspectives on barriers to autism diagnosis, Acad Pediatr 14(3):301–308, 2014.
  2024. Acevedo-Garcia D, Osypuk TL, McArdle N, Williams DR: Toward a policy-relevant analysis of geographic and racial/ethnic disparities in child health, Health Aff (Millwood) 27(2):321–333, 2008.
  2025. Anderson AT, Jackson A, Jones L, et al: Minority parents’ perspectives on racial socialization and school readiness in the early childhood period, Acad Pediatr 15(4):405–411, 2015.
  2026. Bailey ZD, Krieger N, Ag?nor M, et al: Structural racism and health inequities in the USA: evidence and interventions, Lancet 389:1453–1463, 2017.
  2027. Bassett MT: #BlackLivesMatter: a challenge to the medical and public health communities, N Engl J Med 372(12):1085–1087, 2015.
  2028. Beck AF, Huang B, Auger KA, et al: Explaining racial disparities in child asthma readmission using a causal inference approach, JAMA Pediatr 170(7):695–703, 2016.
  2029. Chae DH, Clouston S, Martz CD, et al: Area racism and birth outcomes among Blacks in the United States, Soc Sci Med 199:49–55, 2018.
  2030. Colen CG, Ramey DM, Cooksey EC, Williams DR: Racial disparities in health among nonpoor African Americans and Hispanics: the role of acute and chronic discrimination, Soc Sci Med 199:167–180, 2018.
  2031. Escala MK, Hall BG: Dead wrong: the growing list of racial/ethnic disparities in childhood mortality, J Pediatr 166(4):790–793, 2015.
  2032. Fiscella K, Williams DR: Health disparities based on socioeconomic inequities: implications for urban health care, Acad Med 79(12):1139–1147, 2004.
  2033. Gee GC, Ford CL: Structural racism and health inequities: old issues, new directions, Du Bois Rev 8(1):115–132, 2011.
  2034. Hardeman RR, Medina EM, Kozhimannil KB: Structural racism and supporting black lives—the role of health professionals, N Engl J Med 375(22):2113–2116, 2016.
  2035. Krieger N: The ostrich, the albatross, and public health: an ecosocial perspective—or why an explicit focus on health consequences of discrimination and deprivation is vital for good science and public health practice, Public Health Rep 116(5):419–423, 2001.
  2036. Krieger N: Discrimination and health inequities, Int J Health Serv 44(4):643–710, 2014.
  2037. Maroney T, Zuckerman B: «The Talk,» Physician Version: Special considerations for African-American male adolescents, Pediatrics 141(2):e20171462, 2018.
  2038. McCluney CL, Schmitz LL, Hicken MT, Sonnega A: Structural racism in the workplace: does perception matter for health inequalities? Soc Sci Med 199:106–114, 2018.
  2039. NAACP Criminal Justice Fact Sheet.
  2040. Priest N, Paradies Y, Trenerry B, et al: A systematic review of studies examining the relationship between reported racism and health and well-being for children and young people, Soc Sci Med 95:115–127, 2013.
  2041. Slopen N, Shonkoff JP, Albert MA, et al: Racial disparities in child adversity in the US: interactions with family immigration history and income, Am J Prev Med 50(1):47–56, 2016.
  2042. The Lancet: Living in colour—American children, race, and well-being, Lancet 388:307, 2016.
  2043. Umberson D, Olson JS, Crosnoe R, et al: Death of family members as an overlooked source of racial disadvantage in the United States, Proc Natl Acad Sci U S A 114(5):915–920, 2017.
  2044. US Institute of Medicine: Unequal treatment: confronting racial and ethnic disparities in health care (full printed version), Washington, DC, 2003, National Academies Press.
  2045. Washington HA, Baker RB, Olakanmi O, et al: Segregation, civil rights, and health disparities: the legacy of African American physicians and organized medicine, 1910–1968, J Natl Med Assoc 101(6):513–527, 2009.
  2046. Wilderman C, Wang EA: Mass incarceration, public health, and widening inequality in the USA, Lancet 389:1464–1472, 2017.
  2047. Williams DR, Collins C: Racial residential segregation: a fundamental cause of racial disparities in health, Public Health Rep 116(5):404–416, 2001.
  2048. Williams DR, Mohammed SA: Discrimination and racial disparities in health: evidence and needed research, J Behav Med 32(1):20–47, 2009.
  2049. Williams DR, Priest N, Anderson NB: Understanding associations among race, socioeconomic status, and health: patterns and prospects, Health Psychol 35(4):407–411, 2016.
  2050. Williams DR, Wyatt R: Racial Bias in Health Care and Health: challenges and opportunities, JAMA 314(6):555–556, 2015.
  2051. Holly M. Biggs, MD, MPH, Medical Epidemiologist, Respiratory Viruses Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  2052. Samra S. Blanchard, MD, Associate Professor, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland
  2053. Joshua A. Blatter, MD, MPH, Assistant Professor of Pediatrics, Allergy, Immunology, and Pulmonary Medicine, Researcher, Patient Oriented, Research Unit, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  2054. Archie Bleyer, MD, FRCP (Glasg), Clinical Research Professor, Knight Cancer Center, Oregon Health & Science University Chair, Institutional Review Board for St. Charles Health System Portland, Oregon; Professor of Pediatrics, University of Texas MD Anderson, Cancer Center, Houston, Texas
  2055. Nathan J. Blum, MD, William H. Bennett Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Chief, Division of Developmental and Behavioral Pediatrics, Childrens Hospital of Philadelphia Philadelphia, Pennsylvania
  2056. John P. Scott, MD, Associate Professor of Anesthesiology and Pediatrics, Divisions of Pediatric Anesthesiology and Pediatric Critical Care, Medical College of Wisconsin Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  2057. Patrick C. Seed, MD, PhD, FAAP, FIDSA, Childrens Research Fund Chair in Basic Science, Professor of Pediatrics, Microbiology and Immunology, Northwestern University Feinberg School of Medicine, Division Head, Pediatric Infectious Diseases, Associate Chief Research Officer of Basic Science, Stanley Manne Childrens Research Institute, Director, Host-Microbial Interactions, Inflammation, and Immunity (HMI3) Program, Ann & Robert H. Lurie Childrens, Hospital, Chicago, Illinois
  2058. Janet R. Serwint, MD, Professor, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland
  2059. Apurva S. Shah, MD, MBA, Assistant Professor, Department of Orthopedic Surgery, University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2060. Dheeraj Shah, MD, FIAP, MAMS, Professor, Department of Pediatrics, University College of Medical Sciences, Guru Teg Bahadur Hospital, New Delhi, India
  2061. Samir S. Shah, MD, MSCE, Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Division of Hospital Medicine, Chief Metrics Officer, James M. Ewell Endowed Chair, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2062. Ala Shaikhkhalil, MD, Pediatric Nutrition Fellow, Division of Gastroenterology,, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2063. Raanan Shamir, MD, Professor of Pediatrics, Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel;, Chairman, Institute of Gastroenterology, Nutrition, and Liver Diseases, Schneider Children’s Medical Center of Petah, Tikva, Israel
  2064. Christina M. Shanti, MD, Chief, Division of Pediatric Surgery Children’s Hospital of Michigan Detroit, Michigan
  2065. Bruce K. Shapiro, MD, Professor of Pediatrics
  2066. The Arnold J. Capute MD, MPH, Chair in Neurodevelopmental Disabilities, The Johns Hopkins University School of Medicine, Vice-President, Training, Kennedy Krieger Institute, Baltimore, Maryland
  2067. Erin E. Shaughnessy, MD, MSHCM, Division Chief, Hospital Medicine, Phoenix Children’s Hospital, Phoenix, Arizona
  2068. Bennett A. Shaywitz, MD, Charles and Helen Schwab, Professor in Dyslexia and Learning Development, Co-Director, Center for Dyslexia and Creativity, Chief, Child Neurology, Yale University School of Medicine, New Haven, Connecticut
  2069. Sally E. Shaywitz, MD, Audrey G. Ratner Professor in Learning Development, Co-Director, Center for Dyslexia and Creativity, Department of Pediatrics, Yale University School of Medicine New Haven, Connecticut
  2070. Oleg A. Shchelochkov, MD, Medical Genomics and Metabolic, Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
  2071. Nicole M. Sheanon, MD, MS, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Endocrinology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2072. Benjamin L. Shneider, MD, Professor of Pediatrics, Texas Children’s Hospital, Baylor College of Medicine, Houston, Texas
  2073. Stanford T. Shulman, MD, Virginia H. Rogers Professor of Pediatric Infectious Diseases Northwestern University Feinberg School of Medicine, Chief Emeritus, Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Childrens, Hospital of Chicago, Chicago, Illinois
  2074. Scott H. Sicherer, MD, Elliot and Roslyn Jaffe Professor of, Pediatrics, Allergy, and Immunology Director, Jaffe Food Allergy Institute Department of Pediatrics, Kravis Children’s Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  2075. Mark D. Simms, MD, MPH, Professor of Pediatrics, Medical College of Wisconsin Medical Director, Child Development Center, Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  2076. Jeffery M. Simmons, MD, MSc, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Associate Division Director for Quality, Division of Hospital Medicine, Safety Officer, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2077. Eric A.F. Simoes, MBBS, DCH, MD, Professor of Pediatrics, University of Colorado School of Medicine, Division of Pediatric Infectious Diseases, Childrens Hospital Colorado, Aurora, Colorado
  2078. Kari A. Simonsen, MD, Professor of Pediatrics, Division of Pediatric Infectious Disease, University of Nebraska, Medical Center, Omaha, Nebraska
  2079. Keneisha Sinclair-McBride, PhD, Assistant Professor of Psychology, Department of Psychiatry, Harvard Medical School, Staff Psychologist, Boston Childrens Hospital, Boston, Massachusetts
  2080. Vidya Sivaraman, MD, Clinical Assistant Professor of Pediatrics, Division of Adult and Pediatric Rheumatology, The Ohio State University Wexner Medical Center, Nationwide Children’s Hospital Columbus, Ohio, Anne M. Slavotinek, MB BS, PhD Professor of Clinical Pediatrics University of California San Francisco School of Medicine, Director, Medical Genetics and Genomics, UCSF Benioff Childrens Hospital, San Francisco, California
  2081. Jessica R. Smith, MD, Assistant Professor of Pediatrics Harvard Medical School, Clinical Director, Thyroid Program, Boston Childrens Hospital, Boston, Massachusetts
  2082. Stephanie H. Smith, MD, Resident Physician, Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  2083. Kim Smith-Whitley, MD, Professor, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Clinical Director, Division of Hematology, Director, Comprehensive Sickle, Cell Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2084. Mary Beth F. Son, MD, Assistant Professor in Pediatrics Harvard Medical School, Staff Physician, Division of Immunology, Boston Children’s Hospital, Boston, Massachusetts
  2085. Laura Stout Sosinsky, PhD, Research Scientist, Research and Evaluation Group Public Health Management Corporation, Philadelphia, Pennsylvania
  2086. Emily Souder, MD, Drexel University College of Medicine, St. Christopher’s Hospital for Children, Philadelphia, Pennsylvania
  2087. Joseph D. Spahn, MD, Professor, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado
  2088. Paul Spearman, MD, Albert B. Sabin Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2089. Mark A. Sperling, MD, Professor Emeritus and Chair, Department of Pediatrics, University of Pittsburgh School of Medicine, Professorial Lecturer, Department of Pediatrics, Division of Endocrinology and Diabetes, Kravis Children’s Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  2090. David A. Spiegel, MD, Professor, Department of Orthopaedic Surgery University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon Pediatric Orthopaedic Surgeon Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  2091. Jaclyn B. Spitzer, PhD, Professor Emerita of Audiology and Speech Pathology in Otolaryngology Columbia University Irving Medical Center, New York, New York
  2092. Jiirgen W. Spranger, MD, Professor Emeritus of Pediatrics, University of Mainz School of Medicine, Children’s Hospital, Mainz, Germany
  2093. James E. Squires, MD, MS, Assistant Professor in Pediatrics, Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  2094. Steven R. Boas, MD, FAAP, FACSM, Director, The Cystic Fibrosis Center of Chicago, President and CEO, The Cystic Fibrosis Institute, Glenview, Illinois; Clinical Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  2095. Walter O. Bockting, PhD, Professor of Medical Psychology (in Psychiatry and Nursing), Research Scientist, New York State, Psychiatric Institute, Division of Gender, Sexuality, and Health, Department of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons New York, New York
  2096. Mark Boguniewicz, MD, Professor of Pediatrics, Division of Allergy-Immunology Department of Pediatrics, University of Colorado School of Medicine, National Jewish Health, Denver, Colorado
  2097. Michael J. Boivin, PhD, MPH, Professor of Psychiatry and of Neurology and Ophthalmology Michigan State University College of Osteopathic Medicine East Lansing, Michigan
  2098. Daniel J. Bonthius, MD, PhD, Professor of Pediatrics and Neurology, University of Iowa Carver College of Medicine, Iowa City, Iowa
  2099. Brett J. Bordini, MD, FAAP, Associate Professor of Pediatrics, Division of Hospital Medicine Nelson Service for Undiagnosed and Rare Diseases, Director, Medical Spanish, Curriculum, Medical College of Wisconsin Milwaukee, Wisconsin
  2100. Kristopher R. Bosse, MD, Instructor in Pediatrics, University of Pennsylvania Perelman School of Medicine, Attending Physician, Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2101. Bret L. Bostwick, MD, Assistant Professor, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  2102. Kenneth M. Boyer, MD, Professor and Womans Board Chair, Emeritus, Department of Pediatrics, Rush University Medical Center Chicago, Illinois
  2103. Jennifer M. Brady, MD, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine Perinatal Institute, Division of Neonatology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2104. Patrick W. Brady, MD, MSc, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Attending Physician, Division of Hospital Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2105. Rebecca C. Brady, MD, Professor of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2106. Samuel L. Brady, MS, PhD, Clinical Medical Physicist Cincinnati Children’s Hospital Associate Professor of Radiology University of Cincinnati Cincinnati, Ohio
  2107. Amanda M. Brandow, DO, MS, Associate Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Medical College of Wisconsin Milwaukee, Wisconsin
  2108. David T. Breault, MD, PhD, Associate Professor of Pediatrics Harvard Medical School, Division of Endocrinology, Boston Children’s Hospital Boston, Massachusetts
  2109. Cora Collette Breuner, MD, MPH, Professor of Pediatrics, Adjunct Professor of Orthopedics and Sports Medicine, University of Washington School of Medicine, Division of Adolescent Medicine, Department of Orthopedics and Sports Medicine, Seattle Children’s Hospital, Seattle, Washington
  2110. Carolyn Bridgemohan, MD, Associate Professor of Pediatrics, Harvard Medical School, Co-Director Autism Spectrum Center Division of Developmental Medicine Boston Children’s Hospital, Boston, Massachusetts
  2111. William J. Britt, MD, Charles A. Alford Professor of Pediatrics, Professor of Microbiology and Neurobiology, University of Alabama Birmingham, School of Medicine, Division of Pediatric Infectious Diseases, Childrens of Alabama, Birmingham, Alabama
  2112. Laura Brower, MD, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Hospital Medicine, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  2113. Rebeccah L. Brown, MD, Professor of Clinical Surgery and Pediatrics, University of Cincinnati College of Medicine, Co-Director of Pectus Program Associate Director of Trauma Services, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  2114. J. Naylor Brownell, MD, Division of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2115. Meghen B. Browning, MD, Associate Professor of Pediatrics, The Medical College of Wisconsin, Division of Pediatric Hematology-Oncology, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
  2116. Nicola Brunetti-Pierri, MD, Associate Professor, Department of Translational Medicine, University of Naples Federico II Associate Investigator, Telethon Institute of Genetics and Medicine (TIGEM), Naples, Italy
  2117. Phillip R. Bryant, DO, Professor, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Rehabilitation Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2118. Rebecca H. Buckley, MD, J. Buren Sidbury Professor of Pediatrics, Professor of Immunology, Duke University School of Medicine Durham, North Carolina
  2119. Cynthia Etzler Budek, MS, APN/NP, CPNP-AC/PC, Pediatric Nurse Practitioner, Department of Pulmonary and Critical Care Medicine, Transitional Care/Pulmonary Habilitation Unit, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  2120. Supinda Bunyavanich, MD, MPH, MPhil, Associate Professor, Associate Director, Jaffe Food Allergy Institute, Department of Pediatrics, Department of Genetics and Genomic Sciences, Kravis Children’s Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  2121. Carey-Ann D. Burnham, PhD D(ABMM), FIDSA, F(AAM), Professor of Pathology and Immunology, Molecular Microbiology, Pediatrics, and Medicine, Washington University School of Medicine in St. Louis, Medical Director, Microbiology Barnes Jewish Hospital, St. Louis, Missouri
  2122. Gale R. Burstein, MD, MPH, Clinical Professor, Department of Pediatrics, University at Buffalo Jacobs School of Medicine and Biomedical Sciences Commissioner, Erie County Department of Health Buffalo, New York
  2123. Amaya L. Bustinduy, MD, PhD, MPH, Associate Professor in Tropical Pediatrics, Department of Clinical Research, London School of Hygiene and Tropical Medicine, London, United Kingdom
  2124. Jill P. Buyon, MD, Professor of Medicine (Rheumatology), Director, Division of Rheumatology, New York University School of Medicine, NYU Langone Medical Center, New York, New York
  2125. Miguel M. Cabada, MD, MSc, Assistant Professor, Division of Infectious Diseases, The University of Texas Medical, Branch at Galveston, Galveston, Texas
  2126. Michaela Cada, MD, FRCPC, FAAP, MPH, Assistant Professor, Department of Pediatrics, University of Toronto Faculty of Medicine, Director, Education Training Program, Division of Hematology/Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada
  2127. Derya Caglar, MD, Associate Professor, Fellowship Director, Pediatric Emergency Medicine, Department of Pediatrics, University of Washington School of Medicine Attending Physician, Division of Emergency Medicine, Seattle Childrens Hospital, Seattle, Washington
  2128. Mitchell S. Cairo, MD, Professor, Departments of Pediatrics, Medicine, Pathology, Microbiology, and Immunology and Cell Biology and Anatomy, New York Medical College, Chief, Division of Pediatric, Hematology, Oncology and Stem Cell, Transplantation, Maria Fareri Childrens Hospital at Westchester Medical Center, New York Medical College, Valhalla, New York
  2129. Diane P. Calello, MD, Associate Professor of Emergency Medicine, Rutgers University New Jersey Medical School, Executive and Medical Director, New Jersey Poison Information and Education System, Newark, New Jersey
  2130. Lauren E. Camarda, MD, Pediatric Pulmonology, Advocate Childrens Hospital, Park Ridge, Illinois
  2131. Lindsay Hatzenbuehler Cameron, MD, MPH, Assistant Professor of Pediatrics, Baylor College of Medicine Pediatric Infectious Diseases, Texas Childrens Hospital Houston, Texas
  2132. Bruce M. Camitta, MD, Rebecca Jean Slye Professor of Pediatrics, Division of Pediatric Hematology/Oncology, Medical College of Wisconsin Midwest Childrens Cancer Center Milwaukee, Wisconsin
  2133. Angela J.P. Campbell, MD, MPH, Medical Officer, Epidemiology and Prevention Branch, Influenza Division National Center for Immunization and Respiratory Diseases Centers for Disease Control and Prevention, Atlanta, Georgia
  2134. Rebecca F. Carlin, MD, Attending Physician, Division of General and Community Pediatrics, Childrens National Health System Assistant Professor of Pediatrics, George Washington University School of Medicine and Health Sciences, Washington, DC
  2135. Michael R. Carr, MD, Assistant Professor of Pediatrics, Division of Cardiology, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Childrens, Hospital of Chicago, Chicago, Illinois
  2136. Robert B. Carrigan, MD, Assistant Clinical Professor, Department of Orthopaedic Surgery University of Pennsylvania Perelman School of Medicine, Pediatric Hand Surgeon, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania, Michael S. Carroll, Research Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  2137. Rebecca G. Carter, MD, Assistant Professor, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland
  2138. Mary T. Caserta, MD, Professor of Pediatrics, University of Rochester School of Medicine and Dentistry, Division of Pediatric Infectious Diseases, Golisano Childrens Hospital Rochester, New York
  2139. Jennifer I. Chapman, MD, Assistant Professor of Pediatrics, George Washington University School of Medicine and Health Sciences, Program Director, Pediatric Emergency Medicine Fellowship Children’s National Medical Center Washington, DC
  2140. Ira M. Cheifetz, MD, FCCM, FAARC, Professor of Pediatrics and Anesthesiology, Duke University School of Medicine Executive Director and Chief Medical Officer, Duke Childrens Hospital Associate Chief Medical Officer, Duke University Hospital, Durham, North Carolina
  2141. Gisela G. Chelimsky, MD, Professor of Pediatrics, Medical College of Wisconsin Division of Pediatric Gastroenterology, Childrens Hospital Milwaukee Milwaukee, Wisconsin
  2142. Thomas C. Chelimsky, MD, Professor of Neurology, Medical College of Wisconsin, Milwaukee, Wisconsin
  2143. Wassim Chemaitilly, MD, Associate Member and Director, Division of Endocrinology Department of Pediatric Medicine St. Jude Childrens Research Hospital Memphis, Tennessee
  2144. Yuan-Tsong Chen, MD, PhD, Professor of Pediatrics and Genetics Duke University Medical Center Durham, North Carolina
  2145. Jennifer A. Chiriboga, PhD, Pediatric and School Psychologist Assistant Professor, Department of Counseling, Psychology, and Special Education Duquesne University School of Psychology, Pittsburgh, Pennsylvania
  2146. Yvonne E. Chiu, MD, Associate Professor of Dermatology and Pediatrics, Medical College of Wisconsin Department of Dermatology Division of Pediatric Dermatology Childrens Hospital of Wisconsin Milwaukee, Wisconsin
  2147. Christine Â. Cho, MD, Assistant Professor of Pediatrics, Division of Allergy-Immunology, Department of Pediatrics, University of Colorado School of Medicine, National Jewish Health, Denver, Colorado
  2148. Hey Jin Chong, MD, PhD, Assistant Professor of Pediatrics, University of Pittsburgh School of Medicine, Chief, Division of Pediatric Allergy and Immunology, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  2149. Stella T. Chou, MD, Associate Professor, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  2150. John C. Christenson, MD, Professor of Clinical Pediatrics, Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, Indianapolis, Indiana
  2151. Robert H. Chun, MD, Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology and Communication Sciences, Medical College of Wisconsin, Milwaukee, Wisconsin
  2152. Michael J. Chusid, MD, Professor (Infectious Disease) Department of Pediatrics Medical College of Wisconsin Medical Director, Infection Prevention and Control, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin
  2153. Theodore J. Cieslak, MD, MPH, FAAP, FIDSA, Associate Professor of Epidemiology Associate Director, Center for Biosecurity, Biopreparedness, and Emerging Infectious Diseases, University of Nebraska, Medical Center, College of Public Health Omaha, Nebraska
  2154. Donna J. Claes, MD, MS, BS Pharm, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Pediatric Nephrology, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  2155. Jeff A. Clark, MD, Associate Professor, Department of Pediatrics, Wayne State University School of Medicine, Childrens Hospital of Michigan Detroit, Michigan
  2156. John David Clemens, MD, PhD (Hon), Professor and Vice Chair, Department of Epidemiology, Founding Director, Center for Global Infectious Diseases, UCLA Fielding School of Public Health, Los Angeles, California; International Centre for Diarrhoeal, Disease Research, Dhaka, Bangladesh
  2157. Thomas D. Coates, MD, Professor of Pediatrics and Pathology University of Southern California Keck School of Medicine, Head, Section of Hematology Children’s Center for Cancer and Blood Diseases, Children’s Hospital of Los Angeles Los Angeles, California
  2158. Susan E. Coffin, MD, MPH, Professor of Pediatrics, Distinguished Chair in the Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Associate Chief, Division of Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2159. Joanna S. Cohen, MD, Associate Professor of Pediatrics and Emergency Medicine, George Washington University School of Medicine, Division of Pediatric Emergency Medicine, Children’s National Medical Center, Washington, DC
  2160. Mitchell B. Cohen, MD, Katharine Reynolds Ireland Endowed Chair in Pediatrics, Professor and Chair, Department of Pediatrics, University of Alabama at Birmingham School of Medicine, Physician-in-Chief, Children’s of Alabama, Birmingham, Alabama
  2161. Michael Cohen-Wolkowiez, MD, Professor of Pediatrics, Duke Clinical Research Institute, Duke University Medical Center Durham, North Carolina
  2162. Robert A. Colbert, MD, PhD, Acting Clinical Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, Chief, Pediatric Translational Branch National Institutes of Health, Bethesda, Maryland
  2163. E Sessions Cole III, MD, Assistant Vice-Chancellor for Children’s Health, Park J. White Professor of Pediatrics Professor of Cell Biology and Physiology, Washington University School of Medicine in St. Louis, Chief Medical Officer, Vice-Chairman, Department of Pediatrics, Director of Newborn Medicine, St. Louis Children’s Hospital, St. Louis, Missouri
  2164. J. Michael Collaco, MD, MS, MBA, MPH, PhD, Associate Professor of Pediatrics Eudowood Division of Pediatric, Respiratory Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
  2165. John L. Colombo, MD, Professor of Pediatrics, University of Nebraska College of Medicine, Division of Pediatric Pulmonology Nebraska Regional Cystic, Fibrosis Center, University of Nebraska, Medical Center, Omaha, Nebraska
  2166. Joseph A. Congeni, MD, Director, Sports Medicine Center Akron Children’s Hospital Akron, Ohio; Associate Professor of Pediatrics and Sports Medicine, Northeast Ohio Medical University Rootstown, Ohio; Clinical Associate Professor of Pediatrics and Sports Medicine Ohio University College of Osteopathic Medicine, Athens, Ohio
  2167. Lindsay N. Conner, MD, MPH, Department of Obstetrics and Gynecology, Benefis Health System, Great Falls, Montana
  2168. Sarah M. Creighton, MBBS, Professor and Consultant Gynaecologist, Department of Women’s Health University College London Hospitals, London, United Kingdom
  2169. James E. Crowe Jr, MD, Ann Scott Carell Chair and Professor of Pediatrics, Division of Pediatric Infectious Diseases, Professor of Pathology, Microbiology, and Immunology, Director, Vanderbilt Vaccine Center, Vanderbilt University School of Medicine, Nashville, Tennessee
  2170. Steven J. Czinn, MD, Professor and Chair, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland
  2171. Aarti S. Dalal, DO, Assistant Professor of Pediatrics, Washington University School of Medicine in St. Louis, Division of Pediatric Cardiology, St Louis Children’s Hospital, St. Louis, Missouri
  2172. Josep O. Dalmau, MD, PhD, Research Professor ICREA-IDIBAPS, Service of Neurology, Hospital Clinic, University of Barcelona, Barcelona, Spain; Adjunct Professor of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
  2173. Lara A. Danziger-Isakov, MD, MPH, Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Immunocompromised Host Infectious Disease, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2174. Toni Darville, MD, Professor of Pediatrics and Microbiology and Immunology, University of North Carolina at Chapel Hill, Chief, Division of Infectious Diseases Vice-Chair of Pediatric Research North Carolina Children’s Hospital Chapel Hill, North Carolina
  2175. Robert S. Daum, MD, CM, MSc, Professor of Medicine, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland
  2176. Nadia Y. Abidi, MD, Resident Physician, Department of Dermatology, University of Missouri School of Medicine, Columbia, Missouri
  2177. Mark J, Abzug, MD, Professor of Pediatrics, Vice Chair for Academic Affairs, University of Colorado School of Medicine, Section of Pediatric Infectious Diseases, Childrens Hospital Colorado Aurora, Colorado
  2178. David R. Adams, MD, PhD, Associate Investigator, Undiagnosed Diseases Program, Senior Staff Clinician, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
  2179. Nicholas S. Adams, MD, Plastic Surgery Resident, Spectrum Health Hospitals, Michigan State University, Grand Rapids, Michigan
  2180. Bado AR, Sathiya Susuman A: Women’s education and health inequalities in under-five mortality in selected sub-Saharan African countries, 1990–2015, PLoS ONE 11(7):e0159186, 2016.
  2181. Blencow H, Cousens S, Jassi FB; Lancet Stillbirth Epidemiology Investigator Group: National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis, Lancet 4(2):e98–e108, 2016.
  2182. Boerma T, Requejo J, Victoria CG: Countdown to 2030: tracking progress towards universal coverage for reproductive, maternal, newborn, and child health, Lancet 391:1538–1548, 2018.
  2183. Bor J, Cohen GH, Galea S: Population health in an era of rising income inequality: USA, 1980–2015, Lancet 389:1475–1490, 2017.
  2184. Costello AM, Dalglish SL; Strategic Review Study Team: Towards a grand convergence for child survival and health: a strategic review of options for the future building on lessons learnt from IMNCI, Geneva, 2016, WHO.
  2185. Cousens S, Blencowe H, Stanton C, et al: National, regional, and worldwide estimates of stillbirth rates in 2009 with trends since 1995: a systematic analysis, Lancet 377:1319–1330, 2011.
  2186. Ezeh A, Oyebode O, Satterthwaite D, et al: The history, geography, and sociology of slums and the health problems of people who live in the slums, Lancet 389:547–558, 2017.
  2187. Gausia K, Moran AC, Ali M, et al: Psychological and social consequences among mothers suffering from perinatal loss: perspective from a low income country, BMC Public Health 11:451, 2011.
  2188. Global Burden of Disease 2016 Mortality Collaborators: Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970–2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet 390:1084–1150, 2017.
  2189. Global Burden of Disease Child and Adolescent Health Collaboration: Child and adolescent health from 1990 to 2015: findings from the Global Burden of Diseases, Injuries, and Risk Factors 2015 Study, JAMA Pediatr 171(6):573–592, 2017.
  2190. Goga A, Muhe LM: Global challenges with scale-up of the integrated management of childhood illness strategy: results of a multi-country survey, BMC Public Health 1:503, 2011.
  2191. Heazell AEP, Siassakos D, Blencowe H, et al; Lancet Ending Preventable Stillbirths groups: Stillbirth: economic and psychosocial consequences, Lancet 387(10018):604–616, 2016.
  2192. Jensen SKG, Berens AE, Nelson CA: Effects of poverty on interacting biological systems underlying child development, Lancet 1:225–238, 2017.
  2193. Khandaker G, Muhit M, Rashid H, et al: Infectious causes of childhood disability: results from a pilot study in rural Bangladesh, J Trop Pediatr 60(5):363–369, 2014.
  2194. Lawn JE, Blencowe H, Waiswa P, et al: Stillbirths: rates, risk factors and potential for progress towards 2030, Lancet 387:587–603, 2016.
  2195. Lawn JE, Kinney MV, Black RE, et al: Newborn survival: a multi-country analysis of a decade of change, Health Policy Plan 27:iii6–iii28, 2012.
  2196. Liu L, Oza S, Hogan D, et al: Global, regional, and national causes of under-5 mortality in 2000–15: an updated systematic analysis with implications for the Sustainable Development Goals, Lancet 388:3027–3034, 2016.
  2197. Patton GC, Sawyer SM, Santelli JS, et al: Our future: a Lancet commission on adolescent health and wellbeing, Lancet 387:2423–2478, 2016.
  2198. Were W, Daelmans B, Bhutta ZA, et al: Children’s health priorities and interventions, BMJ 351:h4300, 2015.
  2199. World Health Organization: Infant mortality data by urban wealth quintiles, Geneva, 2018, WHO.
  2200. Stewart L. Adelson, MD, Assistant Clinical Professor
  2201. Department of Psychiatry, Columbia University College of Physicians and Surgeons, Adjunct Clinical Assistant Professor Weill Cornell Medical College of Cornell University, New York, New York
  2202. Shawn K. Ahlfeld, MD, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Attending Neonatologist, Perinatal Institute, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  2203. Osman Z. Ahmad, MD, Fellow in Pediatric Gastroenterology University of Alabama at Birmingham School of Medicine Birmingham, Alabama
  2204. John J. Aiken, MD, FACS, FAAP, Professor of Surgery, Division of Pediatric General and Thoracic Surgery, Medical College of Wisconsin, The Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
  2205. Cezmi A. Akdis, MD, Professor of Immunology, Swiss Institute of Allergy and Asthma Research, Christine Kiihne Center for Allergy, Research and Education, Davos, Switzerland; Medical Faculty, University of Zurich, Zurich, Switzerland
  2206. Evaline A. Alessandrini, MD, MSCE, Professor of Clinical Pediatrics, University of Cincinnati College of Medicine, Division of Emergency Medicine, Director, Quality Scholars Program in Health Care Transformation, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  2207. Michael A. Alexander, MD, Professor of Pediatrics and Rehabilitation Medicine, Thomas Jefferson Medical College, Philadelphia, Pennsylvania; Emeritus Medical Staff, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware
  2208. Omar Ali, MD, Pediatric Endocrinology, Valley Children’s Hospital, Madera, California
  2209. Karl E. Anderson, MD, FACP, Professor of Preventive Medicine and Community Health and Internal Medicine, Director, Porphyria Laboratory and Center, University of Texas Medical Branch, Galveston, Texas
  2210. Kelly K. Anthony, PhD, PLLC, Assistant Professor, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina
  2211. Alia Y. Antoon, MD, DCH, Senior Fellow, American Academy of Pediatrics Honorary Pediatrician, MassGeneral Hospital for Children, Boston, Massachusetts
  2212. Susan D. Apkon, MD, Professor, Department of Physical Medicine and Rehabilitation, University of Colorado Denver, Colorado; Chief, Pediatric Rehabilitation, Children’s Hospital Colorado Aurora, Colorado
  2213. Stacy P. Ardoin, MD, MHS, Associate Professor of Clinical Medicine, Division of Adult and Pediatric Rheumatology, The Ohio State University Wexner Medical Center, Nationwide Children’s Hospital Columbus, Ohio
  2214. Alexandre Arkader, MD, Attending Orthopaedic Surgeon Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  2215. Thais Armangue, MD, PhD, Pediatric Neurologist Neuroimmunology Program IDIBAPS-Hospital Clinic-Hospital Sant Joan de Deu (Barcelona) University of Barcelona, Barcelona, Spain
  2216. Carola A.S. Arndt, MD, Professor of Pediatrics, Department of Pediatrics and Adolescent Medicine, Division of Pediatric Hematology-Oncology, Mayo Clinic, Rochester, Minnesota
  2217. Paul L. Aronson, MD, Associate Professor of Pediatrics and Emergency Medicine, Yale School of Medicine, New Haven, Connecticut
  2218. David M. Asher, MD, Supervisory Medical Officer and Chief, Laboratory of Bacterial and Transmissible Spongiform Encephalopathy Agents Division of Emerging and Transfusion-Transmitted Diseases, US Food and Drug Administration Silver Spring, Maryland, Ann Ashworth, PhD, Hon FRCPCH Professor Emeritus, Department of Population Health, Nutrition Group, London School of Hygiene and Tropical Medicine, London, United Kingdom
  2219. Amit Assa, MD, Associate Professor of Pediatrics, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel; Head, IBD Unit, Institute of Gastroenterology, Nutrition, and Liver Diseases Schneider Childrens Medical Center Petah Tikva, Israel
  2220. Barbara L. Asselin, MD, Professor of Pediatrics and Oncology, Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Golisano Childrens Hospital and Wilmot Cancer Institute, Rochester, New York
  2221. Christina M. Astley, MD, ScD, Instructor in Pediatrics, Harvard Medical School, Attending Physician, Division of Endocrinology, Boston Childrens Hospital, Boston, Massachusetts
  2222. Joann L. Ater, MD, Professor, Department of Pediatrics Patient Care, University of Texas MD Anderson Cancer Center, Houston, Texas
  2223. Norrell Atkinson, MD, FAAP, Assistant Professor of Pediatrics, Drexel University College of Medicine, Child Protection Program, St. Christophers Hospital for Children, Philadelphia, Pennsylvania
  2224. Erika U. Augustine, MD, Associate Professor of Neurology and Pediatrics, Associate Director, Center for Health + Technology, University of Rochester, Medical Center, Rochester, New York
  2225. Marilyn C. Augustyn, MD, Professor of Pediatrics, Boston University School of Medicine, Boston Medical Center, Boston, Massachusetts
  2226. Yaron Avitzur, MD, Associate Professor, Department of Pediatrics, University of Toronto Faculty of Medicine, Division of Gastroenterology, Hepatology, and Nutrition The Hospital for Sick Children Toronto, Canada
  2227. Carlos A. Bacino, MD, Professor and Vice Chair of Clinical, Affairs, Department of Molecular and Human Genetics, Baylor College of Medicine, Director, Pediatrics Genetics Clinic Texas Children’s Hospital, Houston, Texas
  2228. Zinzi D. Bailey, ScD, MSPH, Assistant Scientist, University of Miami Miller School of Medicine, Miami, Florida
  2229. Binod Balakrishnan, MBBS, Assistant Professor, Department of Pediatrics Medical College of Wisconsin Division of Pediatric Critical Care Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  2230. Frances B. Balamuth, MD, PhD, MSCE Assistant Professor of Pediatrics University of Pennsylvania Perelman School of Medicine
  2231. Associate Director of Research Division of Emergency Medicine Co-Director, Pediatric Sepsis Program Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  2232. Robert N. Baldassano, MD, Colman Family Chair in Pediatric Inflammatory Bowel Disease and Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Director, Center for Pediatric Inflammatory Bowel Disease Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  2233. Keith D. Baldwin, MD, MSPT, MPH, Assistant Professor, Department of Orthopaedic Surgery University of Pennsylvania Perelman School of Medicine, Attending Physician, Neuromuscular Orthopaedics and Orthopaedic Trauma, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  2234. Christina Bales, MD, Associate Professor of Clinical, Pediatrics, University of Pennsylvania Perelman School of Medicine, Medical Director, Intestinal, Rehabilitation Program, Division of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2235. William E Balistreri, MD, Medical Director Emeritus, Pediatric Liver Care Center, Division of Pediatric, Gastroenterology, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2236. Allison Ballantine, MD, MEd, Associate Professor of Clinical Pediatrics, University of Pennsylvania Perelman School of Medicine, Co-Director Med Ed Program, Graduate School of Education Section Chief, Inpatient Services Division of General Pediatrics Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  2237. Robert S. Baltimore, MD, Professor of Pediatrics and Epidemiology, Clinical Professor of Nursing Professor of Pediatrics and Epidemiology, Clinical Professor of Nursing Yale School of Medicine, Associate Director of Hospital Epidemiology (for Pediatrics), Yale-New Haven Hospital New Haven, Connecticut
  2238. Manisha Balwani, MBBS, MS, Associate Professor of Medicine and Genetics and Genomic Sciences Kravis Children’s Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  2239. Vaneeta Barnba, MD, Associate Professor of Clinical Pediatrics, University of Pennsylvania Perelman School of Medicine, Medical Director, Diagnostic and Research Growth Center, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2240. Brenda L. Banwell, MD, Professor of Neurology Grace R. Loeb Endowed Chair in Neurosciences, University of Pennsylvania Perelman School of Medicine, Chief, Division of Neurology Director, Pediatric Multiple Sclerosis Clinic, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2241. Sarah E Barclay, PhD, Department of Medical Genetics Cumming School of Medicine at University of Calgary, Alberta Children’s Hospital Research Institute, Calgary, Alberta, Canada
  2242. Maria E. Barnes-Davis, MD, PhD, Assistant Professor of Pediatrics University of Cincinnati College of Medicine, Attending Neonatologist Division of Neonatology and Pulmonary Biology, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  2243. Karyl S. Barron, MD, Deputy Director, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland
  2244. Donald Basel, MBBCh, Associate Professor of Pediatrics and Genetics, Chief, Medical Genetics Division Medical College of Wisconsin Milwaukee, Wisconsin
  2245. Dorsey M. Bass, MD, Associate Professor of Pediatrics, Stanford University School of Medicine, Division of Pediatric Gastroenterology, Lucile Salter Packard Childrens Hospital, Palo Alto, California
  2246. Mary T. Bassett, MD, MPH, FXB Professor of the Practice of Public Health and Human Rights Harvard Ò.Í. Chan School of Public Health, Boston, Massachusetts
  2247. Christian P. Bauerfeld, MD, Assistant Professor of Pediatrics, Wayne State University School of Medicine, Division of Pediatric Critical Care Medicine, Childrens Hospital of Michigan, Detroit, Michigan
  2248. Rebecca A. Baum, MD, Clinical Associate Professor of Pediatrics, The Ohio State University College of Medicine, Chief, Developmental Behavioral Pediatrics, Nationwide Children’s Hospital, Columbus, Ohio
  2249. Michael J. Bell, MD, Professor, Pediatrics and Critical Care Medicine, Chief, Critical Care Medicine Childrens National Medical Center, The George Washington University School of Medicine, Washington, DC
  2250. Nicole R. Bender, MD, Resident Physician, Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin
  2251. Daniel K. Benjamin Jr, MD, PhD, MPH, Kiser-Arena Professor of Pediatrics Duke Clinical Research Institute, Duke University Medical Center Durham, North Carolina
  2252. Michael J. Bennett, PhD, FRCPath, FACB, Professor of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Director, Michael J. Palmieri, Metabolic Disease Laboratory, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  2253. Daniel Bernstein, MD, Alfred Woodley Salter and Mabel, G. Salter Endowed Professor in Pediatrics, Associate Dean for Curriculum and Scholarship, Stanford University School of Medicine, Palo Alto, California
  2254. Henry H. Bernstein, DO, MHCM, FAAP, Professor of Pediatrics, Zucker School of Medicine at Hofstra/Northwell, Cohen Childrens Medical Center of New York, New Hyde Park, New York
  2255. Diana X. Bharucha-Goebel, MD, Assistant Professor, Neurology and Pediatrics, Childrens National Medical Center, Washington, DC; Clinical Research Collaborator National Institutes of Health/NINDS Neurogenetics Branch/NNDCS Bethesda, Maryland
  2256. Loren T. Davidson, MD, Clinical Professor, Department of Physical Medicine and Rehabilitation, University of California, Davis School of Medicine, Davis, California; Director, Spinal Cord Injury, Shriners Hospital for Children Sacramento, California
  2257. Richard S. Davidson, MD, Emeritus Professor of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  2258. H. Dele Davies, MD, MS, MHCM Vice-Chancellor for Academic Affairs Dean for Graduate Studies University of Nebraska Medical Center Omaha, Nebraska
  2259. Najat C. Daw, MD, Professor, Division of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas
  2260. Shannon L. Dean, MD, PhD, Instructor in Neurology and Pediatrics, University of Rochester Medical Center, Rochester, New York
  2261. Helen M. Oquendo Del Toro, MD, Pediatric and Adolescent Gynecology Clinical Assistant Professor, University of New Mexico Department of Obstetrics and Gynecology, Albuquerque, New Mexico
  2262. David R. DeMaso, MD, Psychiatrist-in-Chief, The Leon Eisenberg Chair in Psychiatry, Boston Childrens Hospital; George P. Gardner and Olga E., Monks Professor of Child Psychiatry Professor of Pediatrics, Harvard Medical School Boston, Massachusetts
  2263. Mark R. Denison, MD, Craig-Weaver Professor of Pediatrics Professor of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center Monroe Carell Jr Children’s Hospital at Vanderbilt, Nashville, Tennessee
  2264. Arlene E. Dent, MD, PhD, Associate Professor of Pediatrics Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio
  2265. Robert J. Desnick, MD, PhD, Dean for Genetics and Genomic Medicine, Professor and Chair Emeritus, Genetics and Genomic Sciences Professor, Departments of Pediatrics, Oncological Sciences, and Obstetrics, Gynecology and Reproductive Science Kravis Childrens Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  2266. Robin R. Deterding, MD, Professor of Pediatrics, University of Colorado School of Medicine, Chief, Pediatric Pulmonary Medicine Director, Breathing Institute Co-Chair, Childrens Interstitial and Diffuse Lung Disease Research Network, Medical Director, Children’s Colorado Innovation Center, Childrens Hospital Colorado Aurora, Colorado
  2267. Prasad Devarajan, MD, FAAP, Louise M. Williams Endowed Chair Professor of Pediatrics and Developmental Biology, University of Cincinnati College of Medicine, Director of Nephrology and Hypertension, CEO, Dialysis Unit, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2268. Gabrielle A. deVeber, MD, MHSc, Professor of Pediatrics, University of Toronto Faculty of Medicine, Children’s Stroke Program, Division of Neurology, Senior Scientist Emeritus, Research Institute, Hospital for Sick Children, Toronto, Ontario, Canada
  2269. Vineet Dhar, BDS, MDS, PhD, Clinical Professor and Chairman Department of Orthodontics and Pediatric Dentistry, Director, Advanced Specialty Education Program, Pediatric Dentistry, Diplomate, American Board of Pediatric Dentistry, University of Maryland School of Dentistry, Baltimore, Maryland
  2270. Anil Dhawan, MD, FRCPCH, Professor of Pediatric Hepatology Pediatric Liver GI and Nutrition Centre, MowatLabs King’s College London School of Medicine at King’s College Hospital NSH Foundation Trust London, United Kingdom
  2271. Andre A.S. Dick, MD, MPH, FACS Associate Professor of Surgery Division of Transplantation, University of Washington School of Medicine, Section of Pediatric Transplantation, Seattle Childrens Hospital, Seattle, Washington
  2272. Harry C. Dietz III, MD, Victor A. McKusick Professor of Medicine and Genetics, Departments of Pediatrics, Medicine, and Molecular Biology and Genetics, Investigator, Howard Hughes Medical Institute, Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  2273. Daren A. Diiorio, MD, Resident Physician, Department of Dermatology, Medical College of Wisconsin, Milwaukee, Wisconsin
  2274. Linda A. DiMeglio, MD, MPH, Professor, Department of Pediatrics, Indiana University School of Medicine, Indiana University Clinical and Translational Science Institute, Riley Hospital for Children, Indianapolis, Indiana
  2275. Bradley P. Dixon, MD, FASN, Associate Professor of Pediatrics and Medicine, Renal Section, Department of Pediatrics, University of Colorado School of Medicine, Kidney Center, Childrens Hospital Colorado, Aurora, Colorado
  2276. Alam N, Hobbelink EL, van Tienhoven AJ, et al: The impact of the use of the early warning score (EWS) on patient outcomes: a systematic review, Resuscitation 85(5):587–594, 2014.
  2277. Balogh E, Miller BT, Ball J: US institute of medicine committee on diagnostic error in health care: improving diagnosis in health care, Washington, DC, 2015, National Academies Press.
  2278. Bonafide CP, Lin R, Zander M, et al: Association between exposure to nonactionable physiologic monitor alarms and response time in a children’s hospital, J Hosp Med 10(6):345–351, 2015.
  2279. Bonafide CP, Localio AR, Holmes JH, et al: Video analysis of factors associated with response time to physiologic monitor alarms in a children’s hospital, JAMA Pediatr 171(6):524–531, 2017.
  2280. Bonafide CP, Roland D, Brady PW: Rapid response systems 20 years later: new approaches, old challenges, JAMA Pediatr 170(8):729–730, 2016.
  2281. Bordini BJ, Stephany A, Kliegman R: Overcoming diagnostic errors in medical practice, J Pediatr 185:19–25, 2017.
  2282. Brady PW, Goldenhar LM: A qualitative study examining the influences on situation awareness and the identification, mitigation and escalation of recognised patient risk, BMJ Qual Saf 23(2):153–161, 2014.
  2283. Brady PW, Muething S, Kotagal U, et al: Improving situation awareness to reduce unrecognized clinical deterioration and serious safety events, Pediatrics 131(1):e298–e308, 2013.
  2284. Brady PW, Wheeler DS, Muething SE, Kotagal UR: Situation awareness: a new model for predicting and preventing patient deterioration, Hosp Pediatr 4(3):143–146, 2014.
  2285. Brady PW, Zix J, Brilli R, et al: Developing and evaluating the success of a family activated medical emergency team: a quality improvement report, BMJ Qua Saf 24(3):203–211, 2015.
  2286. Brennan TA, Leape LL, Laird NM, et al: Incidence of adverse events and negligence in hospitalized patients: results of the Harvard Medical Practice Study I, N Engl J Med 324(6):370–376, 1991.
  2287. Brilli RJ, McClead RE Jr, Davis T, et al: The preventable Harm Index: an effective motivator to facilitate the drive to zero, J Pediatr 157(4):681–683, 2010.
  2288. Carayon P, Schoofs Hundt A, Karsh BT, et al: Work system design for patient safety: the SEIPS model, Qual Saf Health Care 15(Suppl 1):i50–i58, 2006.
  2289. Chan PS, Khalid A, Longmore LS, et al: Hospital-wide code rates and mortality before and after implementation of a rapid response team, JAMA 300(21):2506–2513, 2008.
  2290. Coon ER, Quinonez RA, Moyer VA, Schroeder AR: Overdiagnosis: how our compulsion for diagnosis may be harming children, Pediatrics 134(5):1013–1023, 2014.
  2291. Donabedian A, Wheeler JR, Wyszewianski L: Quality, cost, and health: an integrative model, Med Care 20(10):975–992, 1982.
  2292. Gawande A: The checklist manifesto: how to get things right, New York, 2010, Metropolitan Books.
  2293. Goldenhar LM, Brady PW, Sutcliffe KM, Muething SE: Huddling for high reliability and situation awareness, BMJ Qual Saf 22(11):899–906, 2013.
  2294. Goudie A, Dynan L, Brady PW, et al: Costs of venous thromboembolism, catheter-associated urinary tract infection, and pressure ulcer, Pediatrics 136(3):432–439, 2015.
  2295. Goudie A, Dynan L, Brady PW, Rettiganti M: Attributable cost and length of stay for central line-associated bloodstream infections, Pediatrics 133(6):e1525–e1532, 2014.
  2296. Haynes AB, Weiser TG, Berry WR, et al: A surgical safety checklist to reduce morbidity and mortality in a global population, N Engl J Med 360(5):491–499, 2009.
  2297. Holden RJ, Carayon P, Gurses AP, et al: SEIPS 2.0: a human factors framework for studying and improving the work of healthcare professionals and patients, Ergonomics 56(11):1669–1686, 2013.
  2298. Hollnagel E: Safety-II in practice: developing the resilience potentials, Abingdon, Oxon; New York, 2017, Routledge.
  2299. Institute of Medicine, Committee on Quality of Health Care in America: Crossing the quality chasm: a new health system for the 21st century, Washington, DC, 2001, National Academy Press.
  2300. Institute of Medicine: New frontiers in patient safety, Washington, DC, 2011, National Academies Press.
  2301. Jones DA, DeVita MA, Bellomo R: Rapid-response teams, N Engl J Med 365(2):139–146, 2011.
  2302. Kahneman D, Slovic P, Tversky A: Judgment under uncertainty: heuristics and biases, Cambridge, NY, 1982, Cambridge University Press.
  2303. Kahneman D: Thinking, fast and slow, New York, 2013, Farrar, Straus and Giroux.
  2304. Khan A, Coffey M, Litterer KP, et al: Families as partners in hospital error and adverse event surveillance, JAMA Pediatr 171(4):372–381, 2017.
  2305. Kohn LT, Corrigan J, Donaldson MS: To err is human: building a safer health system, Washington, DC, 2000, National Academy Press.
  2306. Leape LL, Brennan TA, Laird N, et al: The nature of adverse events in hospitalized patients: results of the Harvard Medical Practice Study II, N Engl J Med 324(6):377–384, 1991.
  2307. Luria JW, Muething SE, Schoettker PJ, Kotagal UR: Reliability science and patient safety, Pediatr Clin North Am 53(6):1121–1133, 2006.
  2308. Lyren A, Brilli R, Bird M, et al: Ohio children’s hospitals’ solutions for patient safety: a framework for pediatric patient safety improvement, J Healthc Qual 38(4):213–222, 2016.
  2309. Lyren A, Brilli RJ, Zieker K, et al: Children’s hospitals’ solutions for patient safety: collaborative impact on hospital-acquired harm, Pediatrics 140(3):2017.
  2310. Miller MR, Griswold M, Harris JM 2nd, et al: Decreasing PICU catheter-associated bloodstream infections: NACHRI’s quality transformation efforts, Pediatrics 125(2):206–213, 2010.
  2311. Morimoto T, Gandhi TK, Seger AC, et al: Adverse drug events and medication errors: detection and classification methods, Qual Saf Health Care 13(4):306–314, 2004.
  2312. Parshuram CS, Duncan HP, Joffe AR, et al: Multicentre validation of the bedside paediatric Early Warning System score: a severity of illness score to detect evolving critical illness in hospitalised children, Crit Care 15(4):R184, 2011.
  2313. Parshuram CS, Hutchison J, Middaugh K: Development and initial validation of the bedside Paediatric Early Warning System score, Crit Care 13(4):R135, 2009.
  2314. Principi T, Coates AL, Parkin PC, et al: Effect of oxygen desaturations on subsequent medical visits in infants discharged from the emergency department with bronchiolitis, JAMA Pediatr 170(6):602–608, 2016.
  2315. Quinonez RA, Coon ER, Schroeder AR, Moyer VA: When technology creates uncertainty: pulse oximetry and overdiagnosis of hypoxaemia in bronchiolitis, BMJ 358:j3850, 2017.
  2316. Reason J: Human error: models and management, BMJ 320(7237):768–770, 2000.
  2317. Sakuma M, Ida H, Nakamura T, et al: Adverse drug events and medication errors in Japanese paediatric inpatients: a retrospective cohort study, BMJ Qual Saf 23(10):830–837, 2014.
  2318. Schaffzin JK, Harte L, Marquette S, et al: Surgical site infection reduction by the Solutions for Patient Safety Hospital Engagement Network, Pediatrics 136(5):e1353–e1360, 2015.
  2319. Schein RM, Hazday N, Pena M, et al: Clinical antecedents to in-hospital cardiopulmonary arrest, Chest 98(6):1388–1392, 1990.
  2320. Schondelmeyer AC, Bonafide CP, Goel VV, et al: The frequency of physiologic monitor alarms in a children’s hospital, J Hosp Med 11(11):796–798, 2016.
  2321. Schondelmeyer AC, Simmons JM, Statile AM, et al: Using quality improvement to reduce continuous pulse oximetry use in children with wheezing, Pediatrics 135(4):e1044–e1051, 2015.
  2322. Sharek PJ, Parast LM, Leong K, et al: Effect of a rapid response team on hospital-wide mortality and code rates outside the ICU in a children’s hospital, JAMA 298(19):2267–2274, 2007.
  2323. Smith MD, Institute of Medicine, Committee on the Learning Health Care System in America: Best care at lower cost: the path to continuously learning health care in America, Washington, DC, 2012, National Academies Press.
  2324. Starmer AJ, Sectish TC, Simon DW, et al: Rates of medical errors and preventable adverse events among hospitalized children following implementation of a resident handoff bundle, JAMA 310(21):2262–2270, 2013.
  2325. Starmer AJ, Spector ND, Srivastava R, et al: Changes in medical errors after implementation of a handoff program, N Engl J Med 371(19):1803–1812, 2014.
  2326. Starmer AJ, Spector ND, Srivastava R, et al: I-PASS: a mnemonic to standardize verbal handoffs, Pediatrics 129(2):201–204, 2012.
  2327. Stockwell DC, Bisarya H, Classen DC, et al: A trigger tool to detect harm in pediatric inpatient settings, Pediatrics 135(6):1036–1042, 2015.
  2328. Tundia NL, Heaton PC, Kelton CM: The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database, Pharmacoepidemiol Drug Saf 20(8):866–878, 2011.
  2329. Walsh KE, Roblin DW, Weingart SN, et al: Medication errors in the home: a multisite study of children with cancer, Pediatrics 131(5):e1405–e1414, 2013.
  2330. Weick KE, Sutcliffe KM: Managing the unexpected: resilient performance in an age of uncertainty, ed 2, San Francisco, 2007, Jossey-Bass.
  2331. Wheeler DS, Giaccone MJ, Hutchinson N, et al: A hospital-wide quality-improvement collaborative to reduce catheter-associated bloodstream infections, Pediatrics 128(4):e995–e1004, quiz e1004–e1007, 2011.
  2332. Wilson PF, Dell LD, Anderson GF: Root cause analysis: a tool for total quality management, Milwaukee, WI, 1993, ASQC Quality Press.
  2333. Winters BD, Weaver SJ, Pfoh ER, et al: Rapid-response systems as a patient safety strategy: a systematic review, Ann Intern Med 158(5 Pt 2):417–425, 2013.
  2334. Yin HS, Dreyer BP, van Schaick L, et al: Randomized controlled trial of a pictogram-based intervention to reduce liquid medication dosing errors and improve adherence among caregivers of young children, Arch Pediatr Adolesc Med 162(9):814–822, 2008.
  2335. Nomazulu Dlamini, MBBS, PhD, Assistant Professor of Pediatrics, University of Toronto Faculty of Medicine, Staff Physician in Neurology, Director, Children’s Stroke Program, Hospital for Sick Children, Toronto, Ontario, Canada
  2336. Sonam N. Dodhia, MD, Resident Physician, New York-Presbyterian Hospital, New York, New York
  2337. Patricia A. Donohoue, MD, Professor of Pediatrics, Chief, Pediatric Endocrinology, Medical College of Wisconsin, Medical Director, Pediatric Endocrinology, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin
  2338. Kevin J. Downes, MD, Assistant Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Attending Physician, Division of Infectious Diseases, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  2339. Alexander J. Doyle, MBBS, MDRes, FRCA, William Harvey Research Institute Barts and The London School of Medicine, Queen Mary University of London, London, United Kingdom
  2340. Daniel A. Doyle, MD, Associate Professor of Pediatrics Thomas Jefferson University Sidney Kimmel Medical College Philadelphia, Pennsylvania;, Chief, Division of Pediatric Endocrinology, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware
  2341. Jefferson J. Doyle, MBBChir, PhD, MHS, Assistant Professor of Ophthalmology, Wilmer Eye Institute, Johns Hopkins Hospital, Affiliate Member, Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
  2342. Stephen C. Dreskin, MD, PhD, Professor of Medicine and Immunology, Division of Allergy and Clinical Immunology, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado
  2343. Sherilyn W. Driscoll, MD, Division Chair, Pediatric Rehabilitation, Departments of Physical Medicine and Rehabilitation and Pediatric and Adolescent Medicine, Mayo Clinic Childrens Center Rochester, Minnesota
  2344. Yigal Dror, MD, FRCPC, Professor, Department of Pediatrics, University of Toronto Faculty of Medicine, Head, Hematology Section, Director, Marrow Failure and Myelodysplasia Program, The Hospital for Sick Children Toronto, Ontario, Canada
  2345. Jill N. D’Souza, MD, Assistant Professor, Baylor College of Medicine, Division of Pediatric Otolaryngology-Head and Neck Surgery, Texas Childrens Hospital Houston, Texas
  2346. Howard Dubowitz, MD, MS, FAAP, Professor of Pediatrics, Head, Division of Child Protection Director, Center for Families University of Maryland School of Medicine, Baltimore, Maryland
  2347. J. Stephen Dumler, MD, Professor and Chair, Joint Department of Pathology Uniformed Services University of the Health Sciences, Walter Reed National Military Medical Center, Bethesda, Maryland
  2348. Janet Duncan, MSN, CPNP, Department of Psychosocial Oncology and Palliative Care Boston Childrens Hospital Dana-Farber Cancer Institute Boston, Massachusetts
  2349. Jeffrey A. Dvergsten, MD, Assistant Professor of Pediatrics, Duke University School of Medicine Division of Pediatric Rheumatology Duke University Health System Durham, North Carolina
  2350. Michael G. Earing, MD, Professor of Internal Medicine and Pediatrics, Division of Adult Cardiovascular Medicine and Division of Pediatric Cardiology, Medical College of Wisconsin Director, Wisconsin Adult Congenital Heart Disease Program (WAtCH) Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  2351. Matthew D. Eberly, MD, Associate Professor of Pediatrics, Program Director, Pediatric Infectious Diseases Fellowship Uniformed Services University of the Health Sciences, Bethesda, Maryland
  2352. S. Derrick Eddy, MD, Sports Medicine Education Director Akron Children’s Hospital Clinical Assistant Professor of Pediatrics, Northeast Ohio Medical University Akron, Ohio
  2353. Marie E. Egan, MD, Professor of Pediatrics (Respiratory) and Cellular and Molecular Physiology, Director, Cystic Fibrosis Center Vice Chair for Research, Department of Pediatrics Yale School of Medicine New Haven, Connecticut
  2354. Jack S. Elder, MD, FACS, Chief of Pediatric Urology, Massachusetts General Hospital, Boston, Massachusetts
  2355. Blake MJ, Gaedigk A, Pearce RE, et al: Ontogeny of dextromethorphan O- and N-demethylation in the first year of life, ClinPharmacolTher 81:510–516, 2007.
  2356. Brown JT, Abdel-Rahman SR, van Haandel L, et al: Single dose, CYP2D6 genotype-stratified pharmacokinetic study of atomoxetine in children with ADHD, ClinPharmacolTher 99:642–650, 2016.
  2357. Chen N, Aleksa K, Woodland C, et al: Ontogeny of drug elimination by the human kidney, PediatrNephrol 21:160–168, 2006.
  2358. CYP3A and drug interactions: Med Lett Drugs Ther 47:54–55, 2005.
  2359. Feero WG, Guttmacher AE: Genomics, personalized medicine, and pediatrics, AcadPediatr 14:14–22, 2014.
  2360. Hines RN: The ontogeny of drug metabolism enzymes and implications for adverse drug events, PharmacolTher 118:250–267, 2008.
  2361. Hines RN: Developmental expression of drug metabolizing enzymes: impact on disposition in neonates and young children, Int J Pharmaceut 452:3–7, 2013.
  2362. Koren G, Cairns J, Chitayat D, et al: Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother, Lancet 368:704–705, 2006.
  2363. Leschziner GD, Andrew T, Pirmohamed M, Johnson MR: ABC1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research, Pharmacogenomics J 7:154–179, 2007.
  2364. Liu C, Yang W, Pei D, et al: Genomwide approach validates thiopurinemethyltransferase activity is a monogenic pharmacogenomics trait, ClinPharmacolTher 101:373–381, 2017.
  2365. Moriyama T, Nishii R, Perez-Andreu V, et al: NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity, Nat Genet 48:367–373, 2016.
  2366. Prasad B, Gaedigk A, Vrana M, et al: Ontogeny of hepatic drug transporters as quantified by LC-MS/MS proteomics, ClinPharmacolTher 100:362–370, 2016.
  2367. Prytula AA, Cransberg K, Bouts AH, et al: The effect of weight and CYP3A5 genotype on the population pharmacokinetics of tacrolimus in stable paediatric renal transplant recipients, ClinPharmacokinet 55:1129–1143, 2016.
  2368. Search Collaborative Group: SLCO1B1 variants and statin-induced myopathy: a genomewide study, N Engl J Med 359:789–799, 2008.
  2369. Sorich MJ, Pottier N, Pei D, et al: In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile, PLoS Med 5(4): e83, 2008.
  2370. Stevens JC, Marsh SA, Zaya MJ, et al: Developmental changes in human liver CYP2D6 expression, Drug MetabDisp 36:1587–1593, 2008.
  2371. Van Driest SL, McGregor TL: Pharmacogenetics in clinical paediatrics: challenges and strategies, Personalized Med 10:661–671, 2013.
  2372. Vear SI, Stein CM, Ho RH: Warfarin pharmacogenomics in children, Pediatr Blood Cancer 60:1402–1407, 2013.
  2373. Weiss ST, Litonjua AA, Lange C, et al: Overview of the pharmacogenetics of asthma treatment, Pharmacogenomics J 6:311–326, 2006.
  2374. Wilkinson GR: Drug metabolism and variability among patients in drug response, N Engl J Med 352:2211–2221, 2005.
  2375. Yang JJ, Cheng C, Yang W, et al: Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia, JAMA 301:393–403, 2009.
  2376. Zanger UM, Schwab M: Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation, PharmacolTher 138:103–141, 2013.
  2377. Brouwer KLR, Aleksunes LM, Brandys B, et al: Human ontogeny of drug transporters: review and recommendations of the Pediatric Transporter Working Group, Clin Pharmacol Ther 98:266–287, 2015.
  2378. Harskamp-van Ginkel MW, Hill KD, Becker KC, et al: Drug dosing and pharmacokinetics in children with obesity: a systematic review, JAMA Pediatr 169:678–685, 2015.
  2379. Neville KA, Becker ML, Goldman GL, Kearns JL: Developmental pharmacogenomics, Paediatr Anaesth 21:255–265, 2011.
  2380. Roberts JK, Stockmann C, Constance JE, et al: Pharmacokinetics and pharmacodynamics of antibacterials, antifungals and antivirals used most frequently in neonates and infants, Clin Pharmacokinet 53:581–610, 2014.
  2381. Smith RMD, Gargon E, Kirkham J, et al: Adverse drug reactions: a systematic review, PLoS ONE 2012 March 5.
  2382. Yaffe SJ, Aranda JV, editors: Neonatal and pediatric pharmacology: therapeutic principles in practice, ed 4, Philadelphia, 2011, Lippincott Williams & Wilkins
  2383. Al-alami AA, Zestos MM, Baraka AS: Pediatric laryngospasm: prevention and treatment, Curr Opin Anaesthesiol 22(3):388–395, 2009.
  2384. Allam S, Anderson KJ, O’Brien C, et al: Patient-maintained propofol sedation using reaction time monitoring: a volunteer safety study, Anaesthesia 68:154–158, 2013.
  2385. Bosenberg A: Benefits of regional anesthesia in children, Paediatr Anaesth 22(1):10–18, 2012.
  2386. Brady M, Kinn S, Ness V, et al: Preoperative fasting for preventing perioperative complications in children, Cochrane Database Syst Rev (4):CD005285, 2009.
  2387. Brown EN, Lydic R, Schiff ND: General anesthesia, sleep, and coma, N Engl J Med 363(27):2638–2650, 2010.
  2388. Campagna JA, Miller KW, Forman SA: Mechanisms of actions of inhaled anesthetics, N Engl J Med 348(21):2110–2124, 2003.
  2389. Ceelie I, de Wildt SN, van Dijk M, et al: Effect of intravenous paracetamol on postoperative morphine requirements in neonates and infants undergoing major noncardiac surgery, JAMA 309:149–154, 2013.
  2390. Chorney JM, Kain ZN: Family-centered pediatric perioperative care, Anesthesiology 112(3):751–755, 2010.
  2391. Cots CJ, Zaslavsky A, Downes JJ, et al: Postoperative apnea in former preterm infants after inguinal herniorrhaphy: a combined analysis, Anesthesiology 82(4):809–822, 1995.
  2392. Chrysostomou C, Schulman SR, Castellanos MH, et al: A phase II/III multicenter, safety, efficacy, and pharmacokinetic study of dexmedetomidine in preterm and term neonates, J Pediatr 164:276–282, 2014.
  2393. Dahmani S, Michelet D, Abback PS, et al: Ketamine for perioperative pain management in children: a meta-analysis of published studies, Paediatr Anaesth 21(6):636–652, 2011.
  2394. Davidson AJ, Morton NS, Arnup SJ, et al: Apnea after awake regional and general anesthesia in infants: the General Anesthesia Compared to Spinal Anesthesia Study—comparing apnea and neurodevelopmental outcomes, a randomized controlled trial, Anesthesiology 123(1):38–54, 2015.
  2395. De Oliveria GS Jr, Agarwal D, Benzon HT: Perioperative single dose ketorolac to prevent postoperative pain: a meta-analysis of randomized trials, Anesth Analg 114:424–433, 2012.
  2396. Gurnaney H, Brown A, Litman RS: Malignant hyperthermia and muscular dystrophies, Anesth Analg 109(4):1043–1048, 2009.
  2397. Kam PCA, Cardone D: Propofol infusion syndrome, Anaesthesia 62:690–701, 2007.
  2398. Klein EJ, Brown JC, Kobayashi A, et al: A randomized clinical trial comparing oral, aerosolized intranasal, and aerosolized buccal midazolam, Ann Emerg Med 58:323–329, 2011.
  2399. Kovac AL: Management of postoperative nausea and vomiting in children, Paediatr Drugs 9(1):47–69, 2007.
  2400. Malviya S, Swartz J, Lerman J: Are all preterm infants younger than 60 weeks postconceptual age at risk for postanesthetic apnea? Anesthesiology 78(6):1076–1081, 1993.
  2401. Mason KP, Lubisch N, Robinson F, et al: Intramuscular dexmedetomidine: an effective route of sedation preserves background activity for pediatric electroencephalograms, J Pediatr 161:927–932, 2012.
  2402. Niezgoda J, Morgan PG: Anesthetic considerations in patients with mitochondrial defects, Paediatr Anaesth 23:785–793, 2013.
  2403. Norman E, Wikstr?m S, Hellestr?m-Westas L, et al: Rapid sequence induction is superior to morphine for intubation of preterm infants: a randomized controlled trial, J Pediatr 159:893–898, 2011.
  2404. Reade MC, Eastwood GM, Bellomo R, et al: Effect of dexmedetomidine added to standard care on ventilator-free time in patients with agitated delirium: a randomized clinical trial, JAMA 315(14):1460–1468, 2016.
  2405. Sherer J, Salazar T, Schesing KB, et al: Diphenhydramine for acute extrapyramidal symptoms after propofol administration, Pediatrics 139(2):e20161135, 2017.
  2406. Strom S: Preoperative evaluation, premedication, and induction of anesthesia in infants and children, Curr Opin Anaesthesiol 25(3):321–325, 2012.
  2407. Strom T, Stylsvig M, Toft P: Long-term psychological effects of a no-sedation protocol in critically ill patients, Crit Care 15:R293, 2011.
  2408. Suresh S, Birmingham PK, Kozlowski RJ: Pediatric pain management, Anesthesiol Clin 30(1):101–117, 2012.
  2409. Tait AR, Voepel-Lewis T, Christiansen R, O’Brien LM: The STBUR questionnaire for predicting perioperative respiratory adverse events in children at risk for sleep-disordered breathing, Paediatr Anaesth 23(6):510–516, 2013.
  2410. Tobias JD: Dexmedetomidine and ketamine: an effective alternative for procedural sedation? Pediatr Crit Care Med 13(4):423–427, 2012.
  2411. Tobias J: Current evidence for the use of Suggamedex in children, Paediatr Anaesth 27(2):118–125, 2017.
  2412. Walther-Larsen S, Rasmussen LS: The former preterm infant and risk of post-operative apnoea: recommendations for management, Acta Anaesthesiol Scand 50:888–893, 2006.
  2413. Wilson W, Taubert KA, Gewitz M, et al: Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group, Circulation 116(15):1736–1754, 2007.
  2414. Wolf AR: Effects of regional analgesia on stress responses to pediatric surgery, Paediatr Anaesth 22(1):19–24, 2012.
  2415. Wong JM: Propofol infusion syndrome, Am J Ther 17(5):487–491, 2010
  2416. Coleman K, Robertson ND, Dissen GA, et al: Isoflurane anesthesia has longterm consequences on motor and behavioral development in infant rhesus macaques, Anesthesiology 126:74–84, 2017.
  2417. Davidson AJ, Disma N, de Graaff JC, et al: Neurodevelopmental outcome at 2 years of age after General Anaesthesia and Awake-Regional Anaesthesia in Infancy (GAS): an international multicentre, randomised controlled trial, Lancet 387:239–250, 2016.
  2418. Drake-Brockman TF, Ramgolam A, Zhang G, et al: The effect of endotracheal tubes versus laryngeal mask airways on perioperative respiratory adverse events in infants: a randomized controlled trial, Lancet 389:701–708, 2017.
  2419. Flick RP, Katusic SK, Colligan RC, et al: Cognitive and behavioral outcomes after early exposure to anesthesia and surgery, Pediatrics 128(5):e1053–e1061, 2011.
  2420. Kamat PP, Kudchadkar SR, Simon HK: Sedative and anesthetic neurotoxicity in infants and young children: not just an operating room concern, J Pediatr 204:285–290, 2019.
  2421. Montana MC, Evers AS: Anesthetic neurotoxicity: new findings and future directions, J Pediatr 181:279–285, 2017.
  2422. Raper J, Alvarado MC, Murphy KL, Baxter MG: Multiple anesthetic exposure in infant monkeys alters emotional reactivity to an acute stressor, Anesthesiology 123:1084–1092, 2015.
  2423. Sun L: Early childhood general anaesthesia exposure and neurocognitive development, Br J Anaesth 105(Suppl 1):i61–i68, 2010.
  2424. Sun LS, Li G, Miller TL, et al: Association between a single general anesthesia exposure before age 36 months and neurocognitive outcomes in later childhood, JAMA 315:2312–2320, 2016.
  2425. US Food and Drug Administration: General anesthetic and sedation drugs: drug safety communication. FDA approves label changes for use in young children.
  2426. Ydemann M, Nielsen BN, Henneberg S, et al: Intraoperative clonidine for prevention of postoperative agitation in children anaesthetized with sevoflurane (PREVENT AGITATION): a randomized, placebo-controlled, double-blind trial, Lancet Child Adolesc Health 2:15–24, 2018.
  2427. Cot? CJ, Wilson S: Guidelines for monitoring and management of pediatric patients before, during, and after sedation for diagnostic and therapeutic procedures: update 2016, Pediatrics 138(1):e20161212, 2016.
  2428. Cramton REM, Gruchala NE: Managing procedural pain in pediatric patients, CurrOpinPediatr 24:530–538, 2012.
  2429. Doctor K, Roback MG, Teach SJ: An update on pediatric hospital-based sedation, CurrOpinPediatr 25:310–316, 2013.
  2430. Harrison D, Beggs S, Stevens B: Sucrose for procedural pain management in infants, Pediatrics 130:918–925, 2012.
  2431. Havidich JE, Cravero JP: The current status of procedural sedation for pediatric patients in out-of-operating room locations, CurrOpinAnaesthesiol 25(4):453–460, 2012.
  2432. Krauss BS, Calligaris L, Green SM, Barbi E: Current concepts in management of pain in children in the emergency department, Lancet 387:83–92, 2016.
  2433. Langhan ML, Mallory M, Hertzog J, et al: Physiologic monitoring practices during pediatric procedural sedation: a report from the Pediatric Sedation Research Consortium, Arch PediatrAdolesc Med 166(11):990–998, 2012.
  2434. Sahyoun C, Krauss B: Clinical implications of pharmacokinetics and pharmacodynamics of procedural sedation agents in children, CurrOpinPediatr 24:225–232, 2012.
  2435. Tobias JD: Dexmedetomidine and ketamine: an effective alternative for procedural sedation?, Pediatr Crit Care Med 13(4):423–427, 2012.
  2436. Wetzel RC: Who is doing what to whom: a large prospective study of propofol anesthesia in children, AnesthAnalg 108(3):695–698, 2009.
  2437. Acupuncture, Med Lett 48:38, 2006.
  2438. Alhashemi JA, Daghistani MF: Effects of intraoperative i.v. acetaminophen vs i.m. meperidine on post-tonsillectomy pain in children, Br J Anaesth 96:790–795, 2006.
  2439. Allegaert K, Palmer GM, Anderson BJ: The pharmacokinetics of intravenous paracetamol in neonates: size matters most, Arch Dis Child 96:575–580, 2011.
  2440. American Academy of Pediatrics Committee on Fetus and Newborn and Section on Anesthesiology and Pain Medicine: Prevention and management of procedural pain in the neonate: an update, Pediatrics 137(2):e20154271, 2016.
  2441. American Pain Society: Guideline for the management of cancer pain in adults and children, Glenview, IL, 2005, American Pain Society.
  2442. American Pain Society Task Force on Pediatric Chronic Pain Management. Assessment and management of children with chronic pain, 2012. http://www.ampainsoc.org/advocacy/downloads/aps12-pcp.pdf.
  2443. Anand KJ, Willson DF, Berger J, et al: Tolerance and withdrawal from prolonged opioid use in critically ill children, Pediatrics 125:e1208–e1225, 2010.
  2444. Andavan GS, Lemmens-Gruber R: Voltage-gated sodium channels: mutations, chan-nelopathies and targets, Curr Med Chem 18:377–397, 2011.
  2445. Bang YJ, Yeo JS, Kim SO, Park YH: Sympathetic block for treating primary erythro-melalgia, Korean J Pain 23:55–59, 2010.
  2446. Becker G, Blum HE: Novel opioid antagonists for opioid-induced bowel dysfunction and postoperative ileus, Lancet 373:1198–1206, 2009.
  2447. Bhatt M, Johnson DW, Chan J, et al: Risk factors for adverse events in emergency department procedural sedation for children, JAMA Pediatr 171(10):957–964, 2017.
  2448. Blount RL, Bachanas PJ, Powers SW, et al: Training children to cope and parents to coach them during routine immunizations: effects on child, parent, and staff behaviors, Behav Ther 23:689–705, 1992.
  2449. Bosenberg A: Benefits of regional anesthesia in children, Paediatr Anaesth 22:10–18, 2012.
  2450. Breau LM, Burkitt C: Assessing pain in children with intellectual disabilities, Pain Res Manag 14:116–120, 2009.
  2451. Breau LM, Camfield CS, Symons FJ, et al: Relation between pain and self-injurious behavior in nonverbal children with severe cognitive impairments, J Pediatr 142:498–503, 2003.
  2452. Bredlau AL, McDermott MP, Adams HR, et al: Oral ketamine for children with chronic pain: a pilot phase 1 study, J Pediatr 163:194–200 e1, 2013.
  2453. Brent M, Lobato D, LeLeiko N: Psychological treatments for pediatric functional gastrointestinal disorders, J Pediatr Gastroenterol Nutr 48:13–21, 2009.
  2454. Brousseau DC, McCarver DG, Drendel AL, et al: The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis, J Pediatr 150:623–626, 2007.
  2455. Chapman CR, Lipschitz DL, Angst MS, et al: Opioid pharmacotherapy for chronic non-cancer pain in the United States: a research guideline for developing an evidence-base, J Pain 11:807–829, 2010.
  2456. Cheng X, Dib-Hajj SD, Tyrrell L, et al: Mutations at opposite ends of the DIII/S4-S5 linker of sodium channel Na V 1.7 produce distinct pain disorders, Mol Pain 6:24, 2010.
  2457. Chou R, Fanciullo GJ, Fine PG, et al: Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain, J Pain 10:113–130, 2009.
  2458. Cohen LL, Lemanek K, Blount RL, et al: Evidence-based assessment of pediatric pain, J Pediatr Psychol 33:939–955, 2008.
  2459. Colvin L, Forbes K, Fallon M: Difficult pain, BMJ 332:1081–1083, 2006.
  2460. Cregg R, Momin A, et al: Pain channelopathies, J Physiol 588:1897–1904, 2010.
  2461. Davis KD, Flor H, Greely HT, et al: Brain imaging tests for chronic pain: medical, legal and ethical issues and recommendations, Nat Rev Neurol 13:624–638, 2017.
  2462. Derry S, Wiffen P, Moore A: Topical nonsteroidal anti-inflammatory drugs for acute musculoskeletal pain, JAMA 315(8):813–814, 2016.
  2463. Diatchenko L, Slade GD, Nackley AG, et al: Genetic basis for individual variations in pain perception and the development of a chronic pain condition, Hum Mol Genet 14:135–143, 2005.
  2464. Dowell D, Haegerich TM, Chou R: CDC guideline for prescribing opioids for chronic pain—United States, 2016, MMWR 65(1):1–49, 2016.
  2465. Drendel AL, Gorelick MH, Weisman SJ, et al: A randomized clinical trial of ibuprofen versus acetaminophen with codeine for acute pediatric arm fracture pain, Ann Emerg Med 54:553–560, 2009.
  2466. Dworkin RH, O’Connor AB, Backonja M, et al: Pharmacologic management of neuropathic pain: evidence-based-recommendations, Pain 132:237–251, 2007.
  2467. Eccleston C, Fisher E, Law E, et al: Psychological interventions for parents of children and adolescents with chronic illness, Cochrane Database Syst Rev (4):CD009660, 2015.
  2468. Eccleston C, Malleson PN, Clinch J, et al: Chronic pain in adolescents: evaluation of a programme of interdisciplinary cognitive behaviour therapy, Arch Dis Child 88:881–885, 2003.
  2469. Eccleston C, Palermo TM, Williams AC, et al: Psychological therapies for the management of chronic and recurrent pain in children and adolescents, Cochrane Database Syst Rev (15):CD003968, 2009.
  2470. El-Tahtawy A, Kokki H, Reidenberg BE: Population pharmacokinetics of oxycodone in children 6 months to 7 years old, J Clin Pharmacol 46:433–442, 2006.
  2471. Finnerup NB, Sindrup SH, Jensen TS: Recent advances in pharmacological treatment of neuropathic pain, F1000 Med Rep 2:52, 2010.
  2472. Fisher E, Law E, Palermo TM, Eccleston C: Psychological therapies (remotely delivered) for the management of chronic and recurrent pain in children and adolescents, Cochrane Database Syst Rev (3):CD011118, 2015.
  2473. Freynhagen R, Bennett MI: Diagnosis and management of neuropathic pain, BMJ 339:b3002, 2009.
  2474. Greenland SK: The mindful child, New York, 2010, Free Press, Simon and Schuster.
  2475. Groenewald CB, Palermo TM: The price of pain: the economics of chronic adolescent pain, Pain Manag 5(2):61–64, 2015.
  2476. Groenewald CB, Rabbitts JA, Gebert JT, Palermo TM: Trends in opioid prescriptions among children and adolescents in the United States: a nationally representative study from 1996 to 2012, Pain 157(5):1021–1027, 2016.
  2477. Groenewald CB, Wright DR, Palermo TM: Health care expenditures associated with pediatric pain-related conditions in the United States, Pain 156(5):951–957, 2015.
  2478. Harrop JE: Management of pain in childhood, Arch Dis Child Educ Pract Ed 92:ep101–ep108, 2007.
  2479. Hassett AL, Hilliard PE, Goesling J, et al: Reports of chronic pain in childhood and adolescence among patients at a tertiary care pain clinic, J Pain 14(11):1390–1397, 2013.
  2480. Hechler T, Dobe M, Kosfelder J, et al: Effectiveness of a 3-week multimodal inpatient pain treatment for adolescents suffering from chronic pain: statistical and clinical significance, Clin J Pain 25:156–166, 2009.
  2481. Hermann C, Kim M, Blanchard EB: Behavioral and prophylactic pharmacological intervention studies of pediatric migraine: an exploratory meta-analysis, Pain 60:239–255, 1995.
  2482. Hijazi R, Taylor D, Richardson J: Effect of topical alkane vapocoolant spray on pain with intravenous cannulation in patients in emergency departments: randomized double blind placebo controlled trial, BMJ 228:b215, 2009.
  2483. Hilario MO, Terreri MT, et al: Nonsteroidal anti-inflammatory drugs: cyclooxygenase 2 inhibitors, J Pediatr (Rio J) 82:S206–S212, 2006.
  2484. Hoftun GB, Romundstad PR, Rygg M: Association of parental chronic pain with chronic pain in the adolescent and young adult: family linkage data from the HUNT study, JAMA Pediatr 167:61–69, 2013.
  2485. Huguet A, Miro J: The severity of chronic pediatric pain: an epidemiological study, J Pain 9:226–236, 2008.
  2486. Jahr JS, Lee VK: Intravenous acetaminophen, Anesthesiol Clin 28:619–645, 2010.
  2487. Jalan R, Williams R, Bernuau J: Paracetamol: are therapeutic doses entirely safe?, Lancet 368:2195–2196, 2006.
  2488. Jones VM: Acetaminophen injection: a review of clinical information, J Pain Palliat Care Pharmacother 25:340–349, 2011.
  2489. Kashikar-Zuck S, Ting TV, Arnold LM, et al: A randomized clinical trial of cognitive behavioral therapy for the treatment of juvenile fibromyalgia, Arthritis Rheum 64:297–305, 2012.
  2490. Kashikar-Zuck S, Vaught MH, Goldschneider KR, et al: Depression, coping, and functional disability in juvenile primary fibromyalgia syndrome, J Pain 3:412–419, 2002.
  2491. King S, Chambers CT, Huguet A, et al: The epidemiology of chronic pain in children and adolescents revisited: a systematic review, Pain 152:2729–2738, 2011.
  2492. Krane EJ, Mitchell D: Relieve your child’s chronic pain: a doctor’s program for easing headaches, abdominal pain, fibromyalgia, juvenile rheumatoid arthritis, and more, New York, 2005, Simon & Schuster.
  2493. Krauss BS, Calligaris L, Green SM, Barbi E: Current concepts in management of pain in children in the emergency department, Lancet 387:83–92, 2016.
  2494. Kroenke K: Management of chronic pain in the aftermath of the opioid backlash, JAMA 317(23):2365–2366, 2017.
  2495. Kyriacou DN: Opioid vs nonopioid acute pain management in the emergency department, JAMA 318(17):1655–1656, 2017.
  2496. Levy RL, Langer SL, Romano JM, et al: Cognitive mediators of treatment outcomes in pediatric functional abdominal pain, Clin J Pain 30(12):1033–1043, 2014.
  2497. Levy RL, Langer SL, van Tilburg MAL, et al: Brief telephone-delivered cognitive-behavioral therapy targeted to parents of children with functional abdominal pain: a randomized controlled trial, Pain 158(4):618–628, 2017.
  2498. Levy RL, Langer SL, Walker LS, et al: Twelve-month follow-up of cognitive behavioral therapy for children with functional abdominal pain, JAMA Pediatr 167:178–184, 2013.
  2499. Logan DE, Simons LE, Stein MJ, Chastain L: School impairment in adolescents with chronic pain, J Pain 9:407–416, 2008.
  2500. Lonnqvist PA: Regional anaesthesia and analgesia in the neonate, Best Pract Res Clin Anaesthesiol 24:309–321, 2010.
  2501. Marco CA, Plewa MC, Buderer N, et al: Self-reported pain sores in the emergency department: lack of association with vital signs, Acad Emerg Med 13:974–979, 2006.
  2502. Mathiesen O, Moiniche S, et al: Gabapentin and postoperative pain: a qualitative and quantitative systematic review, with focus on procedure, BMC Anesthesiol 7:6, 2007.
  2503. Maxwell LG, Kaufmann SC, Bitzer S, et al: The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study, Anesth Analg 100:953–958, 2005.
  2504. The Medical Letter: FDA warns against use of codeine and tramadol in children and breastfeeding women, Med Lett 59(1521):86–88, 2017.
  2505. The Medical Letter: Naldemedine (Symproic) for opioid-induced constipation, Med Lett 59(1535):196–198, 2017.
  2506. The Medical Letter: Naloxegol (Movantik) for opioid-induced constipation, Med Lett 57(1478):135–136, 2015.
  2507. The Medical Letter: Nonopioid drugs for pain, Med Lett 60:25–32, 2018.
  2508. Noel M, Groenewald CB, Beals-Erickson SE, et al: Chronic pain in adolescence and internalizing mental health disorders: a nationally representative study, Pain 157(6):1333–1338, 2016.
  2509. Palermo TM: Cognitive-behavioral therapy for chronic pain in children and adolescents, New York, 2012, Oxford University Press.
  2510. Palermo TM, Law EF, Fales J, et al: Internet-delivered cognitive behavioral treatment for adolescents with chronic pain and their parents: a randomized controlled multicenter trial, Pain 157(1):174–185, 2016.
  2511. Perez RS, Zollinger PE, Dijkstra PU, et al: Evidence based guidelines for complex regional pain syndrome type 1, BMC Neurol 10:20, 2010.
  2512. Pollock AB, Tegeler ML, Morgan V, Baumrucker SJ: Morphine to methadone conversion: an interpretation of published data, Am J Hospice Palliat Care 28:135–140, 2011.
  2513. Quigley C: The role of opioids in cancer pain, BMJ 331:825–829, 2005.
  2514. Ramamurthi RJ, Krane EJ: Local anesthetic pharmacology in pediatric anesthesia, Tech Reg Anesth Pain Manag 11:229–234, 2007.
  2515. Relieving Pain in America: a blueprint for transforming prevention, care, education, and research, Washington, DC, 2011, Institute of Medicine of the National Academies.
  2516. Rusy LM, Hainsworth KR, Nelson TJ, et al: Gabapentin use in pediatric spinal fusion patients: a randomized, double-blind, controlled trial, Anesth Analg 110:1393–1398, 2010.
  2517. Saarto T, Wiffen PJ: Antidepressants for neuropathic pain: a Cochrane review, J Neurol Neurosurg Psychiatry 81:1372–1373, 2010.
  2518. Schwartz GE: Testing the biopsychosocial model: the ultimate challenge facing behavioral medicine?, J Consult Clin Psychol 50:1040–1053, 1982.
  2519. Shann F: Suckling and sugar reduce pain in babies, Lancet 369:721–722, 2007.
  2520. Sharma A, Tallchief D, Blood J, et al: Perioperative pharmacokinetics of methadone in adolescents, Anesthesiology 115:1153–1161, 2011.
  2521. Sherry DD, Wallace CA, Kelley C, et al: Short- and long-term outcomes of children with complex regional pain syndrome type I treated with exercise therapy, Clin J Pain 15:218–223, 1999.
  2522. Slater SK, Kashikar-Zuck S, Allen JR, et al: Psychiatric comorbidity in pediatric chronic daily headache, Cephalalgia 32:1116–1122, 2012.
  2523. Stanford EA, Chambers CT, Biesanz JC, Chen E: The frequency, trajectories and predictors of adolescent recurrent pain: a population-based approach, Pain 138:11–21, 2008.
  2524. Straube S, Derry S, Moore RA, et al: Single dose oral gabapentin for established acute postoperative pain in adults, Cochrane Database Syst Rev (5):CD008183, 2010.
  2525. Symons FJ, Harper VN, McGrath PJ, et al: Evidence of increased non-verbal behavioral signs of pain in adults with neurodevelopmental disorders and chronic self-injury, Res Dev Disabil 30:521–528, 2009.
  2526. Ting TV, Haskes PJ, Schikler KN, et al: The role of benign joint hypermobility in the pain experience in juvenile fibromyalgia: an observational study, Pediatr Rheumatol 10:2012.
  2527. Uman LS, Chambers CT, McGrath PJ, et al: A systematic review of randomized controlled trials examining psychological interventions for needle-related procedural pain and distress in children and adolescents: an abbreviated Cochrane review, J Pediatr Psychol 33:842–854, 2008.
  2528. Viscusi ER: Patient-controlled drug delivery for acute postoperative pain management: a review of current and emerging technologies, Reg Anesth Pain Med 33:146–158, 2008.
  2529. Voepel-Lewis T, Malviya S, Tait AR, et al: A comparison of the clinical utility of pain assessment tools for children with cognitive impairment, Anesth Analg 106:72–78, 2008.
  2530. Von Baeyer CL, Spagrud LJ, McCormick JC, et al: Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children’s self-reports of pain intensity, Pain 143:223–227, 2009.
  2531. Walco GA, Dworkin RH, Krane EJ, et al: Neuropathic pain in children: special considerations, Mayo Clin Proc 85:S33–S41, 2010.
  2532. Walker LS, Zeman JL: Parental response to child illness behavior, J Pediatr Psychol 17:49–71, 1992.
  2533. Walker SM: Pain in children: recent advances and ongoing challenges, Br J Anaesth 101:101–110, 2008.
  2534. Waterhouse M, Tsao JC, Zeltzer LK: Commentary on the use of acupuncture in chronic pediatric pain, J Dev Behav Pediatr 30:69–71, 2009.
  2535. Weydert JA, Ball TM, Davis MF: Systematic review of treatments for recurrent abdominal pain, Pediatrics 111:e1–e11, 2003.
  2536. White A, Cummings M: Does acupuncture relieve pain?, BMJ 338:303–304, 2009.
  2537. Zeltzer LK, Zeltzer PM: Pain in children and young adults, Encino, CA, 2016, Shilysca Press.
  2538. Agency for Toxic Substances and Disease Registry (ATSDR): Toxicological profile for pyrethrins and pyrethroids, Atlanta, 2003, US Department of Health and Human Services, Public Health Service.
  2539. American Academy of Pediatrics Committee on Injury, Violence, and Poison Prevention: Poison treatment in the home, Pediatrics 112:1182–1185, 2003.
  2540. Bateman DN, Dear JW, Thanacoody HKR, et al: Reduction of adverse effects from intravenous acetylcysteine treatment for paracetamol poisoning: a randomized controlled trial, Lancet 383:697–704, 2014.
  2541. Benowitz NL: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics, Annu Rev Pharmacol Toxicol 49:57–71, 2009.
  2542. Benzonatate warning, Med Lett Drugs Ther 53:9–10, 2011.
  2543. Beuhler MC, Gala PK, Wolfe HA, et al: Laundry detergent “pod” ingestions: a case series and discussion of recent literature, Pediatr Emerg Care 29:743–747, 2013.
  2544. Boehnert MT, Lovejoy FH Jr: Value of the QRS duration vs the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants, N Engl J Med 313:474–479, 1985.
  2545. Boyer EW: Management of opioid analgesic overdose, N Engl J Med 367:146–154, 2012.
  2546. Boyer EW, Shannon M: The serotonin syndrome, N Engl J Med 352:1112–1120, 2005.
  2547. Brent J: Fomepizole for ethylene glycol and methanol poisoning, N Engl J Med 360:2216–2223, 2009.
  2548. Buckley NA, Dawson AH, Isbister GK: Serotonin syndrome, BMJ 347:f4572, 2013.
  2549. Budnitz DS, Lovegrove MC, Sapiano MRP, et al: Pediatric emergency department visits for buprenorphine/naloxone ingestion—United States, 2008–2015, MMWR 65(41):1148–1149, 2016.
  2550. Callier B, Pilote S, Castonquay A, et al: QRS widening and QT prolongation under bupropion: a unique cardiac electrophysiological profile, Fundam Clin Pharmacol 26:599–608, 2012.
  2551. Carlsson M, Cortes D, Jepsen S, et al: Severe iron intoxication treated with exchange transfusion, Arch Dis Child 93:321–322, 2008.
  2552. Centers for Disease Control and Prevention: Occupational phosphine gas poisoning at veterinary hospitals from dogs that ingested zinc phosphide—Michigan, Iowa, and Washington, 2006–2011, MMWR 61:286–288, 2012.
  2553. Centers for Disease Control and Prevention: Carbon monoxide exposures reported to poison centers and related hurricane Sandy–Northeastern United States, 2012, MMWR 61:2012.
  2554. Centers for Disease Control and Prevention: CDC grand rounds: Prescription drug overdoses—a U.S. epidemic, MMWR 61:10–12, 2012.
  2555. Centers for Disease Control and Prevention: Emergency department visits and hospitalizations for buprenorphine ingestion by children—United States, 2010–2011, MMWR 62(56):2013.
  2556. Centers for Disease Control and Prevention: Vital signs: overdoses of prescription opioid pain relievers and other drugs among women—United States, 1999–2010, MMWR 62:537–542, 2013.
  2557. Centers for Disease Control and Prevention: Acetyl fentanyl overdose fatalities—Rhode Island, March–May 2013, MMWR 62:703–704, 2013.
  2558. Centers for Disease Control and Prevention: Community-based opioid overdose prevention programs providing naloxone—United States, 2010, MMWR 61:101–105, 2012.
  2559. Centers for Disease Control and Prevention: Carbon monoxide exposures after Hurricane Ike: Texas, September 2008, MMWR 58:845–849, 2009.
  2560. Centers for Disease Control and Prevention: Carbon monoxide related deaths—United States, 1999–2004, MMWR 56:1309–1312, 2007.
  2561. Centers for Disease Control and Prevention: Gastrointestinal injuries from magnet ingestion in children—United States, 2003–2006, MMWR 55(48):1296–1300, 2006.
  2562. Centers for Disease Control and Prevention: Jimsonweed poisoning associated with a homemade stew—Maryland, 2008, MMWR 59:102–104, 2010.
  2563. Contini S, Scarpignato C: Caustic injury of the upper gastrointestinal tract: a comprehensive review, World J Gastroenterol 19(25):3918–3930, 2013.
  2564. Creswell PD, Meiman JG, Nehls-Lowe H, et al: Exposure to elevated carbon monoxide levels at an indoor ice arena—Wisconsin, 2014, MMWR 64(45):1267–1270, 2015.
  2565. Dart RC, Borron SW, Caravati EM, et al: Expert consensus guidelines for stocking of antidotes in hospitals that provide emergency care, Ann Emerg Med 54:386–391, 2009.
  2566. Dart RC, Rumack BH: Patient-tailored acetylcysteine administration, Ann Emerg Med 50:280–281, 2007.
  2567. Eddleston M, Buckley NA, Eyer P, et al: Management of acute organophosphorus pesticide poisoning, Lancet 371:597–606, 2008.
  2568. Eddleston M, Juszczak E, Buckley NA, et al: Multiple-dose activated charcoal in acute self-poisoning: a randomised controlled trial, Lancet 371:579–587, 2008.
  2569. Eggleston W, Marraffa JM, Stork CM, et al: Cardiac dysrhythmias after loperamide abuse—New York, 2008–2016, MMWR 65(45):1276, 2016.
  2570. Geib AJ, Babu K, Ewald MB, et al: Adverse effects in children after unintentional buprenorphine exposure, Pediatrics 118:1746–1751, 2006.
  2571. Geller RJ, Barthold C, Saiers JA, et al: Pediatric cyanide poisoning: causes, manifestations, management, and unmet needs, Pediatrics 118:2146–2158, 2006.
  2572. Hampton LM, Nguyen DB, Edwards JR, et al: Cough and cold medication adverse events after market withdrawal and labeling revision, Pediatrics 132:1047–1054, 2013.
  2573. Heard K: Acetylcysteine for acetaminophen poisoning, N Engl J Med 359:285–292, 2008.
  2574. Hendron D, Menagh G, Sandilands EA, et al: Tricyclic antidepressant overdose in a toddler treated with intravenous lipid emulsion, Pediatrics 128:e1628–e1632, 2011.
  2575. Kelly LE, Rieder M, van den Anker J, et al: More codeine fatalities after tonsillectomy in North American children, Pediatrics 129:e1343–e1347, 2012.
  2576. Khine H, Weiss D, Graber N, et al: A cluster of children with seizures caused by camphor poisoning, Pediatrics 123:1269–1272, 2009.
  2577. Kim HK, Smiddy M, Hoffman RS, et al: Buprenorphine may not be as safe as you think: a pediatric fatality from unintentional exposure, Pediatrics 130:e1700–e1703, 2012.
  2578. Kivist JE, Mattilia VM, Arvola T, et al: Secular trends in poisoning leading to hospital admission among Finnish children and adolescents between 1971 and 2005, J Pediatr 153:820–824, 2008.
  2579. Klein-Schwartz W: Trends and toxic effects from pediatric clonidine exposures, Arch Pediatr Adolesc Med 156:392–396, 2002.
  2580. Koren G: Protecting young children from life-threatening drug toxicity, J Pediatr 163:1249–1250, 2013.
  2581. Kostic MA, Gorelick M: Review of the use of lipid emulsion in non-local anesthetic poisoning, Pediatr Emerg Care 30(6):427–433, 2014.
  2582. Lavonas EJ, Banner W, Brandt P, et al: Root causes, clinical effects, and outcomes of unintentional exposures to buprenorphine by young children, J Pediatr 163: 1377–1383, 2013.
  2583. Levine M, Boyer EW, Pozner CN, et al: Assessment of hyperglycemia after calcium channel blocker overdoses involving diltiazem or verapamil, Crit Care Med 35: 2071–2075, 2007.
  2584. Levine M, Brooks DE, Franken A, et al: Delayed-onset seizure and cardiac arrest after amitriptyline overdose, treated with intravenous lipid emulsion therapy, Pediatrics 130:e432–e438, 2012.
  2585. Liebelt EL, Francis PD, Woolf AD: ECG lead aVR versus QRS interval in predicting seizures and arrhythmias in acute tricyclic antidepressant toxicity, Ann Emerg Med 26:195–201, 1995.
  2586. Litovitz T, Whitaker N, Clark L, et al: Emerging battery-ingestion hazard: clinical implications, Pediatrics 125(6):1168–1177, 2010.
  2587. Lynch RE, Hack RA: Methadone-induced rigid-chest syndrome after substantial overdose, Pediatrics 126:e232–e234, 2010.
  2588. Madadi P, Hildebrandt D, Gong IY, et al: Fatal hydrocodone overdose in a child: pharmacogenetics and drug interactions, Pediatrics 126:e986–e989, 2010.
  2589. MacDonald N, MacLeod SM: Has the come to phase out codeine?, CMAJ 183(1):84–85, 2010.
  2590. The Medical Letter: Acetylcysteine (Cetylev) for acetaminophen overdose, Med Lett 59(1523):101–102, 2017.
  2591. Mowry JB, Spyker DA, Cantilena LR Jr, et al: 2008 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 30th annual report, Clin Toxicol (Phila) 51:949–11229, 2013.
  2592. Mowry JB, Spyker DA, Brooks DE, et al: 2015 Annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 33rd annual report, Clin Toxicol (Phila) 54:924–1109, 2016.
  2593. Okie S: A flood of opioids, a rising tide of deaths, N Engl J Med 363:1981–1983, 2010.
  2594. Osterhoudt KC, Durbin D, Alpern ER, et al: Risk factors for emesis after therapeutic use of activated charcoal in acutely poisoned children, Pediatrics 113:806–810, 2004.
  2595. Paul IM, Reynolds KM, Kauffman RE, et al: Adverse events associated with pediatric exposures to dextromethorphan, Clin Toxicol 55(1):25–32, 2017.
  2596. Pawar KS, Bhoite RR, Pillay CP, et al: Continuous pralidoxime infusion versus repeated bolus injection to treat organophosphorus pesticide poisoning: a randomized controlled trial, Lancet 368:2136–2140, 2006.
  2597. Rayar P, Ratnapalan S: Pediatric ingestions of house hold products containing ethanol: a review, Clin Pract 52(3):203–209, 2015.
  2598. Rimsza ME, Newberry S: Unexpected infant deaths associated with use of cough and cold medications, Pediatrics 122:e318–e322, 2008.
  2599. Roberts DM, Aaron CK: Managing acute organophosphorus pesticide poisoning, BMJ 334:629–634, 2007.
  2600. Santos C, Kieszak S, Wang A, et al: Reported adverse health effects in children from ingestion of alocohol-based hand sanitizers—United States, 2011–2014, MMWR 66(8):223–226, 2017.
  2601. Schillie SF, Shehab N, Thomas KE, et al: Medication overdoses leading to emergency department visits among children, Am J Prev Med 37:181–187, 2009.
  2602. Shehab N, Schaefer MK, Kegler SR, et al: Adverse events from cough and cold medications after market withdrawal of products labeled for infants, Pediatrics 126:1100–1107, 2010.
  2603. Vale A, Bradberry S: Assessment and diagnosis of the poisoned patient, Medicine (Baltimore) 44(2):82–86, 2015.
  2604. Walley AY, Xuan Z, Hackman HH, et al: Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis, BMJ 2013.
  2605. Weaver LK: Carbon monoxide poisoning, N Engl J Med 360:1217–1224, 2009.
  2606. Williams JF, Kokotailo PK: Abuse of proprietary (over-the-counter) drugs, Adolesc Med Clin 17(3):733–750, abstract xiii, 2006.
  2607. American Academy of Pediatrics Section on Integrative Medicine
  2608. Academic Consortium Integrative Medicine and Health
  2609. National Institutes of Health, National Center for Complementary and Integrative Health
  2610. American Pain Society; pediatric chronic pain programs by state
  2611. Ammerman S, Ryan S, et al: Committee on Substance Abuse, Committee on Adolescence: The impact of marijuana policies on youth: clinical, research, and legal update, Pediatrics 135:769–785, 2015.
  2612. Asher GN, Corbett AH, Hawke RL: Common herbal dietary supplement: drug interactions, Am Fam Physician 96(2):101–107, 2017.
  2613. Birdee GS, et al: Factors associated with pediatric use of complementary and alternative medicine, Pediatrics 125:249–256, 2010.
  2614. Black LI, Clarke TC, et al: Use of complementary health approaches among children aged 4-17 years in the United States: National Health Interview Survey, 2007–2012, Natl Health Stat Rep 78:1–19, 2015.
  2615. Cotton S, Luberto C, et al: Integrative care therapies and pain in hospitalized children and adolescents: a retrospective database review, J Altern Complement Med 20:98–102, 2014.
  2616. Diego MA, Field T, et al: Preterm infant weight gain is increased by massage therapy and exercise via different underlying mechanisms, Early Hum Dev 90:137–140, 2014.
  2617. Eisenberg D, Kaptchuk T, et al: Establishing an integrative medicine program within an academic health center: essential considerations, Acad Med 91:1223–1230, 2016.
  2618. Gardiner P, Adams D, Filippelli AC, et al: A systematic review of the reporting of adverse events associated with medical herb use among children, Glob Adv Health Med 2:46–55, 2013.
  2619. Hawk C, Schneider M, et al: Best practices for chiropractic care of children: a consensus update, J Manipulative Physiol Ther 39(3):158–168, 2016.
  2620. Hoffenberg E, Newman H, et al: Cannabis and pediatric inflammatory bowel disease: change blossoms a mile high, J Pediatr Gastroenterol Nutr 64(2):265–271, 2017.
  2621. Kemper KJ, Vohra S, Walls R: American Academy of Pediatrics. The use of complementary and alternative medicine in pediatrics, Pediatrics 122(6):1374–1386, 2008.
  2622. Leiby A, Vazirani M: Complementary, integrative, and holistic medicine: integrative approaches to pediatric irritable bowel syndrome, Pediatr Rev 37(4):10–15, 2016.
  2623. Levi JR, Brody RM, McKee-Cole K, et al: Complementary and alternative medicine for pediatric otitis media, Int J Pediatr Otorhinolaryngol 77(6):926–931, 2013.
  2624. Morrow JD, Edeki TI, El Mouelhi M, et al: American Society for Clinical Pharmacology and Therapeutics position statement on dietary supplement safety and regulation, Clin Pharmacol Ther 77(3):113–122, 2005.
  2625. Rao N, Spiller HA, Hodges NL, et al: An increase in dietary supplement exposures reported to US poison control centers, J Med Toxicol 13(3):227–237, 2017.
  2626. Shen J, Oraka E: Complementary and alternative medicine (CAM) use among children with current asthma, Prev Med 54(1):27–31, 2012.
  2627. Sibinga EM, Kemper KJ: Complementary, holistic, and integrative medicine: meditation practices for pediatric health, Pediatr Rev 31(12):e91–e103, 2010.
  2628. Tsai HH, Lin HW, Pickard AS, et al: Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review, Int J Clin Pract 66:1056–1078, 2012.
  2629. Vinson R, Yeh G, et al: Correlates of complementary and alternative medicine use in a pediatric tertiary pain center, Acad Pediatr 14(5):491–496, 2014.
  2630. Vohra S, Surette S, Mittra D, et al: Pediatric integrative medicine: pediatrics’ newest subspecialty?, BMC Pediatr 12:123, 2012.
  2631. Wang GS, Le Lait MC, et al: Unintentional pediatric exposures to marijuana in Colorado, 2009–2015, JAMA Pediatr 170(9):2016.
  2632. Zorzela L, Vohra S: Children and spinal manipulation therapy: ask your patients about all the therapies they seek, Pediatr Child Health 14(6):388, 2009.
  2633. Elizabeth Englander, PhD, Professor of Psychology, Founder and Director, Massachusetts, Aggression Reduction Center, Bridgewater State University, Bridgewater, Massachusetts
  2634. Elizabeth Enlow, MD, MS, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Neonatology Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  2635. Stephen C. Eppes, MD, Professor of Pediatrics, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania; Vice Chair, Department of Pediatrics Division of Pediatric Infectious Diseases, Christiana Care Health System, Newark, Delaware
  2636. Jessica Ericson, MD, Assistant Professor of Pediatrics, Pennsylvania State University College of Medicine, Division of Pediatric Infectious Disease, Milton S. Hershey Medical Center, Hershey, Pennsylvania
  2637. ElifErkan, MD, MS, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Pediatric Nephrology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2638. Yokabed Ermias, MPH, Fellow, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
  2639. Ashley M. Eskew, MD, Fellow, Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  2640. Ruth A. Etzel, MD, PhD, Milken Institute School of Public Health, George Washington University, Washington, DC
  2641. Matthew P. Fahrenkopf, MD, Plastic Surgery Resident, Spectrum Health Hospitals Michigan State University Grand Rapids, Michigan
  2642. Marni J. Falk, MD, Associate Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Executive Director, Mitochondrial Medicine Frontier Program, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  2643. John J. Faria, MD, Assistant Professor of Otolaryngology and Pediatrics, University of Rochester, Rochester, New York
  2644. John H. Fargo, DO, Division of Pediatric Hematology/Oncology, Showers Family Center for Childhood Cancer and Blood Disorders, Akron Children’s Hospital Akron, Ohio
  2645. Kristen A. Feemster, MD, MPH, MSPHR, Director of Research for the Vaccine Education Center, Children’s Hospital of Philadelphia Medical Director of the Immunization Program and Acute Communicable Diseases, Philadelphia Department of Public Health, Adjunct Associate Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
  2646. Susan Feigelman, MD, Professor, Department of Pediatrics University of Maryland School of Medicine, Baltimore, Maryland
  2647. Jeffrey A. Feinstein, MD, MPH, Dunlevie Family Professor of Pulmonary Vascular Disease Division of Pediatric Cardiology Stanford University School of Medicine, Professor, by courtesy, of Bioengineering, Medical Director, Pediatric Pulmonary Hypertension Program Lucile Packard Children’s Hospital at Stanford, Palo Alto, California
  2648. Amy G. Feldman, MD, MSCS, Assistant Professor of Pediatrics University of Colorado School of Medicine, Denver, Colorado; Program Director, Liver Transplant, Fellowship, Childrens Hospital Colorado Research Institute, Aurora, Colorado
  2649. Eric I. Felner, MD, MS, Professor of Pediatrics, Division of Pediatric Endocrinology, Director, Pediatric Clerkships, Emory University School of Medicine, Atlanta, Georgia
  2650. Edward C. Fels, MD, Clinical Assistant Professor of Medicine, Tufts University School of Medicine Boston, Massachusetts; Maine Medical Center, Portland, Maine
  2651. Sing-Yi Feng, MD, FAAP, Associate Professor, Division of Emergency Medicine, Department of Pediatrics, Children’s Medical Center of Dallas, Medical Toxicologist, North Texas Poison Center, Parkland Memorial Hospital, The University of Texas Southwestern, Medical Center at Dallas, Dallas, Texas
  2652. Thomas W. Ferkol Jr, MD, Alexis Hartmann Professor of Pediatrics, Director, Division of Pediatric, Allergy, Immunology, and Pulmonary Medicine, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  2653. Karin E. Finberg MD, PhD, Assistant Professor, Department of Pathology, Yale School of Medicine, New Haven, Connecticut
  2654. Jonathan D. Finder, MD, Professor of Pediatrics, The University of Tennessee Health Science Center, Attending Pediatric Pulmonologist Division of Pediatric Pulmonology Le Bonheur Children’s Hospital Memphis, Tennessee
  2655. Laura H. Finkelstein, MD, Assistant Professor, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland
  2656. Kristin N. Fiorino, MD, Associate Professor of Clinical, Pediatrics, Suzie and Scott Lustgarten, Motility Center, Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia University of Pennsylvania Perelman School of Medicine
  2657. Philip R. Fischer, MD, Professor of Pediatrics, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
  2658. Brian T. Fisher, DO, MSCE, Assistant Professor of Pediatrics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Fellowship Program Director Division of Infectious Diseases, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  2659. Veronica H. Flood, MD, Associate Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin
  2660. Francisco X. Flores, MD, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Medical Director, Clinical Services and MARS Program, Division of Nephrology and Hypertension, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2661. Joseph T. Flynn, MD, MS, Dr. Robert O. Hickman Endowed, Chair in Pediatric Nephrology Professor of Pediatrics, University of Washington School of Medicine, Chief, Division of Nephrology, Seattle Childrens Hospital, Seattle, Washington
  2662. Patricia M. Flynn, MD, Senior Vice President and Medical, Director of Quality and Patient Care, Deputy Clinical Director, Member, Department of Infectious Diseases, Arthur Ashe Chair in Pediatric AIDS Research, St. Jude Childrens Research Hospital Memphis, Tennessee
  2663. Joel A. Forman, MD, Associate Professor of Pediatrics and Preventive Medicine, Vice-Chair for Education, Department of Pediatrics, Kravis Children’s Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  2664. Michael M. Frank, MD, Professor Emeritus of Pediatrics, Medicine, and Immunology, Duke University School of Medicine, Durham, North Carolina
  2665. Robert W. Frenck Jr, MD, Professor of Pediatrics, University of Cincinnati College of Medicine, Medical Director, Division of Infectious Diseases, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2666. Deborah M. Friedman, MD, Pediatric Cardiology, New York Medical College, Maria Fareri Children’s Hospital Westchester Medical Center, Valhalla, New York
  2667. Erika Friehling, MD, Assistant Professor of Pediatrics University of Pittsburgh School of Medicine, Division of Pediatric Hematology/Oncology, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  2668. American Academy of Pediatrics: Palliative care for children, Pediatrics 106:351–357, 2000.
  2669. Berde CB, Sethna NF: Analgesics for the treatment of pain in children, N Engl J Med 347:1094–1103, 2002.
  2670. Contro NA, Larson J, Scofield S, et al: Hospital staff and family: perspectives regarding quality of pediatric palliative care, Pediatrics 114:1248–1252, 2004.
  2671. Durall A, Zurakowski D, Wolfe J: Barriers to conducting advance care discussions for children with life-threatening conditions, Pediatrics 129(4):e975–e982, 2012.
  2672. Feudtner C, Kang TI, Hexem KR, et al: Pediatric palliative care patients: a prospective multicenter cohort study, Pediatrics 127(6):1094–1101, 2011.
  2673. Field MJ, Behrman RE, editors: When children die: improving palliative and end-of-life care for children and their families, Washington, DC, 2003, National Academies Press.
  2674. Kavalieratos D, Corbelli J, Zhang D, et al: Association between palliative care and patient and caregiver outcomes: a systematic review and meta-analysis, JAMA 316(20):2104–2114, 2016.
  2675. Kreicbergs U, Valdimarsd?ttir U, Onel?v E, et al: Talking about death with children who have severe malignant disease, N Engl J Med 351:1175–1186, 2004.
  2676. The Lancet: Guidance for clinicians involved in end-of-life care of children, Lancet 385:1261, 2015.
  2677. Liben S, Papadatou D, Wolfe J: Paediatric palliative care: challenges and emerging ideas, Lancet 371:852–864, 2008.
  2678. Parravicini E: Neonatal palliative care, Curr Opin Pediatr 29:135–140, 2017.
  2679. Quill TE, Abernethy AP: Generalist plus specialist palliative care: creating a more sustainable model, N Engl J Med 368(13):1173–1175, 2013.
  2680. Rosenberg AR, Wolfe J: Approaching the third decade of paediatric palliative oncology investigation: historical progress and future directions, Lancet 1:56–66, 2017.
  2681. Temel JS, Greer JA, Muzikansky A, et al: Early palliative care for patients with metastatic non-small-cell lung cancer, N Engl J Med 363(8):733–742, 2010.
  2682. Wolfe J, Orellana L, Ullrich C, et al: Symptoms and distress in children with advanced cancer: prospective patient-reported outcomes from the PediQUEST Study, J Clin Oncol 33(17):1928–1935, 2015.
  2683. Stephanie A. Fritz, MD, MSCI, Associate Professor of Pediatrics, University of Washington School of Medicine in St. Louis, Division of Infectious Diseases, St. Louis Children’s Hospital, St. Louis, Missouri
  2684. Donald P. Frush, MD, FACR, FAAP, Professor of Radiology, Lucile Packard Children’s Hospital at Stanford, Stanford University School of Medicine Stanford, California
  2685. Anne M. Gadomski, MD, MPH Director, Bassett Research Institute Bassett Medical Center Cooperstown, New York;, Associate Professor of Pediatrics Columbia University Medical Center New York, New York
  2686. James T. Gaensbauer, MD, MScPH Assistant Professor of Pediatrics University of Colorado School of Medicine, Pediatric Infectious Diseases, Denver Health Medical Center and Children’s Hospital Colorado Denver, Colorado
  2687. American Academy of Pediatrics, Committee on Community Health Services: : The pediatrician’s role in community pediatrics, Pediatrics 115(4):1092–1094, 2005. Reaffirmed in Pediatrics 125(4):e978, 2010.
  2688. American Academy of Pediatrics, Committee on Practice and Ambulatory Medicine, Bright Futures Steering Committee: Recommendations for preventive pediatric health care, Pediatrics 139(4):e20170254, 2017.
  2689. American Academy of Pediatrics, Council on Children with Disabilities, Section on Developmental Behavioral Pediatrics: Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening, Pediatrics 118:405–420, 2006. Reaffirmed in Pediatrics 134(5):e1520, 2014.
  2690. American Academy of Pediatrics, Council on Children with Disabilities, Johnson CP, Myers SM: Identification and evaluation of children with autism spectrum disorders, Pediatrics 120:1183–1215, 2007. Reaffirmed in Pediatrics 134(5):e1520, 2014.
  2691. American Academy of Pediatrics, Council on Communications and Media: Children and adolescents and digital media, Pediatrics 2016. doi:10.1542/peds.2016-2593.
  2692. American Academy of Pediatrics, Council on Early Childhood, High PC, Klass P: Literacy promotion: an essential component of primary care pediatric practice, Pediatrics 2014. doi:10.1542/peds.2014-1384.
  2693. American Academy of Pediatrics, Medical Home Initiatives for Children with Special Needs Project, Advisory Committee: The medical home, Pediatrics 110:184–186, 2002. Reaffirmed in Pediatrics 122(2):450, 2008.
  2694. Duncan P, Frankowski B, Carey P, et al: Improvement in adolescent screening and counseling rates for risk behaviors and developmental tasks, Pediatrics 130(5):e1345–e1351, 2012.
  2695. Garner AS, Saul RA: Thinking developmentally: nurturing wellness in childhood to promote lifelong health, Itasca, IL, 2018, American Academy of Pediatrics.
  2696. Garner AS, Shonkoff JP, Siegel BS, et al: Early childhood adversity, toxic stress, and the role of the pediatrician: translating developmental science into lifelong health, Pediatrics 129:e224, 2012.
  2697. Hagan JF, Shaw JS, Duncan PM, editors: Bright futures: guidelines for health supervision of infants, children, and adolescents, ed 4, Elk Grove Village, IL, 2017, American Academy of Pediatrics.
  2698. McAllister JW, et al: Achieving a shared plan of care for children and youth with special health care needs, Palo Alto, CA, 2014, The Lucille Packard Foundation for Children’s Health.
  2699. American Academy of Pediatrics: Committee on injury, Violence, and poison prevention: policy statement—role of the pediatrician in youth violence prevention?, Pediatrics 124:393–402, 2009.
  2700. American Academy of Pediatrics: Committee on injury, Violence, and poison prevention, Committee on adolescence: the teen driver, Pediatrics 118:2570–2581, 2006.
  2701. Balan B, Lingam L: Unintentional injuries among children in resource poor settings: where do the fingers point?, Arch Dis Child 97(1):35–38, 2012.
  2702. Barry CL, Webster DW, Stone E, et al: Public support for gun violence prevention policies among gun owners and non-gun owners, Am J Public Health 108(7):878–881, 2018.
  2703. Brenner RA, Taneja GS, Haynie DL: Association between swimming lessons and drowning in childhood: a case-control study, Arch Pediatr Adolesc Med 163:203–210, 2009.
  2704. Bull MJ, Engle WA: Committee on injury, Violence, and poison prevention and committee on fetus and newborn: safe transportation of preterm and low birth weight infants at hospital discharge, Pediatrics 123(5):1424–1429, 2009.
  2705. Centers for Disease Control and Prevention: CDC grand rounds: reducing severe traumatic brain injury in the United States, MMWR Morb Mortal Wkly Rep 62(27):549–552, 2013.
  2706. Centers for Disease Control and Prevention: Drowsy driving—19 states and the district of columbia 2009–2010, MMWR Morb Mortal Wkly Rep 61(51/52):1033–1037, 2013.
  2707. Centers for Disease Control and Prevention: Firearm homicides and suicides in major metropolitan areas—United States, 2006–2007 and 2009–2010, MMWR Morb Mortal Wkly Rep 62(30):597–602, 2013.
  2708. Centers for Disease Control and Prevention: Helmet use among motorcyclists who died in crashes and economic cost savings associated with state motorcycle helmet laws — United States, 2008–2010, MMWR Morb Mortal Wkly Rep 61(23):425–430, 2012.
  2709. Centers for Disease Control and Prevention: Homicide rates among persons aged 10–24 years—United States, 1981–2010, MMWR Morb Mortal Wkly Rep 62(27):545–552, 2013.
  2710. Centers for Disease Control and Prevention: Mobile device use while driving—United States and seven European countries, MMWR Morb Mortal Wkly Rep 62(10):177–182, 2013, 2011.
  2711. Centers for Disease Control and Prevention: Motor vehicle crash deaths in metropolitan areas—United States, MMWR Morb Mortal Wkly Rep 61(28):523–528, 2012, 2009.
  2712. Centers for Disease Control and Prevention: Surveillance for violent deaths—national violent death reporting system, 18 states, MMWR Morb Mortal Wkly Rep 67(2):1–31, 2018, 2014.
  2713. Centers for Disease Control and Prevention: Vital signs: unintentional injury deaths among persons aged 0–19 years—United States, 2000–2009, MMWR Morb Mortal Wkly Rep 61(15):270–276, 2012.
  2714. Chapman S, Alpers P, Jones M: Association between gun law reforms and intentional firearm deaths in Australia, 1979–2013, JAMA 316(3):291–299, 2016.
  2715. Committee on Injury, Violence, and Poison Prevention, Durbin DR: Child passenger safety, Pediatrics 127(4):788–793, 2011.
  2716. David-Ferdon C, Simon TR, Spivak H, et al: CDC grand rounds: preventing youth violence, MMWR Morb Mortal Wkly Rep 64(7):171–174, 2015.
  2717. Dennis J, Ramsay T, Turgeon AF, et al: Helmet legislation and admissions to hospital for cycling related head injuries in Canadian provinces and territories: interrupted time series analysis, BMJ 346:15, 2013.
  2718. Dowd MD: Firearm injury prevention in clinical practice: staying on message, J Pediatr 179:15–17, 2016.
  2719. Fowler KA, Dahlberg LL, Haileyesus T, et al: Childhood firearm injuries in the United States, Pediatrics 140(1):e20163486, 2017.
  2720. Haagsma JA, Graetz N, Bolliger I, et al: The global burden of injury: incidence, mortality, disability-adjusted life years and time trends from the global burden of disease study, Inj Prev 22(1):3–18, 2016, 2013.
  2721. Huang P, Kallan MJ, O’Neil J, et al: Children with special health care needs: patterns of safety restraint use, seating position, and risk of injury in motor vehicle crashes, Pediatrics 123:518–523, 2009.
  2722. Johnson BD: A safer world, Inj Prev 22(1):1–2, 2016.
  2723. Kalesan B, Mobily ME, Keiser O, et al: Firearm legislation and firearm mortality in the USA: a cross-sectional, state-level study, Lancet 387:1847–1854, 2016.
  2724. Keim SA, Fletcher EN, TePoel MR, et al: Injuries associated with bottles, pacifiers, and sippy cups in the United States, 1991–2010, Pediatrics 129(6):1104–1110, 2012.
  2725. Kendrick D, Young B, Mason-Jones AJ, et al: Home safety education and provision of safety equipment for injury prevention, Cochrane Database Syst Rev (9):CD005014, 2012.
  2726. Klauer SG, Guo F, Simons-Morton BG, et al: Distracted driving and risk of road crashes among novice and experienced drivers, N Engl J Med 370(1):54–59, 2014.
  2727. The Lancet: Reducing road dangers, Lancet 377:2011, 1543.
  2728. Meehan WP 3rd, Lee LK, Fischer CM, et al: Bicycle helmet laws are associated with a lower fatality rate from bicycle-motor vehicle collisions, J Pediatr 163(3):726–729, 2013.
  2729. Miller M, Barber C, White RA, et al: Firearms and suicide in the United States: is risk independent of underlying suicidal behavior?, Am J Epidemiol 178(6):946–955, 2013.
  2730. Newgard CD, Kupperman N, Holmes JF, et al: Gunshot injuries in children saved by emergency services, Pediatrics 132(5):862–870, 2013.
  2731. Palfrey JS, Palfrey S: Preventing gun deaths in children, N Engl J Med 368(5):401–403, 2013.
  2732. Peden M, Oyegbite K, Ozanne-Smith J, et al, editors: World report on child injury prevention, Geneva, 2008, World Health Organization.
  2733. QuickStats: Age-adjusted rates for homicides, by race/ethnicity—United States, 1999–2015, MMWR Morb Mortal Wkly Rep 66:839, 2017.
  2734. Shields BJ, Pollack-Nelson C, Smith GA: Pediatric submersion events in portable above-ground pools in the United States, 2001–2009, Pediatrics 128(1):45–52, 2011.
  2735. Shults RA, Williams AF: Graduated driver licensing night driving restrictions and drivers aged 16 or 17 years involved in fatal night crashes—United States, 2009–2014, MMWR Morb Mortal Wkly Rep 65(29):725–728, 2016.
  2736. Taichman DB, Bauchner H, Drazen JM, et al: Firearm-related injury and death—a US health care crisis in need of health care professionals, JAMA 318(19):2017, 1875.
  2737. Tyler MD, Richards DB, Reske-Nielsen C, et al: The epidemiology of drowning in low- and middle-income countries: a systematic review, BMC Public Health 17(1):2017.
  2738. Wolf LL, Chowdhury R, Tweed J, et al: Factors associated with pediatric mortality from motor vehicle crashes in the United States: a state-based analysis, J Pediatr 187:295–302, 2017.
  2739. Alio AP, Nana PN, Salihu HM: Spousal violence and potentially preventable single and recurrent spontaneous fetal loss in an African setting: cross-sectional study, Lancet 373:318–324, 2009.
  2740. American Academy of Pediatrics, Committee on Public Education: Media violence, Pediatrics 108:1222–1226, 2001.
  2741. American Academy of Pediatrics: Children and disasters.
  2742. Augustyn M, Groves BM: Training clinicians to identify the hidden victims: children and adolescents who witness violence, Am J Prev Med 29(5 Suppl 2):272–278, 2005.
  2743. Barr SC, Hanson R, Begle AM, et al: Examining the moderating role of family cohesion on the relationship between witnessed community violence and delinquency in a national sample of adolescents, J Interpers Violence 27(2):239–262, 2012.
  2744. Boynton-Jarrett R, Fargnoli J, Suglia SF, et al: Association between maternal intimate partner violence and incident obesity in preschool-aged children: results from the fragile families and child Well-being study, Arch Pediatr Adolesc Med 164(6):540–546, 2010.
  2745. Browne KD, Hamilton-Giachritsis C: The influence of violent media on children and adolescents: a public-health approach, Lancet 365:702–710, 2005.
  2746. Buka SL, Stichick TL, Birdthistle I, Earls FJ: Youth exposure to violence: prevalence, risks, and consequences, Am J Orthopsychiatry 71(3):298–310, 2001.
  2747. Calvert SL, Appelbaum M, Dodge KA, et al: The American psychological association task force assessment of violent video games: science in the service of public interest, Am Psychol 72(2):126–143, 2017.
  2748. Chung EK, Siegel BS, Garg A, et al: Screening for social determinants of health among children and families living in poverty: a guide for clinicians, Curr Probl Pediatr Adolesc Health Care 46(5):135–153, 2016.
  2749. Cross TP, Mathews B, Tonmyr L, et al: Child welfare policy and practice on children’s exposure to domestic violence, Child Abuse Negl 36(3):210–216, 2012.
  2750. Davies P, Lee L, Fox A, et al: Could nursery rhymes cause violent behaviour? A comparison with television viewing, Arch Dis Child 89:1103–1105, 2004.
  2751. Finkelhor D, Turner HA, Shattuck A, et al: Violence, crime, and abuse exposure in a national sample of children and youth: an update, JAMA Pediatr 167:614–621, 2013.
  2752. Flannery DJ, Modzeleski W, Kretschmar JM: Violence and school shootings, Curr Psychiatry Rep 15(1):331, 2013.
  2753. Fusco RA, Fantuzzo JW: Domestic violence crimes and children: a population-based investigation of direct sensory exposure and the nature of involvement, Child Youth Serv Rev 31(2):249–256, 2009.
  2754. Graham-Bermann SA, Castor LE, Miller LE, et al: The impact of intimate partner violence and additional traumatic events on trauma symptoms and PTSD in preschool-aged children, J Trauma Stress 25(4):393–400, 2012.
  2755. Hamby S, Finkelhor D, Turner H, Ormrod R: Children’s exposure to intimate partner violence and other family violence, Washington, DC, 2011, US Government Printing Office, pp 1–12.
  2756. Holtrop TG, Fischer H, Gray SM, et al: Screening for domestic violence in a general pediatric clinic: be prepared! Pediatrics 114:1253–1257, 2004.
  2757. Howell KH, Barnes SE, Miller LE, Graham-Bermann SA: Developmental variations in the impact of intimate partner violence exposure during childhood, J Inj Violence Res 8(1):43–57, 2016.
  2758. Maikovich AK, Jaffee SR, Odgers CL, et al: Effects of family violence on psychopathology symptoms in children previously exposed to maltreatment, Child Dev 79:1498–1512, 2008.
  2759. Marsac ML, Kassam-Adams N, Hildenbrand AK, et al: Implementing a trauma-informed approach in pediatric health care networks, JAMA Pediatr 170(1):70–77, 2016.
  2760. Martin SL, Mackie L, Kupper LL, et al: Physical abuse of women before, during, and after pregnancy, JAMA 285:1581–1584, 2001.
  2761. National Child Traumatic Stress Network.
  2762. National Intimate Partner and Sexual Violence Survey.
  2763. Panter-Brick C, Eggerman M, Gonzalez V, et al: Violence, suffering, and mental health in Afghanistan: a school-based survey, Lancet 374:807–816, 2009.
  2764. Schuster MA, Stein BD, Jaycox LH, et al: A national survey of stress reactions after the September 11, 2001 terrorist attacks, N Engl J Med 345:1507–1512, 2001.
  2765. UN Children’s Fund: The state of the world’s children 2006: excluded and invisible, New York, 2005, UNICEF, pp 1–8.
  2766. Waterston T, Mok J: Violence against children: the UN report, Arch Dis Child 93:85–88, 2008.
  2767. World Health Organization: Violence against women.
  2768. Zinzow HM, Ruggiero KJ, Hanson RF, et al: Witnessed community and parental violence in relation to substance use and delinquency in a national sample of adolescents, J Trauma Stress.22(6):525–533, 2009.
  2769. Sheila Gahagan, MD, MPH, Professor of Clinical Pediatrics, Chief, Division of Academic General Pediatrics, Child Development, and Community Health, Martin Stein Endowed Chair, Developmental-Behavioral Pediatrics University of California, San Diego School of Medicine, La Jolla, California
  2770. William A. Gahl, MD, PhD, Clinical Director, National Human Genome Research Institute, Director, NIH Undiagnosed Diseases Program, National Institutes of Health Bethesda, Maryland
  2771. Patrick G. Gallagher, MD, Professor of Pediatrics, Genetics, and Pathology, Yale University School of Medicine Attending Physician, Yale New Haven Children’s Hospital New Haven, Connecticut
  2772. Hayley A. Gans, MD, Clinical Professor of Pediatrics, Stanford University School of Medicine, Division of Pediatric Infectious, Diseases, Stanford, California
  2773. Cristina Garcia-Maurino, MD, Physician Scientist, Center for Vaccines and Immunity The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio
  2774. Paula M. Gardiner, MD, MPH Associate Professor, Associate Research Director, Department of Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, Massachusetts
  2775. Luigi R. Garibaldi, MD, Professor of Pediatrics, University of Pittsburgh School of Medicine, Clinical Director, Division of Pediatric Endocrinology Children’s Hospital of UPMC Pittsburgh, Pennsylvania
  2776. Gregory M. Gauthier, MD, MS Associate Professor of Medicine Division of Infectious Diseases University of Wisconsin School of Medicine and Public Health Madison, Wisconsin
  2777. Jeffrey S. Gerber, MD, PhD, Associate Professor of Pediatrics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Division of Infectious Diseases Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  2778. Anne A. Gershon, MD, Professor of Pediatrics, Columbia University College of Physicians and Surgeons, Division of Pediatric Infectious Diseases, NewYork-Presbyterian Morgan Stanley Children’s Hospital New York, New York
  2779. Saied Ghadersohi, MD, Resident Physician Department of Otolaryngology - Head and Neck Surgery, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  2780. Mark Gibson, MD, Professor (Clinical) Emeritus, Department of Obstetrics and Gynecology, Chief, Division of Reproductive Endocrinology, University of Utah School of Medicine, Salt Lake City, Utah
  2781. Francis Gigliotti, MD, Professor and Chief of Pediatric, Infectious Diseases and Microbiology and Immunology, Vice Chair for Academic Affairs, University of Rochester, Medical Center, School of Medicine and Dentistry Rochester, New York
  2782. Walter S. Gilliam, MSEd, PhD, Professor of Child Psychiatry and Psychology, Child Study Center, Director, The Edward Zigler, Center in Child Development and Social Policy, Yale School of Medicine, New Haven, Connecticut
  2783. Salil Ginde, MD, MPH, Assistant Professor of Pediatrics, Division of Pediatric Cardiology Medical College of Wisconsin Milwaukee, Wisconsin
  2784. John A. Girotto, MD, Section Chief, Pediatric Plastic Surgery and Dermatology Center, Helen DeVos Children’s Hospital, Grand Rapids, Michigan
  2785. Samuel B. Goldfarb, MD, Medical Director, Pediatric Lung and Heart/Lung, Transplant Programs, Division of Pulmonary Medicine, Medical Director, Solid Organ Transplant Center, Childrens Hospital of Philadelphia Professor of Clinical Pediatrics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, Pennsylvania
  2786. David L. Goldman, MD, Associate Professor of Pediatrics and Microbiology and Immunology Albert Einstein College of Medicine Division of Pediatric Infectious Disease, Montefiore Medical Center, Bronx, New York
  2787. Stanton C. Goldman, MD, Division of Pediatric Hematology, Oncology, and Stem Cell Transplant Medical City Childrens Hospital, Texas Oncology, PA Dallas, Texas
  2788. Neal D. Goldstein, PhD, MBI, Assistant Research Professor of Epidemiology and Biostatistics Drexel University Dornsife School of Public Health, Philadelphia, Pennsylvania; Infectious Disease Epidemiologist Christiana Care Health System Newark, Delaware
  2789. Stuart L. Goldstein, MD, FAAP, FNKF, Clark D. West Endowed Chair and Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Center for Acute Care Nephrology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2790. Joseph Gonzalez-Heydrich, MD Associate Professor of Psychiatry Harvard Medical School, Senior Attending Psychiatrist Boston Children’s Hospital Boston, Massachusetts
  2791. Denise M. Goodman, MD, MS, Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Attending Physician, Division of Critical Care Medicine, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  2792. Tracy S. Goodman, MA, Technical Officer, Expanded Programme on Immunization Department of Immunization, Vaccines, and Biologicals World Health Organization Geneva, Switzerland
  2793. Catherine M. Gordon, MD, MSc, Professor, Department of Pediatrics, Harvard Medical School, Chief, Division of Adolescent/Young Adult Medicine, Robert P. Masland Jr. Chair of Adolescent Medicine, Boston Childrens Hospital Boston, Massachusetts
  2794. Leslie B. Gordon, MD, PhD, Professor of Pediatrics Research, Hasbro Children’s Hospital and Warren Alpert Medical School of Brown University, Providence, Rhode Island; Department of Pediatrics Boston Children’s Hospital and Harvard Medical School, Boston, Massachusetts; Medical Director, The Progeria, Research Foundation, Peabody, Massachusetts
  2795. Collin S. Goto, MD, Professor of Pediatrics, The University of Texas Southwestern Medical Center, Attending Physician, Division of Pediatric Emergency Medicine, Children’s Medical Center, Dallas, Texas
  2796. Chen Y, Baram TZ. Toward understanding how early-life stress reprograms cognitive and emotional brain networks. Neuropsychopharmacology. 2016;41(1):197–206. doi: 10.1038/npp.2015.181.
  2797. Damian RI, Roberts BW. Settling the debate on birth order and personality. Proc Natl Acad Sci USA. 2015;112(46):14119–14120. doi: 10.1073/pnas.1519064112.
  2798. Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev. 2014;94(4):1027–1076. doi: 10.1152/physrev.00029.2013.
  2799. Jernigan TL, Stiles J. Construction of the human forebrain. Wiley Interdiscip Rev Cogn Sci. 2017;e1409. doi: 10.1002/wcs.1409.
  2800. McCarthy MM. Multifaceted origins of sex differences in the brain. Philos Trans R Soc Lond B Biol Sci. 2016;371:20150106. doi.org/10.1098/rstb.2015.0106.
  2801. Traub F, Boynton-Jarrett R. Modifiable resilience factors to childhood adversity for clinical pediatric practice. Pediatrics. 2017;139(5):e20162569.
  2802. American Academy of Pediatrics. Report of the Task Force on the Family. Pediatrics. 2003;111(6):S1541–S1571.
  2803. Baumrind D. Current patterns of parental authority. Dev Psychol. 4:1–103, 1971.
  2804. Duursma E, Augustyn M, Zuckerman B. Reading aloud to children: the evidence. Arch Dis Child. 2008;93(7):554–557.
  2805. Francis D, Diorio J, Liu D, Meaney MJ. Nongenomic transmission across generations of maternal behavior and stress responses in the rat. Science. 1999;286:1155–1158.
  2806. Pew Research Center. Parenting in America: outlook, worries, aspirations are strongly linked to financial situation. 2015;December 17.
  2807. Piotrowski CC, Talavera GA, Mayer JA. Healthy Steps: a systematic review of a preventive practice–based model of pediatric care. J Dev Behav Pediatr. 2009;30(1):91–103.
  2808. Raby KL, Roisman GI, Fraley RC, Simpson JA. The enduring predictive significance of early maternal sensitivity: social and academic competence through age 32. Child Dev. 2015;86(3):695–708.
  2809. Seay A, Freysteinson WM, McFarlane J. Positive parenting. Nurs Forum. 2014;49(3):200–208.
  2810. Shah R, Sobotka SA, Chen Y, Msall ME. Positive parenting practices, health disparities, and developmental progress. Pediatrics. 2015;136(2):318–326.
  2811. Burnett J.R., Hooper A.J. Vitamin E and oxidative stress in abetalipoproteinemia and familial hypobetalipoproteinemia // Free Radic. Biol. Med. 2015. Vol. 88. P. 59–62.
  2812. Iwasa K., Shima K., Komai K. et al. Retinitis pigmentosa and macular degeneration in a patient with ataxia with isolated vitamin E deficiency with a novel c.717 del c mutation in the TTPA gene // J. Neurol. Sci. 2014. Vol. 345. P. 228–230.
  2813. Kitajima H., Kanazawa T., Mori R. et al. Long-term alpha-tocopherol supplements may improve mental development in extremely low birthweight infants // Acta Paediatr. 2015. Vol. 104. P. e82–e89.
  2814. McBurney M.I., Yu E.A., Ciappio E.D. et al. Suboptimal serum alpha-tocopherol concentrations observed among younger adults and those depending exclusively on food sources, NHANES 2003–2006 // PLoS ONE. 2015. Vol. 10. P. e0135510.
  2815. Okebukola P.O., Kansra S., Barrett J. Vitamin E supplementation in people with cystic fibrosis // Cochrane Database Syst. Rev. 2017. CD009422.
  2816. Qi Y.J., Niu Q.L., Zhu X.L. et al. Relationship between deficiencies in vitamin A and E and occurrence of infectious diseases among children // Eur. Rev. Med. Pharmacol. Sci. 2016. Vol. 20. P. 5009–5012.
  2817. Raederstorff D., Wyss A., Calder P.C. et al. Vitamin E function and requirements in relation to PUFA // Br. J. Nutr. 2015. Vol. 114. P. 1113–1122.
  2818. Ulatowski L.M., Manor D. Vitamin E and neurodegeneration // Neurobiol. Dis. 2015. Vol. 84. P. 78–83.
  2819. Zelante G., Patti F., Vinciguerra L. et al. Ataxia with vitamin E deficiency caused by a new compound heterozygous mutation // Neurol. Sci. 2016. Vol. 37. P. 1571–1572.
  2820. Elalfy M.S., Elagouza I.A., Ibrahim F.A. et al. Intracranial haemorrhage is linked to late onset vitamin K deficiency in infants aged 2-24 weeks // Acta Paediatr. 2014. Vol. 103. P. e273–e276.
  2821. Enz R., Anderson R.S.Jr. A blown pupil and intracranial hemorrhage in a 4-week-old: a case of delayed onset vitamin K deficiency bleeding, a rare “can’t miss” diagnosis // J. Emerg. Med. 2016. Vol. 51. P. 164–167.
  2822. Fotouhie A., Desai H., King S. et al. Gastrointestinal bleeding secondary to trimethoprim-sulfamethoxazole-induced vitamin K deficiency // BMJ Case. Rep. 2016. doi: 10.1136/bcr-2016-214437.
  2823. Hamrick H.J., Gable E.K., Freeman E.H. et al. Reasons for refusal of newborn vitamin K prophylaxis: implications for management and education // Hosp. Pediatr. 2016. Vol. 6. P. 15–21.
  2824. Jagannath V.A., Fedorowicz Z., Thaker V. et al. Vitamin K supplementation for cystic fibrosis // Cochrane Database Syst. Rev. 2015. CD008482.
  2825. Miller H., Wheeler B., Kerruish N. Newborn vitamin K prophylaxis: an analysis of information resources for parents and professionals // N. Z. Med. J. 2016. Vol. 129. P. 44–52.
  2826. Rech M.A., Wittekindt L., Friedman S.D. et al. Prothrombin complex concentrate for intracerebral hemorrhage secondary to vitamin K deficiency bleeding in a 6-week-old child // J. Pediatr. 2015. Vol. 167. P. 1443–1444.
  2827. Schulte R., Jordan L.C., Morad A. et al. Rise in late onset vitamin K deficiency bleeding in young infants because of omission or refusal of prophylaxis at birth // Pediatr. Neurol. 2014. Vol. 50. P. 564–568.
  2828. Witt M., Kvist N., Jorgensen M.H. et al. Prophylactic dosing of vitamin K to prevent bleeding // Pediatrics. 2016. Vol. 137. N. 5. doi: 10.1542/peds.2015-4222.
  2829. Khera D, Sharma B, Singh K: . Copper deficiency as a cause of neutropenia in a case of coeliac disease, . BMJ Case Rep. 2016;2016:2016.
  2830. Kunzler E, Cernik C, Weaver J: . Psoriasiform rash in a toddler, . J Pediatr. 2016;170:332-e1, 2016.
  2831. Lamberti LM, Fischer Walker CL, Black RE: . Zinc deficiency in childhood and pregnancy: evidence for intervention effects and program responses, . World Rev Nutr Dietet. 2016;115:125–133, 2016.
  2832. Lazzerini M, Wanzira H: . Oral zinc for treating diarrhoea in children, . Cochrane Database Syst Rev. 2016;(12):CD005436, 2016.
  2833. Li Q, Zhao ZJ, Yang PZ, et al: . The prevention effect of selenium on prevalence of children Kaschin-Beck disease in active endemic areas in Qinghai Plateau, . Biol Trace Element Res. 2016;169:17–21, 2016.
  2834. Salerno M, Capalbo D, Cerbone M, et al: . Subclinical hypothyroidism in childhood: current knowledge and open issues, . Nat Rev Endocrinol. 2016;12:734–746, 2016.
  2835. Shah A, Ullah Shah F, Ud-Din Khan S, et al: . Impact of micronutrient malnutrition on the health of preschool children: a cross-sectional study, . Int J Vit Nutr Res. 2015;85:31–38, 2015.
  2836. Tang M, Xu C, Lin N, et al: . Toxic effects of trace elements on newborns and their birth outcomes, . Sci Total Environ. 2016;550:73–79, 2016.
  2837. Vanderpump MP: . Epidemiology of iodine deficiency, . Minerva Med. 2017;108:116–123, 2017.
  2838. Williams FLR, Ogston S, Hume R, et al: . Supplemental iodide for preterm infants and developmental outcomes at 2 years: an RCT, . Pediatrics. 2017;139:2017.
  2839. Allardet-Servent J., Lebsir M., Dubroca C. et al. Point-of-care versus central laboratory measurements of hemoglobin, hematocrit, glucose, bicarbonate and electrolytes: a prospective observational study in critically ill patients // PLoS ONE. 2017. Vol. 12. P. e0169593.
  2840. Gavala A., Myrianthefs P. Comparison of point-of-care versus central laboratory measurement of hematocrit, hemoglobin, and electrolyte concentrations // Heart Lung. 2017. Vol. 46. P. 246–250.
  2841. Goldwasser P., Ayoub I., Barth R.H. Pseudohypernatremia and pseudohyponatremia: a linear correction // Nephrol. Dial. Transplant. 2015. Vol. 30. P. 252–257.
  2842. Jain A. Body fluid composition // Pediatr. Rev. 2015. Vol. 36. P. 141–150.
  2843. Kraut J.A. Diagnosis of toxic alcohols: limitations of present methods // Clin. Toxicol. (Phila). 2015. Vol. 53. P. 589–595.
  2844. Liamis G., Filippatos T.D., Liontos A. et al. Serum osmolal gap in clinical practice: usefulness and limitations // Postgrad. Med. 2017. Vol. 129. P. 456–459.
  2845. Uysal E., Acar Y.A., Kutur A. et al. How reliable are electrolyte and metabolite results measured by a blood gas analyzer in the ED? // Am. J. Emerg. Med. 2016. Vol. 34. P. 419–424.
  2846. Knepper M.A., Kwon T.H., Nielsen S. Molecular physiology of water balance // N. Engl. J. Med. 2015. Vol. 372. P. 1349–1358.
  2847. Kortenoeven M.L., Pedersen N.B., Rosenbaek L.L. et al. Vasopressin regulation of sodium transport in the distal nephron and collecting duct // Am. J. Physiol. Renal. Physiol. 2015. Vol. 309. P. F280–F299.
  2848. Mecawi Ade S., Ruginsk S.G., Elias L.L. et al. Neuroendocrine regulation of hydromineral homeostasis // Compr. Physiol. 2015. Vol. 5. P. 1465–1516.
  2849. Schweda F. Salt feedback on the renin-angiotensin-aldosterone system // Pflugers Arch. 2015. Vol. 467. P. 565–576.
  2850. Berl T. Vasopressin antagonists // N. Engl. J. Med. 2015. Vol. 372. P. 2207–2216.
  2851. Cuesta M., Garrahy A., Thompson C.J. SIAD: Practical recommendations for diagnosis and management // J. Endocrinol. Invest. 2016. Vol. 39. P. 991–1001.
  2852. Cuesta M., Thompson C.J. The syndrome of inappropriate antidiuresis (SIAD) // Best Pract. Res. Clin. Endocrinol. Metab. 2016. Vol. 30. P. 175–187.
  2853. Henry D.A. Hyponatremia // Ann. Intern. Med. 2015. Vol. 163. N. 3. P. ITC1–ITC19.
  2854. Hew-Butler T., Rosner M.H., Fowkes-Godek S. et al. Statement of the Third International Exercise-Associated Hyponatremia Consensus Development Conference, Carlsbad, California, 2015 // Clin. J. Sport Med. 2015. Vol. 25. P. 303–320.
  2855. Leth M?ller K., Hansen A., Torstensson M. et al. Antidepressants and the risk of hyponatremia: a Danish register-based population study // BMJ Open. 2016. Vol. 6. P. e011200.
  2856. Manish S., Nader M., Kuppachi S. Essential hypernatremia: evidence of reset osmostat in the absence of demonstrable hypothalamic lesions // Am. J. Med Sci. 2014. Vol. 347. N. 4. P. 341–342.
  2857. Oude Lansink-Hartgring A., Hessels L., Weigel J. et al. Long-term changes in dysnatremia incidence in the ICU: a shift from hyponatremia to hypernatremia // Ann. Intensive Care. 2016. Vol. 6. P. 22.
  2858. Powell C.V.E. Not enough salt in maintenance fluids // Arch. Dis. Child. 2015. Vol. 100. N. 11. P. 1013–1015.
  2859. Powers K.S. Dehydration: isonatremic, hyponatremic, and hypernatremic recognition and management // Pediatr. Rev. 2015. Vol. 36. P. 274–283.
  2860. Sinha V.K., Ko B. Hyponatremia in cirrhosis: pathogenesis, treatment, and prognostic significance // Adv. Chronic Kidney. Dis. 2015. Vol. 22. P. 361–367.
  2861. Sterns R.H. Disorders of plasma sodium: causes, consequences, and correction // N. Engl. J. Med. 2015. Vol. 372. P. 55–65.
  2862. Suarez-Rivera M., Bonilla-Felix M. Fluid and electrolyte disorders in the newborn: Sodium and potassium // Curr. Pediatr. Rev. 2014. Vol. 10. P. 115–122.
  2863. Wallace D., Lichtarowicz-Krynska E., Bockenhauer D. Non-accidental salt poisoning // Arch. Dis. Child. 2017. Vol. 102. N. 2. P. 119–122.
  2864. Emma F., Pizzini C., Tessa A. et al. “Bartter-like” phenotype in Kearns-Sayre syndrome // Pediatr. Nephrol. 2006. Vol. 21. P. 355–360.
  2865. Gumz M.L., Rabinowitz L., Wingo C.S. An integrated view of potassium homeostasis // N. Engl. J. Med. 2015. Vol. 373. P. 60–72.
  2866. Jain G., Ong S., Warnock D.G. Genetic disorders of potassium homeostasis // Semin. Nephrol. 2013. Vol. 33. N. 3. P. 300–309.
  2867. Kosiborod M., Rasmussen H.S., Lavin P. et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia // JAMA. 2014. Vol. 312. N. 21. P. 2223–2233.
  2868. Lee A.C., Reduque L.L., Luban N.L. et al. Transfusion-associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion // Transfusion (Paris). 2014. Vol. 54. P. 244–254.
  2869. Matsunoshita N., Nozu K., Shono A. et al. Differential diagnosis of Bartter syndrome, Gitelman syndrome, and pseudo-Bartter/Gitelman syndrome based on clinical characteristics // Genet. Med. 2016. Vol. 18. P. 180–188.
  2870. Meng Q.H., Wagar E.A. Pseudohyperkalemia: A new twist on an old phenomenon // Crit. Rev. Clin. Lab. Sci. 2015. Vol. 52. P. 45–55.
  2871. Packham D.K., Rasmussen H.S., Lavin P.T. et al. Sodium zirconium cyclosilicate in hyperkalemia // N. Engl. J. Med. 2015. Vol. 372. N. 23. P. 222–231.
  2872. Palmer B.F. Regulation of potassium homeostasis // Clin. J. Am. Soc. Nephrol. 2015. Vol. 10. P. 1050–1060.
  2873. Sterns R.H., Grieff M., Bernstein P.L. Treatment of hyperkalemia: something old, something new // Kidney Int. 2016. Vol. 89. P. 546–554.
  2874. Suarez-Rivera M., Bonilla-Felix M. Fluid and electrolyte disorders in the newborn: sodium and potassium // Curr. Pediatr. Rev. 2014. Vol. 10. P. 115–122.
  2875. Weir M.R., Bakris G.L., Bushinsky D.A. et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors // N. Engl. J. Med. 2015. Vol. 372. N. 3. P. 211–220.
  2876. Zieg J., Gonsorcikova L., Landau D. Current views on the diagnosis and management of hypokalaemia in children // Acta Paediatr. 2016. Vol. 105. P. 762–772.
  2877. Blaine J., Chonchol M., Levi M. Renal control of calcium, phosphate, and magnesium homeostasis // Clin. J. Am. Soc. Nephrol. 2015. Vol. 10. P. 1257–1272.
  2878. Costello R., Wallace T.C., Rosanoff A. Magnesium // Adv. Nutr. 2016. Vol. 7. P. 199–201.
  2879. Huang J.W., Famure O., Li Y. et al. Hypomagnesemia and the risk of new-onset diabetes mellitus after kidney transplantation // J. Am. Soc. Nephrol. 2016. Vol. 27. P. 1793–1800.
  2880. Janett S., Bianchetti M.G., Milani G.P. et al. Hypomagnesemia following prolonged use of proton-pump inhibitors // J. Pediatr. Gastroenterol. Nutr. 2016. Vol. 62. P. e39.
  2881. Jiang L., Chen C., Yuan T. et al. Clinical severity of Gitelman syndrome determined by serum magnesium // Am. J. Nephrol. 2014. Vol. 39. P. 357–366.
  2882. Konrad M., Schlingmann K.P. Inherited disorders of renal hypomagnesaemia // Nephrol. Dial Transplant. 2014. Vol. 29. Suppl. 4. P. iv63–iv71.
  2883. Tilman M., Wolf F. Inherited and acquired disorders of magnesium homeostasis // Curr. Opin. Pediatr. 2017. Vol. 29. P. 187–198.
  2884. Van der Made C.I., Hoorn E.J., de la Faille R. et al. Hypomagnesemia as first clinical manifestation of ADTKD-HNF1B: A case series and literature review // Am. J. Nephrol. 2015. Vol. 42. P. 85–90.
  2885. William J.H., Danziger J. Magnesium deficiency and proton-pump inhibitor use: a clinical review // J. Clin. Pharmacol. 2016. Vol. 56. P. 660–668.
  2886. Blaine J., Chonchol M., Levi M. Renal control of calcium, phosphate, and magnesium homeostasis // Clin. J. Am. Soc. Nephrol. 2015. Vol. 10. P. 1257–1272.
  2887. Clinkenbeard E.L., White K.E. Heritable and acquired disorders of phosphate metabolism: etiologies involving FGF23 and current therapeutics // Bone. 2017. Vol. 102. P. 31–39.
  2888. Econs M.J. Genetic diseases resulting from disordered FGF23/Klotho biology // Bone. 2017. Vol. 100. P. 56–61.
  2889. Fukumoto S. FGF23-FGF receptor/Klotho pathway as a new drug target for disorders of bone and mineral metabolism // Calcif. Tissue Int. 2016. Vol. 98. P. 334–340.
  2890. Guven A., Al-Rijjal R.A., BinEssa H.A. et al. Mutational analysis of PHEX, FGF23 and CLCN5 in patients with hypophosphataemic rickets // Clin. Endocrinol. (Oxf.). 2017. Vol. 87 P. 103–112.
  2891. Imel E.A., Carpenter T.O. A practical clinical approach to paediatric phosphate disorders // Endocr. Dev. 2015. Vol. 28. P. 134–161.
  2892. Minisola S., Peacock M., Fukumoto S. et al. Tumour-induced osteomalacia // Nat. Rev. Dis. Primers. 2017. Vol. 3. P. 17044.
  2893. Shetty S., Kapoor N., Mathai S. et al. Hyperphosphatemic tumoural calcinosis // BMJ Case Rep. 2016. 2016. doi: 10.1136/bcr-2015-213537.
  2894. Wagner C.A., Rubio-Aliaga I., Biber J. et al. Genetic diseases of renal phosphate handling // Nephrol. Dial. Transplant. 2014. Vol. 29. Suppl. 4. P. :iv45–iv54.
  2895. Adrogue H.J., Madias N.E. Assessing acid-base status: physiologic versus physicochemical approach // Am. J. Kidney. Dis. 2016. Vol. 68. P. 793–802.
  2896. Faisy C., Meziani F., Planquette B. et al. Effect of acetazolamide vs placebo on duration of invasive mechanical ventilation among patients with chronic obstructive pulmonary disease: a randomized clinical trial // JAMA. 2016. Vol. 315. P. 480–488.
  2897. Gomez H., Kellum J.A. Understanding acid base disorders // Crit. Care Clin. 2015. Vol. 31. P. 849–860.
  2898. Hamm L.L., Nakhoul N., Hering-Smith K.S. Acid-base homeostasis // Clin. J. Am. Soc. Nephrol. 2015. Vol. 10. P. 2232–2242.
  2899. Kitterer D., Schwab M., Alscher M.D. et al. Drug-induced acid-base disorders // Pediatr. Nephrol. 2015. Vol. 30. P. 1407–1423.
  2900. Kraut J.A., Madias N.E. Lactic acidosis // N. Engl. J. Med. 2014. Vol. 371. P. 2309–2319.
  2901. Protti A., Ronchi D., Bassi G. et al. Changes in whole-body oxygen consumption and skeletal muscle mitochondria during linezolid-induced lactic acidosis // Crit. Care Med. 2016. Vol. 44. P. e579–e582.
  2902. Soleimani M., Rastegar A. Pathophysiology of renal tubular acidosis: core curriculum 2016 // Am. J. Kidney Dis. 2016. Vol. 68. P. 488–498.
  2903. Foster BA, Tom D, Hill V: . Hypotonic versus isotonic fluids in hospitalized children: a systematic review and meta-analysis, . J Pediatr. 2014;165:163–169, e2, 2014.
  2904. Friedman JN, Beck CE, DeGroot J, et al: . Comparison of isotonic and hypotonic intravenous maintenance fluids: a randomized clinical trial, . JAMA Pediatr. 2015;169:445–451, 2015.
  2905. Green J, Lillie J: . Intravenous fluid therapy in children and young people in hospital N29, . Arch Dis Child. 2017102(6):327–331, 2017.
  2906. McNab S: . Isotonic vs hypotonic intravenous fluids for hospitalized children, . JAMA. 2015;314:720–721, 2015.
  2907. McNab S, Duke T, South M, et al: . 140 mmol/L of sodium versus 77 mmol/L of sodium in maintenance intravenous fluid therapy for children in hospital (PIMS): a randomized controlled double-blind trial, . Lancet. 2015;385:1190–1196, 2015.
  2908. Moritz ML, Ayus JC: . Maintenance intravenous fluids in acutely ill patients, . N Engl J Med. 2015;373:1350–1360, 2015.
  2909. National Institutes of Health: Intravenous fluid therapy in children and young people in hospital. NICE Guideline, December 2015.
  2910. Padua AP, Macaraya JR, Dans LF, et al: . Isotonic versus hypotonic saline solution for maintenance intravenous fluid therapy in children: a systematic review, . Pediatr Nephrol. 2015;30:1163–1172, 2015.
  2911. Wang J, Xu E, Xiao Y: . Isotonic versus hypotonic maintenance IV fluids in hospitalized children: a meta-analysis, . Pediatrics. 2014;133:105–113, 2014.
  2912. Ben-Shalom E., Toker O., Schwartz S. Hypernatremic dehydration in young children: is there a solution? // Isr. Med. Assoc. J. 2016. Vol. 18. P. 95–99.
  2913. Chisti M.J., Ahmed T., Ahmed A.M. et al. Hypernatremia in children with diarrhea: presenting features, management, outcome, and risk factors for death // Clin. Pediatr. (Phila). 2016. Vol. 55. P. 654–663.
  2914. Emrath E.T., Fortenberry J.D., Travers C. et al. Resuscitation with balanced fluids is associated with improved survival in pediatric severe sepsis // Crit. Care Med. 2017. Vol. 45. P. 1177–1183.
  2915. Erdemir A., Kahramaner Z., Cosar H. et al. Comparison of oral and intravenous fluid therapy in newborns with hypernatremic dehydration // J. Matern. Fetal Neonatal. Med. 2014. Vol. 27. P. 491–494.
  2916. Freedman S.B., DeGroot J.M., Parkin P.C. Successful discharge of children with gastroenteritis requiring intravenous rehydration // J. Emerg. Med. 2014. Vol. 46. P. 9–20.
  2917. Freedman S.B., Vandermeer B., Milne A. et al. Diagnosing clinically significant dehydration in children with acute gastroenteritis using noninvasive methods: a meta-analysis // J. Pediatr. 2015. Vol. 166. P. 908–916.
  2918. Freedman S.B., Willan A.R., Boutis K. et al. Effect of dilute apple juice and preferred fluids vs electrolyte maintenance solution on treatment failure among children with mild gastroenteritis: a randomized clinical trial // JAMA. 2016. Vol. 315. P. 1966–1974.
  2919. Guarino A., Ashkenazi S., Gendrel D. et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition/European Society for Pediatric Infectious Diseases evidence-based guidelines for the management of acute gastroenteritis in children in Europe: update 2014 // J. Pediatr. Gastroenterol. Nutr. 2014. Vol. 59. P. 132–152.
  2920. Janet S., Molina J.C., Maranon R. et al. Effects of rapid intravenous rehydration in children with mild-to-moderate dehydration // Pediatr. Emerg. Care. 2015. Vol. 31. P. 564–567.
  2921. Marquard J., Lerch C., Rosen A. et al. Nasogastric vs. intravenous rehydration in children with gastroenteritis and refusal to drink: a randomized controlled trial // Klin. Padiatr. 2014. Vol. 226. P. 19–23.
  2922. Powers K.S. Dehydration: isonatremic, hyponatremic, and hypernatremic recognition and management // Pediatr. Rev. 2015. Vol. 36. P. 274–283.
  2923. Sen A., Keener C.M., Sileanu F.E. et al. Chloride content of fluids used for large-volume resuscitation is associated with reduced survival // Crit. Care Med. 2017. Vol. 45. P. e146–e153.
  2924. Shahrin L., Chisti M.J., Huq S. et al. Clinical manifestations of hyponatremia and hypernatremia in under-five diarrheal children in a diarrhea hospital // J. Trop. Pediatr. 2016. Vol. 62. P. 206–212.
  2925. Toaimah F.H., Mohammad H.M. Rapid intravenous rehydration therapy in children with acute gastroenteritis: a systematic review // Pediatr. Emerg. Care. 2016. Vol. 32. P. 131–135.
  2926. Weiss S.L., Keele L., Balamuth F. et al. Crystalloid fluid choice and clinical outcomes in pediatric sepsis: a matched retrospective cohort study // J. Pediatr. 2017. Vol. 182. P. 304–310.e10.
  2927. Thomas A, Chess S, Birch HG. The origin of personality. Sci Am. 1970;223(2):102–109.
  2928. US Centers for Disease Control and Prevention. Parent training programs: insight for practitioners. Atlanta, 2009. CDC.
  2929. Weisleder A, Brockmeyer Cates C, Dreyer B, et al. Promotion of positive parenting and prevention of socioemotional disparities. Pediatrics. 2016;137(2):e20153239.
  2930. Caudle WM. This can’t be stressed enough: the contribution of select environmental toxicants to disruption of the stress circuitry and response. Physiol Behav. 2016;166:65–75. doi:10.1016/j.physbeh.2015.09.021.
  2931. DiPietro JA. Prenatal development. Haith MM, Benson JB, editors. Encyclopedia of infant and early child development. New York: Academic Press, 2008.
  2932. Graignic-Philippe R, Dayan J, Chokron S, et al. Effects of prenatal stress on fetal and child development: a critical literature review. Neurosci Biobehav Rev. 2014;43:137–162.
  2933. Moore CA, Staples JE, Dobyns WB, et al. Characterizing the pattern of anomalies in congenital Zika syndrome for pediatric clinicians. JAMA Pediatr. 2017;171(3):288–295. doi:10.1001/jamapediatrics.2016.3982.
  2934. Reid VMKD, Young RJ, et al. The human fetus preferentially engages with face-like visual stimuli. Curr Biol. 2017;27:1–4.
  2935. Scott-Goodwin AC, Puerto M, Moreno I. Toxic effects of prenatal exposure to alcohol, tobacco and other drugs. Reprod Toxicol. 2016;61:120–130. doi:10.1016/j.reprotox.2016.03.043. [Epub 2016 Mar 29].
  2936. W. Adam Gower, MD, MS, Associate Professor of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina
  2937. Neera K. Goyal, MD, Associate Professor of Pediatrics, Sidney Kimmel College of Medicine at Thomas Jefferson University Philadelphia, Pennsylvania
  2938. Nicholas P. Goyeneche, MD, Department of Physical Medicine and Rehabilitation, Ochsner Health Center-Covington, Covington, Louisiana
  2939. Kevin W. Graepel, PhD, Medical Scientist Training Program, Vanderbilt University School of Medicine, Vanderbilt University Medical Center Nashville, Tennessee
  2940. Robert J. Graham, MD, Associate Professor, Department of Anesthesiology, Critical Care, and Pain Medicine Harvard Medical School, Division of Pediatric Critical Care, Medicine, Boston Children’s Hospital, Boston, Massachusetts
  2941. John M. Greally, DMed, PhD, FACMG, Professor of Genetics, Medicine, and Pediatrics, Albert Einstein College of Medicine, Department of Genetics, Children’s Hospital at Montefiore Bronx, New York
  2942. Cori M. Green, MD, MSc, Assistant Professor of Clinical Pediatrics, Weill Cornell Medicine, New York-Presbyterian Komansky, Children’s Hospital, New York, New York
  2943. Michael Green, MD, MPH, Professor of Pediatrics, Surgery, and Clinical and Translational Science, University of Pittsburgh School of Medicine, Division of Infectious Diseases, Director, Antimicrobial Stewardship and Infection Prevention, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  2944. Larry A. Greenbaum, MD, PhD, Marcus Professor of Pediatrics Director, Division of Pediatric Nephrology, Emory University School of Medicine, Childrens Healthcare of Atlanta, Atlanta, Georgia
  2945. V. Jordan Greenbaum, MD, International Centre for Missing and Exploited Children, Alexandria, Virginia
  2946. James M. Greenberg, MD, Professor of Pediatrics, Director, Division of Neonatology University of Cincinnati College of Medicine, Co-Director, Perinatal Institute, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  2947. Anne G. Griffiths, MD, Pediatric Pulmonologist, Children’s Respiratory and Critical Care Specialists, Director, Primary Ciliary Dyskinesia Center Children’s Minnesota Minneapolis, Minnesota
  2948. Kenneth L. Grizzle, PhD, Associate Professor of Pediatrics, Medical College of Wisconsin Child Development Center Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  2949. Judith A. Groner, MD, Clinical Professor of Pediatrics, The Ohio State University College of Medicine, Section of Ambulatory Pediatrics Nationwide Children’s Hospital Columbus, Ohio
  2950. Alfredo Guarino, MD, Professor of Pediatrics, Department of Translational Medical Sciences, University of Naples Federico II Napoli, Italy
  2951. Juan P. Gurria, MD, Fellow in Pediatric Trauma, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  2952. Anat Guz-Mark, MD, Attending Physician, Institute of Gastroenterology, Nutrition and Liver Disease Schneider Children’s Medical Center of Israel, Petah Tikva, Israel; Sackler Faculty of Medicine Tel Aviv University, Tel Aviv, Israel
  2953. Gabriel G. Haddad, MD, Distinguished Professor of Pediatrics and Neuroscience, Chairman, Department of Pediatrics University of California, San Diego School of Medicine, Physician-in-Chief and Chief Scientific Officer, Rady Children’s Hospital-San Diego
  2954. Joseph Haddad Jr, MD, Lawrence Savetsky Professor Emeritus, Columbia University Irving Medical Center, New York, New York
  2955. Joseph F. Hagan Jr, MD, FAAP, Clinical Professor, Department of Pediatrics The Robert Larner College of Medicine at the University of Vermont College of Medicine Hagan, Rinehart, and Connolly Pediatricians, PLLC, Burlington, Vermont
  2956. James S. Hagood, MD, Professor of Pediatrics (Pulmonology) Director, Program in Rare and Interstitial Lung Disease, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  2957. Suraiya K. Haider, MD, Sleep Physician, Fairfax Neonatal Associates, Fairfax, Virginia
  2958. Goknur Haliloglu, MD, Professor of Pediatrics, Department of Pediatric Neurology Hacettepe University Children’s Hospital, Ankara, Turkey
  2959. Scott B. Halstead, MD, Adjunct Professor, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, Maryland
  2960. Allison R. Hammer, MSN, APRN, CPNP-PC, Advanced Practice Nurse, Department of Otolaryngology -Head and Neck Surgery, Ann & Robert H. Lurie Childrens, Hospital of Chicago, Chicago, Illinois
  2961. Margaret R. Hammerschlag, MD, Professor of Pediatrics and Medicine Director, Pediatric Infectious Disease Fellowship Program, SUNY Down State Medical Center, Brooklyn, New York
  2962. Aaron Hamvas, MD, Raymond and Hazel Speck Barry Professor of Neonatology, Northwestern University Feinberg School of Medicine, Head, Division of Neonatology Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  2963. James C. Harris, MD, Professor of Pediatrics, Psychiatry and Behavioral Sciences, Mental Health, and History of Medicine Division of Child and Adolescent Psychiatry, Director, Developmental, Neuropsychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland
  2964. Douglas J. Harrison, MD, MS, Associate Professor of Pediatrics Director of Patient Care and Programs, Co-Chair Pediatric Solid Tumor and Sarcoma Team, The Children’s Cancer Hospital of MD Anderson, The University of Texas MD Anderson Cancer Center, Houston, Texas
  2965. Corina Hartman, MD, Pediatric Gastroenterology and Nutrition Unit, Lady Davis Carmel Medical Center Haifa, Israel
  2966. Mary E. Hartman, MD, MPH, Assistant Professor of Pediatrics Washington University School of Medicine in St. Louis, Division of Pediatric Critical Care Medicine, St. Louis Children’s Hospital, St. Louis, Missouri
  2967. David B. Haslam, MD, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Antimicrobial Stewardship, Program, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  2968. H. Hesham Abdel-Kader Hassan, MD, MSc, Professor of Pediatrics, Chief, Division of Pediatric Gastroenterology and Nutrition, The University of Arizona College of Medicine, Tucson, Arizona
  2969. Fern R. Hauck, MD, MS, Spencer P. Bass MD Twenty-First Century Professor of Family Medicine, Departments of Family Medicine and Public Health Sciences, University of Virginia School of Medicine, Charlottesville, Virginia
  2970. Fiona P. Havers, MD, MHS, Medical Epidemiologist Epidemiology and Prevention Branch, Influenza Division National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  2971. Ericka V. Hayes, MD, Associate Professor, Department of Pediatrics, Division of Infectious Diseases Washington University School of Medicine in St. Louis, Medical Director, Pediatric and Adolescent HIV Program Medical Director, Infection Prevention, St. Louis Children’s Hospital, St. Louis, Missouri
  2972. Ampofo K: Infectious disease issues in adoption of young children, Curr Opin Pediatr 25:78–87, 2013.
  2973. Barnett ED, Weld LH, McCarthy AE, et al: Spectrum of illness in international migrants seen at geosentinel clinics in 1997–2009. Part 1. US-bound migrants evaluated by comprehensive protocol-based health assestment, Clin Infect Dis 57:913–924, 2013.
  2974. Barratt MS: International adoption, Pediatr Rev 34:145–146, 2013.
  2975. Centers for Disease Control and Prevention: Guidelines for using the QuantiFERON-TB gold test for detecting Mycobacterium tuberculosis infection-United States, MMWR Recomm Rep 54(RR–15):49–55, 2005.
  2976. Centers for Disease Control and Prevention: Recommendation regarding screening of refugee children for treponemal infection, MMWR 54(37):933–934, 2005.
  2977. Centers for Disease Control and Prevention: Travelers’ health.
  2978. Council on Community Pediatrics: Providing care for immigrant, migrant, and border children, Pediatrics 131:e2028–e2034, 2013.
  2979. Jones VF, Committee on Early Childhood, Adoption, and Dependent Care: Comprehensive health evaluation of the newly adopted child, Pediatrics 129:e214–e223, 2012.
  2980. Jones VF, Schulte EE, Committee on Early Childhood and Council on Foster Care, Adoption, and Kinship Care: The pediatrician’s role in supporting adoptive families, Pediatrics 130:e1040–e1049, 2012.
  2981. Pediatric HIV testing and treatment guidelines (website).
  2982. Sciauvaud J, Rigal E, Pascal J, et al: Transmission of infectious diseases from internationally adopted children to their adoptive families, Clin Microbiol Infect 20:746–751, 2014.
  2983. Stadler LP, Mezoff AG, Staat MA, et al: Hepatitis B virus screening for internationally adopted children, Pediatrics 122:1223–1228, 2008.
  2984. Technical instructions for panel physicians completing overseas medical exams.
  2985. US Department of Justice, Executive Office for Immigration Review: Statistics and publications: annual immigration statistics.
  2986. Bennett MJ: A developmental approach to training for intercultural sensitivity, Int J Intercult Rel 10(2):179–196, 1986.
  2987. Betancourt JR: Cultural competence and medical education: many names, many perspectives, one goal, Acad Med 81(6):499–501, 2006.
  2988. Dao DK, Goss AL, Hoekzema AS, et al: Integrating theory, content, and method to foster critical consciousness in medical students: a comprehensive model for cultural competence training, Acad Med 92(3):335–344, 2017.
  2989. Fisher-Borne M, Cain JM, Martin SL: From mastery to accountability: cultural humility as an alternative to cultural competence, Soc Work Educ 34(2):165–181, 2015.
  2990. Foronda C, Baptiste DL, Reinholdt MM, Ousman K: Cultural humility: a concept analysis, J Transcult Nurs 27(3):210–217, 2016.
  2991. Gregg J, Saha S: Losing culture on the way to competence: the use and misuse of culture in medical education, Acad Med 81(6):542–547, 2006.
  2992. Hook JN, Davis DE, Owen J, et al: Cultural humility: measuring openness to culturally diverse clients, J Couns Psychol 60(3):353–366, 2013.
  2993. Kleinman A, Eisenberg L, Good B: Culture, illness, and care: clinical lessons from anthropologic and cross-cultural research, Ann Intern Med 88(2):251–258, 1978.
  2994. McIntosh P: White privilege: unpacking the invisible knapsack, 2008.
  2995. Riess H, Kraft-Todd G: EMPATHY: a tool to enhance nonverbal communication between clinicians and their patients, Acad Med 89(8):1108–1112, 2014.
  2996. Tervalon M, Murray-Garcia J: Cultural humility versus cultural competence: a critical distinction in defining physician training outcomes in multicultural education, J Health Care Poor Undeserved 9:117–125, 1998.
  2997. White AA, Heather J, Logghe DA, et al: Self-awareness and cultural identity as an effort to reduce bias in medicine, J Racial Ethn Health Disparities 5(1):34–49, 2018.
  2998. Jacqueline T. Hecht, PhD, Professor and Division Head Pediatric Research Center Vice-Chair for Research, Leah L. Lewis Distinguished Chair Department of Pediatrics, McGovern Medical School at UTHealth, Associate Dean for Research, UTHealth School of Dentistry Houston, Texas
  2999. Sabrina M. Heidemann, MD, Professor, Department of Pediatrics, Wayne State University School of Medicine, Director, Intensive Care Unit, Co-Director of Transport, Childrens Hospital of Michigan, Detroit, Michigan
  3000. Jennifer R. Heimall, MD, Assistant Professor of Clinical Pediatrics, University of Pennsylvania Perelman School of Medicine, Attending Physician, Division of Allergy and Immunology Childrens Hospital of Philadelphia Philadelphia, Pennsylvania
  3001. Cheryl Hemingway, MBChB, PhD, Consultant Pediatric Neurologist Great Ormond Street Hospital for Children, London, United Kingdom
  3002. J. Owen Hendley, MD, Professor of Pediatric Infectious Diseases, University of Virginia School of Medicine, Charlottesville, Virginia
  3003. Michelle L. Hernandez, MD, Associate Professor of Pediatrics University of North Carolina School of Medicine, Chief Medical Officer, UNC Center for Environmental, Medicine, Asthma, and Lung Biology Chapel Hill, North Carolina
  3004. Andrew D. Hershey, MD, PhD, FAAN, FAHS, Professor of Pediatrics, University of Cincinnati College of Medicine, Endowed Chair and Director, Division of Neurology Headache Medicine Specialist Cincinnati Childrens Medical Center Cincinnati, Ohio
  3005. Cynthia E. Herzog, MD, Professor of Pediatrics, University of Texas MD Anderson Cancer Center, Houston, Texas
  3006. Jesse P. Hirner, MD, Resident Physician, Department of Dermatology University of Missouri School of Medicine, Columbia, Missouri
  3007. Jessica Hochberg, MD, Assistant Professor of Clinical Pediatrics, Division of Pediatric Hematology, Oncology, and Stem Cell Transplant New York Medical College Maria Fareri Childrens Hospital at Westchester Medical Center, Valhalla, New York
  3008. Deborah Hodes, MBBS, BSc, DRCOG, FRCPCH, Consultant Community Paediatrician Department of Paediatrics University College London Hospitals London, United Kingdom
  3009. Holly R. Hoefgen, MD, Assistant Professor, Pediatric and Adolescent Gynecology Washington University School of Medicine in St. Louis, Co-Director, Integrated Care and Fertility Preservation Program St. Louis Childrens Hospital St. Louis, Missouri
  3010. Lauren D. Holinger, MD, FAAP, FACS Paul H. Holinger MD Professor Division of Pediatric Otolaryngology Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Childrens, Hospital of Chicago, Chicago, Illinois
  3011. Cynthia M. Holland-Hall, MD, MPH Associate Professor of Clinical Pediatrics, The Ohio State University College of Medicine, Section of Adolescent Medicine, Nationwide Childrens Hospital Columbus, Ohio
  3012. David K. Hooper, MD, MS, Associate Professor of Pediatrics University of Cincinnati College of Medicine, Medical Director of Kidney Transplantation, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3013. Julie E. Hoover-Fong, MD, PhD, Associate Professor, Department of Pediatrics McKusick-Nathans Institute of Genetic Medicine, Director, Greenberg Center for Skeletal Dysplasias, Johns Hopkins University School of Medicine, Baltimore, Maryland
  3014. Jeffrey D. Hord, MD, The LOPen Charities and Mawaka Family Chair in Pediatric, Hematology/Oncology, Director, Showers Family Center for Childhood Cancer and Blood Disorders, Akron Children’s Hospital, Akron, Ohio
  3015. B. David Horn, MD, Associate Professor, Department of Orthopaedic Surgery University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  3016. Helen M. Horstmann, MD, Associate Professor, Department of Orthopaedic Surgery University of Pennsylvania Perelman School of Medicine, Attending Physician, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3017. William A. Horton, MD, Professor, Department of Molecular Medical, Genetics, Oregon Health & Science University Director Emeritus of Research Shriners Hospitals for Children Portland, Oregon
  3018. Peter J. Hotez, MD, PhD, Dean, National School of Tropical Medicine, Professor, Pediatrics and Molecular, Virology and Microbiology, Head, Section of Pediatric Tropical Medicine, Baylor College of Medicine; Endowed Chair of Tropical Pediatrics Center for Vaccine Development Texas Children’s Hospital; Professor, Department of Biology Baylor University, Waco, Texas; Baker Institute Fellow in Disease and Poverty, Rice University, Houston, Texas
  3019. Samantha A. House, DO, Assistant Professor of Pediatrics Geisel School of Medicine at Dartmouth and The Dartmouth Institute, Hanover, New Hampshire
  3020. Evelyn Hsu, MD, Associate Professor of Pediatrics University of Washington School of Medicine, Medical Director, Liver, Transplantation, Seattle Childrens Hospital, Seattle, Washington
  3021. Katherine Hsu, MD, MPH, FAAP, Associate Professor of Pediatrics Section of Pediatric Infectious Diseases, Boston University Medical Center Boston, Massachusetts; Medical Director, Division of STD Prevention and HIV/AIDS Surveillance, Director, Ratelle STD/HIV Prevention Training Center, Bureau of Infectious Disease and Laboratory Sciences, Massachusetts Department of Public Health, Jamaica Plain, Massachusetts
  3022. Felicia A. Scaggs Huang, MD, Clinical Fellow, Division of Infectious Diseases, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  3023. Heather G. Huddleston, MD, Assistant Professor, Department of Obstetrics, Gynecology, and Reproductive Sciences University of California, San Francisco School of Medicine, San Francisco, California
  3024. Sarah P. Huepenbecker, MD, Resident Physician, Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  3025. Vicki Huff, PhD, Professor, Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, Texas
  3026. Winston W. Huh, MD, Assistant Professor of Clinical Care, Childrens Hospital of Los Angeles, Los Angeles, California
  3027. Stephen R. Humphrey, MD, Assistant Professor, Department of Dermatology, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin
  3028. Stephen P. Hunger, MD, Professor and Jeffrey E. Perelman, Distinguished Chair, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Chief, Division of Pediatric Oncology Director, Center for Childhood Cancer Research, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3029. David A. Hunstad, MD, Professor of Pediatrics and Molecular Microbiology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  3030. Carl E. Hunt, MD, Research Professor of Pediatrics, Uniformed Services University of the Health Sciences, Division of Neonatology, Walter Reed National Military, Medical Center, Bethesda, Maryland; Adjunct Professor of Pediatrics, George Washington University, School of Medicine and Health, Sciences, Washington, DC
  3031. Stacey S. Huppert, PhD, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Gastroenterology,, Hepatology, and Nutrition, Division of Developmental Biology, Cincinnati Childrens Hospital, Medical Center, Cincinnati, Ohio
  3032. Anna R. Huppler, MD, Assistant Professor, Pediatric Infectious Diseases, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin
  3033. Patricia I. Ibeziako, MBBS, Assistant Professor of Psychiatry, Harvard Medical School, Director, Psychiatry Consultation Service, Boston Childrens Hospital, Boston, Massachusetts
  3034. Samar H. Ibrahim, MBChB, Assistant Professor of Pediatrics, Division of Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota
  3035. Allison M. Jackson, MD, MPH, FAAP, Division Chief, Child and Adolescent Protection Center, Childrens National Health System Washington Childrens Foundation Professor of Child and Adolescent Protection, Associate Professor of Pediatrics, The George Washington University School of Medicine and Health, Sciences, Washington, DC
  3036. Elizabeth C. Jackson, MD, Professor Emerita of Pediatrics, University of Cincinnati College of Medicine, Division of Nephrology, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3037. Mary Anne Jackson, MD, Clinical Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Department of Pediatric Infectious Diseases, Childrens Mercy Hospitals and Clinics, Kansas City, Missouri
  3038. Ashlee Jaffe, MD, MEd, Assistant Professor of Clinical Pediatrics, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Attending Physician, Division of Rehabilitation Medicine, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3039. Andrew B. Janowski, MD, Instructor in Infectious Diseases, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  3040. Tara C. Jatlaoui, MD, MPH, Medical Epidemiologist, Division of Reproductive Health Centers for Disease Control and Prevention, Atlanta, Georgia
  3041. Elena J. Jelsing, MD, Assistant Professor, Departments of Physical Medicine and Rehabilitation and Division of Sports Medicine, Mayo Clinic Sports Medicine Center, Minneapolis, Minnesota
  3042. M. Kyle Jensen, MD, Associate Professor, Department of Pediatrics, University of Utah School of Medicine, Division of Pediatric Gastroenterology, Primary Children’s Hospital, Salt Lake City, Utah
  3043. Brian P. Jenssen, MD, MSHP, Assistant Professor, Department of Pediatrics, University of Pennsylvania Perelman, School of Medicine, Division of General Pediatrics, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3044. Karen E. Jerardi, MD, MEd, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Attending Physician, Division of Hospital Medicine, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3045. Chandy C. John, MD, MS, Ryan White Professor of Pediatrics, Director, Ryan White Center for Pediatric Infectious Diseases and Global Health, Indiana University School of Medicine, Indianapolis, Indiana
  3046. Brian D. Johnston, MD, MPH, Professor of Pediatrics, Associate Chief of Clinical Services, Division of General Pediatrics, University of Washington School of Medicine, Chief of Service, Department of Pediatrics, Harborview Medical Center, Seattle, Washington
  3047. Michael V. Johnston, MD, Executive Vice President and Chief, Medical Officer, Kennedy Krieger Institute, Professor of Pediatrics and Neurology Johns Hopkins University School of Medicine, Baltimore, Maryland
  3048. Richard B. Johnston Jr, MD, Professor Emeritus of Pediatrics, University of Colorado School of Medicine, Aurora, Colorado;, National Jewish Health, Denver, Colorado, Bridgette L. Jones, MD, Associate Professor of Pediatrics, Division of Allergy, Asthma, and Immunology, University of Missouri - Kansas City School of Medicine, Division of Allergy, Asthma, and Immunology, Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children’s Mercy, Kansas City, Missouri
  3049. Marsha Joselow, MSW, LICSW, Department of Psychosocial Oncology and Palliative Care Boston Children’s Hospital Dana-Farber Cancer Institute Boston, Massachusetts
  3050. Cassandra D. Josephson, MD, Professor of Pathology and Pediatrics Emory University School of Medicine Director of Clinical Research, Center for Transfusion and Cellular Therapies, Program Director, Transfusion Medicine, Fellowship Medical Director Children’s Healthcare of Atlanta Blood, Tissue, and Apheresis Services Atlanta, Georgia
  3051. Nicholas Jospe, MD, Professor of Pediatrics, University of Rochester School of Medicine and Dentistry Chief, Division of Pediatric Endocrinology, Golisano Children’s Hospital Rochester, New York
  3052. Joel C. Joyce, MD, Pediatric Dermatologist, NorthShore University Health System Skokie, Illinois;, Clinical Assistant Professor of Dermatology, University of Chicago Pritzker School of Medicine, Chicago, Illinois
  3053. Marielle A. Kabbouche, MD, FAHS, Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Acute and Inpatient, Headache Program, Division of Neurology, Cincinnati Children’s Medical Center, Cincinnati, Ohio
  3054. Joanne Kacperski, MD, FAHS, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Headache Medicine Specialist, Division of Neurology, Director, Post-Concussion Headache Program, Director, Headache Medicine, Fellowship, Cincinnati Children’s Medical Center, Cincinnati, Ohio
  3055. Deepak Kamat, MD, PhD, Professor of Pediatrics Vice Chair for Education, Wayne State University School of Medicine, Designated Institutional Official Detroit, Michigan
  3056. Beena D. Kamath-Rayne, MD, MPH, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Attending Neonatologist, Division of Neonatology and Pulmonary Biology Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3057. Alvina R. Kansra, MD, Associate Professor of Pediatrics, Medical College of Wisconsin Division of Pediatric Endocrinology Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  3058. David M. Kanter, MD, Assistant Professor, Department of Physical Medicine and Rehabilitation, State University of New York, SUNY Upstate Medical University, Syracuse, New York
  3059. Aaron M. Karlin, MD, Clinical Associate Professor, Department of Physical Medicine and Rehabilitation, Louisiana State University School of Medicine, Chair, Department of Physical Medicine and Rehabilitation, Section Head, Pediatric Rehabilitation Ochsner Clinic Medical Center Ochsner Children’s Health Center New Orleans, Louisiana
  3060. Jacob Kattan, MD, MSCR, Assistant Professor, Department of Pediatrics, Jaffe Food Allergy Institute, Kravis Children’s Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  3061. James W. Kazura, MD, Distinguished University Professor Adel A. Mahmoud Professorship in Global Health and Vaccines Director, Center for Global Health and Diseases, Case Western Reserve University School of Medicine, Cleveland, Ohio
  3062. Gregory L. Kearns, PharmD, PhD, FAAP, President, Arkansas Children’s, Research Institute, Senior Vice President and Chief, Research Officer, Arkansas Children’s, Ross and Mary Whipple Family Distinguished Research Scientist Professor of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas
  3063. Andrea Kelly, MD, MSCE, Associate Professor of Pediatrics University of Pennsylvania Perelman School of Medicine, Attending Physician, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3064. Desmond P. Kelly, MD, Professor of Pediatrics, University of South Carolina School of Medicine Greenville, Chief Medical Research Officer Health Sciences Center, Prisma Health-Upstate, Greenville, South Carolina
  3065. Kevin J. Kelly, MD, Professor of Pediatrics (Emeritus) Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina
  3066. Matthew S. Kelly, MD, MPH, Assistant Professor of Pediatrics Division of Infectious Diseases, Duke University School of Medicine Durham, North Carolina
  3067. Michael Kelly, MD, PhD, Chief Research Officer, Akron Childrens Hospital, Akron, Ohio
  3068. Kimberly M. Ken, MD, Resident Physician, Department of Dermatology University of Missouri School of Medicine, Columbia, Missouri
  3069. Melissa A. Kennedy, MD, Assistant Professor of Clinical Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, University of Pennsylvania Perelman School of Medicine, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3070. Eitan Kerem, MD, Professor and Chair, Department of Pediatrics, Hadassah University Medical Center Jerusalem, Israel
  3071. Joseph E. Kerschner, MD, Dean of the Medical School, Provost and Executive Vice President Professor of Otolaryngology and Microbiology and Immunology Medical College of Wisconsin Milwaukee, Wisconsin
  3072. Seema Khan, MD, Associate Professor of Pediatrics Division of Gastroenterology and Nutrition, George Washington University School of Medicine and Health Sciences Children’s National Medical Center, Washington, DC
  3073. Ameneh Khatami, BHB, MBChB, MD, Clinical Senior Lecturer, Discipline of Child and Adolescent Health, University of Sydney, Department of Microbiology and Infectious Diseases, The Children’s Hospital at Westmead, Sydney, Australia
  3074. Soumen Khatua, MD, Associate Professor of Pediatrics Section Chief, Neuro-Oncology, Department of Pediatrics Patient Care, The University of Texas MD, Anderson Cancer Center, Houston, Texas
  3075. Alexandra Kilinsky, DO, Fellow, Pediatric Hospital Medicine, Department of Pediatrics, Cohen Childrens Medical Center of New York, New Hyde Park, New York
  3076. Chong-Òàå Kim, MD, PhD, Associate Professor, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Rehabilitation Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3077. Wendy E. Kim, DO, Assistant Professor of Internal Medicine and Pediatrics, Division of Pediatric Dermatology, Loyola University Chicago Stritch, School of Medicine, Evanston, Illinois
  3078. Charles H. King, MD, Professor Emeritus of International Health, Center for Global Health and Diseases, Case Western Reserve University, School of Medicine, Cleveland, Ohio
  3079. Paul S. Kingma, MD, PhD, Associate Professor of Pediatrics, University of Cincinnati of College of Medicine, Neonatal Director, Cincinnati, Fetal Center, Co-Director, Cincinnati, Bronchopulmonary Dysplasia Center, The Perinatal Institute, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3080. Stephen L. Kinsman, MD, Associate Professor of Pediatrics, Medical University of South Carolina, Charleston, South Carolina
  3081. Priya S. Kishnani, MD, MBBS, C.L. and Su Chen Professor of Pediatrics, Chief, Division of Medical Genetics Duke University Medical Center Durham, North Carolina
  3082. Bruce L. Klein, MD, Associate Professor of Pediatrics, Johns Hopkins University School of Medicine, Interim Director, Pediatric, Emergency Medicine, Director, Pediatric Transport Johns Hopkins Children’s Center Baltimore, Maryland
  3083. Bruce S. Klein, MD, Professor of Pediatrics, Internal, Medicine, and Medical Microbiology and Immunology, Chief, Pediatric Infectious Disease Division, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  3084. Robert M. Kliegman, MD, Professor and Chairman Emeritus Department of Pediatrics Medical College of Wisconsin Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  3085. William C. Koch, MD, Associate Professor of Pediatrics, Virginia Commonwealth University School of Medicine, Division of Pediatric Infectious Diseases, Children’s Hospital of Richmond at VCU, Richmond, Virginia
  3086. Patrick M. Kochanek, MD, MCCM, Ake N. Grenvik Professor of Critical Care Medicine, Vice Chair, Department of Critical Care Medicine, Professor of Anesthesiology, Pediatrics, Bioengineering, and Clinical and Translational Science Director, Safar Center for Resuscitation Research, UPMC Children’s Hospital of Pittsburgh, John G. Rangos Research Center, Pittsburgh, Pennsylvania
  3087. Eric Kodish, MD, Professor of Pediatrics, Lerner College of Medicine, Cleveland Clinic, Cleveland, Ohio
  3088. Stephan A. Kohlhoff, MD, Associate Professor of Pediatrics and Medicine, Chief, Pediatric Infectious Diseases SUNY Downstate Medical Center, Brooklyn, New York
  3089. Mark A. Kostic, MD, Professor of Emergency Medicine and Pediatrics, Medical College of Wisconsin, Associate Medical Director, Wisconsin Poison Center, Milwaukee, Wisconsin
  3090. Karen L. Kotloff, MD, Professor of Pediatrics Division Head, Infectious Disease and Tropical Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland
  3091. Elliot J. Krane, MD, FAAP, Professor of Pediatrics, and Anesthesiology, Perioperative, and Pain Medicine, Stanford University School of Medicine, Chief, Pediatric Pain Management Stanford Childrens Health, Lucile Packard Childrens Hospital at Stanford, Stanford, California
  3092. Peter J. Krause, MD, Senior Research Scientist in Epidemiology (Microbial Diseases), Medicine (Infectious Diseases), and Pediatrics (Infectious Diseases) Lecturer in Epidemiology (Microbial Diseases), Yale School of Public Health, New Haven, Connecticut
  3093. Richard E. Kreipe, MD, FAAAP, FSAHM, FAED, Dr. Elizabeth R. McArnarney Professor in Pediatrics funded by Roger and Carolyn Friedlander Department of Pediatrics, Division of Adolescent Medicine, University of Rochester, Medical Center, Golisano Childrens Hospital Director, New York State ACT for Youth Center of Excellence, Medical Director, Western New York Comprehensive Care Center for Eating Disorders, Rochester, New York
  3094. Steven E. Krug, MD, Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Division of Pediatric Emergency Medicine, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  3095. Janet L. Kwiatkowski, MD, MSCE, Professor, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Hematology, Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  3096. Jennifer M. Kwon, MD, Professor of Child Neurology Department of Neurology University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  3097. Catherine S. Lachenauer, MD, Assistant Professor of Pediatrics Harvard Medical School, Director, Infectious Diseases, Outpatient Practice, Boston Children’s Hospital, Boston, Massachusetts
  3098. Stephan Ladisch, MD, Professor of Pediatrics and Biochemistry/Molecular Biology George Washington University School of Medicine, Center for Cancer and Immunology Research and Center for Cancer and Blood Disorders, Children’s Research Institute, Children’s National Medical Center, Washington, DC
  3099. Oren J. Lakser, MD, Assistant Professor of Pediatrics Northwestern University Feinberg School of Medicine, Associate Clinician Specialist Division of Pulmonary Medicine Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois
  3100. Philip J. Landrigan, MD, MSc, FAAP, Director, Global Public Health, Program, Schiller Institute for Integrated, Science and Society, Professor of Biology, Boston College, Chestnut Hill, Massachusetts
  3101. Gregory L. Landry, MD, Professor Emeritus Department of Pediatrics, University of Wisconsin - Madison School of Medicine and Public Health, Madison, Wisconsin
  3102. Wendy G. Lane, MD, MPH, FAAP, Associate Professor, Department Epidemiology and Public Health, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland
  3103. A. Noelle Larson, MD, Associate Professor, Orthopedic Surgery, Division of Pediatric Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota
  3104. Phillip S. LaRussa, MD, Professor of Pediatrics, Columbia University College of Physicians and Surgeons Division of Pediatric Infectious Diseases, NewYork-Presbyterian Morgan Stanley Children’s Hospital New York, New York
  3105. Oren J. Lakser, MD, Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Division of Pulmonary Medicine Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  3106. J. Todd R. Lawrence, MD, PhD, Assistant Professor, Department of Orthopaedic Surgery University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  3107. Brendan Lee, MD, PhD, Robert and Janice McNair, Endowed Chair in Molecular and Human Genetics, Professor and Chairman, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  3108. K. Jane Lee, MD, MA, Associate Professor, Department of Pediatrics, Medical College of Wisconsin Division of Pediatric Special Needs Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  3109. J. Steven Leeder, PharmD, PhD, Marion Merrell Dow I Missouri, Endowed Chair in Pediatric Pharmacology, Chief, Division of Pediatric, Pharmacology and Medical Toxicology Children’s Mercy Hospitals and Clinics, Kansas City, Missouri; Adjunct Professor, Department of Pharmacology, Toxicology, and Therapeutics, Kansas University School of Medicine, Kansas City, Kansas
  3110. Jennifer W. Leiding, MD, Assistant Professor of Pediatrics, University of South Florida College of Medicine, St. Petersburg, Florida
  3111. Michael J. Lentze, MD, Professor Emeritus of Pediatrics Zentrum fur Kinderheilkunde, Universitatsklinikum Bonn, Bonn, Germany
  3112. Steven Î. Lestrud, MD, Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Medical Director, Respiratory Care Ann & Robert H. Lurie Childrens, Hospital of Chicago, Chicago, Illinois
  3113. Donald Y. M. Leung, MD, PhD, Edelstein Family Chair of Pediatric, Allergy-Immunology, National Jewish Health, Professor of Pediatrics, University of Colorado School of Medicine, Denver, Colorado
  3114. Michael N. Levas, MD, Associate Professor of Pediatrics, Medical College of Wisconsin, Division of Pediatric Emergency Medicine, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
  3115. Rona L. Levy, MSW, PhD, MPH, Professor and Director, Behavioral Medicine Research Group Assistant Dean for Research, School of Social Work, University of Washington, Seattle, Washington
  3116. Â U.K. Li, MD, Clinical Professor of Pediatrics, Medical College of Wisconsin, Division of Pediatric Gastroenterology, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin
  3117. Chris A. Liacouras, MD, Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Co-Director, Center for Pediatric, Eosinophilic Disorders, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3118. Christopher W. Liebig, MD, Clinical Assistant Professor of Pediatrics, Northeast Ohio Medical University Rootstown, Ohio; Director, Sports Medicine in Mahoning Valley, Akron Children’s Hospital, Boardman, Ohio
  3119. Paul H. Lipkin, MD, Associate Professor of Pediatrics, Director, Medical Informatics, Director, Interactive Autism Network, Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
  3120. Deborah R. Liptzin, MD, MS, Assistant Professor of Pediatrics University of Colorado School of Medicine, Associate Director, Colorado chILD, Children’s Hospital Colorado, Aurora, Colorado
  3121. Andrew H. Liu, MD, Professor Department of Pediatrics, Children’s Hospital Colorado, University of Colorado School of Medicine, Aurora, Colorado
  3122. Lucinda Lo, MD, Clinical Assistant Professor of Pediatrics, Physician Advisor, CDI and CM University of Pennsylvania Perelman School of Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3123. Stanley F. Lo, PhD, Associate Professor of Pathology, Medical College of Wisconsin, Technical Director, Clinical Chemistry, ÐÎÑÒ, and Biochemical Genetics, Director, Reference Standards Library, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin, Kathleen A. Long, MD, Department of Child Health, University of Missouri School of Medicine, Columbia, Missouri
  3124. Sarah S. Long, MD, Professor of Pediatrics, Drexel University College of Medicine Division of Infectious Diseases, St. Christopher’s Hospital for Children, Philadelphia, Pennsylvania
  3125. Anna Lena Lopez, MD, MPH, Director, Institute of Child Health and Human Development, Research Associate Professor, University of the Philippines Manila-National Institutes of Health, Manila, Philippines
  3126. Santiago M.C. Lopez, MD, Assistant Professor of Pediatrics, University of South Dakota School of Medicine, Pediatric Infectious Diseases, Sanford Children’s Hospital/Specialty Clinic, Sioux Falls, South Dakota
  3127. Steven V. Lossef, MD, Associate Professor of Radiology, George Washington University, School of Medicine and Health Sciences, Head, Pediatric Interventional Radiology, Division of Diagnostic Imaging and Radiology, Children’s National Medical Center, Washington, DC
  3128. Jennifer A. Lowry, MD, Professor of Pediatrics, University of Missouri - Kansas City School of Medicine, Director, Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Childrens Mercy, Kansas City, Missouri
  3129. Ian R. Macumber, MD, MS, Assistant Professor of Pediatrics, University of Connecticut School of Medicine, Division of Nephrology, Connecticut Children’s, Medical Center, Hartford, Connecticut
  3130. Mark R. Magnusson, MD, PhD, Co-Director, Diagnostic and Complex Care Center, Medical Director, Spina Bifida, Program, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3131. Pilar L. Magoulas, MS, Assistant Professor, Clinical Program Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  3132. Prashant V. Mahajan, MD, MPH, MBA, Professor of Emergency Medicine and Pediatrics, Vice-Chair, Department of Emergency Medicine, Division Chief, Pediatric Emergency, Medicine, University of Michigan, Ann Arbor, Michigan
  3133. Joseph A. Majzoub, MD, Thomas Morgan Rotch Professor of Pediatrics, Harvard Medical School, Division of Endocrinology, Boston Childrens Hospital, Boston, Massachusetts
  3134. Robert J. Mann, MD, The Karl and Patricia Betz Family Endowed Director of Research Helen DeVos Children’s Hospital Grand Rapids, Michigan
  3135. Irini Manoli, MD, PhD, National Human Genome Research, Institute, National Institutes of Health, Bethesda, Maryland
  3136. Asim Maqbool, MD, Associate Professor of Clinical Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  3137. Ashley M. Maranich, MD, Program Director, Pediatrics, Residency, Tripier Army Medical Center Honolulu, Hawaii
  3138. Nicole Marcantuono, MD, Associate Professor, Department of Pediatrics, Thomas Jefferson Medical College Philadelphia, Pennsylvania;, Attending Physician, Alfred I. du Pont Hospital for Children, Wilmington, Delaware
  3139. David Margolis, MD, Professor and Associate Chair Department of Pediatrics, Medical College of Wisconsin Program Director, Bone Marrow Transplantation, Childrens Hospital of Wisconsin Milwaukee, Wisconsin
  3140. Mona Marin, MD, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
  3141. Joan C. Marini, MD, PhD, Chief, Bone and Extracellular, Matrix Branch, National Institute for Child Health and Development, National Institutes of Health, Bethesda, Maryland
  3142. Thomas C. Markello, MD, PhD, Associate Staff Clinician, Medical Genetics Branch, National Human Genome Research, Institute, National Institutes of Health, Bethesda, Maryland
  3143. Morri Markowitz, MD, Professor of Pediatrics and Medicine Albert Einstein College of Medicine Director, Lead Poisoning Prevention and Treatment Program, The Childrens Hospital at Montefiore Bronx, New York
  3144. Stacene R. Maroushek, MD, PhD, MPH, Assistant Professor of Pediatrics Divisions of Pediatric Infectious Diseases and General Pediatrics University of Minnesota, Medical School, Hennepin County Medical Center, Minneapolis, Minnesota
  3145. Justin D. Marsh, MD, Assistant Professor of Pediatric Ophthalmology, University of Missouri-Kansas City, School of Medicine, Kansas City, Missouri
  3146. Kari L. Martin, MD, Assistant Professor of Dermatology and Child Health, University of Missouri School of Medicine, Columbia, Missouri
  3147. Maria G. Martinez, MD, Clinical Fellow, Pediatric Rehabilitation Medicine, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  3148. Wilbert H. Mason, MD, MPH, Professor Emeritus of Clinical Pediatrics, University of Southern California Keck School of Medicine, Chief, Pediatric Infectious Diseases Childrens Hospital of Los Angeles Los Angeles, California
  3149. Reuben K. Matalon, MD, PhD, Professor of Pediatrics and Genetics University of Texas Medical Branch University of Texas Children’s Hospital, Galveston, Texas
  3150. Sravan Kumar Reddy Matta, MD Assistant Professor of Pediatrics Division of Gastroenterology and Nutrition, Children’s National Medical Center, Washington, DC
  3151. Aletha Maybank, MD, MPH, Deputy Commissioner, Founding Director, Center for Health Equity, New York City Department of Health and Mental Hygiene, Long Island City, New York
  3152. Robert L. Mazor, MD, Clinical Associate Professor, Department of Pediatrics, University of Washington School of Medicine, Division of Critical Care and Cardiac Surgery, Clinical Director, CICU, Seattle Children’s Hospital and Regional Medical Center, Seattle, Washington, Jennifer McAllister, MD, IBCLC Assistant Professor of Pediatrics University of Cincinnati College of Medicine, Medical Director, West Chester Hospital Special Care Nursery and University of Cincinnati Medical Center Newborn Nursery, Medical Director, NICU Follow Up Clinic-NAS Clinic, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3153. Megan E. McCabe, MD, FAAP, Director, Pediatric Residency Program Director, Pediatric Critical Care, Fellowship Program, The Children’s Hospital at Montefiore The University Hospital for Albert Einstein College of Medicine, Bronx, New York
  3154. Megan E. McClean, MD, Resident Physician, Department of Dermatology University of Missouri School of Medicine, Columbia, Missouri
  3155. Susanna A. McColley, MD, Professor of Pediatrics, Northwestern University Feinberg School of Medicine, Associate Chief Research Officer for Clinical Trials, Stanley Manne Children’s Research Institute, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  3156. Patrick T. McGann, MD, MS, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Hematology, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3157. Margaret M. McGovern, MD, PhD, Knapp Professor of Pediatrics Physician-in-Chief, Stony Brook Children’s Hospital, Dean for Clinical Affairs, Stony Brook University School of Medicine, Stony Brook, New York
  3158. Sharon A. McGrath-Morrow, MD, MBA, Professor of Pediatrics, Eudowood Division of Pediatric, Respiratory Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland
  3159. Jeffrey S. McKinney, MD, PhD, Professor of Pediatrics, Vice Chair for Education, Harry W Bass Jr. Professorship in Pediatric Education, Distinguished Teaching Professor Division of Pediatric Infectious Diseases, UT Southwestern Medical Center, Dallas, Texas
  3160. Matthew J. McLaughlin, MD, Assistant Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Division of Pediatric Physical Medicine and Rehabilitation, Childrens Mercy Hospitals and Clinics, Kansas City, Missouri
  3161. Rima McLeod, MD, Professor of Ophthalmology and Visual Science and Pediatrics, Medical Director, Toxoplasmosis Center, University of Chicago Medicine Chicago, Illinois, Asuncion Mejias, MD, PhD, MSCS Associate Professor of Pediatrics Division of Infectious Diseases, The Ohio State University College of Medicine, Principal Investigator, Center for Vaccines and Immunity, The Research Institute at Nationwide, Childrens Hospital, Columbus, Ohio
  3162. Peter C. Melby, MD, Professor of Internal Medicine (Infectious Diseases), Microbiology and Immunology, and Pathology Director, Division of Infectious Diseases, Director, Center for Tropical Diseases University of Texas Medical, Branch (UTMB), Galveston, Texas
  3163. Marlene D. Melzer-Lange, MD, Professor of Pediatrics, Medical College of Wisconsin Program Director, Project Ujima Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  3164. Matthew D. Merguerian, MD, PhD, Fellow, Division of Pediatric Oncology Department of Oncology, Johns Hopkins Hospital, Pediatric Oncology Branch, National Cancer Institute, Baltimore, Maryland
  3165. Stephanie L. Merhar, MD, MS, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Attending Neonatologist, Division of Neonatology and Pulmonary Biology Research Director, NICU Follow-Up Clinic, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  3166. Diane E Merritt, MD, Professor, Department of Obstetrics and Gynecology, Director, Pediatric and Adolescent Gynecology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  3167. Kevin Messacar, MD, Assistant Professor of Pediatrics, University of Colorado School of Medicine, Section of Pediatric Infectious Diseases, Section of Hospital Medicine Childrens Hospital Colorado Aurora, Colorado
  3168. Marian G. Michaels, MD, MPH, Professor of Pediatrics and Surgery University of Pittsburgh School of Medicine, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  3169. Thomas F. Michniacki, Pediatric Hematology/Oncology Fellow, Division of Pediatric Hematology/Oncology, University of Michigan Medical School, Ann Arbor, Michigan
  3170. Mohamad A. Mikati, MD, Wilburt C. Davison Professor of Pediatrics, Professor of Neurobiology Chief, Division of Pediatric Neurology, Duke University Medical Center Durham, North Carolina
  3171. Henry Milgrom, MD, Professor of Pediatrics, National Jewish Health, University of Colorado School of Medicine, Denver, Colorado
  3172. Jonathan W. Mink, MD, PhD, Frederick A. Horner MD Endowed Professor in Pediatric Neurology Professor of Neurology and Pediatrics Chief, Division of Child Neurology Vice-Chair, Department of Neurology University of Rochester, Medical Center, Rochester, New York
  3173. R. Justin Mistovich, MD, Assistant Professor, Department of Orthopaedic Surgery Case Western Reserve University School of Medicine, MetroHealth Medical Center University Hospitals, Rainbow and Babies Children’s Hospital, Cleveland, Ohio
  3174. Jonathan A. Mitchell, PhD, MsC, Research Assistant Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Gastroenterology, Hepatology, and Nutrition Children’s Hospital of Philadelphia
  3175. Mark M. Mitsnefes, MD, MS Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Clinical and Translational Research Center, Division of Pediatric Nephrology Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3176. Sindhu Mohandas, MD, Assistant Professor of Pediatrics Division of Infectious Diseases Keck School of Medicine, University of Southern California Los Angeles, California
  3177. Rachel Y. Moon, MD, Professor of Pediatrics, Head, Division of General Pediatrics University of Virginia School of Medicine, Charlottesville, Virginia
  3178. Joan P. Moran, BSN, RN, Infection Preventionist, Infection Prevention and Control Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  3179. Eva Morava, MD, PhD, Professor of Pediatrics, Tulane University Medical School Clinical Biochemical Geneticist, Hayward Genetics Center, New Orleans, Louisiana
  3180. Megan A. Moreno, MD, MSEd, MPH, Professor of Pediatrics, Division Chief, General Pediatrics and Adolescent Medicine Vice Chair of Digital Health University of Wisconsin School of Medicine and Public Health Madison, Wisconsin
  3181. Esi Morgan, MD, MSCE, Associate Professor of Pediatrics University of Cincinnati College of Medicine, Division of Rheumatology, James M. Anderson Center for Health Systems Excellence, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3182. Peter E. Morrison, DO, Senior Instructor, Department of Neurology, University of Rochester Medical Center Rochester, New York
  3183. Lovern R. Moseley, PhD, Clinical Assistant Professor of Psychiatry, Boston University School of Medicine Boston, Massachusetts
  3184. Yael Mozer-Glassberg, MD, Head, Pediatric Liver Transplant Program, Institute of Gastroenterology, Nutrition, and Liver Diseases Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
  3185. Louis J. Muglia, MD, PhD, Professor of Pediatrics, University of Cincinnati College of Medicine, Co-Director, Perinatal Institute, Director, Center for Prevention of Preterm Birth, Director, Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3186. Kevin P. Murphy, MD, Medical Director, Pediatric, Rehabilitation, Sanford Health Systems, Bismarck, North Dakota;, Medical Director, Gillette Childrens, Specialty Healthcare, Duluth Clinic, Duluth, Minnesota
  3187. Timothy E Murphy, MD, SUNY Distinguished Professor of Medicine, Senior Associate Dean for Clinical and Translational Research, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, Buffalo, New York
  3188. Karen E Murray, MD, Professor and Interim-Chair, Chief, Division of Gastroenterology and Hepatology, Department of Pediatrics, University of Washington School of Medicine, Interim Pediatrician-In-Chief, Seattle Childrens Hospital, Seattle, Washington
  3189. Thomas S. Murray, MD, PhD, Associate Professor of Medical Sciences, Quinnipiac University Frank H, Netter MD School of Medicine, Hamden, Connecticut
  3190. Sona Narula, MD, Assistant Professor of Clinical Neurology, Children’s Hospital of Philadelphia, University of Pennsylvania Perelman, School of Medicine, Philadelphia, Pennsylvania
  3191. Mindo J. Natale, PsyD, Assistant Professor of Psychology, University of South Carolina School of Medicine, Senior Staff Psychologist, GHS Children’s Hospital, Greenville, South Carolina
  3192. Amy T. Nathan, MD, Associate Professor of Pediatrics University of Cincinnati College of Medicine, Medical Director, Perinatal Institute, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3193. Dipesh Navsaria, MD, MPH, MSLIS, FAAP, Associate Professor of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
  3194. William A. Neal, MD, Professor Emeritus of Pediatrics, Division of Pediatric Cardiology West Virginia University School of Medicine, Morgantown, West Virginia
  3195. Grace Nehme, MD, Fellow, Department of Pediatrics, University of Texas MD Anderson, Cancer Center, Houston, Texas
  3196. Edward J. Nehus, MD, MS, Assistant Professor of Clinical Pediatrics, University of Cincinnati College of Medicine, Division of Nephrology and Hypertension, Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  3197. Maureen R. Nelson, MD, Associate Professor of Physical, Medicine & Rehabilitation and Pediatrics, Baylor College of Medicine, Medical Director, Physical Medicine & Rehabilitation, The Children’s Hospital of San, Antonio, San Antonio, Texas
  3198. Caitlin M. Neri, MD, Assistant Professor of Pediatrics, Boston University School of Medicine Boston, Massachusetts
  3199. Mark I. Neuman, MD, MPH, Associate Professor of Pediatrics and Emergency Medicine, Harvard Medical School, Department of Emergency Medicine, Boston Childrens Hospital, Boston, Massachusetts
  3200. Mary A. Nevin, MD, FAAP, FCCP Associate Professor of Pediatrics Northwestern University Feinberg School of Medicine, Department of Pediatrics, Division of Pulmonary Medicine, Ann & Robert H. Lurie Childrens, Hospital of Chicago, Chicago, Illinois
  3201. Jane W. Newburger, MD, Commonwealth Professor of Pediatrics, Harvard Medical School, Associate Cardiologist-in-Chief, Research and Education, Director, Cardiac, Neurodevelopmental Program Boston Children’s Hospital Boston, Massachusetts
  3202. Jonathan Newmark, MD, MM, FAAN Adjunct Professor of Neurology E Edward Hebert School of Medicine Uniformed Services University of the Health Sciences, Bethesda, Maryland; Clinical Assistant Professor of Neurology, George Washington University School of Medicine and Health Sciences, Staff Neurologist, Washington DC VA Medical Center Washington, DC
  3203. Linda S. Nield, MD, Assistant Dean for Admissions Professor of Medical Education and Pediatrics, West Virginia University School of Medicine, Morgantown, West Virginia
  3204. Omar Niss, MD, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Division of Hematology, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3205. Zehava L. Noah, MD, Associate Professor of Pediatrics Northwestern University Feinberg School of Medicine, Division of Pediatric Critical Care Medicine, Ann & Robert H. Lurie Childrens Hospital of Chicago, Chicago, Illinois
  3206. James J. Nocton, MD, Professor of Pediatrics, Section of Pediatric Rheumatology Medical College of Wisconsin Milwaukee, Wisconsin
  3207. Lawrence M. Nogee, MD, Professor of Pediatrics, Eudowood Neonatal Pulmonary Division, Johns Hopkins University School of Medicine, Baltimore, Maryland
  3208. Corina Noje, MD, Assistant Professor, Pediatric Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, Medical Director, Pediatric Transport, Johns Hopkins Bloomberg, Childrens Center, Baltimore, Maryland
  3209. Laura E. Norton, MD, MS, Assistant Professor of Pediatrics, Division of Pediatric Infectious, Diseases and Immunology, University of Minnesota, Medical School, Minneapolis, Minnesota
  3210. Anna Nowak-Wagrzyn, MD, PhD, Professor of Pediatrics, Jaffe Food Allergy Institute, Division of Allergy and Immunology, Department of Pediatrics, Kravis Childrens Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  3211. Stephen K. Obaro, MD, PhD, Professor of Pediatric Infectious, Diseases, Director, Pediatric International Research, University of Nebraska, Medical Center, Omaha, Nebraska
  3212. Makram M. Obeid, MD, Assistant Professor of Pediatrics and Adolescent Medicine, Pediatric Epileptologist, Division of Child Neurology, Department of Pediatrics and Adolescent Medicine, Department of Anatomy, Cell Biology and Physiology, American University of Beirut, Beirut, Lebanon
  3213. Hope L. O’Brien, MD, MBA, FAHS, FAAN, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Program Director, Headache, Medicine Education, Co-Director Young Adult Headache Program, Cincinnati Childrens Medical Center Cincinnati, Ohio
  3214. Jean-Marie Okwo-Bele, MD, MPH, Director, Department of Immunization, Vaccines, and Biologicals, World Health Organization, Geneva, Switzerland
  3215. Joyce L. Oleszek, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, Childrens Hospital Colorado, Denver, Colorado
  3216. Scott E. Olitsky, MD, Professor of Ophthalmology, University of Kansas School of Medicine, University of Missouri - Kansas City School of Medicine, Section Chief, Ophthalmology, Childrens Mercy Hospitals and Clinics, Kansas City, Missouri
  3217. John M. Olsson, MD, CPE, Professor of Pediatrics, Medical Director, Well Newborn, Services, Division of General Pediatrics University of Virginia School of Medicine, Charlottesville, Virginia
  3218. Amanda K. Ombrello, MD, Associate Research Physician, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
  3219. Meghan E. O’Neill, MD, Fellow in Neurodevelopment, Disabilities, Kennedy Krieger Institute, Baltimore, Maryland
  3220. Mutiat T. Onigbanjo, MD, Assistant Professor, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland
  3221. Walter A. Orenstein, MD, DSc (Hon), Professor of Medicine, Pediatrics, and Global Health, Emory University, Associate Director, Emory Vaccines Center, Atlanta, Georgia; Former Deputy Director for Immunization Programs Bill & Melinda Gates Foundation Seattle, Washington; Former Director, National Immunization Program Centers for Disease Control and Prevention, Atlanta, Georgia
  3222. Rachel C. Orscheln, MD, Associate Professor of Pediatrics, Washington University School of Medicine in St. Louis, Director, Ambulatory Pediatric Infectious Diseases, Director, International, Adoption Center, St. Louis Children’s Hospital, St. Louis, Missouri
  3223. Marisa Osorio, DO, Assistant Professor, Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle Children’s Hospital Seattle, Washington
  3224. Christian A. Otto, MD, MMSc, Director of TeleOncology, Associate Attending Physician, Memorial Sloan Kettering, Cancer Center, New York, New York
  3225. Judith A. Owens, MD, MPH, Professor of Neurology, Harvard Medical School, Director of Sleep Medicine Boston Children’s Hospital Boston, Massachusetts
  3226. Seza Ozen, MD, Professor of Paediatrics, Divisions of Paediatric Rheumatology Hacettepe University, Ankara, Turkey
  3227. Lee M. Pachter, DO, Professor of Pediatrics and Population Health, Sidney Kimmel Medical College and Jefferson College of Population Health Thomas Jefferson University Director, Community and Clinical Integration, Nemours Alfred I. duPont Hospital for Children, Wilmington, Delaware; Director, Health Policy Program Jefferson College of Population Health Philadelphia, Pennsylvania
  3228. Amruta Padhye, MD, Assistant Professor of Clinical, Child Health, Division of Pediatric Infectious Diseases, University of Missouri School of Medicine, Columbia, Missouri
  3229. Suzinne Pak-Gorstein, MD, PhD, MPH, Associate Professor of Pediatrics Adjunct Associate Professor of Global Health, University of Washington School of Medicine, Seattle, Washington
  3230. Jennifer Panganiban, MD, Assistant Professor of Clinical Pediatrics, University of Pennsylvania Perelman School of Medicine, Director, Non Alcoholic Fatty Liver Disease Clinic, Division of Gastroenterology, Hepatology, and Nutrition Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  3231. Diane E. Pappas, MD, JD, Professor of Pediatrics, Director of Child Advocacy University of Virginia School of Medicine, Charlottesville, Virginia
  3232. John J. Parent, MD, MSCR, Assistant Professor of Pediatrics, Indiana University School of Medicine Section of Cardiology, Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana
  3233. Alasdair P.J. Parker, MBBS (Lond), MRCP, MD, MA (Camb), Consultant in Pediatric Neurology, Addenbrooke’s Hospital, Associate Lecturer, University of Cambridge School of Clinical Medicine, Cambridge, United Kingdom
  3234. Elizabeth Prout Parks, MD, MSCE, Assistant Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Gastroenterology, Hepatology, and Nutrition Childrens Hospital of Philadelphia Philadelphia, Pennsylvania
  3235. Briana C. Patterson, MD, MS, Associate Professor of Pediatrics, Division of Pediatric Endocrinology, Director, Pediatric Endocrine, Fellowship Program, Emory University School of Medicine Atlanta, Georgia
  3236. Maria Jevitz Patterson, MD, PhD, Professor Emeritus of Microbiology and Molecular Genetics, Michigan State University College of Human Medicine, East Lansing, Michigan
  3237. Anna L. Peters, MD, PhD, Clinical Fellow, Division of Gastroenterology,, Hepatology, and Nutrition, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3238. Timothy R. Peters, MD, Professor of Pediatrics, Wake Forest School of Medicine, Division of Pediatric Infectious, Diseases, Wake Forest Baptist Medical Center Winston-Salem, North Carolina
  3239. Rachel A. Phelan, MD, MPH, Assistant Professor of Pediatrics, Medical College of Wisconsin, Division of Hematology/ Oncology/BMT, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin
  3240. Anna Pinto, MD, PhD, Lecturer of Neurology, Harvard Medical School, Co-Director, Sturge Weber Clinic, Department of Neurology, Boston Children’s Hospital Boston, Massachusetts
  3241. Brenda B. Poindexter, MD, MS, Professor of Pediatrics, University of Cincinnati College of Medicine, Director of Clinical and Translational, Research, Perinatal Institute, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3242. Andrew J. Pollard, FRCPCH, PhD, FMedSci, Professor of Paediatric Infection and Immunity, Department of Paediatrics, University of Oxford, Children’s Hospital, Oxford, United Kingdom
  3243. Diego Preciado, MD, PhD, Professor of Pediatrics, Surgery, and Integrative Systems Biology, George Washington University School of Medicine and Health Sciences, Vice-Chief, Division of Pediatric Otolaryngology, Children’s National Health System, Washington, DC
  3244. Mark R. Proctor, MD, Franc D. Ingraham Professor of Neurosurgery, Harvard Medical School, Neurosurgeon-in-Chief, Boston Children’s Hospital, Boston, Massachusetts
  3245. Howard I. Pryor II, MD, Instructor of Surgery, Division of Pediatric Surgery, Johns Hopkins University School of Medicine, Johns Hopkins Children’s Center, Baltimore, Maryland
  3246. Lee A. Pyles, MD, MS, Associate Professor of Pediatrics, Division of Pediatric Cardiology West Virginia University School of Medicine, Morgantown, West Virginia
  3247. Molly Quinn, MD, Fellow, Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, San Francisco, California
  3248. Elisabeth H. Quint, MD, Professor of Obstetrics and Gynecology, Director, Fellowship in Pediatric and Adolescent Gynecology, University of Michigan, Medical School, Ann Arbor, Michigan
  3249. Amy E. Rabatin, MD, Fellow, Pediatric Rehabilitation and Board Certified Sports Medicine Department of Physical Medicine and Rehabilitation, Mayo Clinic Children’s Center Rochester, Minnesota
  3250. C. Egla Rabinovich, MD, MPH, Professor of Pediatrics, Duke University School of Medicine Co-Chief, Division of Pediatric Rheumatology, Duke University Health System Durham, North Carolina
  3251. Leslie J. Raffini, MD, Associate Professor, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Hematology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3252. Shawn L. Ralston, MD, MS, Associate Professor and Vice Chair for Clinical Affairs, Department of Pediatrics, Geisel School of Medicine at Dartmouth, Chief, Section of Pediatric Hospital Medicine, Children’s Hospital at Dartmouth-Hitchcock, Hanover, New Hampshire
  3253. Sanjay Ram, MD, Professor of Medicine, University of Massachusetts, Medical School, Division of Infectious Diseases and Immunology, UMass Memorial Medical Center Worcester, Massachusetts
  3254. Octavio Ramilo, MD, Professor of Pediatrics, Henry G. Cramblett Chair in Medicine The Ohio State University College of Medicine, Chief, Division of Infectious Diseases Nationwide Children’s Hospital Columbus, Ohio
  3255. Kacy A. Ramirez, MD, Assistant Professor of Pediatrics Wake Forest School of Medicine Division of Pediatric Infectious Diseases, Wake Forest Baptist Medical Center Winston-Salem, North Carolina
  3256. Casey M. Rand, BS, Project Manager, Center for Autonomic Medicine in Pediatrics Ann & Robert H. Lurie Children’s Hospital of Chicago, Chicago, Illinois
  3257. Adam J. Ratner, MD, MPH, Associate Professor of Pediatrics and Microbiology, New York University School of Medicine, Chief, Division of Pediatric Infectious Diseases, New York University Langone Medical Center, New York, New York
  3258. Lee Ratner, MD, PhD, Professor of Medicine, Professor of Molecular Microbiology and of Pathology and Immunology Washington University School of Medicine in St. Louis, St. Louis, Missouri
  3259. Gerald V. Raymond, MD, Professor of Neurology, University of Minnesota School of Medicine, Chief of Pediatric Neurology University of Minnesota Medical Center, Fairview, Minneapolis, Minnesota
  3260. Ann M. Reed, MD, Professor of Pediatrics, Chair, Department of Pediatrics, Physician-in-Chief, Duke Childrens, Duke University, Durham, North Carolina
  3261. Shimon Reif, MD, Chairman, Department of Pediatrics, Hadassah Medical Center, Hebrew University, Jerusalem, Israel
  3262. Megan E. Reller, MD, PhD, MPH, Associate Professor of Medicine Associate Research Professor of Global Health, Duke University Medical Center Durham, North Carolina
  3263. Caroline H. Reuter, MD, MSCI, Associate Medical Director, Pharmacovigilance, Bioverativ, Waltham, Massachusetts
  3264. Jorge D. Reyes, MD, Professor and Roger K. Giesecke Distinguished Chair, Department of Surgery, University of Washington School of Medicine, Chief, Division of Transplant Surgery Seattle Childrens Hospital, Seattle, Washington
  3265. Firas Rinawi, MD, Attending Physician, Institute of Gastroenterology, Nutrition, and Liver Diseases Schneider Childrens Medical Center of Israel, Petah Tikva, Israel
  3266. A. Kim Ritchey, MD, Professor and Vice-Chair of International Affairs, Department of Pediatrics, University of Pittsburgh School of Medicine, Division of Hematology/Oncology UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  3267. Frederick P. Rivara, MD, MPH, Seattle Children’s Guild Endowed Chair in Pediatrics, Professor and Vice-Chair, Department of Pediatrics University of Washington School of Medicine, Seattle, Washington
  3268. Eric Robinette, MD, Attending Physician in Infectious Diseases, Akron Children’s Hospital, Akron, Ohio
  3269. Angela Byun Robinson, MD, MPH, Associate Professor, Cleveland Clinic Lerner College of Medicine, Staff, Pediatrics Institute, Cleveland Clinic Children’s, Cleveland, Ohio
  3270. Kristine Knuti Rodrigues, MD, MPH, Assistant Professor of Pediatrics University of Colorado School of Medicine, Department of Pediatrics, Denver Health Medical Center, Denver, Colorado
  3271. David F. Rodriguez-Buritica, MD, Assistant Professor, Department of Pediatrics, Division of Medical Genetics McGovern Medical School at UTHealth, Houston, Texas
  3272. Rosa Rodriguez-Fernandez, MD, PhD, Hospital General Universitario Gregorio Maranon, Institute de Investigacidn Sanitaria, Gregorio Maranon (IISGM), Madrid, Spain; Center for Vaccines and Immunity The Research Institute at Nationwide, Children’s Hospital, The Ohio State University College of Medicine, Columbus, Ohio
  3273. Genie E. Roosevelt, MD, MPH, Professor of Emergency Medicine University of Colorado School of Medicine, Department of Emergency Medicine Denver Health Medical Center, Denver, Colorado
  3274. David R. Rosenberg, MD, Chair, Department of Psychiatry and Behavioral Neurosciences, Chief of Child Psychiatry and Psychology, Wayne State University School of Medicine, Detroit, Michigan
  3275. Cindy Ganis Roskind, MD, Program Director, Pediatric Emergency Medicine Fellowship, Children’s Hospital of New York-Presbyterian, Associate Professor of Pediatrics, Columbia University Irving, Medical Center, Columbia University College of Physicians and Surgeons New York, New York
  3276. A. Catharine Ross, PhD, Professor and Dorothy Foehr, Huck Chair, Department of Nutritional Sciences The Pennsylvania State University College of Health and Human Development, University Park, Pennsylvania
  3277. Joseph W. Rossano, MD, MS, Chief, Division of Cardiology Co-Executive Director, The Cardiac Center, Jennifer Terker Endowed Chair in Pediatric Cardiology, Associate Professor of Pediatrics, Children’s Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania
  3278. Jennifer A. Rothman, MD, Associate Professor, Department of Pediatrics, Division of Pediatric Hematology/Oncology, Duke University Medical Center, Durham, North Carolina
  3279. Ranna A. Rozenfeld, MD, Professor of Pediatrics, The Warren Alpert Medical School Brown University, Division of Pediatric Critical Care Medicine, Hasbro Children’s Hospital, Providence, Rhode Island
  3280. Colleen A. Ryan, MD, Instructor in Psychiatry, Harvard Medical School, Boston Children’s Hospital, Boston, Massachusetts
  3281. Monique M. Ryan, M Med BS, FRACP, Professor of Paediatric Neurology Director, Department of Neurology Honorary Fellow, Murdoch Children’s Research Institute, University of Melbourne, Royal Children’s Hospital, Parkville, Victoria, Australia
  3282. Julie Ryu, MD, Professor of Pediatrics, University of California, San Diego School of Medicine, Interim Chief, Division of Respiratory Medicine, Chief Research Informatics Officer, Department of Pediatrics, Rady Childrens Hospital-San Diego San Diego, California
  3283. H.P.S. Sachdev, MD, FIAP, FAMS, FRCPCH, Senior Consultant, Departments of Pediatrics and Clinical Epidemiology, Sitaram Bhartia Institute of Science and Research, New Delhi, India
  3284. Manish Sadarangani, MRCPCH, DPHIL, BM.BCh, MA, Assistant Professor of Pediatrics, Sauder Family Chair in Pediatric, Infectious Diseases, University of British Columbia, Faculty of Medicine, Director, Vaccine Evaluation Center British Columbia Childrens Hospital Vancouver, British Columbia, Canada
  3285. Rebecca E. Sadun, MD, PhD, Assistant Professor of Adult and Pediatric Rheumatology Departments of Medicine and Pediatrics, Duke University School of Medicine, Durham, North Carolina
  3286. Mustafa Sahin, MD, PhD, Professor of Neurology Harvard Medical School, Director, Translational, Neuroscience Center, Boston Childrens Hospital, Boston, Massachusetts
  3287. Nina N. Sainath, MD, Division of Gastroenterology, Hepatology, and Nutrition Childrens Hospital of Philadelphia Philadelphia, Pennsylvania
  3288. Robert A. Salata, MD, Professor and Chairman, Department of Medicine, Case Western Reserve University School of Medicine, Physician-in-Chief, University Hospitals Case Medical Center, Cleveland, Ohio
  3289. Edsel Maurice T. Salvana, MD, Clinical Associate Professor of Medicine, University of the Philippines College of Medicine, Director, Institute of Molecular, Biology and Biotechnology, National Institutes of Health, Manila, The Philippines;, Adjunct Professor of Global Health University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania
  3290. Hugh A. Sampson, MD, Kurt Hirschhorn Professor of Pediatrics, Jaffe Food Allergy Institute, Kravis Children’s Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  3291. Chase B. Samsel, MD, Instructor in Psychiatry, Harvard Medical School, Boston Children’s Hospital, Boston, Massachusetts
  3292. Thomas J. Sandora, MD, MPH, Associate Professor of Pediatrics, Harvard Medical School, Hospital Epidemiologist, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Massachusetts
  3293. Tracy L. Sandritter, PharmD, Division of Clinical Pharmacology, Toxicology, and Therapeutic Innovation, Children’s Mercy, Adjunct Clinical Professor, University of Missouri - Kansas City, School of Pharmacy, Kansas City, Missouri
  3294. Wudbhav N. Sankar, MD, Associate Professor, Department of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3295. Eric J. Sarkissian, MD, Resident Physician, Department of Orthopaedic Surgery, Stanford University School of Medicine, Stanford, California
  3296. Ajit A. Sarnaik, MD, Associate Professor of Pediatrics, Wayne State University School of Medicine, Director, Pediatric Critical Care, Medicine Fellowship Program, Children’s Hospital of Michigan, Detroit, Michigan
  3297. Ashok P. Sarnaik, MD, Professor and Former Interim Chair, Department of Pediatrics, Wayne State University School of Medicine, Former Pediatrician-in-Chief, Children’s Hospital of Michigan, Detroit, Michigan
  3298. Harvey B. Sarnat, MD, MS, FRCPC, Professor of Pediatrics, Pathology (Neuropathology), and Clinical Neurosciences, University of Calgary Cumming School of Medicine, Division of Pediatric Neurology Alberta Childrens Hospital Research Institute, Calgary, Alberta, Canada
  3299. Joshua K. Schaffzin, MD, PhD, Assistant Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Infection Prevention and Control, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3300. Laura E. Schanberg, MD, Professor of Pediatrics, Duke University School of Medicine Division of Pediatric Rheumatology Duke University Medical Center Durham, North Carolina
  3301. Michael S. Schechter, MD, MPH, Professor of Pediatrics, Virginia Commonwealth University School of Medicine, Chief, Division of Pulmonary Medicine Director, Cystic Fibrosis Center Director, UCAN Community Asthma Program, Children’s Hospital of Richmond at VCU, Richmond, Virginia
  3302. Mark R. Schleiss, MD, Professor of Pediatrics, American Legion and Auxiliary Heart Research Foundation, Endowed Chair, Division of Pediatric Infectious, Diseases and Immunology, University of Minnesota, Medical School, Minneapolis, Minnesota
  3303. Nina F. Schor, MD, PhD, Deputy Director, National Institute of Neurological, Disorders and Stroke, National Institute of Health, Bethesda, Maryland
  3304. James W. Schroeder Jr, MD, FACS, FAAP, Associate Professor, Department of Otolaryngology - Head and Neck Surgery Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  3305. Elaine E. Schulte, MD, MPH, Professor of Pediatrics, Albert Einstein College of Medicine Vice Chair, Academic Affairs and Faculty Development, Division of Academic General Pediatrics, The Childrens Hospital at Montefiore Bronx, New York
  3306. Mark A. Schuster, MD, PhD, Founding Dean and CEO, Professor, Kaiser Permanente School of Medicine, Pasadena, California
  3307. Daryl A. Scott, MD, PhD, Assistant Professor, Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas
  3308. J. Paul Scott, MD, Professor, Department of Pediatrics, Division of Pediatric Hematology, Oncology, Medical College of Wisconsin Blood Center of Southeastern, Wisconsin, Milwaukee, Wisconsin
  3309. Siddharth Srivastava, MD, PhD, Instructor in Neurology, Harvard Medical School, Department of Neurology, Boston Children’s Hospital Boston, Massachusetts
  3310. Joseph W. St Geme III, MD, Professor of Pediatrics and Microbiology and Chair of the Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Chair of the Department of Pediatrics and Physician-in-Chief, Leonard and Madlyn Abramson Endowed Chair in Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3311. Amy P. Stallings, MD, Assistant Professor of Pediatrics, Division of Pediatric Allergy and Immunology, Duke University School of Medicine, Durham, North Carolina
  3312. Virginia A. Stallings, MD, Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Director, Nutrition Center, Division of Gastroenterology, Hepatology, and Nutrition, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3313. Kathryn C. Stambough, MD, Resident Physician, Department of Obstetrics and Gynecology, Washington University School of Medicine in St. Louis, St. Louis, Missouri
  3314. Lawrence R. Stanberry, MD, PhD, Associate Dean for International Programs, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons New York, New York
  3315. Charles A. Stanley, MD, Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Division of Endocrinology, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3316. Jeffrey R. Starke, MD, Professor of Pediatrics, Baylor College of Medicine, Pediatric Infectious Diseases, Texas Children’s Hospital, Houston, Texas
  3317. Taylor B. Starr, DO, MPH, Associate Professor of Pediatrics Division of Adolescent Medicine University of Rochester, Medical Center, Rochester, New York
  3318. Andrew P. Steenhoff, MBBCh, DCH, FAAP, Assistant Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Medical Director, Global, Health Center, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3319. Ronen E. Stein, MD, Assistant Professor of Clinical Pediatrics, University of Pennsylvania Perelman School of Medicine, Attending Physician, Division of Gastroenterology, Hepatology, and Nutrition Children’s Hospital of Philadelphia Philadelphia, Pennsylvania
  3320. William J. Steinbach, MD, Professor of Pediatrics, Molecular, Genetics, and Microbiology, Chief, Pediatric Infectious Diseases Duke University Medical Center Durham, North Carolina
  3321. Janet Stewart, MD, Associate Professor Emerita, Department of Pediatrics, University of Colorado School of Medicine, Spina Bifida Clinic, Childrens Hospital Colorado, Denver, Colorado
  3322. Gregory A. Storch, MD, Ruth L. Siteman Professor of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis Children’s Hospital, St. Louis, Missouri
  3323. Ronald G. Strauss, MD, Professor Emeritus, Departments of Pediatrics and Pathology, University of Iowa Carver College of Medicine, Iowa City, Iowa; Medical Director, Vitalant (formerly LifeSource), Rosemont, Illinois
  3324. Gina S. Sucato, MD, MPH, Director, Adolescent Center, Washington Permanente, Medical Group, Adjunct Investigator, Kaiser Permanente Washington Health Research Institute, Seattle, Washington
  3325. Frederick J. Suchy, MD, Professor of Pediatrics, Associate Dean for Child Health Research, University of Colorado School of Medicine, Denver, Colorado;, Chief Research Officer and Director, Children’s Hospital Colorado Research Institute, Aurora, Colorado
  3326. Kristen R. Suhrie, MD, Assistant Professor, Department of Pediatrics, University of Cincinnati College of Medicine, Neonatologist, Perinatal Institute, Division of Neonatology, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3327. Kathleen E. Sullivan, MD, PhD, Professor of Pediatrics, University of Pennsylvania Perelman School of Medicine, Chief, Division of Allergy and Immunology, Frank R. Wallace Endowed Chair in Infectious Diseases, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3328. Moira Szilagyi, MD, PhD, Professor of Pediatrics, David Geffen School of Medicine at UCLA, Section Chief, Developmental Studies, UCLA Mattel Children’s Hospital, Los Angeles, California
  3329. Sammy M. Tabbah, MD, Assistant Professor of Obstetrics and Gynecology, University of Cincinnati College of Medicine, Maternal-Fetal Medicine Specialist, Cincinnati Fetal Center, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3330. Robert R. Tanz, MD, Professor of Pediatrics, Division of Academic General, Pediatrics and Primary Care, Northwestern University Feinberg School of Medicine, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois, Acute Pharyngitis
  3331. Cristina Tarango, MD, Associate Professor of Pediatrics, University of Cincinnati College of Medicine, Medical Director, Hemophilia, Treatment Center, Clinical Director, Hematology Program, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3332. Nidale Tarek, MD, Assistant Professor of Pediatrics, Department of Pediatrics and Adolescent Medicine, American University of Beirut Beirut, Lebanon
  3333. Robert C. Tasker, MBBS, MD, Professor of Neurology, Professor of Anesthesia, Harvard Medical School, Senior Associate, Critical Care, Medicine, Director, Pediatric NeuroCritical, Care Program, Boston Children’s Hospital, Boston, Massachusetts
  3334. Dmitry Tchapyjnikov, MD, Assistant Professor of Pediatrics and Neurology, Duke University Medical Center, Durham, North Carolina
  3335. Brenda L. Tesini, MD, Assistant Professor of Medicine and Pediatrics, University of Rochester Medical Center Division of Pediatric Infectious, Diseases, Golisano Children’s Hospital Rochester, New York
  3336. Jillian L. Theobald, MD, PhD, Assistant Professor of Emergency Medicine, Medical College of Wisconsin, Toxicologist, Wisconsin, Poison Center, Milwaukee, Wisconsin
  3337. Beth K. Thielen, MD, PhD, Fellow, Infectious Diseases and International Medicine, Department of Medicine, Fellow, Pediatric Infectious Diseases and Immunology, Department of Pediatrics, University of Minnesota, Medical School, Minneapolis, Minnesota
  3338. Anita A. Thomas, MD, MPH, Assistant Professor, Department of Pediatrics, University of Washington School of Medicine, Attending Physician, Division of Emergency Medicine, Seattle Children’s Hospital, Seattle, Washington
  3339. Cameron W. Thomas, MD, MS, Assistant Professor of Pediatrics and Neurology, University of Cincinnati College of Medicine, Fetal and Neonatal Neurology, Specialist, Division of Neurology Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3340. Courtney D. Thornburg, MD, MS Professor of Clinical Pediatrics University of California San Diego , School of Medicine, La Jolla, California;, Medical Director, Hemophilia and Thrombosis Treatment Center, Rady Childrens Hospital, San Diego, San Diego, California
  3341. Joel S. Tieder, MD, MPH, Associate Professor of Pediatrics, Seattle Children’s Hospital, University of Washington School of Medicine, Division of Hospital Medicine, Seattle Childrens Hospital, Seattle, Washington
  3342. Cynthia J. Tifft, MD, PhD, Director, Pediatric Undiagnosed, Diseases Program, Senior Staff Clinician, Medical Genetics Branch, National Human Genome Research, Institute, National Institutes of Health, Bethesda, Maryland
  3343. James K. Todd, MD, Professor Emeritus of Pediatrics, Jules Amer Chair in Community, Pediatrics, University of Colorado School of Medicine, Section Head, Epidemiology (Pediatrics), Director, Epidemiology, Clinical, Outcomes, and Clinical Microbiology Children’s Hospital Colorado, Denver, Colorado
  3344. Victor R. Tolentino Jr, JD, MPH, NP, Healthcare Consultant, Jackson Heights, New York
  3345. Camilo Toro, MD, Senior Staff Clinician, Director, Adult Undiagnosed Diseases Program, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
  3346. Richard L. Tower II, MD, MS, Assistant Professor, Department of Pediatrics, Division of Pediatric Hematology, Oncology, Medical College of Wisconsin, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
  3347. Joseph M. Trapasso, MD, Resident Physician, Department of Pediatrics, University of Texas Medical Branch, University of Texas Children’s Hospital, Galveston, Texas
  3348. Riccardo Troncone, MD, Professor and Director, Department of Pediatrics, University of Naples Federico II Napoli, Italy
  3349. Elaine Tsao, MD, Assistant Professor, Department of Rehabilitation Medicine, University of Washington School of Medicine, Seattle Children’s Hospital Seattle, Washington
  3350. David G. Tubergen, MD, Medical Director, Host Program MD Anderson Physicians Network Houston, Texas
  3351. Lisa K. Tuchman, MD, MPH Associate Professor of Pediatrics Chief, Division of Adolescent and Young Adult Medicine Center for Translational Science, Childrens Research Institute Childrens National Health System Washington, DC
  3352. Margaret A. Turk, MD, Professor, Departments of Physical Medicine and Rehabilitation and Pediatrics State University of New York SUNY Upstate Medical University Syracuse, New York
  3353. David A. Turner, MD Associate Professor Department of Pediatrics Duke University School of Medicine Director, Pediatric Critical Care Fellowship Program, Medical Director, Pediatric Intensive Care Unit, Duke University Medical Center Durham, North Carolina
  3354. Christina Ullrich, MD, PhD Assistant Professor in Pediatrics Department of Psychosocial Oncology and Palliative Care Harvard Medical School Boston Children’s Hospital Dana-Farber Cancer Institute Boston, Massachusetts
  3355. Nicole Ullrich, MD, PhD, Associate Professor of Neurology Harvard Medical School, Director, Neurologic NeuroOncology, Associate Director, Clinical Trials Neurofibromatosis Program Boston Children’s Hospital Boston, Massachusetts, Krishna K. Upadhya, MD, MPH Assistant Professor, Division of Adolescent and Young Adult Medicine, Children’s National Health System Washington, DC
  3356. David K. Urion, MD, Associate Professor and Charles E Barlow Chair of Neurology Harvard University Medical School Director, Behavioral Neurology, Clinics and Programs, Boston Children’s Hospital, Boston, Massachusetts
  3357. Taher Valika, MD, Clinical Instructor of Otolaryngology -Head and Neck Surgery Northwestern University Feinberg School of Medicine, Attending Physician, Otorhinolaryngology - Head and Neck Surgery, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  3358. George F. Van Hare, MD, Professor of Pediatrics, Washington University School of Medicine in St Louis, Division of Pediatric Cardiology St Louis Children’s Hospital St. Louis, Missouri
  3359. Heather A. Van Mater, MD, MS Associate Professor of Pediatrics Duke University School of Medicine Division of Pediatric Rheumatology Duke University Health System Durham, North Carolina
  3360. Charles D. Varnell Jr, MD, MS, Instructor of Pediatrics, University of Cincinnati College of Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio
  3361. Ana M. Vaughan, MD, MPH, FAAP Assistant in Medicine, Division of Infectious Diseases Associate Hospital Epidemiologist Boston Children’s Hospital Instructor in Pediatrics Harvard Medical School, Boston, Massachusetts
  3362. Timothy J. Vece, MD, Associate Professor of Pediatrics University of North Carolina School of Medicine, Medical Director, Airway Center North Carolina Children’s Hospital Chapel Hill, North Carolina
  3363. Aarthi P. Vemana, MD, Pediatric Sleep Physician Fairfax Neonatal Associates Fairfax, Virginia
  3364. Charles P. Venditti, MD, PhD, Head, Organic Acid Research, Section, Senior Investigator, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland
  3365. Sarah Vepraskas, MD, Assistant Professor of Pediatrics Section of Hospital Medicine Medical College of Wisconsin Milwaukee, Wisconsin
  3366. James W. Verbsky, MD, PhD, Associate Professor of Pediatrics (Rheumatology) and Microbiology and Immunology, Medical Director, Clinical, Immunology Research Laboratory Medical Director, Clinical and Translational Research, Medical College of Wisconsin Milwaukee, Wisconsin
  3367. Jennifer A. Vermilion, MD, Instructor in Neurology and Pediatrics, University of Rochester, Medical Center, Rochester, New York
  3368. Brian P. Vickery, MD, Associate Professor of Pediatrics, Emory University School of Medicine Director, Food Allergy Center at Emory and Childrens Healthcare of Atlanta, Atlanta, Georgia, Bernadette E. Vitola, MD, MPH Associate Professor of Pediatrics Medical College of Wisconsin Children’s Hospital of Wisconsin Milwaukee, Wisconsin
  3369. Judith A. Voynow, MD, Professor of Pediatrics, Virginia Commonwealth University School of Medicine, Edwin L. Kendig Jr. Professor of Pediatric Pulmonology, Childrens Hospital of Richmond at VCU Richmond, Virginia
  3370. Jonathan B. Wagner, DO, Assistant Professor of Pediatrics, University of Missouri-Kansas City School of Medicine, Division of Pediatric Cardiology Childrens Mercy Hospitals and Clinics, Kansas City, Missouri
  3371. Steven G. Waguespack, MD, FACE Professor, Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, Texas
  3372. David M. Walker, MD, Chief, Pediatric Emergency Medicine Department of Pediatrics, Joseph M. Sanarzi Childrens Hospital Hackensack University, Medical Center, Hackensack, New Jersey
  3373. Kelly J. Walkovich, MD, Clinical Associate Professor of Pediatrics and Communicable, Diseases, Division of Pediatric Hematology/Oncology, University of Michigan, Medical School, Ann Arbor, Michigan
  3374. Heather J. Walter, MD, MPH, Professor of Psychiatry and Pediatrics Boston University School of Medicine Senior Attending Psychiatrist, Boston Childrens Hospital Senior Lecturer on Psychiatry Harvard Medical School, Boston, Massachusetts
  3375. Jennifer A. Wambach, MD, Assistant Professor of Pediatrics, Washington University School of Medicine in St. Louis, Division of Newborn Medicine, St. Louis Childrens Hospital, St. Louis, Missouri
  3376. Julie Wang, MD, Professor of Pediatrics, Jaffe Food Allergy Institute Kravis Childrens Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  3377. Michael F. Wangler, MD, Assistant Professor of Molecular and Human Genetics, Baylor College of Medicine Jan and Dan Duncan Neurological Research Institute, Texas Children’s Hospital, Houston, Texas
  3378. Russell E. Ware, MD, PhD, Professor of Pediatrics, University of Cincinnati College of Medicine, Director, Division of Hematology Co-Director, Cancer and Blood Diseases Institute, Director, Global Health Center Marjory J. Johnson Chair of Hematology Translational Research Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio
  3379. Stephanie M. Ware, MD, PhD, FACMG, Professor of Pediatrics and Medical and Molecular Genetics, Vice Chair of Clinical Affairs in Medical and Molecular Genetics Program Leader in Cardiovascular Genetics, Herman  Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana
  3380. Matthew C. Washam, MD, MPH, Assistant Professor of Pediatrics, The Ohio State University Nationwide Children’s Hospital Columbus, Ohio
  3381. Ari J. Wassner, MD, Assistant Professor of Pediatrics, Harvard Medical School, Director, Thyroid Program, Boston Children’s Hospital, Boston, Massachusetts
  3382. Rachel Wattier, MD, MHS, Assistant Professor of Pediatrics, University of California San Francisco, School of Medicine, San Francisco, California
  3383. David R. Weber, MD, MSCE, Assistant Professor of Pediatrics, University of Rochester School of Medicine and Dentistry, Division of Endocrinology and Diabetes, Pediatric Bone Health Program, Golisano Children’s Hospital, Rochester, New York
  3384. Debra E. Weese-Mayer, MD, Beatrice Cummings Mayer Professor of Pediatrics and Pediatric Autonomic, Medicine, Northwestern University Feinberg, School of Medicine, Chief, Division of Pediatric, Autonomic Medicine, Ann & Robert H. Lurie Children’s, Hospital of Chicago, Chicago, Illinois
  3385. Jason B. Weinberg, MD, Associate Professor of Pediatrics, Associate Professor of Microbiology and Immunology, University of Michigan, Medical School, Division of Pediatric Infectious Diseases, C. S. Mott Children’s Hospital, Ann Arbor, Michigan
  3386. Jason P. Weinman, MD, Associate Professor of Radiology, University of Colorado School of Medicine, Aurora, Colorado
  3387. Kathryn L. Weise, MD, MA, Program Director, Cleveland, Fellowship in Advanced Bioethics, Department of Bioethics, The Cleveland Clinic Foundation, Cleveland, Ohio
  3388. Anna K. Weiss, MD, MSEd, Assistant Professor of Clinical, Pediatrics, University of Pennsylvania Perelman School of Medicine, Director of Pediatric Resident, Education, Division of Emergency Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3389. Pamela E Weiss, MD, MSCE, Associate Professor of Pediatrics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Division of Rheumatology, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3390. Carol Weitzman, MD, Professor of Pediatrics, Director, Developmental-Behavioral, Pediatrics Program, Yale School of Medicine, New Haven, Connecticut
  3391. Morgan P. Welebir, MD, Department of Obstetrics and Gynecology, Providence Saint Joseph, Medical Center, Burbank, California
  3392. Lawrence Wells, MD, Associate Professor, Department of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon, Childrens Hospital of Philadelphia, Philadelphia, Pennsylvania
  3393. Jessica W. Wen, MD, Associate Professor of Clinical Pediatrics, University of Pennsylvania Perelman School of Medicine, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3394. Danielle Wendel, MD, Assistant Professor, Division of Gastroenterology and Hepatology, Department of Pediatrics, University of Washington School of Medicine, Seattle Childrens Hospital, Seattle, Washington
  3395. Steven L. Werlin, MD, Professor Emeritus of Pediatrics, The Medical College of Wisconsin, Milwaukee, Wisconsin
  3396. Michael R. Wessels, MD, John F. Enders Professor of Pediatrics, Professor of Medicine (Microbiology) Harvard Medical School, Division of Infectious Diseases, Boston Children’s Hospital, Boston, Massachusetts
  3397. Ralph F. Wetmore, MD, Professor, Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Perelman School of Medicine, E. Mortimer Newlin Professor and Chief, Division of Pediatric Otolaryngology Children’s Hospital of Pennsylvania Philadelphia, Pennsylvania
  3398. Scott L. Wexelblatt, MD, Associate Professor, Department of Pediatrics, University of Cincinnati College of Medicine, Medical Director Regional Newborn Services, Cincinnati Children’s Hospital, Medical Center, Cincinnati, Ohio
  3399. Isaiah D. Wexler, MD, PhD, Associate Professor, Department of Pediatrics, Hadassah University Medical Center, Jerusalem, Israel
  3400. A. Clinton White Jr, MD, Professor of Medicine, Division of Infectious Diseases, The University of Texas Medical, Branch at Galveston, Galveston, Texas
  3401. Perrin C. White, MD, Professor of Pediatrics, Audre Newman Rapoport, Distinguished Chair in Pediatric Endocrinology, Chief, Division of Pediatric Endocrinology, University of Texas Southwestern, Medical Center, Dallas, Texas
  3402. John V. Williams, MD, Henry L. Hillman Professor of Pediatrics, Professor of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Chief, Division of Pediatric Infectious Diseases, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, Pennsylvania
  3403. Rodney E. Willoughby Jr, MD, Professor of Pediatrics, Medical College of Wisconsin, Division of Pediatric Infectious Diseases, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
  3404. Michael Wilschanski, MBBS, Professor of Pediatrics, The Hebrew University-Hadassah School of Medicine, Director, Pediatric, Gastroenterology Unit, Hadassah University Hospitals, Jerusalem, Israel
  3405. Karen M. Wilson, MD, MPH, Professor of Pediatrics, Debra and Leon Black Division Chief of General Pediatrics, Vice-Chair for Clinical and Translational Research, Kravis Childrens Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  3406. Pamela Wilson, MD, Associate Professor, Department of Physical Medicine and Rehabilitation, University of Colorado School of Medicine, Children’s Hospital Colorado, Denver, Colorado
  3407. Jennifer J. Winell, MD, Clinical Assistant Professor of Orthopaedic Surgery, University of Pennsylvania Perelman School of Medicine, Attending Orthopaedic Surgeon, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania
  3408. Glenna B. Winnie, MD, Director, Pediatric and Adolescent, Sleep Center, Fairfax Neonatal Associates, PC, Fairfax, Virginia
  3409. Lawrence Wissow, MD, MPH, James P. Connaughton Professor of Community Psychiatry, Division of Child and Adolescent, Psychiatry, Johns Hopkins School of Medicine, Baltimore, Maryland
  3410. Peter Witters, MD, Professor of Pediatrics, Metabolic Center, University Hospitals Leuven, Leuven, Belgium
  3411. Joshua Wolf, MBBS, Assistant Member, St. Jude Faculty St. Jude Children’s Research Hospital Memphis, Tennessee
  3412. Peter M. Wolfgram, MD, Assistant Professor, Medical College of Wisconsin, Division of Endocrinology, Children’s Hospital of Wisconsin, Milwaukee, Wisconsin
  3413. Joanne Wolfe, MD, MPH, Professor of Pediatrics, Harvard Medical School, Chief, Division of Pediatric, Palliative Care, Dana-Farber Cancer Institute, Director, Pediatric Palliative Care, Boston Childrens Hospital, Boston, Massachusetts
  3414. Brandon T. Woods, MD, Fellow, Critical Care Medicine, Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington
  3415. Benjamin L. Wright, MD, Assistant Professor, Department of Allergy, Asthma, and Clinical Immunology, Mayo Clinic, Scottsdale, Arizona; Phoenix Children’s Hospital Phoenix, Arizona
  3416. Joseph L. Wright, MD, MPH, Adjunct Research Professor Department of Family Science University of Maryland School of Public Health, Adjunct Professor of Emergency, Medicine and Health Policy, George Washington University, Washington, DC
  3417. Terry W. Wright, PhD, Associate Professor of Pediatrics, (Infectious Diseases) University of Rochester, Medical Center, School of Medicine and Dentistry, Rochester, New York
  3418. Eveline Y. Wu, MD, Assistant Professor, Department of Pediatrics, Division of Allergy, Immunology, and Rheumatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
  3419. Pablo Yagupsky, MD, Professor of Pediatrics and Clinical Microbiology (Emeritus), Ben-Gurion University of the Negev Department of Pediatrics, Soroka Medical Center, Beer-Sheva, Israel
  3420. E. Ann Yeh, MD, MA, Associate Professor of Pediatrics (Neurology) University of Toronto Faculty of Medicine, Director, MS and Demyelinating, Disorders Program, Hospital for Sick Children, Toronto, Ontario, Canada
  3421. Anusha K. Yeshokumar, MD, Assistant Professor, Departments of Neurology and Pediatrics, Kravis Childrens Hospital at the Icahn School of Medicine at Mount Sinai, New York, New York
  3422. Wafik Zaky, MD, Professor, Department of Pediatrics Patient Care The University of Texas MD Anderson Cancer Center, Houston, Texas
  3423. Lauren B. Zapata, PhD, Epidemiologist, Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, Georgia
  3424. Lonnie K. Zeltzer, MD, Distinguished Research Professor Departments of Anesthesiology, Psychiatry, and Biobehavioral Science, David Geffen School of Medicine at UCLA, Los Angeles, California
  3425. Amy Zhou, BA, Clinical Research Coordinator, Center for Autonomic Medicine in Pediatrics, Ann & Robert H. Lurie Childrens, Hospital of Chicago, Chicago, Illinois
  3426. Barry S. Zuckerman, MD, Professor of Pediatrics and Chair, Emeritus, Boston University School of Medicine Boston Medical Center, Boston, Massachusetts

Òðóäû îòå÷åñòâåííûõ àâòîðîâ ïðè ïîäãîòîâêå ñòàòåé ïî ïåäèàòðèè äëÿ ïîëüçîâàòåëåé ñàéòà - íå èñïîëüçîâàëèñü, òàê êàê èõ âû âñåãäà ìîæåòå íàéòè â áèáëèîòåêàõ.

- Âåðíóòüñÿ â ðàçäåë "òðàâìàòîëîãèÿ"

Ðåäàêòîð: Èñêàíäåð Ìèëåâñêè. Äàòà ïóáëèêàöèè: 25.1.2024

Ìåäóíèâåð Ìû â Telegram Ìû â YouTube Ìû â VK Ôîðóì êîíñóëüòàöèé âðà÷åé Êîíòàêòû, ðåêëàìà
Èíôîðìàöèÿ íà ñàéòå ïîäëåæèò êîíñóëüòàöèè ëå÷àùèì âðà÷îì è íå çàìåíÿåò î÷íîé êîíñóëüòàöèè ñ íèì.
Ñì. ïîäðîáíåå â ïîëüçîâàòåëüñêîì ñîãëàøåíèè.